key: cord-0007024-a0jtmuqr
authors: nan
title: Neurocritical Care Society 12(th) Annual Meeting
date: 2014-08-28
journal: Neurocrit Care
DOI: 10.1007/s12028-014-0034-4
sha: caa8cf9af21de5415dca2abf9e0862291243a536
doc_id: 7024
cord_uid: a0jtmuqr

nan

Fever is common after spontaneous intracerebral hemorrhage (ICH), and may indicate a sterile systemic inflammatory response syndrome (SIRS) rather than infection. Blood cultures (BCx) are often obtained when evaluating intensive care unit (ICU) patients for possible infection, but have limited utility in populations where bacteremia is rare. We hypothesized BCx would be commonly obtained in the first 48 hours after ICH but have low diagnostic yield.

We performed a secondary analysis of a large, multicenter cohort of adult patients requiring ICU admission after spontaneous ICH. We excluded patients with hemorrhage from ischemic transformation, structural lesion or trauma, comfort measures only, brain death or immunodeficiency. We recorded demographic and clinical characteristics, daily vital signs, laboratory and BCx results (obtained at the discretion of the treating clinician). We defined fever as temperature >38.3C. A board-certified infectious disease physician reviewed all BCx results, and considered all fungi and bacteria, pathogens if they were non skin flora or contaminate species. We estimated a cost of US$50 per BCx and US$50 for speciation and sensitivities.

Clinical scales for intracerebral hemorrhage (ICH), such as the ICH and FUNC Scores, utilize a number of clinical and radiographic components for outcome prediction. The factors that physicians and nurses incorporate into subjective predictions of ICH outcome and how those factors relate with ICH and FUNC Score components are unknown.

For each consecutive adult patient admitted with primary ICH at 5 centers, one physician and one nurse on the treatment team were asked for a prediction of modified Rankin Scale at 3 months. All predictions were prospectively collected within 24 hours of admission. Providers were also asked to indicate up to 10 factors influencing their prediction, as well as whether they would recommend comfort measures. Percentages of responses were calculated.

We collected 100 physician and 100 nurse predictions for 100 ICH patients. With regards to ICH or FUNC Score components, 84.5% of all respondents listed the Glasgow Coma Scale (GCS) or a component of the GCS as a factor in outcome prediction. Only 41.0% listed age, 44.5% listed ICH volume, and 24.0% listed ICH location. Of all the factors listed on surveys, 36.4% were not ICH or FUNC Score components. With regards to clinical factors that are not ICH or FUNC Score components, 66.0% listed pre-existing co-morbidities, with 10.0% specifically mentioning prior functional disability. The most common non-clinical factors were family support (8.5%) and the patient's baseline personality and compliance with clinical treatment (6.0%). Only 3.5% of providers listed a surrogate request for comfort measures as a factor for outcome prediction.

Physicians and nurses rely heavily on GCS Score in comparison to age, volume, and location when prognosticating ICH outcome. Consideration of patient co-morbidities, prior functional disability, family support, and treatment compliance may account for any difference between providers and clinical scales for predicting ICH outcome. 

Cerebral edema has been conventionally measured indirectly either through invasive monitors or through imaging studies. We used Volumetric Integral phase shift spectroscopy (VIPS), a non -invasive device that detects phase shifts in the radiofrequency waves transmitted through the brain. End Stage Renal Disease (ESRD) patients undergoing hemodialysis who did not have baseline acute brain injury were chosen because they experience a drop in serum osmolarity as a result of removal of uremic metabolites during dialysis. Consecutive readings from the same patient were obtained on two successive dialysis days for internal control.

The protocol was approved by the institutional review board of Baylor college of Medicine. Patients without a prior history of stroke or other intracranial serious illnesses were enrolled. VIPS monitoring was performed pre, intra and post dialysis. Measured and calculated serum osmolarity was obtained and mini mental state examination was performed before and after dialysis. Of the total 20 patients with 40 readings planned for enrolment we report initial data from the first 9 readings.

Twelve patients (7 males) were enrolled. Mean age of our cohort was 47.8 years. As of now, eleven patients underwent the VIPS monitoring before, during and after dialysis. One patient withdrew from the study and two patients had too many artifacts. OF the remaining 8, the average osmolar difference pre and post dialysis was 8.3 mOsm. There was a mean increase in the intracranial fluid compartment of 7.44% from baseline as measured by VIPS.

VIPS provides real time non-invasive monitoring of intracranial fluid shifts. Patients with ESRD develop serum osmolar reductions during dialysis which can potentially be a model for non-invasive evaluation of early cerebral edema.

Financial Support: The study was funded by Cerebrotech Medical Systems Inc.

Traumatic brain injury (TBI) is a major cause of morbidity and mortality and a common presentation to US Emergency Departments (ED). Neurologic decline in the ED is a significant event in the course of care of TBI patients. We sought to elucidate the relationship between acute neurologic decline in the ED and six month outcomes in a cohort of TBI patients.

It is now well accepted that traumatic white matter injury constitutes a critical determinant of post-traumatic functional impairment. However, the contribution of preexisting white matter rarefaction on outcome following traumatic brain injury (TBI) is unknown. Hence, we sought to determine whether the burden of preexisting leukoaraiosis of presumed ischemic origin is independently associated with outcome after TBI.

We retrospectively analyzed consecutive, prospectively enrolled patients of 50 years (n = 136) who were admitted to a single neurological/trauma intensive care unit. Supratentorial white matter hypoattenuation on head CT was graded on a 5-point scale (range 0-4) reflecting increasing severity of leukoaraiosis. Outcome was ascertained according to the modified Rankin Scale (mRS) and Glasgow outcome scale (GOS) at 3 and 12 months, respectively.

Prevention of secondary ischemic brain injury by maintaining perfusion and oxygenation is a core principle of neurocritical care. Identifying episodes of reduced cerebral perfusion in brain-injured patients remains a challenge. We used DCS, a novel non-invasive optical method that measures light scattering by moving particles in optically thick tissues, combined with static near infrared spectroscopy (NIRS) to provide real time measurements of relative changes in cerebral blood flow(rCBF), cerebral metabolic rate for oxygen(rCMRO2), and oxygen extraction fraction(rOEF) in patients with severe brain injury.

We recruited 16 patients with acute subarachnoid hemorrhage (SAH), severe traumatic brain injury (TBI) or primary intracerebral hemorrhage (ICH) from a single NeuroICU. rCBF and tissue oxygen saturation(StO2) in both hemispheres were measured for ~2 hours daily for up to 7 consecutive days using a custom built, NIRS-DCS apparatus. For each recording epoch, rOEF was calculated based on StO2 and peripheral arterial O2 saturation, and time-varying changes in rCMRO2 were calculated by multiplying rOEF by rCBF.

Overall, rCMRO2 was highly correlated with rCBF, suggesting that for the majority of time points changes in rCBF matched the metabolic demands of brain tissue. However, we identified multiple instances with abrupt decreases in the correlation between rCMRO2 and rCBF; these instances occurred during abrupt changes in OEF. The strength of the correlation between rCMRO2 and rCBF varied with initial assumed values for mean total hemoglobin (THB) and mean tissue oxygenation (StO2). Time points with abrupt increases in rOEF and time matched reductions in rCMRO2/CBF correlation may correspond to acute ischemic events, even though these events were not always accompanied by reductions in rCBF.

Brain tissue oxygenation (PbtO2) monitoring has been utilized in the severe traumatic brain injury (sTBI) population as an in vivo tool to detect oxygenation changes. It has been previously reported that the longer the time a patient experiences a PbtO2 of 15 torr, the greater the mortality. The purpose of this study is to assess PbtO2 values and its relationship to 3 and 6-month outcome in adult sTBI.

PbtO2 data were prospectively collected on sTBI patients (Glasgow Coma Scale (GCS) score < 9) during the acute 5 days following injury. Glasgow Outcome Scale (GOS) score was assessed at 3 and 6-months from injury and dicotomized into poor (GOS 1-3) and favorable outcome . Statistical analyses were performed using a logistic regression model controlling for age and initial severity of injury.

258 adult, sTBI patients with 3 and 6-month outcome were included. The mean age (± SD) was 38 (± 17) years, with 69% male and a median GCS of 6. ICU management included ICP management per Guidelines of sTBI Management; however, PbtO2 was not treated, just monitored. Post-trauma day (PTD) 2 PbtO2 data was chosen for analysis to avoid insertional microtrauma. Logistic regression resulted in cut-off values of minimum PbtO2 < 16.03 and maximum PbtO2 < 37.15 being significant for poor 3-month neurological outcome [OR 2.46 (1.29, 4 .68), p=.004, OR 2.71 (1.37, 5.33), p=.006 respectively). There was no residual significance for 6-month neurological outcome at these same cutoffs; however, PTD2 PbtO2 values in combination for minimum < 18.3, maximum < 37.2 and average < 24.3 had a OR 2.02 (1.11, 3.67), p=.021.

Monitoring of PbtO2 in the adult sTBI population may be predictive of 3 month neurological outcome and providing a target cohort for early rehabilitation efforts. Additional studies are needed to assess the effectiveness of treating PbtO2 values.

Delayed deterioration after subarachnoid hemorrhage (SAH) is an important untreatable complication in the management of cerebral aneurysm ruptures. Until recently, research focus has been on the vasculopathy (vasospasm) that is associated with the deterioration. Our lab has shown that selective depletion of Ly6G/C+ cells (dLy6G/C) PRIOR TO SAH ameliorates both vasospasm and behavioral deficits seen in delayed deterioration. In this study we test the hypothesis that depletion of Ly6G/C and Ly6G+ cells (dLy6G) AFTER SAH have similar effects.

In our murine model of mild SAH, we subjected animals to sham surgery, experimental SAH, or SAH followed by depletion of Ly6G+ cells and Ly6G/C+ cells after SAH. We evaluated the development of vasospasm by India ink angiography, short-term behavioral deficits with the Barnes Maze test, and longer-term behavioral deficits with the Morris Water Maze test.

dLy6G 0.5 and 1 days after SAH did not significantly improve vasospasm (remained significantly different from Sham) on India ink at 6 days (p=0.0006 and p=0.0003, respectively). Three days after SAH, both dLy6G and dLy6G/C ameliorated vasospasm at day 6 (p=NS for both). Likewise, dLy6G 0.5 and 1 days after SAH did not improve performance on Barnes Maze (ANOVA, p=0.3771). Alternatively, dLy6G and dLy6G/C 3 days after SAH improved performance on Barnes Maze (ANOVA, p=0.0002 and p=0.0003 respectively). dLy6G 0.5 and 3 days after SAH showed rescue from cognitive deficits in Morris water maze trials (ANOVA, p=0.0068 and p=0.0464, respectively).

Conclusions dLy6G/C and dLy6G 3 days after SAH prevents the development of vasospasm and the development of behavioral deficits up to 11 days after SAH. This suggests that myeloid cell physiology around day 3 is critical for the development of the delayed deterioration syndrome. This opens the door for a potential treatment of this syndrome by targeting innate immune cells at the proper time.

Cognitive dysfunction (CD) is a significant cause of disability after subarachnoid hemorrhage (SAH). New mandates from the joint commission have emphasized the importance of measuring early CD after SAH. In this study, we sought to assess the feasibility of using mini-Montreal Cognitive Assessment (mini-MoCA) to measure CD after SAH in the acute setting.

This is a retrospective study of patients admitted with SAH between February 2013 and December 2013 at a tertiary academic institution. Patients were assessed by a speech pathologist for presence of cognitive dysfunction using the mini-MoCA. Attempts were made to perform the mini-MoCA 1-2 days before discharge. A cut-off of less than 9 was used as a positive screening for CD.

134 patients were admitted with SAH: mean age 55 years (±13), 62% woman, median Hunt-Hess score 3. 85% (105/124) of all eligible patients were screened for CD, the median (IQR) MoCA score was 8 (4-9). 59% (62/105) of patients screened positive for CD (score< 9). Screening positive for CD was associated with female sex (OR 2.6, p< 0.05), poor grade HH (3-5) (OR 3.8,p< 0.01) and delayed cerebral ischemia (OR 3.5, p< 0.05). Lower Mini-MoCA scores were associated with outcome at discharge (mRS) independent of age, sex and initial HH score (p=0.03). Mini-MoCA scores have a strong negative correlation with hospital length of stay and ICU length of stay (r=-0.536, p< 0.01; r=-0.471, p< 0.01).

In-hospital systematic screening and early identification of CD is feasible. CD in the acute setting after SAH is very common. Patients with poor HH grade and those who develop delayed cerebral ischemia are more likely to develop CD. Further studies are needed to elucidate the relationship between early CD and long term clinical outcomes.

Aneurysmal subarachnoid hemorrhage (SAH) causes high morbidity and mortality. Survivors suffer cognitive dysfunction, which goes undetected during the acute illness, as neuropsychological testing at this time is unfeasible. No biomarkers exist to detect early subclinical neurological injury that may be responsible for noninfarct related neurological deficits.

We performed MRI and spectroscopy (MRS) on SAH patients in the first two weeks. Good clinical grade patients with no neurological deficit were included. Patients with hydrocephalus requiring ventriculostomy and those with visible blood products on imaging at 7 days, were excluded to reduce artifacts on MRS. Patients with delayed cerebral ischemia, perfusion deficits or angiographic spasm were also excluded. Routine MRI was performed with FLAIR, DWI, ADC and SWI sequences. Multi-slice 1 H MRS imaging was performed and raw data was processed slice-by-slice according to standard fast Fourier transform algorithm. Resulting spectral data was fitted to derive metabolite peak areas using software developed in-house. Total NAA, NAA/Creatine, Choline/Creatine data were acquired from multiple voxels in bilateral frontal subcortical white matter.

Ten patients with SAH had MR imaging done for clinical indications. MRI showed no infarcts or FLAIR hyperintensities. MRS from 3 patients had degraded images due to motion artifact while another patient had artifact from subarachnoid blood. The MRS spectra showed significantly decreased NAA peaks and concentrations in bilateral frontal lobes in SAH patients. tNAA in SAH patients was 11.11±3.8 vs. 18.82±1.2 in controls (healthy volunteers) (p=0.01); NAA/Cr was 1.92±0.16 in SAH patients vs. 2.65±0.23 (p=0.001) in controls; Cho/Cr was 1.16±0.19 in SAH vs. 1. 35±0.01 (p=0.12) .

This study provides preliminary evidence that tNAA and NAA/Cr are decreased early after good-grade SAH. This may represent early subclinical neuronal injury. A larger study as well as further neuropsychological examination of these patients will help determine association with functional deficits. 

The evidence to support the role of nutritional status in the prevention of cognitive decline during normal aging and in patients with Alzheimer's dementia is increasing and has great implications for the prevention of dementia. However, the impact of premorbid nutritional status on cognitive outcomes in patients with subarachnoid hemorrhage is not known.

Adult patients >=18 with aneurysmal subarachnoid hemorrhage were enrolled in a single center, prospective, observational cohort database. Clinical, radiographic and outcomes data were collected prospectively. Admission albumin and BMI were assessed as markers of pre-morbid nutritional status. Univariate and multivariate logistic regression analysis were performed and controlled for known markers of cognitive outcomes in patients in SAH. Cognitive outcomes were assessed using the validated Telephone Interview for Cognitive Status (TICS) at 3 months which was dichotomized at 30; < 30 was defined as poor cognitive outcome while >=30 was defined as good cognitive outcome.

Over a period of 18 years from July 1996 to April 2014, 1617 patients were admitted to our neurological intensive care unit with subarachnoid hemorrhage and prospectively enrolled in our subarachnoid hemorrhage outcomes project (SHOP) database. We conducted a binary logistic regression analysis to examine the impacts of surrogate markers of nutritional status; admission albumin and BMI on cognitive outcomes. Predictors included age, sex, severity of SAH, presence of vasospasm, hydrocephalus, re-bleed, albumin and BMI. In the multivariate model after controlling for known predictors of cognitive outcomes in patients with SAH, albumin and BMI were not found to be significantly associated with cognitive outcomes at 3 months (BMI OR 0.99, 95% CI 0.96-1.035; albumin OR 1.068, 95% CI 0.939-1.214).

Premorbid nutritional status does not influence cognitive outcomes in patients with SAH.

Financial Support: None ePoster 17

Therapeutic hypothermia [TH] is an established neuroprotective strategy after cardiac arrest and growing evidence supports TH as supportive treatment in stroke. In subarachnoid hemorrhage [SAH] only few data exists comprising heterogeneous TH-strategies. Therefore, this study evaluates for the first time the influence of early and prolonged TH on the key complications in poor-grade SAH -vasospasm and delayed cerebral infarction [DCI] .

This observational matched-controlled investigation included n=36 poor-grade SAH-patients (Hunt & Hess-Scale>3, WFNS-Scale>3). Mild TH (35°C) was initiated early (< 48h) in 12 patients for a prolonged period (7±1days). Twenty-four patients were matched from our prospective SAH-database by neuro-status, imagingscales, and age. Vasospasm was evaluated by serial Doppler-examinations and DCI was defined as new infarction on follow-up CT. Functional outcome was assessed at 6-months using the modified-Rankin-Scale and categorized as favorable-(mRS=0-2) versus unfavorable-(mRS=3-6) outcome.

Doppler-based vasospasm were present in 86.1% of patients. TH neither influenced occurrence nor duration of vasospasm, but its degree was significantly reduced over 5 days, as well were peak-vasospastic velocities decreased over 7 days (p< 0.05). The frequency of DCI was 87.5% in non-TH versus 50% in TH-treated patients, translating into a risk reduction of 44% (OR:7.1(CI:1.3-36.7);p=0.022). Favorable functional outcome was observed in 33.3% of non-TH versus 66.7% in TH-treated patients (p=0.061).

Early and prolonged TH significantly decreased the degree of vasospasm and the occurrence of DCI, possibly ameliorating functional outcome. TH may represent a promising therapy targeting the relevant pathways involved in DCI development, notably vasospasm, which strongly warrants further evaluation of its clinical impact.

We report a case of a variant basal form of NSM in a patient with an AVM associated aneurysmal SAH.

The patient is a 23-year-old woman who presented with sudden severe headache, left facial droop and left extremity weakness. CT showed SAH, right temporoparietal hemorrhage and subfalcine herniation. Angiogram showed a complex AVM with associated anterior choroidal aneurysm. She underwent onyx embolization. This was complicated by partial occlusion of right MCA, re-bleeding and eventual decompressive craniotomy for intractable ICPs. She developed sudden pulmonary edema and shock. ECG showed sinus tachycardia with no ST-T abnormalities. An echocardiogram revealed LV dysfunction with severe circumferential basal hypokinesis and hyperkinetic apical segments. The ejection fraction was 25-30%. The patient was diagnosed with variant NSM.

Neurogenic stunned myocardium is an important complication of SAH with wall motion abnormalities associated with worse outcome. There are 66 cases of SAH-induced NSM reported. Like classical SCM, SAH-induced forms predominate in women (85%) with a mean age of 57 years. Among these, all but 6 showed changes on ECG and mildly elevated cardiac biomarkers. Even among the small number of reported cases our patient is an outlier. Her heart failure occurred after embolization when she developed re-bleeding and elevated ICP. She represents 1 of 4 cases, which exhibited no changes on ECG; her diagnosis was made after developing pulmonary edema. NSM was unexpected given her young age. Our patient is the only reported case of AVM associated NSM and the only woman in her 20s where SAH-induced NSM was present.

In conclusion, to aid in better recognition of NSM in the neurosurgical ICU we presented a unique case of a young woman with variant NSM precipitated by SAH from rupture of a complex AVM and associated aneurysm. Although rare, this case represents the variability in neurogenic stunned myocardium.

Introduction Dexmedetomidine (DEX) may be associated with alpha2B-mediated alteration of vasoreactivity leading to decreased cerebral blood flow, which could have deleterious consequences acutely brain injured patients. Little is known about the effects of DEX on brain physiology in acute brain injury. Here we tested whether initiation of DEX infusion was associated with changes in cerebral pressure reactivity index (PRx), intracranial pressure (ICP), and partial pressure of oxygen in brain tissue (PbtO2).

We identified all aneurysmal subarachnoid hemorrhage patients admitted between 2006-2013 that had continuous PRx, ICP, and PbtO2 data available prior to, during, and following DEX infusion. A generalized estimating equation (GEE) model was used to determine changes in PRx, ICP, and PbtO2 during the six hours immediately before and after drug administration and discontinuation.

We identified 18 patients with a total of 77 DEX initiations. All had Hunt and Hess Grade 4 and 5 subarachnoid hemorrhage. The median age was 46 years (range 31-66IQR 42-54). The average duration of DEX administration was 36 +/-49 hours. During DEX administrations patient were also administered propofol(N=17), fentanyl(N=15X), pentobarbital(N=3), and midazolam(N=2). The average PRx across the entire duration of monitoring was 0.13+/-0.4. Dexmedetomidine DEX was associated with a brief increase in average PRx of 0.151(p=0.002) in the initial two hours at the start of the infusion(p=0.018). TSimilarly, the cessation of DEX infusion is associated with a transient decrease in average PRx(p< 0.001) of 0.192(p=0.007) for two hours. There was no change in ICP or PbtO2 with starting (p=0.3, p=0.09, respectively) or stopping (p=0.46, p=0.17) DEX.

In acute brain injury, DEX is associated with a transient disruption in cerebral autoregulation, the opposite effect can be seen when discontinuing the medication. This effect on autoregulation in brain-injured patients is, however, only transient and not associated with alterations of brain tissue oxygenation or ICP.

Two formulations of nimodipine are currently available in the US: a 30 mg liquid filled capsule (Nimotop®) and a recently developed oral solution (Nymalize®). Traditionally, the drug has been given to patients who could not swallow the capsules by extracting the liquid from the capsule with a syringe and needle and administering enterally. Despite the reports of inadvertent administration linked to this method of extraction and the associated FDA Black Box warning, many institutions across the country continue to prepare doses at the bedside. The accuracy of bedside extraction has not been determined, but may yield considerable variability in the dose administered. The aim of this study is to evaluate accuracy of nurse extraction of nimodipine from intact capsules.

This study included nurses who commonly work in a neurological critical care ICU. The nurses extracted liquid from nimodipine 30 mg capsules using a syringe and 16-gauge needle. The mean weight of extracted nimodipine liquid from each capsule was compared to batch pharmacy prepared syringes and a pre-calculated weight of 30 mg nimodipine liquid.

Twenty-eight nurses participated in the study. Nurse extraction yielded a mean of 0.91gm/capsule (SD 0.19gm) nimodipine liquid or the equivalent of 22.61mg (SD 4.6mg) nimodipine. This equates to a total nimodipine dose of approximately 45mg (or a 24.65% reduction in dose associated with bedside extraction).

Comparison of simulated bedside extraction of nimodipine to controls suggests bedside extraction is a less accurate method of nimodipine dose preparation which exhibits marked variability. Our data suggests that approximately 25% of the prescribed dose of nimodipine is unintentionally omitted with nurse extraction. Given the available data and relevant safety concerns, bedside extraction of nimodipine has no role in clinical practice. Use of batch pharmacy preparation or the commercially available solution is recommended.

Financial Support: Dr. Cook has received consulting honoraria from Arbor Pharmaceuticals ePoster 21

Pulmonary edema occurs in 8-23% of patients following subarachnoid hemorrhage (SAH). Early detection of pulmonary edema is vital to appropriate fluid management, particularly during the risk period for Delayed Cerebral Ischemia (DCI). Lung ultrasound (LUS), which is inexpensive and noninvasive, has been shown to rapidly and accurately differentiate common causes of acute respiratory failure. Our objective was to determine the accuracy of daily screening LUS for the detection of pulmonary edema following SAH.

Lung ultrasound is routinely performed in conjunction with daily Transcranial Doppler (TCD) evaluation in our neuroICU for SAH patients within the DCI risk period. We reviewed records of SAH patients admitted 7/2012-5/2014 who underwent at least 5 consecutive days of screening with bilateral LUS. Ultrasound videos were reviewed for the presence of B+lines by an investigator blinded to the final diagnosis. B+lines were defined as >= 3 B-lines in any anterior intercostal space. A second investigator blinded to ultrasound results determined whether radiographic pulmonary edema (RPE) as well as pulmonary edema with acute respiratory failure (PE-ARF) were present during the period of evaluation on the basis of chart review and direct examination of radiographic images. The diagnostic accuracy of B+lines for the detection of PE-ARF and RPE was determined.

Of 54 patients meeting criteria for inclusion in the study, 20(37%) had PE-ARF, 23(43%) had RPE and 18(33%) had B+lines. The presence of B+lines demonstrated sensitivity 90%(95%CI 68-99%), specificity 79%(62-91%), positive predictive value (PPV) 72%(51-88%) and negative predictive value (NPV) 93%(77-99%) for PE-ARF and sensitivity 78%(56-92%), specificity 79%(62-91%), PPV 72%(51-88%) and NPV 84%(67-95%) for RPE. Median days from B+lines onset to PE-ARF was 1(IQR 0-1).

Screening LUS was a sensitive and moderately specific test for the detection of symptomatic pulmonary edema following SAH. Screening LUS may be a useful adjunct to daily TCD evaluation.

Cardiac uncoupling has been shown to be associated with poor outcome after intracerebral hemorrhage and traumatic brain injury. We sought to determine the frequency of cardiac uncoupling after subarachnoid hemorrhage and its relationship to the development of secondary complications and poor outcome.

Continuous EKGs recorded from 327 of 449 consecutively admitted SAH patients between 2006 and 2011 were analyzed. Cardiac uncoupling is defined as a five second integer heart rate standard deviation between 0.3 and 0.6 over a five minute period. Patients with any periods of cardiac uncoupling in SAH days 0-3 were labelled at risk. Logistic regression was used to test the relationship of cardiac uncoupling to secondary complications and threemonth morbidity and mortality (modified Rankin Score >= 4). We performed multiple imputation using Bayesian methods to account for outcome scores lost to follow-up.

Episodes of cardiac uncoupling (median time of monitoring: 13%, IQR: 2% to 45%) during SAH days 0-3 was present in 167 (51%) patients. Cardiac uncoupling was associated with myocardial infarction (P=0.01) and infarction from delayed cerebral ischemia from vasospasm (P=0.01). Patients with cardiac uncoupling during SAH days 0-3 were at significantly higher risk for poor outcome (OR: 2.7; 95% CI: 1.2 to 3.5) after controlling for age (OR: 1.06; 95% CI: 1.03 to 1.09), Hunt and Hess grade (OR: 4.0; 95% CI: 4.6 to 41), APACHE-II Physiological subscore (OR: 1.2; 95% CI: 1.1 to 1.3), aneurysm size greater than 10mm (OR: 6.0; 95% CI: 1.9 to 19), and infarction secondary to cerebral vasospasm (OR: 5.9; 95% CI: 1.1 to 31).

Cardiac uncoupling may serve as an early injury severity marker to help differentiate patients with similar clinical grades. Further research is needed to determine its prognostic value whether it may represent a modifiable factor that can be targeted for treatment.

Financial Support: Support was provided by the Charles A. Dana Foundation and by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number KL2 TR000081, formerly the National Center for Research Resources, Grant Number KL2 RR024157. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Nimodipine is the only pharmacologic neuroprotectant that has been shown to improve outcome in SAH patients by reducing the incidence of delayed cerebral ischemia (DCI). However, Nimodipine is known to cause hypotension, which in some patients following SAH may potentially have deleterious effects. We seek to study the effects of Nimodipine by evaluating CBF and brain tissue oxygenation changes that occur after administration.

We prospectively collect data in SAH patients admitted to our neuroscience critical care unit at a tertiary academic center from late 2013 to May 2014. High grade SAH patients with GCS < 9 undergo multimodality monitoring as part of standard practice at our institution. CBF (Hemedex) and brain tissue oxygenation (Licox, Integra) measurements were obtained from sensors fixed in proximity, inserted through a Hummingbird Duo (Innerspace) bolt. All data, including intracranial monitoring data as well as basic ICU vital signs are recorded in a digital system (CNS, Moberg Research) and are time-locked.

We had 6 patients who were receiving Nimodipine for prophylaxis against DCI with a full complement of multimodality monitoring. This analysis focused on the initial days post SAH prior to any evidence of DCI. Mean arterial pressure (MAP) dropped in all patients. (Range 3-20 mmHg). There was a concomitant drop in CBF (range3-20) in 4/5 patients and drop in PbtiO2 (range 0.2-8) in 5/5 patients.

A decrease in CBF in response to a decrease in MAP is consistent with a loss of cerebral autoregulation. The concomitant decrease in tissue oxygen defines a severe loss of vascular reserve. These results suggest Nimodipine can cause ischemia in a subset of SAH patients. Further study with a larger patient sample is warranted.

Financial Support: Last author has a minor stock position with Innerspace

Delayed cerebral ischemia (DCI) and delayed ischemic neurologic decline (DIND) are frequent and significant complications of aneurysmal subarachnoid hemorrhage (SAH) . Discrepancies in the definitions of DCI and DIND, however, make outcome studies problematic. A recent consensus statement advocated standardized definitions for DCI and DIND events in clinical trials of SAH. We sought to evaluate the inter-rater agreement (IRA) of these definitions.

Based on consensus definitions, we assessed for: 1. delayed cerebral ischemia (DCI), defined as radiographic cerebral infarction; 2. delayed ischemic neurologic decline Type 1 (DIND1), defined as focal neurological decline; and 3. DIND2, defined as global decline in arousal. Four neurologists retrospectively reviewed detailed electronic records of 59 SAH patients. Three reviewers had access to and reviewed neuroradiology imaging. IRA was assessed using Gwet's kappa statistic.

There was almost perfect agreement (k=95.67%) on the overall presence or absence of DCI, DIND1 and DIND2 events. Agreement was "fair" for DIND1 (k=36.86%) events identified by at least one rater, but "substantial" for DIND2 (69.66%) events. We observed greater agreement for DIND1 events when there was a significant focal motor decline of at least 1 point in the motor strength exam. There was poor agreement (k=3.12%) on DCI events; CT imaging was the predominant radiology modality.

Consensus definitions for DCI and DIND after SAH yield good agreement for events involving a global decline in arousal (DIND2). However, ascertainment of focal DIND events and DCI based on CT is unreliable. In addition to a strict process of adjudication, both an explicit threshold for determining focal neurologic decline and use of MRI imaging to discriminate edema from infarction may improve the inter-rater reliability of DIND and DCI determination. These improvements are critical for success in clinical trials and quality improvement interventions.

Financial Support: This study was supported by the Andrew David Heitman Foundation for Neuroendovascular Research (PI,Eric Rosenthal, Michael Brandon Westover) . Michael Brandon Westover was funded by a grant from the American Brain Foundation

Clevidipine is an alternative to nicardipine for acute blood pressure (BP) reduction in stroke patients secondary to its rapid onset of action. The purpose of this study was to determine whether the time to systolic blood pressure (SBP) goal is reduced with the use of clevidipine leading to improved patient outcomes.

A retrospective analysis was conducted in patients with acute ischemic stroke (AIS) or spontaneous intracranial hemorrhage (ICH) from 11/2011 to 12/2013 at a tertiary care facility. Blood pressure management was evaluated in the first 24 hours of patients who initially received either nicardipine (NIC) or clevidipine (CLEV). Secondary endpoints included percent time below SBP goal, door-to-needle time for alteplase administration, number of hypotensive episodes, and outcomes.

A total of 210 patients were included; 140 NIC and 70 CLEV patients. Except for diagnosis, baseline demographics were similar between groups: AIS: 28.6%; NIC vs. 52.9%; CLEV (p=0.001). Admission SBP was NIC; 194 ± 34 mmHg vs. CLEV; 199 ± 30 mmHg (p=NS) . Median time to SBP goal of 150 mmHg (ICH) or 180 mmHg (AIS) from first reported reading > goal was 119 (IQR; 60 -249) min; NIC vs. 60 (IQR; 38 -153) min; CLEV. (p = 0.0001). In AIS, CLEV was able to maintain SBP goal < 180 mmHg 85% of time vs. 78%; NIC (p=0.001). In ICH, CLEV was able to maintain SBP goal < 150 mmHg 67% of time vs. 64%; NIC (p =0.001). Time to alteplase administration was NIC; 59.1 ± 24.8 min. vs. CLEV; 56 ± 22.1 min (p=NS). Three patients in each group had significant hypotension. There was no difference in outcome variables.

Clevidipine appears to reduce time to SBP goals faster. Additionally, it may be able to maintain SBP goal more often. A prospective analysis is required.

High-dose intravenous antibiotics remain the first-line treatment for bacterial CNS infections. However, in patients with complicated, persistent or recurrent CNS infections, intraventricular or intrathecal (IVT/IT) antibiotics may be considered due to the poor blood-brain-barrier penetration of antibiotics for deep-seated CNS infections. We analyzed the English literature to compare outcomes between the use of local (IVT/IT only) or combined systemic and local antibiotic therapy.

Publications on IVT/IT antibiotic therapy from 1946-2014 were identified. Data for demographic features, treatment regimen, and clinical/microbiological outcome were collected. Of 1,166 citations retrieved, 204 studies met inclusion criteria. Review of all individual patients within each publication resulted in 567 eligible patients. After excluding uncommon antibiotics used in < 5 patients, 147 studies with 298 patients remained available for analysis. Stata 12 statistical program was used for chi square and Fisher's exact tests.

In decreasing frequency, the most commonly IVT/IT studied antibiotics included vancomycin (94 patients combined group; 43 local therapy group), gentamicin (37; 27), amikacin (18; 11), colistin (27; 28) and teicoplanin (7; 6). Most treatment indications (>80%) were ventriculitis and meningitis. Microbiological clearance and clinical cure for vancomycin given combined IVT/IT/IV were 55% and 84% respectively, compared to 44% and 75% for IVT/IT alone. Successful sterilization and clinical cure rates for combined IVT/IT/IV with gentamicin were 84% and 70% and for IVT/IT 85% and 82%, respectively. Similar microbiological and clinical cure rates among the IV/IVT/IT and IVT/IT groups were observed in patients treated with amikacin, colistin, and teicoplanin. None of the group differences were statistically significant.

Microbiological and clinical cure rates in bacterial ventriculitis/meningitis infections were similar between patients treated with direct local antibiosis (IVT/IT) alone or combined with IV therapy. However, as these results were obtained from retrospective analyses of published data, only prospective, randomized controlled trials would provide definite conclusions.

Severe hyperammonemia may have catastrophic neurologic consequences. The initial neurologic manifestations are often non-specific but can range from mild encephalopathy to rapidly progressive coma. Left untreated, profound elevation in serum ammonia may lead to catastrophic cerebral edema and death. Prompt recognition is critical regardless of etiology, as early treatment may be lifesaving.

We report two consecutive cases of severe hyperammonemia from adult onset inborn errors of urea cycle metabolism and review their clinical course, imaging findings, and available literature.

Two 27-year-old patients, one female, presented with rapidly progressive encephalopathy leading to coma. Initial cranial imaging was unremarkable; however, subsequent serologic studies demonstrated marked elevation of ammonia concentration. Progressive hernation syndromes developed and one underwent bifrontal decompressive craniotomy despite hyperosmolar therapy and emergent hemodialysis for hyperammonemia. Multifocal myoclonus was common, and one developed refractory status epilepticus. Repeat cranial imaging demonstrated characteristic severe bihemispheric cortical changes suggestive of ischemia. Urine and serum studies of organic and amino acids were compatible with adult onset urea cycle defects of metabolism for both. Despite maximum medical and surgical therapy, one patient progressed to brain death while the other remained in a persistent vegetative condition

Inherited disorders of urea cycle metabolism are rare causes of hyperammonemia in adulthood. Progressive neurologic decline with the accompanying characteristic neuroimaging changes should prompt appropriate diagnostic testing, while urgent empiric therapy should be initiated to lower concentrations. Persistently elevated ammonia may lead to permanent cortical injury, independent of the pathology and rise in intracranial pressure may ensue. Routine hyperosmolar therapy may be of limited benefit, and early surgical decompression should be considered.

Listeria monocytogenes, a common cause of community-acquired meningitis, can rarely involve the central nervous system (CNS) in the form of multiple cerebral ring enhancing lesions.

An 81-year-old woman presented with a rapidly progressive decline in mental status in the setting of multiple cortically predominant ring enhancing lesions. A few days earlier, she had developed symptoms of a mild upper respiratory tract infection, as well as diarrhea. Her past medical history was significant only for type 2 diabetes mellitus. Prior to her transfer to our unit, she had been empirically treated with Acyclovir and Ciprofloxacin at another hospital. Brain imaging, CSF studies, brain biopsy and continuous electroencephalogram were obtained at our institution. In light of the patient's age, presence of hyponatremia and history of diabetes mellitus, empiric antimicrobial treatment was modified to include Ampicillin, Meropenem, Vancomycin, Voriconazole and Pyrimethamine/Sulfadiazine, to cover for opportunistic infections. IV dexamethasone was added due to significant perilesional vasogenic edema.

The patient presented with stupor, but neither fever nor leukocytosis. CSF results were significant only for a mildly elevated protein level; special studies, stains, and cultures were unremarkable. The report of a repeat brain MRI, with and without gadolinium, was as follows: "large areas of high flair signal and tubular/lobulated/ring enhacement in bifrontal regions with a smaller focus in the left anterior midbrain; overall these findings are concerning for underlying multicentric glioma or multicentric primary CNS lymphoma." Brain biopsy, however, revealed early abscess formation caused by Listeria monocytogenes infection.

Listeria brain abscesses are rare. High index of suspicion in patients with risk factors for this infection (e.g. advanced age, diabetes mellitus) is key to ensure timely initiation of appropriate empirical antibiotic therapy in the setting of cerebral ring enhancing lesions. IV ampicillin is considered the treatment of choice, but meropenem represents a valid alternative.

Tuberculosis meningitis is the most severe form of tuberculosis and is rarely encountered in the midwest United States. Diagnosis is challenging due to the non-specific presentation and limited diagnostic methods. We present a case of tuberculous meningitis diagnosed in an elderly man with initial concerns for metastatic cerebral disease.

This is a case presentation of 80-year-old Caucasian male with a history sick sinus syndrome (status post pacemaker) who presented to from a community hospital with worsening altered mental status and tetraplegia requiring mechanical ventilation after five months of progressive failure to thrive. He had no recent travel history and had been living in care facilities on and off since presentation. Spinal fluid revealed neutrophilic-predominant pleocytosis, elevated protein and hypoglycorrhachia with negative cultures. He was started on broad spectrum antibiotics before transfer for presumptive meningitis without improvement.

MRI could not be obtained due to the pacemaker. Head CT with contrast revealed small enhancing lesions with surrounding edema in the frontal white matter, cervical spinal cord and pons interpreted as metastatic disease. Work-up for primary source was initiated. However, sputum QuantiFERON-TB Gold Test returned positive after six days and repeated spinal fluid studies confirmed TB. Treatment was initiated and his mental status improved. He regained ability to follow commands two weeks after therapy initiation.

Tuberculous meningitis is rare in developed countries and diagnosis is difficult due to its indolent presentation and limits in laboratory studies available. Interestingly, our case was initially interpreted as metastatic brain disease due to similar spinal fluid and CT imaging characteristics that both diseases share. This highlights another challenge in the diagnosis of TB meningitis in immunocompentent hosts, stressing the importance of spinal fluid and sputum surveillance for TB in cases of subacute meningitis despite misleading radiographic features.

Catheter-associated urinary tract infections (CAUTIs) are a major contributor to morbidity in critically ill patients. We developed a multi-faceted approach towards CAUTI reduction after our Neurocritical Care Unit (NCCU) was identified with a high incidence of CAUTIs.

We analyzed CAUTI rates over a 10-month period prior to and after implementation of practice guidelines which focused on daily chlorhexidine baths, daily electronic medical record reminders for urinary catheter (UC) removal and standardized protocols for bladder scanning and intermittent catheterization after UC removal. We hypothesized that many of the CAUTIs were due to asymptomatic bacteriuria rather than active infection so a new 2-step practice was implemented whereby cultures were only obtained if the urinalysis demonstrated pyuria defined as 10 WBC/mm 3 . CAUTIs were defined using criteria established by the Centers for Disease Control. Data was tracked daily by infection control staff. We calculated monthly UC days by dividing the total number of UC days by patient days. UC days were defined as the total number of days of exposure to a UC for all patients during the implementation period. UC days included the number of patients in the NCCU with UCs each day.

There was no difference in age (57 years old), gender (48% women) or diagnoses. There was no difference in monthly patient days (626 days v. 640 days, P=0.2) but there was a trend towards a reduction in mean monthly UC days (306 days v. 279 days, P=0.08), and a reduction in the monthly UC days (0.49 v. 0.44, P=0.03). The new urine culture policy reduced the mean number of urine cultures analyzed monthly from 53 to 28 (P=0.004). Overall, monthly CAUTI rates were reduced from 8.6 to 3.7 per 1,000 patient days (P=0.01).

Implementation of a unit-based CAUTI reduction program successfully lowered the incidence of CAUTIs in our NCCU.

Anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) is a rare autoimmune encephalitis affecting primarily young women. It often manifests as a paraneoplastic syndrome with clinical features that include progressive behavioral changes, psychosis, central hypoventilation, seizures, and autonomic instability. Although cardiac arrhythmias often accompany NMDARE, they are rarely detailed in literature. We seek to describe the course of a previously healthy female who was positive for Anti-NMDAR antibodies but was negative for primary tumor. Her course was complicated by intermittent bradyarrhythmias which progressed at times to asystole, and ultimately warranted permanent pacemaker implantation. Our patient was a 31-year-old African American female with no significant past medical history. She initially presented to the psychiatric portion of our hospital with new onset psychosis. She was transferred to our neurologic intensive care unit after a seizure and persistent altered mental status likely secondary to catatonia. The severity of her catatonia and the frequency of her seizures contributed to respiratory failure requiring mechanical ventilation. Her course was then further complicated by hemodynamically significant bradycardia induced by vasovagal maneuvers. The episodes were initially self-limited, with spontaneous return to hemodynamic stability. However, they eventually necessitated pharmacologic intervention for resolution. Initial therapy was thus targeted at preventing vasovagal episodes, such as intravenous fentanyl and endotracheal lidocaine for cough suppression. As her disease progressed, the hemodynamically significant bradycardia began to occur independently of vagal stimuli. It also became refractory to pharmacologic intervention. Cessation only occurred by chest compressions or transcutaneous pacing, thus warranting implantation of a permanent pacemaker.

Pulmonary embolism (PE) remains a significant risk in critically ill patients, but detection is obscured by nonspecific signs like tachycardia and tachypnea that are common and overlap with other cardiopulmonary disorders seen in this population. Predictive models, validated in the Outpatient/Emergency setting, perform poorly in hospitalized patients. We evaluated factors predictive of PE in patients with acute cardiopulmonary deterioration, in order to develop a model of which patients require further testing.

All Neuro-ICU patients who underwent CT pulmonary angiography (CTPA) for suspicion of PE in 2013 were retrospectively reviewed. Vital signs, labs, radiologic/ Doppler testing, and risk factors for PE were ascertained. Relationship between these findings and presence/ absence of PE was evaluated using the Chi-square test for discrete and T-test for continuous data. Variables with p < 0.1 were entered into multivariate analysis using stepwise logistic regression.

Tachycardia and tachypnea were present in over 90% of the 40 patients undergoing CTPA testing, while acute hypoxia (SaO2< 90%) was seen in 57%; these variables did not predict the 13 (33%) who were positive for PE. Instead, PE was associated with active malignancy, acute DVT, normal chest x-ray, and not being on DVT chemoprophylaxis. These factors were independently associated with PE in multivariate analysis (R 2 = 0.68) while fever and acute respiratory failure (intubation within 48 hours) were more likely in those with diagnoses other than PE (e.g. pneumonia, mucous plugging).

Tachycardia, tachypnea, and hypoxia, while sensitive markers of PE in ICU patients are not specific enough to aid in its diagnosis. We identified other risk factors that better distinguish PE from competing diagnoses in those with acute cardiopulmonary instability. A predictive model incorporating these variables may allow refinement of who requires CTPA testing while avoiding unnecessary testing in low-risk patients.

The most widely used and most studied coma scale to date is the Glasgow Coma Scale (GCS). The GCS was incorporated into several scoring systems, like the Acute Physiology, Age and Chronic Health Evaluation (APACHE) III score. APACHE III score is used mainly for critically ill patients of all disease categories admitted to the intensive care unit (ICU). APACHE III looks at 27 variables for each patient. In addition to GCS, these variables include the patient's diagnosis, age, vital signs, and laboratory values. These two scoring systems have not been compared in predicting hospital mortality in patients admitted to NeuroICU.

We retrospectively identified all patients admitted to our 16 bed NeuroICU between 06/2009 and 2/2014 using the APACHE Outcomes database. We calculated correlation coefficients for GCS and APACHE III scores in predicting hospital mortality. Receiver-operating characteristic (ROC) curves were also used to assess mortality predictions.

We identified a total of 2025 patients. Patient characteristics included average age of 61 ± 18 years, 51 % males, average GCS score of 13 ± 4, and average APACHE III score of 48 ± 21. Hospital mortality was 8.8 %. Both GCS (r = 0.43) and APACHE III scores (r = 0.45) had very good correlations with hospital mortality (p < 0.01). There was no statistically significant difference between the 2 correlations (p = 0.4). ROC area under the curve (AUC) was 0.85 (95 % CI = 0.82 -0.88) for GCS, and 0.84 (95 % CI = 0.81 -0.87) for APACHE III, suggesting that both scores have very good discriminative powers for predicting hospital mortality.

This study shows that both GCS and APACHE III scores were very strong predictors of hospital mortality in NeuroICU patients. GCS was as good as APACHE III in predicting hospital mortality in NeuroICU patients.

The purpose of this study was to compare outcomes with regard to efficiency of monitoring intravenous unfractionated heparin infusion using activated partial thromboplastin time(aPTT) and antifactorXa(anti-Xa), we then analyzed the correlation between paired values of anti-Xa and aPTT.

This is a single center prospective cohort pilot study.

85 patients met the criteria for heparin continuous infusion;aPTT monitoring(n=48),anti-Xa monitoring(n=37).The number of times aPTT and anti-Xa test performed were (median, IQR)14(2-34)vs7(2-76);p=0.23. The time to reach therapeutic range for both groups were (mean,SD)22(20)vs15(13)in hours; p=0.08. 5(10%) in the aPTT group versus 21(57%) in the anti-Xa group were within the therapeutic range>50-100% of the time (p=< 0.01). 38(78%) patients in the aPTT group versus 14(38%) in the anti-Xa group had supratherapeutic reading >50-100%of the time (p< 0.01). There were no differences in the number of days on heparin or bleeding complication during infusion between groups. Discordant aPTT and anti-Xa values were reported from 230 paired values of 37 patients. 131 anti-Xa values were less than 0.3 IU/mL. When simultaneous aPTTs were examined, 49% correlated with an aPTT< 60s, 28% with an aPTT between 60-80s and 24% with an aPTT>80s. 98 anti-Xa values were between 0.3-0.7 IU/mL; simultaneous aPTT values were 12%< 60s, 34% between 60-80s,51%>80s. Supratherapeutic anti-Xa levels were from 5 readings; correlating a 100% with an aPTT>80s. 3/37 pts had bleeding complications. 1 pt required blood transfusion. 1 pt required discontinuation of the pilot protocol.

aPTT and anti-Xa values are frequently discordant in monitoring heparin infusion. 57% of time there was discordance between anti-Xa values and aPTT. The clinical significance of this finding is unclear. Anti-Xa levels remained within range more often than aPTT levels. However, it's still unclear if a therapeutic anti-Xa level is an adequate indicator of thrombosis risk versus bleeding risk in the face of discordant aPTT values.

A 30-year-old Hispanic male who was admitted to the hospital with an aneurysmal SAH. He underwent clipping of his Anterior communicating artery aneurysm. He had an IVC filter placed for a right Popliteal vein deep vein thrombosis. He developed an acute massive Inferior venacaval thrombosis (IVC) thrombosis from propagation of clot trapped within the filter, causing severe shock and multi-organ failure.

A case report discussing the acute complications of IVC filter placement, but importantly talks about the risks of Post IVC filter DVT, PE and Phlegmasia Cerulea Dolens (PCD).

This poster specifically discusses the pathophysiology of shock in patients with an acute total IVC thrombosis after IVC filter placement, and also discusses the rare but fatal complication Phlegmasia Cerulea Dolens (PCD)

As a neurointensivist, it is very important to know the potential complications of IVC filter. Certain complications such as PE despite previous filter implantation, acute total IVC thrombosis from propagation of clot trapped within the filter, and PCD can be fatal if not early detected and aggressively treated. Filters should be removed once the patients risk of DVT is reduced, and prompt initiation of chemoprophylaxis should be considered (even in patients with IVC filter in place) once the bleeding risk has decreased Introduction Prognostication in brain-injured patients can be challenging. Physicians and families want to avoid early withdrawal of care in those who may have a chance at good outcome. However, overly hopeful prognostication can leave patients with unwanted poor functional outcomes.

This is a subanalysis of a prospective observational cohort of patients with primary brain injury admitted to a neurointensive care unit (NeuroICU) at a tertiary care center who were intubated for airway protection, mechanically ventilated for >24 hours and expected to have a trial of extubation from March 2012 to January 2014.

Thirty-three patients were enrolled. Nine patients (29%) were terminally extubated and 24 patients had a trial of extubation or tracheostomy. Sixteen patients had intracerebral hemorrhage, seven patients had traumatic brain injury, seven patients had subarachnoid hemorrhage and three patients had ischemic stroke. Terminally extubated patients were older (median age 64 years vs. 53 years [33.5-60], p=0.034). Enrollment Glasgow Coma Scale (GCS) scores were similar between terminally and non-terminally extubated patients (7 [7-8] vs. 8 [7-9.5], p=0.12); however, terminally extubated patients had significantly lower enrollment Four Scores, a tool to assess level of consciousness and brainstem function (8 [6-8] vs. 9 [8-12], p=0.021). Adjusted for age, patients with lower eye opening scores by GCS and by Four Score were at increased risk for terminal extubation ), p=0.031 and OR 2.87 (95% CI 1.08-7.65), p=0.034, respectively].

A large percentage of patients are terminally extubated in the NeuroICU. Among patients ventilated for >24 hours, aggressive medical care was continued for a similar number of days before the decision to extubate terminally. Despite similar coma scores, lack of eye opening is a predictor of terminal extubation in the NeuroICU.

Hypotension and low cerebral perfusion pressure (CPP) are associated with low cerebral blood flow (CBF), ischemia, impaired autoregulation and poor outcomes after traumatic brain injury (TBI). TBI is the leading cause of death in children, and boys and younger children have poor outcomes compared to girls and older children. CPP is often normalized by use of inotropes and vasopressors to increase MAP and optimize CBF. Since ethical considerations constrain mechanistic studies in children, we use an established porcine model of fluid percussion brain injury (FPI). Phenylephrine (Phe) prevented in female but exacerbated impairment of autoregulation in male piglets after FPI. In contrast, dopamine (DA) prevented impairment of autoregulation in both sexes after FPI, suggesting that pressor choice impacts outcome. Activation of Katp and Kca channels is an important mechanism for vasodilation, including autoregulation. K channel mediated dilation is blunted after FPI via upregulation of ERK mitogen activated protein kinase (MAPK). Phe protected impairment of K channel mediated dilation in females but aggravated impairment in male piglets after FPI. We hypothesized that DA protected autoregulation in both males and females because it equally protected K channel mediated dilation in both sexes after FPI.

Lateral FPI was produced in anesthetized piglets. Pial artery reactivity was measured via a closed cranial window.

Cromakalim (Katp agonist) and NS 1619 (Kca agonist) produced dilation which was blunted by FPI in males and females. DA (30 min post FPI) elevated MAP and CPP equally in male and female piglets after FPI. DA protected cromakalim and NS 1619 induced dilation and blocked upregulation of ERK MAPK equivalently in males and females after FPI.

These data indicate that DA protects K channel mediated cerebrovasodilation equally in both male and female piglets because of equivalent blockade of ERK MAPK upregulation in both sexes after FPI.

Coagulation changes after traumatic brain injury (TBI) are common, but whether these changes are associated with mortality remains unclear. We sought to determine whether the prothrombin time (PT), activated partial thromboplastin time (aPTT) and/or platelet count correlate with mortality after severe TBI.

143 patients with severe TBI admitted between January 1, 2006 and December 31, 2009 were identified from the Brain Oxygen Monitoring and Outcome (BOMO) registry at a University-affiliated, level-1 trauma center. Admission demographic variables and laboratory parameters were collected upon admission. Patients taking anticoagulant medications were excluded. Coagulation abnormalities were dichotomized at PT >13.8s; aPTT >34.4s, and thrombocytopenia < 150,000/mL. Modified Rankin scores were obtained at 3-months after discharge. Logistic regression analysis was performed to determine the effect of coagulation abnormalities on 3-month mortality.

100/143 (70%) of all study patients were men; mean age was 44 (range 15 -91) years. 43/143 (30.1%) died. The mechanism of trauma was falls in 59 (41%) patients. The incidence of PT prolongation was 47/143 (32.9%) and aPTT prolongation was 27/143 (18.9%). Thrombocytopenia occurred in 15 (10.5%) of patients. In univariate analysis, an elevated PT was associated with increased mortality [21/43 versus 21/100; p=0.001]. In step-wise multivariable logistic regression accounting for age, coma, hematoma expansion, surgical intervention and mechanism of injury, the only coagulation parameter that was associated with mortality was the aPTT [1.15 (1.04-1.28); p< 0.01]. Age [OR=1.05 (1.02-1.08); p< 0.01] and surgical intervention [OR=3.91 (1.40 -10.90); p=0.03] were also significantly associated with 3-month mortality. Any coagulopathy increased the odds of death by 3.0 [95% CI(1.2-7.40; p=0.02].

The aPTT was more closely correlated with 3-month mortality than the PT, although the incidence of aPTT prolongation was lower than PT prolongation. Any coagulation abnormality on admission was associated with increased 3-month mortality. Neither admission nor nadir platelet count correlates with mortality.

Use of antiplatelet agents may be associated with worse outcomes after Traumatic Brain Injury (TBI). We sought to determine whether pre-injury use of antiplatelet agents was associated with larger initial hematoma volumes or progressive hemorrhagic injury (PHI) after TBI.

A retrospective cohort of severe TBI patients who underwent brain oxygen monitoring at an academic level-1 trauma center between January 1, 2006 and December 31, 2009 was identified. Hematoma volumes were calculated manually from initial and 24-hour head CT using the maximal width for subdural (SDH) or epidural hematoma (EDH) and ABC/2 for the volume of an intra-cerebral hematoma. PHI was defined as >25% increase in SDH/EDH width or ICH volume.

138 patients were included in our analysis. Median age was 41 (21.1). Mean GCS score was 6.6 (4.5) and mean APACHE II score was 22.6 (5.3). Eighteen patients (12.6%) were taking antiplatelet agents and 36 patients died (25.2%). Seventy-one percent of patients had SDH, 11.6% had EDH, 62.3% had contusions and 87.7% had SAH. Antiplatelet use was associated with larger initial (9.5 vs 1.9cc, p=< 0.01) and maximum contusion volumes (21 vs 5cc, p=< 0.01), as well as initial SDH width (11 vs. 6.1mm, p=< 0.01), but not maximum SDH width (8.8 vs. 6.9mm, p=0.14). In univariate analysis, maximum hematoma volume and initial SDH width were associated with mortality (p=0.02 and 0.01 respectively) although these associations did not hold in a multivariate model. PHI occured in 88 patients (63.7%); there was no difference in PHI rates between the two groups (p=0.6). Mortality in the antiplatelet group was significantly higher (55.6% vs. 20.8%, p=< 0.01).

Antiplatelet use is associated with larger initial contusion and SDH volumes. Mortality is higher in the antiplatelet group, but this is not likely mediated through PHI after initial head CT.

The Brain Trauma Foundation (BTF) recommends that cerebral perfusion pressure (CPP) be kept between 50 -70 mm Hg for patients who have severe traumatic brain injury. The main objective of this study was to assess adherence to this CPP target and to determine if adherence to this target is associated with hospital mortality.

Retrospective cohort study 127 patients who had a TBI that required ICP monitoring admitted to the ICU between April 2006 and May 2012. Adherence to BTF guidelines was measured as the time that the CPP was within 50 -70 mm Hg divided by the total time of CPP monitoring (CPP time index). Using logistic regression, we modelled the association between CPP time index and hospital mortality.

The percentage of time that the CPP was within the recommended range was 31.6% (SD 22.2) whereas patients had a CPP greater than 70 mm Hg for 63.9% (SD 26.2) of the time. Patients had a CPP < 50 mm Hg for an average of 4.5% of the time (SD 16.3). After adjustment for covariates, CPP time index inside 50 -70 mm Hg was not associated with hospital mortality (OR 1.2, 95%CI 0.98 -1.6, p=0.079). CPP time index for CPP 70mm Hg and < 50mm Hg were associated with decreased (OR 0.66, 95%CI: 0.52 -0.82, p< 0.0001) and increased (OR 9.9, 95%CI: 1.4 -69.6, p=0.021) mortality, respectively.

CPP was greater than 70 mm Hg for most of the time. This level of CPP was associated with decreased mortality.

Prior observational studies suggest that a mean hemoglobin concentration below 90 g/L is associated with increased mortality. However, these studies are limited by possible exposure misclassification and lack of standardized functional outcomes. The purpose of this study was to determine if hemoglobin above 90 g/L was associated with improved 6 month functional outcomes in patients with severe traumatic brain injury.

Retrospective cohort study 116 patients who had a TBI and underwent multimodal neuromonitoring between 2006 -2013. A hemoglobin time-index (HTI) was calculated for each patient by dividing the total number of hours where the hemoglobin was 90g/L by the total number of hours where hemoglobin was measured. Using a generalized linear model, we modelled the association between HTI and 6 month favourable neurologic outcome (Glasgow Outcome Score 4 or 5).

Retrospective cohort study 116 patients who had a TBI and underwent multimodal neuromonitoring between 2006 -2013. A hemoglobin time-index (HTI) was calculated for each patient by dividing the total number of hours where the hemoglobin was 90g/L by the total number of hours where hemoglobin was measured. Using a generalized linear model, we modelled the association between HTI and 6 month favorable neurologic outcome (Glasgow Outcome Score 4 or 5).

Percentage of time with a hemoglobin 90 g/L was associated with improved 6 month neurologic outcomes in patients with severe TBI.

Neuroinflammation is a key secondary injury mechanism following traumatic brain injury (TBI). While measurement of inflammatory mediators in jugular venous blood and brain microdialysate can characterize global and focal inflammation in TBI, they do not provide a means of mapping spatial variations in neuroinflammation across the brain. A recent study used [ 11 C](R)PK11195 positron emission tomography (PET) to demonstrate persistent thalamic inflammation years after TBI, which was related to outcome. We have applied [ 11 C](R)PK11195 to map the spatiotemporal patterns of microglial activation in acute moderate/severe TBI.

Six patients (4 male, admission Glasgow Coma Score: 3-11) underwent [ 11 C](R)PK11195 PET (including metabolite-corrected plasma kinetic modelling) and magnetic resonance imaging (MRI) at two time points (3-9 days and 13-22 days) following TBI. [ 11 C](R)PK11195 binding potentials were calculated in the core, in the perilesional area and in normal appearing areas of the brain.

Two patients with contusions showed a pattern consistent with microglial activation in ischaemic stroke, with early perilesional increases in [ 11 C](R)PK11195 binding, which increased and included the lesion core at the later time point. However, the spatial and temporal progression of microglial activation did not conform to this pattern in other patients. None of the studies showed significant thalamic binding of [ 11 C](R)PK11195.

There is marked variability in patterns of microglial activation in early TBI, which may relate to differences in injury type and severity, host response characteristics, and possibly therapy. However, the late thalamic microglial activation reported in past studies does not appear to be a feature of acute TBI, and may represent a late neuroinflammatory response with a long therapeutic window. Further studies are needed to better characterize microglial activation in vivo and its meaning in the context of TBI.

Blood and cerebrospinal fluid (CSF) levels of brain injury markers may serve as useful diagnostic and prognostic indicators for traumatic brain injury (TBI). Levels of Ubiquitin C-terminal hydrolase-L1 (UCH-L1) and the 145 kDa spectrin breakdown product (SBDP145) have been shown to correlate with outcome after severe TBI. The response profiles of these biomarkers in children after TBI have not been characterized. We examined the acute time-course of serum and CSF levels of UCH-L1, as well as serum SBDP145, in pediatric patients with severe TBI.

Patients aged 0-17 years admitted for severe TBI from September 2011 to October 2013 were prospectively enrolled. Blood and CSF were collected at up to 5 time-points from 12 to 120 hours after injury, and a single timepoint for non-injured control patients.

Nineteen TBI patients (median age = 8 years; range 0.42-15) were evaluated. Serum UCH-L1 levels were greater than control levels (median across all time-points = 361 versus 147 pg/ml, p < 0.001). Serum SBDP145 showed a similar overall magnitude of increase (172 vs 69 pg/ml, p < 0.001). Serum and CSF UCH-L1 levels correlated well (r=0.70; p < 0.001). In both serum and CSF, the overall trend across time-points was a decreasing one (p < 0.001 and p = 0.003, respectively). In contrast, serum SBDP145 levels peaked at a later time-point (overall comparison p = 0.011). ROC analysis on serum UCH-L1 revealed a cut-off value for distinguishing TBI of 400 pg/ml, with AUC = 0.74. The optimal cut-off value for serum SBDP145 was 100 pg/ml, with AUC = 0.81.

Blood and CSF levels of UCH-L1 display a rapid and transient time-course in children after TBI, while serum SBDP145 follows a more sustained response. These findings are discussed in relation to clinical characteristics and EEG markers evaluated concurrently in these patients.

Adequate adrenal response is fundamental for maintenance of physiological homeostasis in the setting of trauma and severe illness. Patients with neurogenic shock are at risk of severe consequences if adrenal insufficiency is not rapidly identified and treated. Our objective was to analyze the incidence of adrenal insufficiency in patients with acute cervical spinal cord injury and its effect on in-hospital complications and mortality at 6 and 12 months.

The medical records of patients older than 18 years who were admitted to the adult neurosurgery service at the University District Hospital due to neurogenic shock following acute cervical spinal cord injury from January 2004 to December 2009 were reviewed retrospectively. Patients were re-evaluated at 6 and 12 months.

One hundred and ninety-nine patients were admitted with acute cervical spinal cord injury. 37 patients met the preestablished criteria for neurogenic shock. The incidence of adrenal insufficiency (AI) in patients with neurogenic shock was 22%. The average random cortisol was 9.3 μg/dL in patients with AI vs. 29.2 μg/dL in Non-AI. The presence of AI was positively correlated with complications and an increase in the risk of intubation (P = 0.01 and P = 0.002). The 30-day mortality rate in patients with AI was 13% compared with the 3% in the Non-AI group (P = 0.39). Two patients died in the post-hospitalization period at 3 month and 5 months respectively. The overall survival rate at 1 year was 78% in the AI group as compared with the NON-AI group which as 95% (P>0.05).

Adrenal insufficiency is a poorly recognized complication in patients with acute cervical spinal cord injury and its aggressive treatment is of utmost importance to avoid further neurological injury. At follow up at 1 year the occurrence of adrenal insufficiency does affect the survival of patients with acute cervical spinal cord injury.

Maintaining an adequate hemoglobin concentration has been thought to minimize early cerebral ischemia after severe traumatic brain injury. The goal of this analysis was to examine the effect of maintaining hemoglobin concentration at two randomized transfusion thresholds, at least at 10 gm/dl (10TT group) or 7 gm/dl (7TT group), on pre-specified early hemodynamics.

Cerebral hemodynamics, including intracranial pressure (ICP), mean arterial pressure (MAP), and brain tissue hypoxia (brain tissue PO2 less than 10 mmHg), were compared among the two transfusion threshold groups in a randomized clinical trial.

Median ICP was 15.6 mmHg in 7TT, and 15.6 mmHg in 10TT. There was no difference in the median time that ICP was greater than 30 mmHg (0 hours in 7TT, 1 hour in 10TT, p=0.07) or in maximum ICP treatment score (p=0.10) in the two transfusion threshold groups. Average MAP was 88.8 mmHg in 7TT, and 92.3 mmHg in 10TT (p=0.001). The proportion of patients who never had a MAP below 70 mmHg was 37.1% in 7TT and 35.0% in 10TT (p=0.76) . For all patients, there was no difference in the occurrence of brain tissue hypoxia. However, when location of the probe was considered, there were significant differences. When the probe was located in normal appearing brain, brain tissue hypoxia occurred in 25% of patients in 7TT, compared to 10.2% of patients in 10TT (p=0.04). No difference in the incidence of brain tissue hypoxia was observed when the probe was placed in abnormal brain.

A small increase in MAP and fewer episodes of global tissue hypoxia (probe in normal appearing brain) were observed when hemoglobin concentration was maintained at least 10 g/dl. However, these effects were small and may not outweigh the potential adverse consequences of the transfusions needed to maintain hemoglobin concentration.

Financial Support: NIH grant #P01-NS38660

Development of a non-invasive intracranial pressure (ICP) monitor has long been a goal in neurocritical care. The Orsan CPM monitor is a novel use of cerebral bio-impedance technology that is sensitive to changes in fluid content of the brain and also to pressure and volume changes induced by the pulsatility of the cardiac cycle. We studied the feasibility of using the Orsan CPM monitor to non-invasively measure ICP in severe TBI patients.

We studied consecutive severe TBI patients admitted to 3 neurointensive care units in Israel who underwent ICP monitoring and did not undergo surgical intervention during the time of monitoring. We compared invasive and noninvasive ICP waveforms and measurements.

We studied 30 patients with a mean age of 40 ± 20 years and a median GCS of 5 (IQR 3-8). We analyzed 1338 hours of validated data. Waveform analysis revealed a very strong correlation between the invasive and noninvasive ICP (nICP) waveform (r=0.95, p< 0.0001). Mean error between invasive and nICP measurements on an hourly basis was 0.38 ± 4.5 mm Hg. The correlation between mean hourly ICP from the invasive and non-invasive monitors was robust (r = 0.7, p< 0.0001). Importantly, when ICP was intractably elevated (>25 mm Hg for > 90% of a given hour) mean nICP was 49 ± 16 versus a mean invasive ICP of 52 ± 15 mm Hg, indicating that the noninvasive monitor is able to reliably detect very high ICP. In patients that never experienced elevated ICP mean nICP was 12 ± 4 mm Hg (invasive ICP 10 ± 3 mm Hg).

The results of this preliminary study suggest that cerebral bio-impedance is a promising technology that may offer continuous non-invasive estimation of ICP, and is able to accurately detect significant elevations of ICP. Further investigations using this technology are warranted.

The presenting author has served as a scientific advisor for Orsan and has received consulting fees.

Dietary Docosahexaenoic Acid (DHA) decreased lesion volume and cognitive impairment in our controlled cortical impact (CCI) model of developmental TBI, associated with decreased oxidative stress and inflammation. Mechanisms of DHA's neuroprotection are poorly understood. In systemic macrophages, DHA decreases inflammatory (M1) activation while promoting reparatory (M2) activation. DHA is a peroxisome proliferator gamma (PPAR ) ligand. Effects of DHA on M1/M2 activation of resident microglia or infiltrating macrophages after TBI are unknown. We hypothesized that DHA would decrease mRNA levels of M1 activation markers in microglia and infiltrating macrophages after CCI in the 17 day old rat, associated with increased PPAR 1 mRNA.

CCI or SHAM surgery was delivered to 17 day old male rats exposed to 0.1% DHA (DHA) or otherwise equivalent chow (REG). At post injury day (PID) 3, M1 (IL-1 , IL-12p35, IL-18, CCL2, INF , TNF , iNOS) and M2 marker (IL-1R , IL-12p40, CD206, IL-10, TGF , Arg2) and PPAR 1 mRNA were measured in microglia/macrophages isolated using flow cytometry and CD11b/ CD45 antibodies. IL2, 4 and 6 mRNA levels were measured in injured tissue.

Preliminary results suggest DHA did not affect total CD11b+ cells but decreased infiltrating macrophages (30±3 vs 22±3% total, p=0.04); decreased microglial M1 marker mRNA (TNF to 43±2% and INF to 25±6% REG, p< 0.05 for both; iNOS to 33±8% and IL-1 to 30±1%, trend of p< 0.1 for both). Increased CD206 in DHACCI microglia approached significance (362±37% REG, p=0.05).

Exposure to a 0.1% DHA diet after CCI may be associated with decreased infiltrating macrophages and decreased microglial M1/M2 mRNA ratio. We anticipate that DHA will decrease M1/M2 mRNA ratios in microglia and macrophages, associated with increased PPAR 1 mRNA. We speculate that DHA improves neurologic outcomes in rat pups after CCI via immunomodulation.

Increased intracranial pressure (ICP) is associated with worse outcomes following traumatic brain injury (TBI). Studies have confirmed that ICP is correlated with optic nerve sheath diameter (ONSD) on ultrasound. The aim of our study was to assess the independent relationship between ONSD measured using CT and mortality in a population of patients admitted with severe TBI.

We conducted a retrospective cohort study of patients with a TBI requiring ICP monitoring admitted to the ICU between April 2006 and May 2012 to two neurotrauma centers. ONSD was independently measured by two physicians blinded to patient outcomes. Multivariable logistic regression modeling was used to assess an association between ONSD and hospital mortality.

A total of 220 patients were included in the analysis. Overall, the cohort had a mean age of 35 (SD 17) years and 171 of 220 (79%) were male. The median admission GCS was 6 (IQR 3 -8). Intra-class correlation coefficient between raters for ONSD measurements was 0.92 (95%CI: 0.90 -0.94, P< 0.0001). On multivariable analysis, each 1 mm increase in ONS was associated with a two-fold increase in hospital mortality (OR 2.0, 95%CI: 1.2 -3.2, P=0.007). Using linear regression, ONSD was independently associated with increased ICP in the first 48 hours after admission ( =4.4, 95%CI: 2.5 -6.3, P< 0.0001).

In patients with TBI, ONSD measured on CT scanning was independently associated with ICP and mortality.

Existing evidence suggests that the utilization of Advanced Practice Providers (APPs) in critical care settings is safe, cost effective, yields significant benefit in continuity/quality of care and improves patient outcomes. We aimed to identify published literature regarding the role of Acute Care Nurse Practitioners (ACNPs) and Physician Assistants (PAs) specific to Neurocritical Care (NCC) and to identify implications for practice.

A systematic search of PubMed and CINAHL was carried out using the terms "Neurocritical Care", "Acute Care Nurse Practitioner", "Physician Assistant", "Neurosurgery", "Neuroscience" and "24 hour models" from 1999 through May 2014.

A preliminary review of the literature revealed over 100 articles referencing APPs in critical care settings. A total of 7 articles focused on APPs in the NCC setting. Of those, three articles focused on the role and scope of practice for ACNPs in a NCC unit, one focused on a potential NP orientation competency for a 24-hour NP coverage model, one focused on the tandem collaborative practice of NP-Physician colleagues in a neurosurgical practice and only one focused on the significant clinical and financial outcomes with care provided by ACNPs. The most current study was a survey of Neurocritical Care Society (NCS) members that focused on intensivist and staff perceptions of ACNPs and PAs. None of these studies addressed issues related to contemporary scope of practice, patient satisfaction or the long term financial consequences of sustaining such a program.

There is currently a very low level of evidence in the literature to support the impact of APPs in NCC. Further research is needed to explore the impact of NCC APPs on quality of care measures and patient outcomes. Additionally, evaluation of the economic ramifications of creating and maintaining such models are needed to improve APP utilization.

This study is to determine the feasibility of evaluating the effect of music therapy, specifically Beethoven's Ninth Symphony on brain-injured patients in the neurointensive care unit. A secondary aim of this study is to evaluate the feasibility of commercially available wrist accelerometers (Fitbit ®) as non-invasive neurologic monitors.

Patients with a GCS score 5-12 admitted > 24 hours and < 7 days were recruited from the Neuro ICU. The study design is a 3-part randomized cross-over study consisting of daily 67-minute sessions: Beethoven's Ninth Symphony via MP3 player with noise cancelling ear-buds, noise cancelation only, or control group with ear-buds and music turned off. Outcome measurements included sedation and pain medication requirements, FOUR score, NIHSS and activity with Fitbits ® placed on each wrist.

Seven patients were identified and met study criteria. Three patients were excluded after consent was obtained: 2 due to an improvement in GCS after extubation and one due to incorrect date of onset. Four patients completed the study protocol. Neurologic exam changed during the intervention for 75% patients (3/4). Anecdotal observations during suggest patients appear to be more restful during the music session compared to other sessions. Analysis of the Fitbit® data failed to show any lateral differences even when the patient had a hemiplegic exam. There were no observed complications from this study.

Studying the effects of music on brain injured patients is feasible. Anecdotal evidence during the intervention periods suggests music may be a safe and effective method of inducing restfulness in this patient population. Future studies are needed to determine significance. This study was not powered to do so. Due to medical necessity, all patients were restrained during the study period, which likely affected the results of Fitbit®. Fitbits® do not appear to be useful neurologic monitors.

Continuous renal replacement therapies (CRRT) are preferred to intermittent therapies in the critical care setting for patients with hemodynamic instability or acute neurologic injury. The management of CRRT is often led by consulting nephrologists. We describe the development of a neurocritical care driven CRRT program.

In July 2012 a team of neurointensivists, nurse practitioners, nurses, and pharmacist, developed a comprehensive plan for a neurocritical managed CRRT program. Needs surrounding education, quality improvement, and research were identified. Team members completed an 8-hour competency course, on-line training, a 4-hour simulation, and precepting by experienced clinicians. The program started in February 2013.

Between February 2013 and April 2014, nineteen patients (median age 60, median GCS 11) have undergone CRRT. Primary diagnoses included subarachnoid hemorrhage (n = 3), ischemic stroke (n =2), intracerebral hemorrhage (n = 7), status epilepticus (n = 4), subdural hematoma (n = 2), and anoxic brain injury (n = 1). Indications for CRRT included acute kidney injury (n = 7), ESRD (n = 3), CHF/volume overload (n = 5), and acidosis (n = 4). The median duration of therapy was 4 days (range: 1 -21 days). The median ICU length of stay was 7 days with a mortality rate of 26%. The majority of patients have been managed with CVVH without anticoagulation. Nursing, pharmacy and advanced practitioners have been satisfied with the program and feel it has contributed to care. Early in our program, filter clotting was problematic, largely attributed to CRRT prescription management.

Our neurocritical care team has successfully managed a variety of patients on CRRT. Antibiotic and antiepileptic drug utilization and biomarkers are areas for future study. The incidence of filter clotting is being addressed with modifications in our prescription and the addition of a citrate protocol. The program will include therapeutic plasma exchange in the future.

The exposure to ionizing radiation has increased significantly with the wide availability of CT scans and portable imaging technology. We examine the pattern of use of inpatient diagnostic imaging and radiation exposure in the Neuro ICU patient population at a large academic medical center.

We retrospectively evaluated all patients admitted to the Neuro ICU at Vanderbilt University Medical Center from Jan to Dec 31, 2013. We focused on CT scans since they contribute the maximum radiation exposure. Data was electronically mined and cross-referenced to the patients EMR and radiology records. Radiation dose estimates were calculated based on published reference values and conversion factors (primarily CT head w/wo contrast (2msv), CT angio (7-10mSv), Ct Chest Abd, pelvis (10mSv), CT cerebral perfusion analysis (3.3 mSv).

In the calendar year 2013, we had a total of 2154 admission encounters (F=1078). The mean age on admission was 56.55Y ± 16.7. The mean length of ICU stay was 6.3 days. Mechanical ventilation was initiated on 420 with a mean length on mechanical ventilation was 5.09 days. 2028 CT based scans were completed of which the vast majority were Head CT without contrast (n=1209). 379 patients had multiple CT based studies. The mean number of studies was 3.8 ± 2. The maximum number of studies on a single patient was 21. The number of patients with more than 3 studies during their ICU stay was 159. The mean radiation exposure in all patients with more than one CT study was 7.71 mSv±5.2 with a median exposure of 6mSv. This increased to a mean exposure of 10.11 ± 5.4mSv with a median of 8mSv.

Patients in the Neuro ICU are at a risk for significant exposure to ionizing radiation. Radiation exposure must be factored into the culture of quality and patient safety in the ICU.

There is a significant shortage of neurologists in sub-Saharan Africa. While this impacts management of chronic diseases such as epilepsy, movement disorders, dementias, the impact on acute neurological illnesses is also significant and under-recognized.

Educational visits were made by a neurologist over three years with participation in clinical and educational activities. Patients were examined on ward rounds and teaching conferences. Medical residents were tested on neurological examination and localization.

Acute stroke, ischemic and hemorrhagic, meningitis, myelopathy and tetanus formed the most common neurological diagnoses. Initial clinical examination from medical residents was limited for neurological details and localization of lesion was not performed. Skull x-rays were performed in all trauma patients, while spine x-rays were routinely performed in patients with para-or tetraplegia. CT scan was frequently non-functional and MRI unavailable in the area. Lumbar punctures were performed routinely while myelograms were rarely performed. Patients with tetanus were admitted to the ICU while patients with other acute illnesses were admitted to the ward. Patients with tetanus were aggressively treated with benzodiazepenes and occasionally mechanical ventilation. No treatment was available for patients with acute stroke and myelopathy. They were discharged home with residual neurological deficit. We have developed an educational curriculum for medical residents, with emphasis on clinical examination as a cornerstone in making clinical diagnoses. Utilisation of locally available techniques such as myelography has been encouraged, while expeditious use of resources such as CSF analysis has been classified as essential. Protocols for safe performance of lumbar puncture have been developed for patients with altered mental status, based on clinical examination.

While intermittent visits and teaching by visiting specialists are helpful, there is an immense need to develop educational programs for neurologists locally. Establishing robust patient databases may assist in estimating burden of acute neurological illness in areas with scarcity of specialists.

Large population-based studies show declining mortality after cardiac arrest (CA) in hospitalized patients, but the impact of the components of "chain of survival" of cardiac arrest on changing mortality is unclear. To explore this further, we studied trends in mortality of all cardiac arrests treated in emergency departments in the US.

We searched the Nationwide Emergency Department Sample (NEDS) from 2006-2011, a 20% stratified sample of all ED visits in the US for adults with diagnosis of cardiac arrest (ICD-9 427.5). Trends in ED-mortality, inpatient mortality among hospitalized patients, and overall survival to discharge were calculated by using logistic regression using calendar year as a predictor variable. Population estimates were calculated using complex sample analysis that accounts for weighting, clustering and stratification used for NEDS sampling design.

Of the 1,623,940 (median age 68 year, 58.9% males) cases with CA, 53.7% died in the ED, and of the 618,928 patients surviving to admission, 62.4% died during hospitalization. The annual incidence of CA increased by 5,353 (95% CI: 3,649-7,075, P=0.001) cases with each calendar year. There was a statistically non-significant trend toward increased ED-mortality from 52.4% (95% CI: 51-53.8%) in 2006 to 54% (52.7-55.3%) in 2011 (P=0.064). In contrast, inpatient mortality among hospitalized patients decreased from 67.5% in 2006 (66.4-68.6%) to 59.3% (58.3-60.3%) in 2011 resulting in 6.9% decreased odds of mortality (95% CI: 5.9-7.9%, P< 0.001) each year. Overall survival after CA increased from 20.9% in 2006 (19.9-21.9%) to 23.9% (22.9-24.9%) in 2011, a 3.3% (95% CI: 2-3.7%, P< 0.001) yearly increase in survival.

Recent improvement in post-CA mortality is largely limited to patients surviving to hospital admission, possibly highlighting improving post-resuscitation care. The lack of improvement in ED-mortality suggests the need to revisit and improve pre-hospital and active resuscitative components of the survival chain.

Cerebral critical closing pressure (CrCP) is a value of arterial pressure at which brain small vessels collapse and cerebral circulation ceases. It is theoretically equal or higher than intracranial pressure (ICP). The difference between CrCP and ICP represents wall tension, a parameter expressing vasomotor tone of small arteries. The value of CrCP is used in several models describing cerebral hemodynamics. Its accurate calculation is important for assessment of continuity of cerebral blood flow. However, methods in use for calculation of CrCP (first harmonic or systolic-diastolic values of Flow Velocity and Arterial Blood Pressure) often show non-interpretable negative values, limiting the clinical use of this concept.

A data set of 35 severe TBI patients acquired between 2000 and 2009 at Addenbrooke's Hospital, Cambridge, which showed negative CrCP values with the first harmonic method, was re-analysed. The recorded variables were: transcranial Doppler cerebral blood flow velocity, invasive arterial blood pressure, and intracranial pressure. Data were acquired at a frequency of 50 Hz, with a computer data acquisition system ICM+ (www.neurosurg.cam.ac.uk/icmplus) . The data, which showed negative values with the first harmonic method (M1), were compared with a new impedance based estimator (M2). It takes into account systemic and cerebral hemodynamic variables, as compliance and resistance of cerebral arterioles. Mean, minimum, and maximum CrCP values, SD, percentage of values below zero, were studied and compared with M1 results. Continuous values were also graphically analysed and compared.

The median values of CrCP M1/M2 in these 35 patients, were -15/20.The lowest values were -168/0 mm Hg respectively. With M2 all the values were positive and higher than ICP. There was a significant difference between M1 and M2 values attributed to absence of negative values on M2.

This paper reinforces the fact that the impedance model renders physiologic values for CrCP, enhancing its promise for use in clinical reality.

Financial Support: Financial Support: Conflict of interest: MC has a share of licensing fee for a software ICM+ distributed by Cambridge Enterprise Ltd.

Brain tissue oxygen (ptiO2) monitoring is widely accepted as a diagnostic tool for early detection of secondary ischemia. We aimed to investigate the relationship between ptiO2 monitoring and specific parameters obtained by a novel multi-parametric brain tissue probe (NeMo Probe).

Neuromonitoring including a ptiO2-probe (Licox, Integra LifeScience, USA) and NeMo Probe (NeMoDevices AG, Switzerland) was performed in two patients with subarachnoid hemorrhage. Changes of oxygenated and deoxygenated hemoglobin (Hboxy and Hbdeoxy) were measured using the NeMo Probe with integrated optical fibers for near infrared spectroscopy. After intravenous injection of indocyanine green (ICG), the mean transit time of ICG (mttICG), cerebral blood volume (CBV), and cerebral blood flow (CBF) were calculated. The Pearson correlation was generated for statistical analysis.

During the total monitoring period (217 hours) there was a significant correlation between ptiO2 and both Hboxy and Hbdeoxy (p< 0.0001). In 59% of 66 analyzed intervals of 30 minutes duration with ptiO2 changes >5mmHg, a strong correlation (r > 0.6) between ptiO2 and Hboxy was observed. In 30% of intervals there was still a significant correlation (0.3 < r < 0.6). A similar trend existed for the correlation between ptiO2 and Hbdeoxy, but the frequency of intervals with no correlation was lower for Hboxy compared to Hbdeoxy (11% vs. 30%; p=0.009). A total of 24 ICG-measurements were performed. Mean values were for mttICG 6.1 ± 0.8 s, CBV 3.6 ± 0.2 ml/100g and CBF 38.0 ± 7.2 ml/100g/min. There was a strong correlation between ptiO2 and both mttICG (p< 0.001) and CBF (p=0.006).

This preliminary report indicates a good correlation between conventional ptiO2 monitoring and parameters of cerebral blood flow and oxygenation changes obtained by the NeMo Probe. Further development of new algorithms is necessary to estimate Hboxy and Hbdeoxy as absolute values and to define hypoxic thresholds.

Financial Support: NeMoDevices provided technical equipment for this clinical trial. M. Seule received grant support by the "Stiefel-Zangger Foundation" of the University Zurich, Switzerland. E. Keller has a financial interest as founder and member of board of NeMoDevices AG.

Secondary brain damage in acute brain injury occurs due to low cerebral perfusion and cerebral oxygenation. Impaired cerebral autoregulation occurs during acute phase and maintenance of cerebral perfusion pressure between 50-70mmHg has been advocated to prevent cerebral hypoxemia. Cerebral oximetry using near infrared spectroscopy is a novel monitoring method to detect cerebral hypoxemia. We hypothesize that cerebral hypoxemia detected by 7600 Equanox is associated with outcome in patients with acute brain injury

Patients with acute brain injuries admitted to Neuro-ICU were included in study after informed consent from surrogate decision maker. Cerebral oximetry using 7600 Equanox was started and continued until 7 days or discharge, whichever came first. Patients who were younger than 18 years, expected survival less than 48 hours, being considered for withdrawal of care were excluded from enrollment.CPP and cerebral oxygenation values were used for analysis. Aberrant values of oximetry were discarded prior to data analysis. The association between outcome was analysed using chi-square against percentage of CPP values between 50-70 and cerebral oxygenation values above 60%

Data for 6 patients and 541 hours of recording was available for analysis of CPP.5 patients had combination of traumatic SDH,IPH and SAH.1 patients had malignant MCA stroke.3/6 patients died. Survivors had greater time within the target CPP compared with non-survivors(49.51%vs30.15%,chi-square=20.82,p< 0.001).Data for 14 patients was available for analysis of oximetry values with 980 hours of data.10 patients had a combination of traumatic SDH,IPH and SAH,3 patients had malignant MCA stroke and 1 patient had non-convulsive status.7/14 patients died. Cerebral hypoxemia (defined as oximetry value below 60% measured by 7600 Equinox) was detected in 2.83% of monitoring time in survivors compared with 7.96% in non-survivors (chi-square=24.53,p< 0.001)

Cerebral hypoxia detected by 7600 Equinox were more common among nonsurvivors in acute brain injury. Whether cerebral oximetry-guided cerebral perfusion optimization strategy will affect outcome in acute brain injury is unknown. Further studies using longer monitoring and more patients are needed to confirm these findings Financial Support: 7600 Equanox was provided by Nonin Inc.

The growth of Neurocritical Care (NCC), restrictions placed on resident work-hours, and the need for consistent, competent care providers all have increased the need for nurse practitioners (NPs) with specialized training in NCC. While this need is present the description of how to adequately prepare NCC NPs is yet to be consistently established. The purpose of this abstract is to understand available literature to support post-graduate education for NPs and to explore competencies and training required to adequately prepare NPs to provide specialized care in a NCC environment.

A literature review to assess existing post-graduate training for NPs was conducted. The programs were qualitatively reviewed for content including program structure and competency and curriculum utilization.

While mostly qualitative program evaluations exist describing individual programs it supports post-graduate education for NPs. The review suggests with a structured post-graduate education program there is a decrease in time to independent practice, increase in job satisfaction and confidence, increase in retention, and improved compliance with practice guideline (Bahouth & Esposito-Herr, 2009; Brown, Besunder, & Bachmann, 2008; Flinter, 2011; Harrington, 2011a) . Only 2 reviews include NCC NP evaluations and none describe standardizing competencies for training in NCC.

The lack of standardized NCC NP competencies weakens the ability to effectively evaluate and compare NCC NP residency programs throughout the country. The proposed solution is the development of an NCC NP residency structured within a Doctorate of Nursing Practice (DNP) program with support from national societies in neuroscience such as the Neurocritical Care Society (NCS) and the American Association of Neuroscience Nurses (AANN) in order to collaborate and establish minimal competence required to safely practice NCC.

Healthcare providers today are under an unprecedented amount of pressure to efficiently deliver safe and effective care despite challenging healthcare environments and limited resources. For stroke care providers, this presents a unique challenge. Acute stroke interventions mandate effective communication across multiple disciplines, settings and phases of care. These challenges have been appreciated by professional and regulatory agencies that are charged with improving patient safety and quality outcomes via consistent implementation of evidence-based guidelines, "meaningful use", and integration of information technology with clinical practice.

An interdisciplinary team involving nursing, physicians, speech language pathology (SLP), pharmacy and information technology built an electronic stroke flowsheet in EPIC to facilitate timely communication and documentation of stroke care across the continuum. Several barriers, including difficulties with Primary Stroke Center metrics compliance, served as catalysts for the implementation of this change. The final product consisted of a separate stroke doc flowsheet with integrated clinical decision support in the form of "Best Practice Advisories (BPAs)", automated consults and targeted clinical prompts. The expectation was that the stroke doc flowsheet would be completed for all patients presenting with suspected acute stroke or who were designated as "stroke alert" status during their hospital stay.

As a result, compliance with stroke metrics improved over a six month time frame (November 2012 through April 2013): documentation of post IV t-PA vital signs and neurological assessments (14.3% to 100%), adherence to safe blood pressure parameters (78.6% to 100%), swallow screen evaluations prior to PO intake (69.8% to 90.4%). In addition, real-time data capture enhanced the ability to maintain door-to-needle times less than sixty minutes in at least 50% of eligible patients.

Well-designed, interdisciplinary electronic medical record enhancements promote quality and patient safety. In addition, having stroke metrics captured in a consistent manner facilitates documentation and subsequent data abstraction.

Rewarming to normothermia is an important step in induced therapeutic hypothermia (TH). Several models have shown that mild TH has anti-inflammatory effects but the molecular changes during subsequent rewarming are not clearly understood. We have previously shown that rats exposed to TH for 2 h show a significant decrease in the mRNA level of IL-6, a pro-inflammatory cytokine. Here, we analyze the gene expression of pro-and antiinflammatory cytokines after rewarming in a model of isolated controlled hypothermia.

Male rats were subjected to TH (32°C for 2 h) followed by a rewarming phase (37°C for 2 h) vs. Control rats (37°C). Gene expression analysis was performed using real-time PCR in samples of peripheral blood taken at the end of the rewarming phase or control.

Rewarming from hypothermia led to a significant decrease in the mRNA levels of both IL-2 (p < 0.05) and IL-6 (p < 0.01) and an increase in the mRNA levels of TNF-RI (p < 0.05) as compared to the normothermic control. The rest of the pro-and anti-inflammatory genes were not significantly different among groups (p > 0.05).

Our data show that exposing rats to TH followed by rewarming to normothermia is associated to a significant decrease in the genetic expression of two pro-inflammatory cytokines, IL-2 and IL-6 and an increase in the genetic expression of the anti-inflammatory cytokine TNF-RI. These findings if reproduced in a larger group of animals exposed to TH and rewarming for longer periods of time, could explain some of the potential neuroprotectant effects of TH in human clinical models.

Short-term therapeutic hypothermia has been linked with higher blood glucose (BG) levels, increased BG variability, and greater insulin requirements. However, no data exists investigating glycemic control in patients undergoing controlled normothermia (CN). The purpose of this study was to analyze BG levels, variability, and insulin requirements during CN.

This was a retrospective cohort study of adult patients with acute brain injury admitted to UNC Hospitals between May 2010 and September 2013 who underwent CN for >24 hours. Data was collected at baseline, 48-hours prior to CN, throughout CN, and 48-hours post-CN.

Twenty-one patients comprising 1119 BG concentrations met inclusion criteria. The mean age was 50 (±17) years and aneurysmal subarachnoid hemorrhage accounted for 48% of admitting diagnoses. The mean days from injury to cooling was 4.4 (±2.4). Median BG was higher during pre-cooling (150±34 mg/dL) compared to CN (130±41 mg/dL) and post-cooling (134±40.5 mg/dL), while BG variability was similar during pre-cooling (51±34 mg/dL) compared to post-cooling (51±37 mg/dL) and lower during CN (44±34.5 mg/dL). Fifteen patients pre-CN, 16 patients during CN, and 12 patients post-CN required insulin. Among patients who required insulin, median BG was higher during pre-CN (160.5±28 mg/dL) compared to CN (150±35 mg/dL) and post-CN (147±40 mg/dL) while BG variability was similar among all groups (Pre:56±31 vs. CN:54±32 vs. Post:55±27 mg/dL). Daily insulin usage was higher during CN (27±47.5 units/day) compared to pre-CN (9±26 units/day) and post-CN (13±42 units/day).

Higher median BG levels occurred during pre-CN, suggesting the acute phase after injury has the greatest impact on elevated BG concentrations. In patients who received insulin, greater insulin requirements during CN compared to post-CN were required to achieve similar median BG concentrations, suggesting an altered response to insulin during CN.

MRI is a good prognosis tool in the various neurological disorders. However, the role of MRI in the prognostication has not been confirmed. We evaluated the possible role of diffusion-weighted imaging (DWI) in the comatose patients who received therapeutic hypothermia after cardiac arrest.

Integrated, team-based therapeutic hypothermia was set on September 2011 and MRI was performed in the comatose patients 72 hours after cardiac arrest per protocol. Clinical outcome was assessed with cerebral performance category. DWI findings, laboratory data, and outcomes of the patients between September 2011 and October 2013 were analyzed. The voxels below different ADC thresholds was calculated at 50 x 10 -6 mm 2 /sec intervals, and % brain volume cut -off was estimated. Qualitative analysis of various brain region was compared.

54 patients (out of 81 patients) received MRI per protocol was included. When the volume less than ADC value 550 x 10 -6 mm 2 /sec was bigger than 7.5% of brain volume or the volume less than ADC value 650 x 10 -6 mm 2 /sec was bigger than 17.8% of brain volume, the sensitivity was 67.7% and 64.5%, respectively with specificity of 95.7% for all (by ROC analysis; AUC, 0.804 and 0.794). Positive predictive value of poor outcome was 100% when ADC value 550 x 10 -6 mm 2 /sec was bigger than 10.9% or ADC value 650 x 10 -6 mm 2 /sec was bigger than 27.6% or ADC value 700 x 10 -6 mm 2 /sec was bigger than 38.2% of brain volume. Analysis of diffusion restriction in the different cortical and subcortical structures revealed basal ganglia, thalami, and occipital lobe as most appropriate target (sensitivity, 74.9%, 71%, 77.4%; specificity 91.3%, 91.3%, 82.6%, respectively; AUC, 0.806 to 0.841) for poor prognosis.

Using both quantitative and qualitative analysis, DWI can improve power of prognostication in patients with therapeutic hypothermia after cardiac arrest.

Even under optimal conditions, cardiopulmonary resuscitation (CPR) generates no more than 20% of normal cardiac output 1 . Low cardiac output, and medications could lead to brainstem reflex depression similar to cardiac tissue stunning 2 .

After IRB approval, we retrospectively reviewed a consecutive series of cardiac arrest (CA) patients treated with therapeutic hypothermia at Mayo Clinic Florida (January2006 to January 2012) and Arizona (August 2010 to March 2014). Cerebral Performance Category (CPC) was dichotomized into good outcome 1-2 and poor outcome 3-5.

We identified 99 patients who had successful resuscitation after cardiac arrest. The mean age 60.5 years (IQR 48-74), male 57 (57.5%) and ventricular fibrillation (VF) 34 was the most common code rhythm. Good outcome was present in 15 of VF and 8 of asystole patients. 29 (29%) had non-reactive pupils at admission exam, of which 8 later had return of pupil reactivity by day 3 of hospitalization (D3). Two of these patients had good outcome

Early absent pupillary reflexes on the first day after resuscitation may result from transient brainstem reflex stunning or possibly code drugs given during CPR. Caution is advised during the first 24 hours in neurological prognostication since a minority of patients ultimately had a good neurological outcome Financial Support: None

Early onset pneumonia affects up to 65% patients undergoing targeted temperature management (TTM) after cardiac arrest. Prophylactic antibiotics (PRO) reduce the incidence of early-onset pneumonia in intubated patients with diffuse brain injuries and coma but have yet to be examined in TTM. We investigated the effect of PRO on the development of pneumonia in cardiac arrest survivors undergoing TTM.

This retrospective study interrogated the multinational Northern Hypothermia Network registry (2004) (2005) (2006) (2007) (2008) . Patients were 18 years old, had a GCS < 8 at hospital admission, and were treated with TTM. There were no formal exclusion criteria. Differences between the PRO and no PRO cohorts were analyzed through a univariate analysis using standard parametric testing. Logistic regression models were created to evaluate the independent effects of various clinical and demographic factors on the risk of developing pneumonia and on the incidence of good functional outcome (CPC 1-2 at 6-12 month follow-up).

Of the 1,240 patients, 416 (34%) received PRO and 824 (66%) did not. Groups were similar in age, gender, arrest location, initial rhythm, and time to return of spontaneous circulation. More PRO patients were cooled via endovascular methods (22.2% vs. 11.5%, p< 0.001). PRO patients had a lower incidence of pneumonia (12.6% vs. 54.9%, p< 0.0001), less severe sepsis (1.2% vs. 5.7%, p< 0.001), and a shorter ICU stay (121 vs. 152 hours, p=0.001) but a similar incidence of good functional outcome (41.1% vs. 36.6%, p=0.19). In the multivariable models, stepwise logistic regression demonstrated PRO was independently associated with a lower incidence of pneumonia (OR 0.09, p< 0.0001) but was not associated with good functional outcome.

Prophylactic antibiotics in patients treated with TTM after cardiac arrest was associated with a reduced incidence of pneumonia but not with improved functional outcome. Further prospective studies on the impact of prophylactic antibiotics are warranted.

Status epilepticus (SE) after cardiac arrest has been known as a predictor of grave prognosis. However, SE is not a definite predictor of poor prognosis favoring the withdrawal of life supports, and small percentage of the patients may benefit from the aggressive treatment. We studied the benefit of aggressive antiepileptic treatments in patients with SE who received therapeutic hypothermia after cardiac arrest.

Integrated, team-based therapeutic hypothermia was set to start on September 2011. SE was aggressively managed with intravenous midazolam and various antiepileptic drugs as soon as possible under continuous EEG monitoring. Clinical characteristics, laboratory data, and outcomes of the SE patients after cardiac arrest between September 2011 and October 2013 were used in analysis.

Total 81 patients (65 men, mean age 55.8 years) were included in the study. SE was present in 23 patients (28.4%), and 78.3% of them (18 out of 23) had myoclonic SE. Good prognosis (CPC 4-5) was found in 17.4% (4 out of 23) of the SE patients, which was in contrast with 40.7% of good prognosis in entire study population. Mortality was found in only two patients (8.7%), although most patients were remained in CPC 4 outcome (16 out of 23, 69.6%). Five patients recovered to fully communicable status were all in cardiac origin (60% non-shockable rhythm), and had 41.8 minute of arrest time. Three of the five good survivors had non-myoclonic SE and successfully treated with antiepileptic drugs. One patient with myoclonic SE had persistent myoclonic seizure, and one patient showed only generalized spikes on EEG without clinical myoclonus.

Considerable number of the SE patients regained their consciousness and 60% of them suffered from nonmyoclonic SE, indicating the importance of identifying myoclonic or non-myoclonic SE. Further study to delineate the positive effect of aggressive antiepileptic treatment should be considered. 

Shivering is a common and problematic side effect of targeted temperature modulation and general anesthesia. Antishivering strategies often employ a combination of pharmacological and physical interventions utilized in a stepwise approach according to institutional treatment protocols. We evaluated the quality of antishivering protocols and guidelines with respect to reliability and strength of evidence-based recommendations.

A total of 3,062 publications were retrieved from four medical databases and 2,445 excluded due to lack of relevance. After applying predefined eligibility criteria with respect to minimal protocol standards, 16 protocols/guidelines remained. Each was assessed using the modified Appraisal-of-Guidelines-for-Research-and-Evaluation-II (mAGREEII). Each of the 23 quality items within 6 domains was applied using a nominal scale (Yes=1, No=0 point; total score range 0-23).

Among the 16 protocols/guidelines, only one embodied systematically reviewed recommendations; the remaining 15 aimed at establishing standardized protocols. 14/16 protocols/guidelines focused on therapeutic cooling in which skin counterwarming and meperidine were most commonly cited. Of all 14 protocols a variety of individual and combination treatments were recommended and their mAGREEII scores were within the lowest quartile ranging from 1 to 6 (median 5). Most commonly unaddressed domains were stakeholder involvement (Domain 2), rigor of development (Domain 3) and editorial independence (Domain 6). 2/16 protocols/guidelines addressed postanesthetic antishivering strategies. Of these two, the ASA (American Society of Anesthesiologists) guideline containing recommendations of forced-air warming device and meperidine received the highest mAGREE II score (14 points); the other protocol suggesting the combination of warming device with clonidine or meperidine had a lower mAGREE II score (4 points).

Current published antishivering protocols/guidelines lack evidence-based recommendations. Only one guideline fulfilled more than fifty percent of the quality items. To be consistent with the most up-to-date, evidence-based practice, future antishivering treatment protocols should optimize methodological rigor and transparency.

Fever in neurologically injured patients is associated with poor outcome. Pharmacokinetics studies have demonstrated comparable bioavailability of enteral (PO) and intravenous (IV) ibuprofen in healthy adults. We hypothesized that fever control in critically ill patients is comparable between IV and PO ibuprofen.

A single-center, retrospective study on patients admitted at Columbia University Medical Center NeuroICU from 2011-2013 and received at least 4 doses of PO or IV ibuprofen in a 24 hour time period. Fever burden was calculated hourly by subtracting each patient's recorded temperature from 37°C. Complications were collected only for the period of drug administration.

There were 39 patients (median age 56; 49% women) with 1505 hours of data (PO: 1090; IV: 450) on brain hemorrhages (54%), ischemic stroke (13%), meningo-encephalitis (18%), and other diagnoses (15%). Median dose of ibuprofen and acetaminophen were 2200 and 650 mg respectively. Mean fever burden was statistically lower with IV vs PO ibuprofen (0.59+/-0.7 vs 0.75+/-0.8, p=0.001). Acetaminophen when administered with ibuprofen regardless of ibuprofen dose or route, resulted in a lower fever burden compared to those who didn't receive acetaminophen for both PRN (0.13+/-0.05 p=0.01) and standing doses of acetaminophen (0.4+/-0.06, p< 0.01). Higher doses of acetaminophen taken with ibuprofen regardless of ibuprofen dose or route resulted in a lower fever burden (0.36+/-0.06, p< 0.01) compared to lower doses (0.16+/-0.05, p=0.002). Complications from ibuprofen included 5 (13%) patients with hemoglobin drop > 2 g/dL, 7 (18%) developed a serum creatinine (mg/dL) >1.5 times from baseline and 7 (18%) developed a platelet drop > 20% from the prior day lab.

Intravenous ibuprofen resulted in better fever control compared to enteral. The combination of acetaminophen to ibuprofen regardless of ibuprofen route or dose results in better fever control than ibuprofen alone. The high complication rates warrant caution with use.

The presenting author has received research support for a different study by Cumberland Pharmaceuticals

Treatment goals for patients with traumatic brain injury (TBI) address minimizing the effects of primary injury and avoiding secondary injury. Targeted temperature management is a strategy to avoid secondary injury following TBI. The purpose of this study was to examine the association between body temperature and neurologic outcome in adults after moderate or severe TBI.

Secondary analysis of 340 patients with moderate or severe TBI (GCS < 13) was completed. Aberrant temperatures were defined as < 36.5°C (hypothermia) or > 37.5°C (fever). Temperature profiles were evaluated in 24 hour increments (0 to < 24; 24 to < 48; 48 to < 72; 72 to 96 hours). Neurological outcome was measured at six months after injury using the Extended Glasgow Outcome Scale (GOS-E).

Eighty-six percent of those patients with any temperature < 36.5°C and 79% with any temperature > 37.5°C in the first 24 hours died. Variability in body temperature over the 96-hour period was significantly associated with GOS-E both in univariate (p=0.000) and multivariate (p=0.035) assessment. When stratified by temperature severity, both mild fever (37.6-38.2°C; p=0.046) and high fever (>39.0°C; p=0.038) were significantly associated with GOS-E. Hypothermia in the first 24-hour period (p=0.018) and fever in the first 24 hours (p=0.012) or the 24 to < 48-hour period (p=0.006) were all significantly associated with GOS-E. Controlling for known predictors of neurologic outcome, fever in the first 48 hours after injury, hypothermia in the first 24 hours after injury, minimum and maximum temperature in the 48-72 hour period, and variation in temperature across the 96-hour period were all predictors of GOS-E.

Body temperature in the 96 hours after moderate to severe TBI significantly influenced neurologic outcome. Controlled normothermia may be a beneficial approach in reducing secondary injury following TBI. Further research is necessary to confirm these findings in a controlled prospective environment.

Financial Support: National Institute of Nursing Research, NIH, Grant #F31NR013813 Gordon and Betty Moore Foundation

Therapeutic hypothermia (TH) has been strongly recommended for post-cardiac arrest (CA) comatose patients by the American Heart Association and the International Liaison Committee on Resuscitation since 2003 but it remains underutilized in the United States (US). With accumulating evidence of benefit, improving techniques, attitudes toward therapy, we studied recent trends and epidemiologic predictors of TH utilization after CA.

We searched the Nationwide Inpatient Sample (NIS) 2006-2011, a stratified random sample of 20% of all hospitalizations in non-federal US hospitals for adults with CA (ICD-9 code 427.5) who underwent therapeutic hypothermia (code 99.81). Logistic regression analysis was performed to identify independent predictors of TH utilization. We calculated TH utilization trends using Mantel-Haenszel test for linear association. Population estimates and variance were calculated using complex sample analysis that accounts for weighting, clustering and stratification used for NIS sampling design. 

There exist significant socio-economic disparities in TH utilization after CA with lower rates of utilization among elderly, females and non-white patients and those with Medicare insurance and low income. Though TH utilization has increased in recent years, a substantial proportion of eligible patients do not receive this treatment. Barriers to the TH utilization need further study.

Shivering is a frequent complication observed in the perioperative and induced hypothermia (IH) settings. Despite effective antishivering pharmacological treatment options, non-pharmacologic (physical) interventions are often employed in order to reduce the risk for adverse drug effects associated with many of these medications. Our objective was to critically evaluate the published evidence of non-pharmacologic antishivering interventions.

4,258 clinical trials on non-pharmacological antishivering methodologies were retrieved as of April 2014 from several medical databases using predefined search terms. After applying exclusion criteria, 62 trials (3,146 subjects) studied non-pharmacological interventions on patients without thermoregulatory dysfunction. Publications were descriptively analyzed by types of clinical setting, comparison of intervention, and study design, and then underwent a quality assessment.

Physical interventions identified were a) active cutaneous warming (forced-air warming, electric heating pad/blanket, radiant heating, and water-circulating mattress), b) body core warming (fluid or gas warming system), c) passive cutaneous warming (space blankets, towels), and d) electroacupuncture. Comparisons against controls were most common (57/72) while 15 studies compared treatments against each other. Clinical settings included a) perioperative setting without IH (55/72) and b) with IH (9/72) and c) IH without anesthesia (8/72). Active cutaneous warming was most commonly studied (32/72) and consistently reported better outcomes than controls in all three settings. In contrast, results from studies investigating passive cutaneous warming and body core warming were contradicting. Evidence for the usefulness of electroacupuncture was lacking. Comparison evaluations among different interventions were inconclusive due to the paucity and heterogeneity of studies comparing directly different interventions against one another.

Comparative assessment of the effectiveness of non-pharmacological antishivering methods delineates active cutaneous warming as the most effective non-pharmacologic intervention. However, the heterogeneity of the published evidence, lack of adequately designed studies, and relatively low number of intervention comparison trials precluded statistically appropriate analysis for definitive evidence-based recommendations.

Short-term therapeutic hypothermia (TH) has been linked with higher blood glucose (BG) levels, increased BG variability, and greater insulin requirements. No data exists investigating glycemic control during prolonged TH. The purpose of this study was to analyze BG levels, variability, and insulin requirements during prolonged TH.

This was a retrospective cohort study of adult patients with acute brain injury admitted to UNC Hospitals between May 2010 and September 2013 who underwent TH for >24 hours. Data was collected at baseline, 48-hours prior to TH, throughout TH, and 48-hours post-TH.

Sixteen patients comprising 1071 BG concentrations met inclusion criteria. The mean age was 41±18 years and TBI accounted for 56.3% of the admitting diagnoses. The mean days from injury to cooling was 2.8±2.4. Median BG (143±25.5 vs. 110±35.25 vs. 116.5±28.8 mg/dL) and BG variability (82±71 vs. 46±53 vs. 61±29 mg/dL) were higher during pre-TH compared to TH and post-TH, respectively. Nine patients during pre-TH and TH and 7 patients during post-TH required insulin. Among patients who required insulin, median BG (147±34 vs. 133±35.5 vs. 132±10.5 mg/dL) and BG variability (96±111 vs. 75±68 vs. 61±22 mg/dL) were higher during pre-TH compared to TH and post-TH. Insulin usage was higher during TH (34±60 units/day) compared to pre-TH (18±25.5) and post-TH (4±4 units/day). More patients who received insulin experienced at least one hypoglycemic event during TH (33.3%) compared to pre-TH (11.1%) and post-TH (0%) and at least one hyperglycemic event during pre-TH (77.8%) compared to TH (55.6%) and post-TH (42.9%).

Higher BG levels and increased variability occurred during pre-TH, suggesting the acute phase after injury has the greatest impact on BG and variability. In patients who received insulin, greater insulin requirements, increased BG variability and more hyper-and hypoglycemic events occurred during TH compared to post-TH, suggesting an altered response to insulin during TH.

Critically ill patients have been shown to exhibit a hyperdynamic response and sustained elevation of creatinine clearance, termed augmented renal clearance (ARC). Controlled normothermia (CN) is utilized in patients with acute brain injury to manage fever. Therapeutic hypothermia has been shown to decrease metabolic rate. However, no data exists investigating the impact of ARC and controlled normothermia on achieving target vancomycin therapeutic concentrations. The purpose of this study was to evaluate pharmacokinetic parameters of vancomycin in patients with acute brain injury undergoing CN.

This was a retrospective cohort study of adult patients with acute brain injury admitted to UNC Hospitals between May 2010 and March 2014 who underwent CN and received vancomycin. Predicted PK parameters based on population data were compared with calculated PK parameters based on serum concentrations.

Seventeen patients comprising 24 vancomycin steady-state serum concentrations met inclusion criteria. Aneurysmal subarachnoid hemorrhage (47%) and traumatic brain injury (41%) accounted for the majority of admitting diagnoses. Serum concentrations were obtained a median of 3.5±4 days into CN. Patients had a median creatinine clearance of 121±70 mL/min and median volume of distribution of 58.1±16.1 L, estimated according to standard methods. The median dosing regimen was 17.1±5.7 mg/kg every 8±2 hours. The median measured trough concentration (10.8±5.9 vs. 17.2±11.2 g/mL;p=0.001) and median calculated half-life (4.6±2.3 vs. 6.7±3.3 hr;p=0.043) were significantly lower than predicted values. The median calculated elimination rate constant (0.15±0.059 vs. 0.105±0.064 hr -1 ;p=0.044) was significantly higher than the predicted value.

Patients with acute brain injury who underwent CN exhibited PK alterations favoring increased elimination of vancomycin when compared to predicted PK parameters based on population data. This suggests that the elevated renal elimination of vancomycin due to ARC outweighs a potential reduction in drug elimination caused by CN, which may result in serious complications as a consequence of undertreatment of infections.

Critically ill patients have been shown to exhibit a hyperdynamic response and sustained elevation of creatinine clearance, termed augmented renal clearance (ARC). Pentobarbital infusion and prolonged induced moderate therapeutic hypothermia (TH) decrease the metabolic rate and are used for complications associated with acute brain injury. No data exists investigating the impact of ARC, TH, and pentobarbital on achieving target vancomycin therapeutic concentrations. The purpose of this study was to evaluate pharmacokinetic parameters of vancomycin in patients with acute brain injury undergoing TH or pentobarbital infusion.

This was a retrospective cohort study of adult patients with acute brain injury admitted to UNC Hospitals between May 2010 and March 2014 who underwent pentobarbital infusion or TH and received vancomycin. Predicted PK parameters based on population data were compared with calculated PK parameters based on serum concentrations.

Ten patients comprising 14 vancomycin steady-state serum concentrations met inclusion criteria. Traumatic brain injury accounted for 50% of admitting diagnoses and serum concentrations were obtained a median of 4±4 days into TH or pentobarbital infusion. Patients had a median creatinine clearance of 122±63 mL/min and median volume of distribution of 57.8±16.1 L, estimated according to standard methods. The median dosing regimen was 15.7 mg/kg every 8 hours. No significant differences were found for the median measured compared to predicted trough concentration (15.5±6.3 vs. 15.9±13.2 g/mL;p=0.818), median calculated compared to predicted elimination rate constant (0.107±0.027 vs. 0.107±0.047 hr -1 ;p=0.982), and median calculated compared to predicted half-life (6.5±1.9 vs. 6.5±3.6 hr;p=0.945).

Patients with acute brain injury who underwent pentobarbital infusion or therapeutic hypothermia did not exhibit PK alterations when compared to predicted PK parameters based on population data. This suggests that the decreased metabolic rate caused by therapeutic hypothermia and pentobarbital infusions may counterbalance the augmented renal clearance experienced by patients with acute brain injury.

Cases of sudden unexpected cardiac death in lower brainstem infarction have been described the literature. However, the pathogenesis surrounding the mechanism of cardiac arrest is not well understood. We report a case of sudden death in a patient who presented with acute lateral medullary syndrome.

This is a case review with review of previously described case reports (Pubmed search). Our patient presented with a clinical diagnosis of acute lateral medullary (Wallenberg) syndrome with CTangiography notable for occluded left vertebral artery. As part of stroke evaluation, cardiac biomarkers, electrolytes, echocardiography, and ECG were all normal and the patient had no previously known cardiac pathology. The patient was monitored on telemetry during admission, demonstrating no arrhythmias until the time of sudden unexpected cardiac arrest.

Because of prominent dysphagia, we placed a nasogastric tube (NGT) in the gastric antrum under real-time bedside electromagnetic guidance (Cortrak®). However 15 minutes after placement of the NGT, the patient developed severe bradycardia, progressing to asystole. Return of spontaneous circulation only occurred after 60 minutes of CPR including transvenous cardiac pacing. Family eventually withdrew care.

This case highlights a rare potential complication of lower brainstem ischemia culminating in sudden cardiac arrest. This poorly understood manifestation seems different from well-described sudden cardiac arrest in supratentorial lesions, which usually present as ventricular tachycardia/ ventricular fibrillation followed by asystole and circulatory collapse. In this case, we speculate that brainstem ischemia influencing cardiac and respiratory centers created autonomic dysregulation and vagal overtone in the setting of vagal stimulation from NGT placement led to severe parasympathetic overflow (storm) and culminated in severe bradycardia and asystolic cardiac arrest. In conclusion, rare, yet fatal arrhythmias occur in acute brainstem ischemia, and particularly in lateral medullary syndrome and may be potentially avoidable. We suggest avoiding procedures or maneuvers that may be associated with increased vagal overtone.

Hemorrhagic transformation (HT) is a feared complication of intra-arterial (IA) thrombolytic therapy in patients with acute ischemic stroke (AIS). Predictors of HT in the era of mechanical thrombectomy are not well established. The aim of our study was to evaluate the frequency of HT and its predictors in a series of patients with AIS treated with either IA thrombolysis and/or mechanical thrombectomy outside a clinical trial.

We evaluated a database of consecutive patients admitted to a Brazilian tertiary hospital with AIS treated with either IA thrombolysis and/or mechanical thrombectomy from January 2009 to December 2013. Categorical comparisons were made by the chi-square or Fisher exact test. We used logistic regression analysis to investigate predictors of any HT.

Forty-eight patients were treated. The median baseline National Institutes of Health Stroke Scale score was 16 [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , and mean age was 68.8+/-16.5 years. A total of 33.3% of the patients were treated with IA thrombolysis and mechanical thrombectomy (solitaire and/or penumbra devices used), 22.9% received only IA thrombolysis, 22.9% only mechanical thrombectomy, 12.5% intravenous (IV) rtPA followed by mechanical thrombectomy, 6.4% IV rtPA followed by mechanical thrombectomy and IA thrombolysis and 2% of the patients received only IA thrombolysis. Any 

In this real-world series of patients treated with IA thrombolysis and/or mechanical thrombectomy the burden of ischemic lesion at admission measured using the ASPECTS scores was the only independent predictor of HT.

We report a case of recurrent ischemic strokes resistant to anticoagulation as the first manifestation of poorly differentiated carcinoma (PDC) of unknown etiology. It is first case reported in the literature.

Case Report: A 57-year-old male patient presented to our hospital with non fluent aphasia. Clinical examination revealed a right inferior quadrantanopsia, a right upper extremity hemiparesis, and aphasia. MRI of the brain showed acute infarcts in multiple vascular territories. A 4-vessel cerebral angiogram was normal. Work-up for systemic vasculitis was unremarkable but the hexagonal phase phospholipid neutralization test was abnormal. A systemic anticoagulation was recommended by Hematology team. While the patient was in rehabilitation, he started complaining of abdominal pain. A CT of the abdomen showed heterogeneously enhanced lesion within the lower pole of the right kidney and bulky extensive lymphadenopathy involving the retroperitoneum, gastrohepatic ligament and retrocrural regions. Prior to scheduled a biopsy, the patient developed dysarthria and worsening of his language deficit. He was readmitted. Repeat brain MRI showed new areas of acute ischemic infarction scattered on multiple vascular territories despite adequate anticoagulation. Within 24 hours, the patient's mental status declined. Repeat Brain MRI showed further development of new ischemic infarction affecting multiple cerebral vasculature. Lymph node biopsy revealed poorly malignant carcinoma of unknown primary.

Discussion: Recent study showed that infarction in multiple vascular territories in stroke patients associated with cancer is significantly elevated (34%), compared to 15% of stroke patients not associated with cancer. It may be prudent to include neoplastic screening in cryptogenic stroke evaluation, especially if multiple vascular territories are involved without clear embolic source. Despite adequate anticoagulation, our patient continued to have new embolic infarction leading to his death. Whether early diagnosis and aggressive chemotherapy prior to the recurrence of the patient's strokes could have made a difference is unknown.

Patients and families frequently inquire about the likelihood severe stroke survivors will ever return home. While a survival benefit with Decompressive Hemicraniectomy (DHC) in older adults was shown in DESTINY II, improvement in disability is controversial. To better inform decision-making, we estimated rates of mortality and location of long-term care with a nationwide retrospective cohort of ischemic stroke patients over the age of 65 following DHC.

Cases were identified by ICD-9 principal diagnosis codes for Acute Ischemic Stroke (434.x and 436.x) from all Medicare fee for service hospital discharges from January 1, 2008 to December 31, 2008. Inclusion criteria consisted of ICD-9 procedure codes for craniectomy within seven days of the index admission. Secondary ICD codes for traumatic head injuries and spontaneous cerebral hemorrhage were excluded. A per-person chronological history of health care utilization and location of care, including being a long stay nursing home resident, was developed using linked Medicare Part A, Part B, Minimum Data Set Assessments, and Online Survey, Certification and Reporting (OSCAR) files. Mortality rates were calculated from Medicare enrollment files.

Among 397,503 ischemic stroke cases identified, 152(.04%) underwent DHC. Median age was 71, 53% were male, 78% were white. The 30-day acute hospital readmission rate was 25%. One and two year mortality rates were 53% and 57% respectively. Among survivors, 24% were in a nursing home at 1 year, and 15% at 2 years. One-third of the total cohort (33.5%) returned home by one and two years after stroke and DHC.

U.S. mortality rates for older persons undergoing DHC are similar those found in DESTINY II. A large proportion of surviving DHC patients return home. Further study of caregiver quality of life may provide useful insights for discussing outcomes after DHC with patients and families.

Diastolic dysfunction (DD) is associated with an increased risk of mortality in subjects with myocardial infarction, and even in the general population. We hypothesized that DD has a negative impact on functional outcome and mortality in patients with acute ischemic stroke

We consecutively included 503 patients with ischemic stroke. Transthoracic echocardiography and tissue Doppler image were used to evaluate diastolic function and DD grading. We used logistic regression and Cox-regression analyses to examine an independent relation of DD with functional outcome and mortality, respectively.

Included patients were male dominance (male, 63%) and age was 67.2 ± 11.8. A parameter of diastolic function, E/e' (Early mitral inflow velocity/early diastolic mitral annulus velocity), was independently associated with unfavorable outcome at 3 months and mortality after ischemic stroke. The patients with E/e' of > 14 (the highest quartile) have a 3-fold increased risk of unfavorable outcome (odds ratio, 2.97; 95% confidence interval [CI], 1.61-5.48) compared to those with E/e' of < 8.8 (the lowest quartile). In addition, corresponding hazard ratio for mortality was 4.74 (95% CI, 1.64-13.66). Compared with patients having normal diastolic function, those with moderate-tosevere DD had a greater risk of unfavorable outcome (odds ratio, 2.66; 95% CI, 1.10-6.41) and mortality (hazard ratio, 6.75; 95% CI, 1.81-25.15). Furthermore, these associations were consistent across stroke subtypes and in sensitivity analyses.

Diastolic dysfunction is associated with poor neurologic outcome and mortality in patients with acute ischemic stroke.

Controversy exists as to the management of cervical artery dissection. Medical management with either antiplatelet agents or anticoagulation is considered first line treatment, but endovascular therapy may be used to manage patients with carotid dissections that have flow limiting stenosis that fails to respond to medical therapy.

Case series at a tertiary care medical center.

Patient one was a 55-year-old man that presented two weeks after a MVA with transient neurologic symptoms. MRI was negative for diffusion restriction but MRA revealed a severe narrowing of the right internal carotid artery (ICA) lumen extending from the proximal ICA to the distal cervical ICA, consistent with acute right ICA dissection with flow limitation. Diagnostic angiogram confirmed a flow limited cervical right ICA stenosis. Several hours post procedure patient developed perfusion dependent symptoms. Repeat angiogram showed delayed anterograde grade flow through the dissected segment. Five stents were placed from the origin to the petrous segment of the internal carotid artery and anterograde flow was restored. Patient two was a 53-year-old man that presented after multiple episodes of neurologic symptoms. MRA showed left ICA dissection immediately distal to the bifurcation with reduced flow. MRI showed two acute punctuate infarcts in the left MCA distribution. Patient was discharged on therapeutic coagulation, but returned several days later and repeat MRI showed a new infarct. On re-admission angiogram showed non opacification of the cervical and proximal petrous segments of the left ICA. Five stents were placed extending from the origin to the petrous segment of the internal carotid artery and flow was restored. Post intervention carotid ultrasounds confirmed stent patency in both patients. Both patients did clinically well, with resolution of their neurological symptoms.

These cases illustrate situations of flow compromise due to cervical artery dissection successfully treated with stenting. In assessment of dissection patients, flow limitation should be considered during evaluation and stenting may be considered a therapeutic option.

Financial Support: None ePoster 79 ___________________________________________________________________________________ 

Thrombectomy is considered an option for all stroke patients who are either not or failed candidate for intravenous thrombolytic. Objectives: To identify the rate of recanalization and outcome in acute ischemic stroke patients with MCA occlusion who underwent thrombectomy using Solitaire retrieval device.

Retrospective review of all consecutive MCA thrombectomy cases from June 2013 to March 28, 2014. Outcomes were measured using NIHSS and mRS.

18 patients including 2 failed IV tPA patients with MCA occlusion underwent thrombectomy. The mean age was 70±14 years old, mean NIHSS 17.1±1.4, 67% female and 33% were 80 years or older. Conscious sedation was given to all but two who were intubated due to the initial impact of stroke. Mean time to MCA microcatheter placement was 30±3 minutes. Compete recanalization (TICI3) was observed in 89% and partial (TICI2a) 11% with mean time of recanalization from groin puncture of 65±6 minutes. Immediate post procedure 10 point improvement of NIHSS was observed in 50% cases including 3 with NIHSS 0. 24 hours 10 point improvement was observed in 67% cases including 33% with NIHSS 0. 44% were discharged home directly from critical care unit. 30 days good outcome (mRS 2 or less) was observed in 12 cases (66%) (mRS 0 = 3, 1=6, and 2=3). Two patients who were intubated at presentation died due to the withdrawal of care. Poor outcome (mRS 4) was observed in 3 cases Poor outcome was observed on those who had NIHSS close to 20 or higher and or were intubated at presentation.

Solitaire thrombectomy achieves a very high rate of recanalazitation in MCA occlusion which results in an early neurological recovery and good clinical outcome irrespective of patient gender, age and site of occlusion. Therefore, new generation thrombectomy should offer to all ischemic stroke patients who have large artery occlusion.

Extracellular matrix (ECM) plays a key role in cell function and differentiation of stem/progenitor cells. After stroke, several changes in the native ECM occur that inhibit regeneration of brain tissue. However, very little is known about central nervous system (CNS) cell interaction with CNS-ECM. Polylysine is a positively charged molecule that is widely used in cell culture of CNS cells. We hypothesize, that post stroke CNS-ECM modified with polylysine will enhance neurite outgrowth.

Central nervous system ECM was isolated from rat brains 7 days after middle cerebral artery occlusion from the ipsilateral stroke hemisphere and the non-stroke contralateral hemisphere and used to coat 6 well plates. Five groups were used; Stroke-ECM, Normal-ECM, 10% Polylysine, and 10% Polylysine-Stroke-ECM and non-coated wells. Neurons were isolated from E19 rat brains and plated at 2x10 5 cells/well. Cells were incubated for 10 days. Each group was blinded and the number of neurites in 10 random fields (10x) were counted. The length of neurites was then measured for each group. 

Polylysine modification rescued the functional ability of stroke-ECM to support CNS cells neurite outgrowth. These data provide evidence that modification of ECM after stroke may enhance/promote potential novel cell therapies after stroke. 

Intracranial aneurysm was considered an exclusion criteria for intravenous (IV) thrombolysis in acute ischemic stroke in both NINDS and ECASS III studies, possibly due to a hypothetical increase in the risk of bleeding from the aneurysm rupture. On the other hand, aneurysm multiplicity has been shown to be a significant predictive factor for rupture of intracranial aneurysms less than 5mm in diameter. We sought to determine the safety of acute reperfusion therapy in acute ischemic stroke patients with pre-existing multiple intracranial aneurysms.

We retrospectively examined the medical charts and cerebrovascular images of all patients treated with IV thrombolysis for acute ischemic stroke in our center from the beginning of 2006 till the end of April 2014. Those with evidence of multiple unruptured intracranial aneurysms on their cerebrovascular images prior to acute reperfusion therapy were identified. Post thrombolysis brain imagings were reviewed to evaluate for any aneurysmrelated or distant intraparenchymal or subarachnoid hemorrhages.

A total of 637 patients received IV thrombolysis in our center during a 9.4 years period. 33 (5.1%) were found to have at least one intracranial aneurysm, out of those 7 (21.2%) had more than one aneurysm. Five patients received only IV thrombolysis and 2 received combination of IV and intra-arterial thrombolysis. The size of the largest aneurysm was 7.5 mm in diameter (Range: 2 mm to 7.5 mm). In those 7 patients, a total of 16 aneurysms were identified. Six were fusiform, 1 was bilobed saccular and the rest were unilobed saccular aneurysms. None developed any symptomatic intracranial hemorrhage.

Our findings suggests that aneurysm multiplicity does not increase the risk of aneurysmal hemorrhage with acute reperfusion therapy in acute ischemic stroke patients who harbor unruptured intracranial aneurysm less than 7.5 mm in diameter. 

Cerebellar ischemic strokes are known to carry significant risk of early edema which may lead to brainstem compression and death. Earlier identification of patients who are likely to need decompression may improve outcomes. In this study, we aimed to identify clinical and radiographic predictors of medical or surgical intervention in patients with cerebellar ischemic stroke.

This was a retrospective study of all patients with cerebellar ischemic strokes on head CT admitted to our ICU from 2010 through 2013. Patients who had withdrawal of care were excluded. The primary outcome was the need for one or more of these interventions: osmotic therapy, extraventricular drainage (EVD) or surgical decompression. Binary logistic regression was performed to determine predictors of intervention. Predictors of interest included age, GCS, time from onset to scan, the presence of bilateral infarcts, volume of infarction, and a ratio of infarct volume to posterior fossa volume (nVolume).

Forty-six patients with cerebellar ischemic stroke were included. Mean time from stroke onset to CT was 48 hours. Eighteen patients (39%) required intervention, of whom five needed medical intervention, and 13 received surgical decompression. The mean infarct volume for those who did not require any intervention was 24.1 ml versus 45.8 ml in those who did (p< 0.001). Age, GCS, time from onset to scan, and the presence of bilateral infarcts were not significant predictors. Infarct volume did predict intervention, with an OR = 4.0 (95% CI 1.6-10.0) for every 10 ml increase. In a ROC curve analysis, nVolume achieved an AUC of 0.91 (95% CI 0.82-0.99), and an optimal cutoff of 0.28 had 86% sensitivity and 89% specificity for needing intervention.

Infarct volume is a strong predictor of deterioration. It may be possible to identify a volumetric threshold on initial head CT that necessitates further intervention.

Discharge to acute rehabilitation (rather than a nursing facility) is known to improve outcomes in patients with acute stroke. Unfortunately, a number of patients are often excluded because of concerns regarding alertness or attention. Trials of neurostimulants have sometimes been attempted in such situations; it is the objective of this retrospective study to see if such practices have affected disposition outcomes.

A list of all inpatients with ischemic or hemorrhagic stroke who received neurostimulants (amantadine, bromocriptine, or modafinil) over a one year period was obtained, in addition to their age, initial NIHSS, time to initiation (TTI) of neurostimulant, and serial rehab evaluations. This cohort was then compared with a control group of "closest match" pairs (stroke type, NIHSS, age, gender) from our institutional Get With the Guidelines (GWTG) data over that same year.

48 patients were included in the initial cohort-35 with ischemic strokes (mean NIHSS 16.1, age 75.3, TTI 6.1 days), and 13 with ICH (NIHSS 16.2, age 74.7, TTI 7.9 days). These were matched with 35 ischemic (NIHSS 16.0, age 75.4) and 13 hemorrhagic strokes (NIHSS 16.3, age 74.2) from the GWTG database. Of ischemic strokes, for both the neurostimulant cohort and GWTG control, 16/35 qualified for rehab on their first evaluation; of the remaining 19, 7 in the cohort (36.8%) and 3 in the control (15.8%) subsequently converted to rehab. With ICH, 5/13 and 3/13 initially qualified for rehab in the cohort and control, respectively; of the remaining, 1/8 (12.5%) and 3/10 (30%), respectively, subsequently converted.

This study suggests that early neurostimulant use may aid in transitioning patients with ischemic stroke, but not ICH, to acute rehab. The patients who did well with neurostimulants had an earlier TTI (4.6 vs. 7.3 days). Further data is pending from the years 2011 and 2012.

Intracranial neoplasms were an exclusion criteria in NINDS-rtPA trial, possibly due to a hypothetical increase in bleeding risk within the neoplasm, and are currently considered a contraindication for intravenous (IV) thrombolysis in acute ischemic stroke patients. Minimal data is available on the safety of IV thrombolysis for acute ischemic stroke in patients with pre-existing intracranial neoplasm. We sought to determine the safety of IV rtPA in such patients through a retrospective hospital based study.

We retrospectively reviewed the medical records and brain imaging of patients who received IV rtPA for acute ischemic stroke from January 2006 to April 2014 at our center. A subset of patients with intracranial neoplasms were identified. We looked into the bleeding rate within the neoplasm in those patients after IV rtPA administration.

637 patients received IV rtPA for acute ischemic stroke, 15 (2.3%) were found to have an intracranial neoplasm. 14 were meningiomas and one was an intracranial lipoma. Two patients had more than one meningioma (2 each). The size of neoplasms ranged from 9 mm to 34 mm in maximum dimension. Among these 15 patients, 13 received only IV rtPA and 2 received IV rtPA followed by Intra-arterial thrombolysis. Symptomatic intracranial hemorrhage occurred in only 1 patient (6.6%) who had a 9 mm meningioma in the right cerebello-pontine angle. Hemorrhage occurred within the area of infarct and was distant from the neoplasm location.

Our findings suggests that IV rtPA administration for acute ischemic stroke does not increase the risk of hemorrhage within benign neoplasms. Their listing in exclusion criteria for rtPA should be reconsidered to assure appropriate use of intravenous rtPA. To the best of our knowledge, our study is the largest study on the safety of IV rtPA for acute ischemic stroke in patients with pre-existing intracranial neoplasms.

Prognostic value of seizures and other abnormal EEG patterns during and after therapeutic hypothermia (TH) has been poorly studied.

This is a retrospective data analysis of consecutive cardiac arrest patients who survived to ICU admission and underwent both TH with goal temperature of 33 degree Celsius, and continuous EEG monitoring for 72 hours at Columbia University Medical Center from 2008 to 2013. Outcome measures were collected via the Cerebral Performance Categories Scale (CPC) at the time of hospital discharge. CPC scores of >3 were considered as bad outcomes. Known predictors of outcomes were used in the multivariate regression analysis using STATA 13.1.

139 patients included had seizure incidence of 35% (49), generalized periodic discharges (GPD) (N=49; 44%), and status epilepticus (SE) 30.2% (42), (myoclonic 60%, non-convulsive 35.7%, and convulsive 4.3%). Patients with seizures, GPD, and SE, in the first 72 hours were approximately 4, 5 and 7 times respectively, more likely to have a poor outcome at discharge (p value< 0.05). A multivariate model adjusting for 1 st day neuron specific enolase levels (median: 27.5), age (mean: 63±17), time to return of spontaneous circulation (median: 25mins), initial rhythm (ventricular fibrillation: 21%, pulseless electrical activity: 44%, asystole: 35%) and bystander CPR (48%), was created and the association for all three patterns remained significant (OR: 5; 6.8, 7.4, p< 0.05) for CPC>3.

Cardiac arrest patients have a very high incidence of abnormal EEG patterns despite treatment with TH. Seizures, status epilepticus, and GPEDs are highly correlated with poor outcome. Clinical trials of anti-epileptic therapy after cardiac arrest are well justified.

Continuous EEG monitoring (cEEG) use is increasing. Advanced cardiovascular monitoring has the potential to create artifacts on cEEG. It's important to recognize the artifacts as they may affect cEEG interpretation. The Edwards LifeSciences Ref/Ox(D750HF75) continuous cardiac output pulmonary artery catheter and the Cheetah Medical Non-invasive Cardiac Output Monitor(CHEETAH NiCOM) are both electrical impulse generators. The phase and frequency are modified by the device's intrinsic control systems, but these artifacts are the result of the electrical signals to the monitors (thermistor and receiver in the Ref/Ox and electromagnetic pulse impulse with the CHEETAH). (7) or CHEETAH NiCOM (23) were retrospectively identified who had cEEGs. All cEEGs were interpreted by a board certified epileptologist.

Ref/Ox catheter ( Figure 1 ): This artifact is typically identified with a high-amplitude spike followed by a slow-wave that spreads over a non-physiologic electrical field across all channels, alternating polarity across the different channels as well as both hemispheres. This is then followed by a rhythmic monomorphic delta discharge at 2.5-3Hz frequencies. This is of higher amplitude in the frontal regions, and lasts until the next spike with the repeat electrical impulse. CHEETAH NiCOM ( Figure 2 ): This artifact is a low-amplitude, rhythmic, monotonous discharge occurring at frequencies of 16-20Hz that mainly involves the parasagittal channels of both hemispheres. This can be seen more posteriorly as well.

The Ref/Ox artifact can be falsely considered epileptic in nature, especially in patients with a severely suppressed background. The Cheetah artifact can be mistaken for a beta discharge in patients who are deeply sedated, which also can be mistaken for a reactive background. New artifacts are being observed on cEEG with advanced cardiac monitors. It is important to recognize that these artifacts may mask the cEEG interpretation or be falsely recognized as epileptic in nature.

Early prognostication in cardiac arrest (CA) is challenging. Continuous EEG monitoring provides real-time evaluation of brain activity. Prior literature has suggested suppression-burst (SB) pattern on EEG is associated with poor outcome. We explored the association between SB and neurologic outcome. We also explored the association between myoclonic status epilepticus (MSE) and other malignant EEG patterns with outcome in patients managed with induced hypothermia (IH).

From April 2010 to June 2013, medical records and cEEG data from patients undergoing IH after CA were retrospectively reviewed. Patients with SB not accompanied by MSE, status epilepticus, seizures, or generalized periodic discharges were classified as "pure" SB. Poor outcome was defined as Cerebral Performance Category score of 3-5 at discharge.

A total of 294 patients were included, and in-hospital mortality was 74.5% (219/294). Pure SB was not associated with mortality (p=0.45) or poor outcome (p=0.1), having a false-positive rate of 19% [95% Confidence Interval (CI): 11-30%] and 35% (CI: 18-66%), respectively. MSE was present in 60 (20.4%) subjects, and was associated with mortality (p< 0.001; FPR 3%; CI:90-99%) and poor outcome (p=0.007; FPR 0%; CI: 84-100%). Two subjects with MSE survived and were discharged to a rehabilitation facility.

Pure SB was not an accurate predictor of mortality or poor outcome in cardiac arrest patients treated with hypothermia. MSE was strongly associated with mortality and poor outcome, however not unequivocally.

Continuous EEG (cEEG) is a non-invasive method to detect metabolic changes of the brain, seizures and status epilepticus in real time. Manual evaluation of cEEG requires skilled staff with profound knowledge of EEG available 24/7 to optimize treatment gain. A computer based method called NeuroTrend was developed that analyses the EEG based on the ACNS' critical care EEG terminology to allow objective and automatized surveillance of EEG.

NeuroTrend scans the EEG for periodic discharges, spike-and-wave, and rhythmic patterns. The detection results are displayed graphically showing localization, frequency, and amplitude of the EEG patterns. The time extent of the detected markers relates to the time extent of the EEG patterns wherefore the visualization of results for several hours or even days per screen becomes feasible. To assess the sensitivity of the method 143 routine and 21 long-term EEGs from 79 patients of an intermediate care unit with a median GCS of 11 (min 3, max 15) were analyzed manually according to the ACNS terminology. The results of the manual analysis were compared to the NeuroTrend results in a 10 minute granularity.

The agreement between NeuroTrend and manual review was 91% for periodic patterns, 95% for rhythmic delta activity and 73% for spike-and-wave patterns. In addition all seizures and stati of the long term EEGs were clearly visible through rhythmic or spike-wave patterns.

The comparison of automatic and manual evaluation of the EEG showed a high agreement for ACNS patterns. The ability to detect electrographic seizures and status epilepticus with NeuroTrend was shown. The graphical representation of automatically detected EEG patterns in combination with other brain monitoring parameters like i.e. ICP will open new ways in multimodal neuromonitoring.

There is limited evidence from retrospective studies how continuous EEG (cEEG) impacts antiepileptic drug (AED) use. We prospectively investigated the impact of cEEG on AED modifications (n-AED) in patients admitted to ICU.

Patients who received any cEEG were prospectively identified and matched to patients admitted in the same week who did not receive cEEG (non-cEEG) for admission diagnosis, age, and gender. Patients admitted with seizures alone were excluded. The primary outcome was n-AED. Main explanatory variables included demographics, number of comorbidities, admission Glasgow Coma Scale (GCSA), durations of ICU and hospital stay, and duration of cEEG. Generalized linear model was used to identify factors associated with AED changes.

222 patients were enrolled, equally divided between cEEG and non-cEEG groups. Mean(SD) number of AED changes (mean-nAED) for cEEG-group was 2.1(2.9), compared to 0.4(0.9) in non-cEEG-group. Comparison between these two groups after controlling for age, GCSA, and seizures at admission, showed that cEEG use (p< 0.0001) and comorbidities (p=0.0047) had significant impact on nAED. Mean-nAED of the cEEG group during hospital stay was 4.3 times that of the non-cEEG group. An increase of 1 comorbidity resulted in 11% decrease in nAED. Mean ICU stay of 18.0(14.1) days for cEEG-group was significantly different from 13.1(13.7) days for non-cEEG-group (p=0.012). Within the cEEG-group, 59.1% had AED changes made before, 43.6% during and 22.9% after cEEG use. Mean-nAED before, during and after cEEG were 0.7(0.7), 1.2(2.5), and 0.3(0.7), respectively. Mean-nAED during cEEG was 4.3 times the changes during the period both before and after cEEG (p< 0.0001). 66.4% of cEEG patients had AEDs started, 38% increased, 14.5% decreased, and 14.5% stopped. 25.4% of non-cEEG patients had AEDs started, 6.7% increased, 2% decreased and 3% stopped.

In this prospective study, cEEG use leads to significantly more AED modifications when compared to non-cEEG patients.

New onset refractory status epilepticus (NORSE) is an uncommon condition characterized by continuous or intermittent seizures without return to baseline that fail to respond to first and second-line AEDs in patients without preexisting history of seizures/epilepsy.

Ten consecutive patients with NORSE were identified from a retrospective chart review of patients admitted with possible encephalitis. NORSE was defined as continuous or intermittent epileptiform activity on EEG for greater than a week that did not respond to >2 anti-epileptic agents. Collected variables included age, gender, duration, number of AEDs, use of immunosuppression, pertinent laboratory and imaging findings, final diagnosis, and discharge disposition.

9/10 patients were females. Mean age was 37 (range 21-61). Four cases were attributed to Anti-NMDA, Anti-VGKC or Anti-GAD antibodies. Three patients had neurosyphilis, HSV and VZV encephalitis, and other cases were secondary to posterior leukoencephalopathy syndrome, cefepime, or cryptogenic causes. The mean duration of RSE was 62 days (range 10-110). Non-specific encephalopathy and fever were the most common presentations. 7/10 patients exhibited CSF pleocytosis/elevated protein with none having low glucose. Only two patients had positive CSF microbiology (HSV, VDRL). Limbic hyperintensities/cortical diffusion restrictions were most common MRI findings (6/10). Acyclovir was the most commonly used antimicrobial (7/10). The mean number of AEDs tried was 5 (range 4-8). Six patients were treated with high dose steroids and intravenous immunoglobulins, three with plasmapharesis, and one with rituximab and cyclophosphamide. One patient had oophorectomy (Anti-NMDA). Patients who received immunotherapy (6/10) had better outcomes (5/6 discharged home). Two patients died (Neurosyphilis, Anti-VGKC), and three other discharged to nursing home (Anti-GAD, cefepime, HSV).

In addition to AEDs, patients with NORSE may require early aggressive immunotherapy and/or initiation of immunosuppressants to achieve adequate seizure control. Better outcomes can be expected in younger patients and patients with autoimmune etiology for NORSE.

Neurologic paraneoplastic syndromes are rare, occurring in less than 0.01% of patients with cancer. In absence of known malignancy/apparent imaging findings diagnosis may be missed or delayed. We present a patient with heavy smoking history who developed progressively altered mental status and new onset seizures.

A 51-year-old male developed headache several days after fishing that gradually progressed to intermittent confusion. He developed progressive gait instability, lethargy, followed by witnessed tonic-clonic seizures he was admitted for treatment of suspected viral encephalitis. The patient had progressive increase in seizures meeting the definition of status epilepticus; as well as refractory SE. MRI of the brain did show focal intracortical FLAIR signal abnormality in the right cerebellar hemisphere which enhanced with contrast and a non-enhancing lesion in the right superior frontal gyrus. EEG demonstrated numerous clinical and electrographic seizures with repeated focal (left T3) onset electrographic seizures with rapid hemispheric and bihemispheric generalization lasting greater than 1 minute in duration on EEG with > 5minutes of generalized postictal suppression with persistent left hemispheric suppression consistent with clinical Todd's paralysis. CSF had lymphocytic predominance; gram stain and cultures were negative. Serum paraneoplastic panel was positive for -GABA B-receptor and N-type and P/Q-type calcium channel antibodies. CT scan of the chest was unremarkable except for an enlarged subcarinal lymph node. Endobronchial ultrasound-guided lymph node aspiration of the subcarinal lymph node was performed; histopathology was consistent with small cell lung cancer (SCLC).

Paraneoplastic syndromes and encephalitis that present as NORSE is rare and should be kept in the differential of 'aseptic meningitis' other than viral entities since it has a different prognosis and workup. In patients with acute or sub-acute neurologic changes in absence of clear alternative etiology evaluation for underlying malignancy even in absence of obvious imaging findings may therefore be warranted.

Introduction T-wave alternans (TWA), a beat-to-beat fluctuation in the amplitude and shape of the T wave in the electrocardiogram has proven to be a noninvasive marker of risk for sudden cardiac death. Following secondary generalized tonic-clonic seizures, TWA was shown to be markedly elevated (~70 V) in the post-ictal period (Strelczyk, Epilepsia 2011:52:2112-7), which exceeds the 47-V criterion for life-threatening cardiac arrhythmia risk. Our goal was to determine whether there is an elevated level of TWA on cardiac monitoring in patients with convulsive status epilepticus in the ICU when compared to their ECG during times in which their seizures were under control.

Single lead electrocardiogram data was exported from the patient's EEG monitor (Natus system), for patients with convulsive status epilepticus (N=4) and were analyzed for TWA using the Modified Moving Average method. Study was approved by BIDMC's Committee on Clinical Investigations.

In patients actively in convulsive status epilepticus, TWA averaged 113 μV. During the times in which the seizures were better controlled their TWA averaged 35 μV. There was a statistically significant difference of 78 μV (SE ± 22.8; p=0.04).

Patients actively in convulsive status epilepticus show an elevated level of TWA, which was significantly higher than when their seizures were under control. Despite the small sample size, a significant difference was found between the level of TWA when in status and when seizures were controlled. These findings are consistent with earlier studies of TWA following a secondary generalized seizure. This marker of life-threatening cardiac risk may be a novel way to predict the potential for cardiac injury in patients with status epilepticus and may provide further understanding of a possible mechanism involved in sudden unexpected death in epilepsy (SUDEP).

Many abnormal EEG patterns on the ictal-interictal continuum such as periodic epileptiform discharges (PEDs) have been described following acute brain injury. Most are associated with poor outcome but it is unclear if these are epiphenomena or cause additional harm. We investigated the frequency-dependent pathophysiological signature of PEDs using multimodality monitoring (MMM) following subarachnoid hemorrhage (SAH).

We identified 60 SAH patients with MMM and determined the average PEDs frequency for each minute of cEEG by visual inspection of the EEG. We performed generalized estimating equation (GEE) analysis to explore the relationship between PED frequency and MMM data.

We found an increase of CPP between PED-frequencies 0 Hz (mean 91.8, standard deviation (SD) 17.6 mmHg) and 1.5 Hz (mean 100.7, SD 15.8 mmHg) and saturated CPP-values at 2 Hz (mean 104.2, SD 15.8 mmHg), 2.5 Hz (mean 104.7, SD 18.6 mmHg) and 3.0 Hz (mean 104.6, SD 17.5 mmHg). PbtO2 was similar at 0 Hz (mean: 28.0, SD 13.7 mmHg), 0.5 Hz (mean: 27.1, SD 10.8 mmHg) and 1 Hz (mean: 27.9, SD 14.7 mmHg), followed by an increase at 1.5 Hz (mean 35.0: SD 14.5 mmHg), and a marked decrease at 2 Hz (mean: 16.8 SD 12.7 mmHg), 2.5 Hz (mean 12.3, SD 2.3 mmHg) and 3 Hz (mean 12.5, SD 3.9 mmHg). GEE-analysis revealed significant differences of all mean CPP values (when compared to mean CPP at 0 Hz) and significant differences of mean PbtO2 values at 0.5 and 1.5 to 3 Hz (when compared to PbtO2 at 0 Hz).

We confirmed the expected increase in cerebral blood flow with increasing frequency of PED discharges. However, despite this increase in blood flow brain tissue oxygenation dropped with higher frequencies suggesting that increased supply did not adequately match the increased demand.

In 2012, Peter W. Kaplan proposed the concept of malignant non-convulsive status epilepticus (mNCSE) which was preliminarily defined as refractory NCSE which remains uncontrolled for at least 5 days even after an initial anesthetic agent (Epileptic Disord, 2012). However, its clinical spectrum is not delineated yet.

We retrospectively investigated the clinical spectrum of consecutive patients with status epilepticus (SE) [generalized convulsive status epilepticus (GCSE) and NCSE] who were admitted to the Center for Stroke and Neurocritical Care in our University Hospital from May 2006 to March 2014. We classified NCSE into five subcategories, that is, 1) mNCSE, 2) recurrent NCSE, 3) protracted NCSE, 4) comatose NCSE, 5) NCSE with postictal organ dysfuctions.

Among the total 1116 patients, 44 patients suffered from SE (3.9%, 30 males, 65±19 years old). Among them, NCSE alone in 22 patients (50%), GCSE alone in 7 patients (16%), Coexistence of GCSE and NCSE during hospitalization in 15 patients (34%). mNCSE patients (n=4) manifested postictal organ dysfuctions in 4 patients, post-hyperventilatory apnea in 2 patients, central alveolar hypoventilation in 1 patient. Underlying conditions of mNCSE were encephalitis in 2 patients, meningoencephalitis in 1 patient, sepsis and cerebral infarction in 1 patient, and mortality reached 50%. In NCSE other than mNCSE (n=33), recurrent NCSE was observed in 3 patients, protracted NCSE 3 patients, comatose NCSE 4 patients, NCSE with postictal organ dysfuctions 9 patients.

NCSE is more frequently observed than GCSE and they often coexist. mNCSE is a fatal condition and is often associated with inflammation of the central nervous system and postictal organ dysfuctions. Also, there exist those patients with critical NCSE other than mNCSE.

Myxedema coma is a rare presentation of severe hypothyroidism that features altered mental status and hypothermia. Although the association between myxedema coma and abnormal electroencephalogram (EEG) findings has been established since the mid twentieth century, seizures have been rarely reported as a complication of this deadly disease. Here we report a case of myxedema coma that presented with a seizure and later progressed to non-convulsive status epilepticus (NCSE).

Case report.

An 86-year-old female with no past history of seizure disorder presented with lethargy and generalized weakness. Physical exam was significant for hypotension, bradycardia, hypothermia of 33°C, hypoventilation and skin puffiness. Initial evaluation revealed hypoglycemia and urinary tract infection. Thyroid Stimulating Hormone (TSH) was elevated to 350 uIU/ml. Patient was intubated and aggressively managed in critical care unit with intravenous (IV) levothyroxine, hydrocortisone and antibiotics. The following day, eyelid twitching, followed by clonic convulsions of the extremities occurred and was successfully aborted with lorazepam. Levetiracetam was initiated. EEG showed semirhythmic generalized slowing with embedded sharp waves, most prominent in bilateral posterior head regions, consistent with NCSE. These electrographical seizures were successfully terminated using a lorazepam challenge test with re-emergence of voluntary withdrawal to painful stimulation. Despite aggressive treatment with IV levothyroxine and antiepileptis under continuous video-EEG monitoring and achieving full control of her NCSE, she developed multi-organ failure which eventually led to her death.

NCSE following myxedema coma is a rare occurrence. Although the exact mechanism is not clear, few patients were described in the literature to have late-onset seizures that were stopped permanently after replacement of thyroid hormones. To our knowledge, this is the third case reported regarding the association between status epilepticus and myxedema coma. Despite major advances in monitoring and treatment, mortality remains high. 

Subarachnoid hemorrhage (SAH) is associated with an intense inflammatory reaction demonstrated by increase in inflammatory markers in serum, CSF and interstitial fluid. The cerebral inflammatory response is associated with delayed cerebral ischemia and worse outcomes. We analyzed whether levels of plasma inflammatory cytokines, differ in patients with aneurysmal SAH (aSAH) compared to SAH patients without an identified cause for SAH on angiography (nSAH).

We prospectively enrolled patients presenting with SAH to a single tertiary academic medical center between 2009 and 2013. Demographic and clinical information was gathered prospectively. Venous blood was drawn within 24 and 48 hours of presentation. A panel of cytokines was measured using a multiplex bead-based suspension immunoassay. Delayed cerebral ischemia was defined as clinical symptoms from vasospasm or infarction on imaging from vasospasm. Poor clinical outcome was defined as a modified ranking of >3 at discharge.

A total of 126 patients were included, 101 with aSAH and 25 nSAH. Between groups there was no difference in baseline characteristics of age, gender and proportion of Fisher Grade 3 (78% v 89%). There was a trend towards worse Hunt-Hess grades in aSAH (poor grades 8% v 25%, p=0.1). There was no difference in poor clinical outcomes between groups. Incidence of DCI was significantly higher in aSAH (4% versus 24%, p=0.02). The nSAH group had significantly higher MIP-1alpha (13.2 vs 5.01 pg/ml, P< 0.01) and TNF alpha (22.5 vs 16.8 pg/ml, p=0.01) levels compared to aSAH patients.

nSAH was associated with a more intense peripheral cytokine reaction compared to aSAH. Despite previous studies that suggest inflammation after SAH is associated with DCI and worse outcomes our findings suggest a more complicated interaction. Further studies to corroborate these findings are needed.

Vasospasm and brain injury following subarachnoid hemorrhage (SAH) are associated with tissue hypoxia and vascular endothelial growth factor (VEGF) release. Soluble Fms-like tyrosine kinase-1 (sFlt-1) is an endogenous VEGF inhibitor released in response to hypoxia and nitric oxide deficiency. We hypothesize sFlt-1 elevation may be associated with vasospasm and poor SAH outcome in human.

We prospectively enrolled consecutive SAH subjects, banked serial blood samples, and measured their outcome at 3 month intervals using modified Rankin scores (mRS). Poor functional outcome was defined as mRS>2.

Angiographic vasospasm was defined as >50% caliber reduction in any cerebral artery on post-SAH day 7 angiogram. In 63 SAH subjects, we compared plasma sFlt-1 by ELISA on post-SAH days 3 and 5 by vasospasm and by outcome status. We used Wilcoxon rank sum or Student's t-test depending on data distribution. Bonferroni correction was applied for multiple comparisons. Logistic regression was used to adjust for confounders.

Twenty-seven subjects (43%) had poor 3-month outcome and 31 (49%) developed vasospasm. Elevated sFlt-1 level on post-SAH day 3 was associated with poor 3-month outcome (p=0.02) while post-SAH day 5 sFlt-1 level showed no association with outcome. SFlt-1 levels were not associated with Hunt and Hess (HH) or Fisher grades or with vasospasm. SFlt-1 was inversely correlated to VEGF (p=0.04, r=0.26). Post-SAH day 3 sFlt-1 level was independently associated with poor SAH outcome after adjustment for HH grade, age, and VEGF level (p=0.03). VEGF was not associated with vasospasm or SAH outcome.

Early elevation of plasma sFlt-1 on post-SAH day 3 is independently associated with poor 3-month SAH outcome after adjustment for clinical predictors of SAH outcome and for VEGF. Inverse correlation suggests possible negative feedback control between sFlt-1 and VEGF in SAH. Replication in a larger cohort is necessary to validate sFlt-1 as a potential biomarker for SAH outcome.

Financial Support: This work is supported by The Harvard Clinical and Translational Science Center, the American Heart Association (10CRP2610341, Chou) and the National Institute of Health -NINDS (K23NS073806 -Chou, R21NS52498 -Ning, R01NS48422 -Ning, R37NS37074 -Lo, P01NS55104 -Lo).

Ischemic lesions secondary to vasospasm in patients with aneurysmal subarachnoid hemorrhage are known predictors of worse outcome. Currently, there is no clinical method or ancillary test that can reliably predict which subset of patients will develop clinical vasospasm. The aim of our study was to find metabolic derangements that could help identify patients at risk

We retrospectively studied 55 patients admitted to a large academic center with aneurysmal subarachnoid hemorrhage. Data from transcranial doppler ultrasound, metabolic and clinical factors, as well as demographic and radiographic information were collected. We used statistical tools (Pearson´s chi-square and Mann Whitney U statistical tests) to analyze which variables were directly correlated with the development of clinical vasospasm.

Of 55 patients, 14 developed clinical vasospasm. Anemia (hemoglobin< 10mg/dl) and leukocytosis (total white blood cell count>10000 cells/mm3) on the third day after bleeding were statistically correlated with the outcome ( p< 0.0329, CI 1.12-15.16, OR 4.1250 for anemia and p< 0.0463, CI 1.03-26.13, OR 5.1818 for leukocytosis). A multiple logistic regression model was performed and the findings were still statiscally significant after adjustment for age, sex and modified Fisher scale. When used as a diagnostic tool on the third day after the intracranial hemorrhage, the occurrence of both anemia and leukocytosis would have a sensitivity of 42%, specificity of 87% and a negative predictive value of 81%, with same findings replicated in patients with mean flow velocities of the middle cerebral arteries lower than 120cm/s on transcranial doppler assessment.

The presence of leukocytosis and anemia during the third day after subarachnoid hemorrhage is statistically correlated with the occurrence of clinical vasospasm. At the same time, the absence of such findings is also a powerful predictor of patients who are at lower risk of developing clinical vasospasm.

Subarachnoid hemorrhage (SAH) is one of the top admitting diagnoses in the Neuro-ICUs. Delayed cerebral ischemia (DCI) associated to cerebral vasospasm occurs in 30% of the patients with SAH. With optimal therapy the mortality remain high. Previous studies have suggested possible efficacy of milrinone in the treatment for cerebral vasospasm. In the current study we outline the safety, efficacy and complications with the use of milrinone in our SAH population.

Study sample included patients with SAH and with a secure aneurysms (37 endovascular, 3 clipping) were enroll. All patients received prophylactic against vasospams (nimodipin). Workup included head CT and lab assessment to ruled out hypoxia, electrolyte abnormalities or other potential triggers of DCI. Vasospasms was confirmed by DSA in all the patients. Milrinone infusion (0.75 mcg/kg/min) was initiated if predefined parameters were met. Dosage was increased until 1.25 mcg/kg/min or neurological sign and symptoms resolved. Vasopressor(norepinephrine) were used if need. If vasospams did not resolve emergency angioplasty was perform.

Milrinone infusion was kept 48 hours after the basal neurological status was achieved and decreased 0.25mcg/kg/min every 24 hours.

40 patients were enrolled (17 males / 23 females; ages 52 to 70, mean 61) with 24 WFNS III, 10 WFNS IV, 6 WFNS V; all had a modified Fisher scale of 3. No patient experienced rebleeding. The mean time for presenting CVS was 4.9 days. The mean duration of CVS was 8 days. The need for vasopressor was 20% (N=8). 28 patients return to the basal neurological status within the first 36 hours, all others also returned to baseline in the next 36 hours. Resolution of CVS was confirmed by DSA in all patients. Only one patient need a emergency mechanical angioplasty. At 12 months follow up 4 patients had died from complications not related to DCI (mostly infectious complications). Good outcome was noted in 92.5% with mRankin score 3.

Milrinone is a safe and effective agent to control vasospasms in patients with SAH. Its vosodilatator and positive inotropic effects may contribute to the beneficial properties noted in our study

Electrocardiographic (ECG) and cardiac enzymatic changes may occur following subarachnoid hemorrhage (SAH). Enzymatic changes are associated with a poor prognosis, but their utility as predictors of poor outcome may be limited by their lower prevalence. We sought to determine if the combination of corrected QT interval (QTc) and ECG changes could predict biomarker elevation, Glasgow Coma Scale (GCS) and mortality.

We reviewed the records of all non-traumatic SAH patients from March 2011 to December 2012 including electrocardiographic changes (ST elevation, T wave inversions or ST depression, anterior or anteroseptal infarcts, any ST or T wave changes) and QTc intervals. Enzymatic changes were dichotomized as troponin T 0.10 ng/mL vs < 0.10 ng/mL, GCS as > 8 vs 8, and mortality as either alive or dead. QTc interval was prolonged if > 500 milliseconds. Statistical analysis was performed by Fisher's exact test.

Electrocardiographic changes were seen in 100 / 159 (63%), and consisted of 10 ST elevations, 20 T wave inversions or ST depressions, 22 anterior or anteroseptal infarcts, and 86 ST or T wave changes. QTc prolongation was found in 64/159 (40%). Troponin T elevations were present in 40/159 (25%). In patients with both QTc prolongation and EKG abnormalities troponin was elevated in 24/49 (49%), compared to 3/47 (6%) with neither EKG abnormality or QTc prolongation, and 22-25% with either EKG abnormality or QTc prolongation. The combination of EKG abnormality and prolonged QTc was strongly associated with troponin elevation (Odds ratio 14.08, 95% CI 3.84-14.50, p< 0.0001), mortality (Odds ratio 8.13, 95% CI 2.94-22.46, P < 0.0001) and GCS 8 (Odds ratio 5.09, 95% CI 2.09-12.40, p< 0.0005).

ECG changes and QT prolongation are more prevalent findings in SAH than cardiac enzymatic changes. When considered jointly, they may predict cardiac injury, lower GCS and increased mortality.

Poor pre-morbid nutritional status has been associated with worse outcomes in critically ill patients. There are few markers of pre-morbid nutritional status which are easily available in hospitalized patients like height, weight, bodymass-index (BMI) and serum albumin. In this study we hypothesized that surrogate markers of nutritional status; albumin at the time of admission and BMI will be associated with mortality and functional outcomes at the time of discharge.

Adult patients >=18 with aneurysmal subarachnoid hemorrhage were enrolled in a single center, prospective, observational cohort database between July 1996 to April 2014. Clinical, radiolographic and outcomes data were collected prospectively. Admission albumin and BMI were assessed for the cohort. Univariate and multivariate logistic regression analysis were performed and controlled for known markers of functional outcomes in patients in SAH. Outcome measures were mortality and a dichmotomized MRS 1,2,3 versus 4,5.

We conducted a binary logistic regression analysis to examine the impacts of surrogate markers of nutritional status; admission albumin and BMI on functional outcomes in 1617 patients. Predictors included age, sex, severity of SAH, presence of vasospasm, hydrocephalus, re-bleed, albumin and BMI. In the multivariate model after controlling for known predictors of functional outcomes in patients with SAH, albumin and BMI were not found to be significantly associated with functional outcomes (BMI OR 1.02, CI 0.99-1.05; albumin OR 1.00, CI 0.99-1.02).

In spite of being important predictors of outcomes in critically ill patients; we did not find BMI and admission albumin to be predictive of functional outcomes and mortality in patients with SAH.

Patients with subarachnoid hemorrhage (SAH) typically exhibit hyperdynamic cardiovascular hemodynamics, which may lead to increased medication clearance. The aim of this study was to evaluate the actual creatinine clearance (CrClA) in an aneurysmal SAH (SAH) population and evaluate how this may impact renally cleared medications.

This was a prospective, single-center study in a neurocritical care ICU at a university hospital. At total of 20 patients were consented and provided a 24-hour urine sample to measure the CrClA. If patients experienced cerebral vasospasm (CV), a 24-hour urine collection was repeated during vasospasm treatment. Serum concentration-time profiles were simulated for multiple IV doses of levetiracetam using Monte Carlo Simulation (MCS) to assess the probability of target attainment (PTA) for attaining levetiracetam trough concentrations of 6mg/L based on the CrClA values obtained in this population.

Among the 20 patients enrolled, the mean baseline CrClA was 689.0 ± 337.8 ml/min/1.73m 2 and this differed significantly from the baseline estimated creatinine clearance (CrClE) 144.9 ± 42.8 ml/min/1.73m 2 (p< 0.001). Four patients developed CV, but their mean CV CrClA was no different than baseline CrClA (814.9 ± 271.4 ml/min/1.73m 2 , p=0.37). MCS suggested that levetiracetam dosing poorly achieved target attainment unless thrice daily dosing was utilized.

Augmented renal clearance appears to be present in patients with recent SAH. The degree of ARC in SAH patients may impact the pharmacokinetics of commonly used agents. More frequent therapeutic drug monitoring for such agents like levetiracetam may be necessary in this population.

Financial Support: None

The use of intravenous (IV) acetaminophen (APAP) may reduce opioid consumption, minimize adverse events, improve pain relief and satisfaction, facilitate earlier recovery, and reduce costs of hospitalization. Currently, no data exist evaluating the effects of IV APAP on pain control in neurocritical care patients. This study evaluates differences in pain scores and the need for rescue medications in patients receiving IV APAP as compared to other analgesics for acute pain in neurocritical care subarachnoid hemorrhage (SAH) patients.

This retrospective study evaluated 157 SAH patients admitted to the Neuroscience ICU between May 2012-2013 who received analgesics < 12hrs after neurosurgical intervention. The mean pain intensity differences (PID) within 6hrs of IV APAP vs. other analgesics were compared. Additionally, the need for rescue medications < 6hrs after the initial analgesic was compared. Data were analyzed using Chi Square, Fisher's Exact or Wilcoxon tests.

Mean pain scores for the IV APAP group (n=15) pre-dose, 0-3hrs post dose, and 3-6hrs post-dose were 2.5, 1.3, and 0.9, respectively. The mean PID for patients receiving IV APAP was 1.6 compared to 0.9 for oral APAP (n=8); 1.8 for fioricet (n=63); 0 for oral opioids (n=3); 2.9 for IV opioid (n=60); and 1.5 for others (n=8) (p=0.2). Rescue medications were needed in 50% of IV APAP patients as compared to 50% receiving oral APAP, 70% fioricet, 100% oral opioids, 70% IV opioids and 100% other analgesics (p=0.2).

The use of IV APAP for acute pain in neurocritical care SAH patients was shown to decrease pain scores over a 6hr period following initial dosing, with only 50% of patients receiving rescue medications. Although beneficial trends were observed for IV APAP, outcomes were statistically comparable to other agents including oral APAP, opioid analgesics and fioricet. Larger studies need to be conducted to determine optimal pain management therapies.

Financial Support: Brophy: Speakers bureau Cadence Pharma (no activity for > 12 months)

The purpose of this study was to examine the incidence of early vs late nosocomial infections after subarachnoid hemorrhage (SAH) and to explore associations with delayed cerebral ischemia (DCI) and clinical outcome.

This is a retrospective cohort study of SAH patients admitted to a tertiary academic medical center from January, 2012 -June, 2013. Definition of ventriculitis/meningitis, pneumonia, blood stream infections, urinary tract infections and Clostridium difficile were adapted from IDSA practice guidelines. Nosocomial infections were categorized into two groups early (before 7 days) and late (after 7 days). DCI was defined as a clinical change due to vasospasm or an infarction on brain image secondary to vasospasm. Poor outcome was defined as a modified rankin scale of >3.

A total of 119 patients were included in our analysis. 40(34%) developed a nosocomial infection. 16 (13%) were early infections and 25 (21%) were late infections. UTI 20(17%) and pneumonia 13(11%) were the most common infectious complications. There were no identified significant risk factors for the development of early infection. Presence of early infection was not associated with an increase rate of DCI or an increase rate of poor outcome. Late infections were associated with presence of IVH (48 % vs 52 %; p=0.04), respiratory failure (72 % vs 26 %; p=< 0.01) and DCI (48 % vs 14 %; p=< 0.01). The occurrence of late infections was significantly associated with longer hospital length of stay and poor outcomes at discharge.

Pneumonia and UTI were common infectious complications. Early infections were not associated with DCI and did not significantly impact clinical outcomes at discharge. Clinical and radiologic severity on presentation was risk factors for occurrence of late infections. Late infections are associated with longer length of stay and worse outcomes at discharge.

Introduction SAH patients have been traditionally treated with significant amounts of intravenous (IV) fluids. HA and crystalloids have been the preferred IV therapy. HA is expensive and its use has been questioned in general ICU populations. Usage of HA in SAH patients in the US is currently unknown. We set out to determine trends in HA usage and associated outcomes.

We studied all adult SAH patients entered into the UHC database from 2009-2013. We collected basic demographics, underlying co-morbidities, severity of illness, type of hospital admission (medical vs surgical), inhospital complications, length of stay (LOS), 30-day re-admission rates, hospital costs, and discharge disposition. We used the Mantel-Haenszel X 2 test to determine the statistical significance of temporal changes in observed outcome and patient characteristics. We evaluated changes in rates of ALB usage by fitting a mixed-effects model with a Poisson link function and state-specific random intercepts, adjusting for age, sex, and race.

We studied 30,464 adult SAH patients: 6,583 (21.6%) received HA and 23,881 (78.4%) did not. Most patients were White (61%) and female (67%). HA use has remained low and unchanged in medical patients but has decreased in surgical cases, especially in higher-volume centers (41% to 24% in centers with > 60 patients per year). Hospital LOS and charges were significantly higher in HA patients (median 21.7 d and $103,864) than in non-HA group (median 12.2 d and $54,638). Home discharges were higher in the non-HA group (50.1% vs 35.3%) and 30-day readmission rates were higher in the HA group (18.6% vs 12.9%).

HA use in SAH patients is associated with higher severity of illness, hospital LOS, and costs. HA use has been declining in surgical SAH patients. The latter may be due to a decline in hypervolemic therapy in recent years.

Aneurysmal subarachnoid hemorrhage (SAH) is associated with a high mortality rate, especially among patients who present with World Federation of Neurological Surgeons (WFNS) grades 4 and 5. The aim of study was to addresses the causes of mortality in the patients who are admitted as WFNS grade 4 and 5.

A consecutive cohort of poor-grade SAH patients (WFNS 4 and 5), admitted to a high-volume SAH center between January 2009 and June 2013, was retrospectively assessed. The primary outcome was in-hospital mortality and its causes.

The study population consisted of 179 poor-grade SAH patients (mean age 56 ±12; 68% female) of which 77 (43%) and 102 patients (57%) were WFNS 4 and 5, respectively. In total, 58 (18%) patients died, of which 46 (79%) were WFNS 5. Thirty-three (57%) patients died before, and 25 (43%) died after aneurysm obliteration. The rate of deaths after aneurysm obliteration were similar (WFNS 4: 10%; WFNS 5: 17%; p=0.33) but significant more WFNS 5 patients died before aneurysm treatment, when compared with WFNS 4 patients (5% and 28%, respectively (p< 0.01)). Five main causes of death were identified (n, %): withdrawal of life support [(WOLS) 33, 57%], death by neurological criteria (16, 28%), cardiac death (3, 5%), rebleed (3, 5%), and refractory intracranial pressure (3, 5%). WOLS and death by neurological criteria alone accounted for 85% of all deaths. The median (±SD) time between hospital admission and death owing to WOLS before and after aneurysm treatment was 2 ±7 and 10 ±58 days, respectively.

The mortality among poor-grade SAH patients in our population was 18%, with the highest risk in WFNS 5 patients without aneurysm obliteration. Withdrawal of life support and death by neurological criteria account for the majority of deaths in this population.

Resting energy expenditure (REE), the caloric requirements needed to maintain vital organ function, is altered with illness, stress, or trauma to the body. Multiple research studies indicate that stroke patients have hypermetabolism up to 140% as a result of increased levels of cytokines and counterregulatory hormones. Provision of adequate calories to meet metabolic demand is crucial in recovery for critically ill stroke patients. Indirect calorimetry is the most accurate method to measure energy expenditure; however cost and lack of access inhibit its use at many facilities. In the absence of indirect calorimetry clinicians rely on the Penn State Equation 2003b to calculate requirements. The aim of this study was to compare measured results of indirect calorimetry to estimated energy requirements calculated by the PSU 2003b equation in critically ill stroke patients.

Ten critically ill, mechanically ventilated patients (mean age 56.5 years, mean BMI 28.2) with diagnosis of subarachnoid hemorrhage (SAH) or ischemic stroke were retrospectively included in this study. Indirect calorimetry was conducted while patients were intubated and results were compared with resting metabolic rate calculated with PSU 2003b.

Eight patients were receiving sedatives at the time of indirect calorimetry with one patient receiving calories from Propofol (218 calories in 24 hours). Enteral nutrition was infusing for eight patients. The enteral regimen was decreased to account for propofol calories. Regression analysis showed poor correlation (r 2 = 0.36) between REE measured by indirect calorimetry and REE calculated with PSU 2003b.

Indirect calorimetry remains the gold standard method to determine REE in hospitalized patients. The PSU 2003b equation underestimates energy requirements in 60% of critically ill stroke patients. Inadequate nutrient delivery in critical illness may delay recovery. Because indirect calorimetry is not available at all facilities, further research studies should address a corrective cofactor for predictive equations used for neurocritically ill patients.

Cerebral venous thrombosis is a rare disorder with an annual incidence estimated to be 3 to 4 cases per million with an increased incidence in pregnant women. We report a challenging case of dural venous sinus thrombosis in a female with known MTHFR deficiency recently started on oral contraceptive pills.

Case: A 49 yo female with known MTHFR deficiency presented to an outside hospital with complaints of a headache that had been continuous for the last two weeks. Of note, she had recently been started on oral contraceptive pills for dysfunctional uterine bleeding. Radiographic imaging revealed a dural venous thrombosis with near complete thrombosis of the right transverse sinus extending into the internal jugular with partial thrombosis of the left transverse sinus. Upon transfer to Vanderbilt, the patient was started on a Heparin drip with a PTT goal of 60-80. Exam was non-focal except for refractory headache. Due to continued clot burden, endovascular thrombectomy was performed. After anticoagulation and intervention, the patient only had continued thrombosis of the anterior portion of the transverse sinus. After intervention, the headache improved and the patient was discharged home on Coumadin therapy with folic acid supplementation.

Venous sinus thrombosis remains a relatively rare cause of intracerebral hemorrhage. The incidence is increased during pregnancy and woman are three times as likely as men to manifest with this clinical syndrome. Risk factors for development include hypercoagulable state, pregnancy, contraceptive use or age less than 40. The majority of patients who are diagnosed have at least one risk factor. MTHFR is the rate limiting enzyme in methionine synthesis. A deficiency in this enzyme may lead to neural tube defects, dementia, colon cancer and occlusive vascular disease.

We sought to characterize the critical care course of patients with acute basilar artery occlusion (BAO) to determine if advances in imaging, thrombolysis and critical care have impacted morbidity.

Retrospective study performed at two large academic centers. BAO patients admitted during a 3 year period where identified and the following variables were abstracted: demographics, time to presentation, NIHSS, BAO occlusion site, use of thrombolysis, infarct location on CT/MRI, and ICU complications (pneumonia, sepsis, extubation failure, myocardial infarction, acute renal failure, acute lung injury, need for gastrostomy, intracranial hemorrhage, withdrawal of care). Fishers exact test was used for categorical variables and proportion of the means test (t test) for continuous.

The sample comprised 59 patients with a median age of 63 (range 35-88) and median NIHSS of 19 (0-37). Men comprised 36/59(61%) of the sample. The median time to presentation was 8 hours (range 1-72). BAO was proximal in 12%, mid in 15%, distal in 39%, multi-focal in 19%, and complete in 15%. 24%of patients did not receive recanalization therapy, while 76% received IV tPA, endovascular therapy, or combination. ICU complications occurred in 61% with the most common being extubation failure in 44%, followed by ICU stay > 7 days in 34%, need for PEG in 29 %, pneumonia in 22%, and sepsis in 20%. Palliative care was instituted in 32%. The leading death cause was withdrawal of care. The most important predictors of complications (any) were NIHSS, intubation on admission, and pontine involvement (p 0.007, 0.01 and 0.03 respectively). The most important predictor of palliative care was age (p 0.02). ICU complications, gastrostomy placement, and extubation failure increased length of stay (P< 0.05 for all).In logistic regression analysis NIHSS was the only predictor of complications.

Despite recent therapeutic advances, BAO patients continue to have complicated ICU stay. NIHSS predicts ICU complications and age predicts palliative care institution.

Neurocritical care patients with primary brain injury and tracheostomy transferred to floor beds are often readmitted and become ventilator dependent. The differences in the incidence of readmission between brain injured and general medical/surgical patients is unknown. Our goal was to identify incidence and patterns of respiratory failure that were directly related to primary brain injury.

Retrospective chart review was conducted on all patients who received a tracheostomy between 2007 and 2013 at a large teaching hospital. Chest x-rays (CXR) were reviewed by independent reviewers. Severity of illness was measured using Sequential Organ Failure Assessment tool (SOFA). Frequencies, percentages, means, and standard deviations were computed. We compared the incidence and reasons for readmission between patients with and without primary brain injury.

Total 1644 ICU patients with tracheostomy (2007-2013). Mean age was 57 years and 61% were men. 58% were Caucasians and 35 % African Americans. 164 (10%) were readmitted to an intensive care unit. Patients with primary brain injury were readmitted with a higher incidence than those from the general medical/surgical patients; 47 of 355 (13.2%) vs.117 of 1289 (9.1%) (p=0.020) even though they had a lower average SOFA score (mean= 4.98 vs. 6) (p=0.039) with fewer medical comorbidities. Of these 47 patients, 29 were readmitted for pulmonary complications including atelectasis, pleural effusions, and pulmonary edema.

Brain injured patients with tracheostomy were readmitted to ICU with greater frequency than general surgical/medical patients even though they had a lower severity of illness scores and fewer comorbidities. They also had a variety of pulmonary complications on CXR that include pulmonary edema, pleural effusion, and atelectasis.

Kidney hyperfiltration with augmented renal clearance is frequently observed in patients with traumatic brain injury (TBI). The aim of this study is to report preliminary findings about the relationship between brain autoregulation impairment, estimated kidney glomerular filtration rate and outcome in critically ill patients after TBI.

Data collected from a cohort of 18 consecutive patients with severe TBI managed with intracranial pressure (ICP) monitoring in a Neurocritical Care Unit were retrospectively analyzed. Early morning blood tests were performed for routine chemistry assessments and we analyzed creatinine and estimated creatinine clearance (CrCl), osmolarity and sodium. Daily norepinephrine dose, protein intake, and water balance were documented. Time average of brain monitoring data (ICP, cerebral perfusion pressure and cerebrovascular reactivity pressure index -PRx) were calculated for 6h before blood tests. Patient outcome was evaluated using Glasgow Outcome Scale at 6 month.

Multiple linear regression models to study the effects of the above variables on PRx throughout time were used.

A total of 194 complete daily observations from 18 adult consecutive multiple trauma patients with severeTBI were analyzed. At hospital admission the median post-resuscitation Glasgow Coma Score was 6 (range 3-12), mean SAPSII score was 44.7 with predicted mortality of 36%. Hospital mortality rate was 27% and median GOS at 6 month after discharge was 3. CrCl was found to have a negative correlation with PRx (R = -0.82), with statistically significant crude (p< 0.001) and adjusted (p=0.001) effects. There was a mean decrease of 0.01 in estimated PRx for each increase of 10 ml/min in CrCl. Amongst possible confounders only norepinephrine was shown to have a significant effect. Mean PRx value for GOS< 3 was greater than mean PRx for GOS 3 (p=0.0225).

Better cerebral autoregulation evaluated with cerebrovascular pressure reactivity index (PRx) is significantly correlated with augmented renal clearance in TBI patients and associates with better outcome.

We attempted to determine the CSF lactate concentrations most likely to correspond to a culture-positive CSF infection, with the aim of making more judicious antibiotic decisions for patients with ventriculostomies.

With IRB approval, we reviewed all CSF lactate concentrations for all patients admitted to an academic medical center from 2008 to 2013. There were 1052 patients with 2998 CSF lactate values. Of these, 51 patients had a corresponding positive CSF bacterial culture. We constructed a receiver operating characteristic curve to determine the CSF lactate concentration that most accurately corresponded to a positive CSF culture.

The area under the receiver operating characteristic curve was 0.72. Using a CSF lactate level cutoff of 4.0 the sensitivity and specificity were 60.8% and 76.4% respectively. Increasing the cutoff to 5.0 gave a sensitivity of 56.9% and a specificity of 86.1%.

This is the first single center study with over 1000 patients to determine an appropriate CSF lactate concentration cutoff value for treating presumed CSF infection in patients with ventriculostomies. Many centers use a cutoff of 4.0 mmol/L. According to this data, using a cutoff of 5.0 mmol/L could result in more appropriate empiric antibiotic use pending culture results. This could reduce adverse antibiotic effects for patients, prevent increasing microbial antibiotic resistance, and conserve healthcare resources.

Basilar meningovasculitis causing diffuse vasospasm is an under recognized complication of CNS cryptococcal infection. We report the first case of intraventricular (IVT) nicardipine used to alleviate reversible vasospasm associated with fungal meningitis.

A 28-year-old immunocompetent male diagnosed with Cryptococcal meningitis treated with one month of amphotericin B, flucytosine, and serial lumbar punctures, presented with lethargy and persistent dysmetria and dysarthria. CSF examination showed clearance of the Cryptococcus fungus but ICP remained high; therefore, an external lumbar drain was placed. After an initial two-day improvement, the patient became lethargic and had alternating episodes of hemiplegia, which progressed to a comatose state and bilateral extensor posturing. Continuous EEG showed diffuse slowing and no seizure activity. An extraventricular drain (EVD) was placed for ICP monitoring, however, pressures remained consistently 20 mmHg. Repeat MRI showed scattered bilateral cerebral ischemia and leptomeningeal enhancement. Diffuse vascular spasm was suspected on computed tomography angiography (CTA). This finding prompted an unsuccessful attempt at angiographic spasmolysis of the bilateral ICAs using intra-arterial verapamil. Initial TCD showed severe right (186 cm/s) and left (220 cm/s) middle cerebral artery (MCA) vasospasm. High-dose methylprednisolone and IVT nicardipine 4mg/2mL every 8 hours were initiated. One hour following IVT nicardipine administration, the MCA velocities improved on the right (110 cm/s) and left (104cm/s). Over the next several days, the patient was extubated, communicative, and tolerating a regular diet. A total of 12 doses of nicardipine were administered. A follow up CTA showed no signs of vasospasm. The patient was discharged to a rehabilitation facility on oral antifungals and nimodipine.

The treatment of elevated ICP associated with Cryptococcal meningitis consists of serial LPs, IV steroids, and CSF diversion. However, no literature exists on the association of cerebral vasospasm in Cryptococcal meningovasculitis or its treatment with intraventricular nicardipine.

Invasive pneumococcal disease is a rare entity in the post-antibiotics era. The extension of the infection to the meninges and adjacent paraspinal spaces has never been described in immunocompetent adults. Here we report a case of pneumococcal meningitis that was complicated by multiple abscesses resulting in both ischemic and compressive phenomena. Detailed neurological examination and neuroimaging studies allowed for rapid recognition and treatment.

Case report.

A 62-year-old psychiatric-facility-resident female presented with new-onset fever and altered mental status. Initial physical exam was significant for hyperthermia of 101°F, mild tachycardia and tachypnea, bilateral withdrawal to painful stimulation, and reactive pupils. She soon became stuporous and endolaryngeal tube was inserted for airway protection. Initial work-up revealed leukocytosis of 22,000/ul with a neutrophilic predominance. Lumbar puncture was consistent with bacterial infection. Blood and CSF cultures revealed Streptococcus pneumoniae. Broad-spectrum antibiotics were initiated and laboratory improvement was noted. Repeat physical examination upon extubation two days later revealed left-sided 3rd nerve palsy and hemiplegia. MRI brain revealed small scattered foci of restricted diffusion consistent with infarcts, but did not explain the left-sided findings. CT angiogram showed complete occlusion of the vertebral artery from an adjacent compressive hypodense collection. MRI spine showed osteomyelitis/diskitis in multiple vertebrae and diffuse prevertebral and epidural enhancing fluid collections representing abscesses causing cervical cord compression. Urgent surgical decompression was performed. She is currently stable and has demonstrated mild improvement in her neurologic status.

Pyogenic epidural and prevertebral abscesses are a rare complication of invasive pneumococcal infection. Epidural infection can injure the nervous system either directly by mechanical compression or indirectly by vascular occlusion. We present a case of severe pneumococcal infection which resulted in multiple abscesses, compressive myelopathy, and ischemic strokes from an occluded vertebral artery. Prompt identification and treatment may help avoid permanent neurological damage and improve outcomes.

Between 5-20% of extubation attempts result in reintubation. Protocol driven spontaneous breathing trials (SBT) are utilized to improve rates of successful extubation. Although proven to accurately predict success in the medical population, data is limited regarding efficacy in neurocritical care patients. In this study, we sought to identify parameters common to critical care neurology patients with adequate SBT who failed extubation within 48 hours. We hypothesized that a low Glasgow Coma Scale score (GCS< 8), weak cough/gag, and moderate-to-copious secretions would be common in this population.

This was a retrospective chart review. Subjects consisted of neurocritical care patients with acceptable SBT parameters based on institution protocol who failed extubation and were reintubated within 48 hours. Baseline parameters included age, rapid-shallow-breathing-index (RSBI ), and admitting GCS. At the time of extubation, GCS, strength of cough/gag, secretion grades, and ability to follow commands was recorded.

Fifty-five cases among 48 patients met inclusion criteria, of whom 7 were reintubated twice. Fifty-four cases met SBT parameters for extubation. Mean RSBI=42 (interquartile range 24-54), mean age=63 years (range 18-89). Thirty-two patients (58.2%) had a low admitting GCS. At the time of extubation, 3/55 patients (5.5%) had a low GCS. Secretions were absent (N=3, 5.5%), scant/small (N=35, 63.6%), moderate (N=11, 20%) and large/thick (N=6, 10.9%). Of the 36/55 patients in whom data was available, 8/36 (22%) exhibited a weak cough/gag. Thirteen of 55 (24%) patients were not following commands at the time of extubation. Thus, of the four parameters assessed at the time of extubation, most patients exhibited a high GCS, scant/small secretions, and strong cough/gag, and could follow commands.

Low GCS, weak cough/gag, moderate-to-copious secretions, and inability to follow commands were not common in our cohort. This suggests that other mechanisms unique to neurocritical care patients may be responsible for extubation failure despite an adequate SBT.

Hospital-associated infections (HAIs) are seen in 17% of critically-ill patients. Probiotics might aid in reducing the incidence of HAIs, especially ventilator-associated pneumonia and Clostridium difficile associated disease (CDAD) in intensive care unit (ICU) patients, but the data is limited. To our knowledge, the effect of probiotics on HAIs has not been studied in the neurocritically-ill population. We hypothesized that the implementation of probiotics in mechanically ventilated patients in the NeuroICU would decrease the incidence of HAIs in our patient population.

A retrospective review of mechanically ventilated patients admitted to the NeuroICU from July 1, 2011 to December 31, 2011 and July 1, 2012 to December 31, 2012. In the first group, probiotics were not used. In the second group, Lactobacillus twice daily was added as part of a quality improvement initiative.

None of the patients in the first group were on probiotics, and 98% of patients in the second group were on probiotics for a median of 10 days . Median age between the non-probiotic and probiotic groups was similar [59 years (46-74) vs. 62 years (54-74), respectively]. There was no decrease in the incidence of HAIs in the probiotic group vs. the non-probiotic group [total HAIs 13 vs. 7, p=0.32, VAP 2 vs. 2, p=1, CDAD 2 vs. 0, p=0.23, catheter-associated bloodstream infections (CA-BSI) 3 vs. 0, p=0.11, catheter-associated urinary tract infections (CA-UTI) 4 vs. 5, p=1]. No patients developed Lactobacillus bacteremia. There was also no significant difference in ventilator days, length of ICU or hospital stays, in-hospital mortality or discharge status.

While probiotics can be safely administered in neurocritically-ill patients, the implementation of probiotics did not significantly decrease the incidence of HAIs in our study population.

Hyperosmolar therapy with hypertonic saline (HTS) is a cornerstone in the management of intracranial hypertension due to cerebral edema. Guidelines for initiation, dosing and safety for administration are lacking. Theoretical safety concerns remain for infiltration, thrombophlebitis, tissue ischemia and venous thrombosis associated with continuous 3%HTS administered via peripheral IV (pIV). It is common practice at many institutions to allow only central venous catheter infusion of 3% HTS, with little published safety data in relation to peripheral administration.

We prospectively monitored patients admitted to Parkland Hospital Surgical ICU who received peripheral 3%HTS, as part of a quality improvement project. Our hospital policy was changed to allow the administration of 3%HTS in approved areas via 16-20 gauge pIVs up to a max infusion rate of 50mL/hour in patients without central venous access. We documented gauge, location, maximum infusion rate and total hours of administration. Patients were assessed for infiltration, erythema, swelling, phlebitis, hemolysis, thrombosis and line infection.

From October 2013 -May 2014, 28 subjects across 34 peripheral lines were monitored. The rate of complications was 11.7% (n=4) per lines assessed in 3 patients. The documented complications included infiltration (n=1), erythema (n=1) and swelling (n=1). There was one incidence of right brachial vein thrombosis in one patient who received 3% HTS via pIV for one hour. Overall subjects received 3% HTS for a duration between (1-252 hours) with infusion rates of (30-50 mL/hour).

There is low risk of minor, non-limb or life threatening complications from pIV administration of prolonged 3% HTS infusion therapy. It is generally accepted that central venous infusion may reduce risk of these minor complications but may increase risk of more serious associated complications; blood stream infection, pneumothorax and arterial injury. The concern regarding the safety risks of pIV administration of 3% HTS may be overstated and unfounded.

Streptococcus agalactiae or group B streptococcus (GBS) is recognized as a major cause of neonatal meningitis and sepsis which often follow maternally derived infection during pregnancy. In recent years, the GBS disease spectrum has emerged amongst adults with a reported annual incidence of 2.4 to 4.4 cases per 100,000 population. GBS meningitis in adults is a rare entity which can occur without any predisposing factor or secondary to bacteremia acquired either in the community or noscomially.

We report a case of a 60-year-old male with past medical history of diabetes mellitus, coronary disease and prior myocardial infarction, poor dentition, hypertension, chronic stasis dermatitis, and previous left lower extremity cellulitis admitted with one day onset of disorientation and agitation. CT brain with contrast showed small ring enhancing lesion within left occipital lobe with surrounding vasogenic edema and mass effect concerning for abscess versus less likely neoplastic process. MR Stealth revealed 2.2 x 2 x 2.3 cm ring enhancing lesion in left occipital lobe with marked central restricted diffusion and surrounding vasogenic edema. He underwent left occipital craniotomy and evacuation of brain abscess. While no heart murmurs or peripheral stigmata of infective endocarditis were appreciated, four of four blood cultures were positive for GBS. Cultures from the brain abscess also cultured GBS. Transthoracic echocardiogram was negative for valvular dysfunction and vegetations. Transesophageal echocardiogram could not be completed. He was treated with a six week course of Ceftriaxone for GBS occipital abscess and presumptive endocarditis despite a negative TTE. Poor dentition with bacteremia was the suspected source of infection resulting in secondary hematogenous seeding of the brain.

GBS is an infrequent cause of meningitis in adults but carries a high case-fatality rate and should not be considered an exclusive peripartum infectious process.

Phenytoin toxicity is typically treated with supportive care. Dialysis has been used for patients with life threatening clinical symptoms, but its role remains controversial. We report the efficacy of high-flux hemodialysis and continuous veno-venous hemodiafiltration (CVVHDF), and the successful management of two patients with phenytoin toxicity, one who survived despite phenytoin levels that exceeded the maximum levels previously reported for a survivor.

Patient A was a 23-year-old woman with a history of seizures on phenobarbital who presented to an outside hospital with status epilepticus. She was given high-dose fosphenytoin, then transferred to our facility where initial total phenytoin level was 139.0ug/mL (adjusted level for albumin 193.1ug/mL, normal therapeutic level 10-20ug/mL). After one week of supportive care, total phenytoin levels plateaued between 65-80ug/mL; and, because of prolonged coma, she underwent two sessions of high-flux hemodialysis. Patient B presented after bradycardic arrest with a total phenytoin level of 59.1ug/mL (adjusted 84.4ug/mL) and was immediately treated with 22-hours on CVVHDF due to hypotension.

Patient A's total serum phenytoin concentration level decreased from 64.6ug/mL to 38.4ug/mL after the first high flux dialysis session and her motor exam improved from decorticate posturing to spontaneous, non-purposeful movements. After a second dialysis session, phenytoin levels fell from 31.7ug/mL to 17.0ug/mL with increase wakefulness. On one year follow-up, she had persistent ataxia and tremor but otherwise had minimal neurological deficits. Patient B had a similar rapid reduction in phenytoin levels with CVVHDF (59.1ug/mL prior to CVVHDF, 35.4ug/mL after 12hr, 21.1ug/mL after 22hr); and, the patient rapidly returned to her baseline functional status.

High-flux dialysis and CVVHDF significantly enhances clearance of phenytoin despite high protein binding. These types of extracorporeal removal techniques should be considered as therapy earlier in cases of phenytoin toxicity with significant neurological compromise.

After traumatic brain injury (TBI), delayed enlargement of intraparenchymal hematomas (IPH) has been reported in up to 40% of patients but predictive models for IPH enlargement have not been developed.

The trauma database from the only American College of Surgeons verified trauma center in Hawaii was queried to identify consecutive patients admitted for non-penetrating moderate and severe TBI from 2008-2013. Retrospective chart review was undertaken to collect additional variables. IPH volume was estimated using the ABC/2 method. The primary outcome was IPH enlargement by 10 mL on serial imaging. Chi-square and ANOVA were used to identify factors associated with IPH enlargement (p< 0.1) which were then included in a multivariable logistic regression model.

419 patients were screened, of whom 286 had repeat imaging and were included in the analyses. Mean age was 47.6±26.7 years, 70.6% were male, 38.8% were Asian, 29.7% were Native Hawaiian or Pacific Islander, and 25.2% were white. Mechanism of injury was fall in 48.3%, motor vehicle crash in 25.2%, and assault in 15.0%. In-hospital mortality was 20.6%. Sixty-one patients (21.3%) had delayed IPH enlargement, which was symptomatic in 52% of cases. On univariable analyses, IPH enlargement was associated with older age, higher initial systolic blood pressure, anti-platelet medications, anticoagulants, subarachnoid hemorrhage (SAH), subdural hematoma (SDH), skull fracture, frontal contusion, and shorter interval from injury to initial CT. Packed red blood cells (pRBC) transfusion was protective. In a stepwise logistic regression model, SAH (OR 6.33), SDH (OR 3.46), skull fracture (OR 2.67), and pRBC transfusion (OR 0.31) were independently associated with IPH enlargement (p< 0.05).

We identified risk factors for delayed IPH enlargement after moderate and severe non-penetrating TBI. These factors could be used to identify patients at high risk for IPH enlargement who require closer clinical and radiographic monitoring and may benefit from investigational treatments.

Patients with subdural hematomas (SDH) are frequently transferred to tertiary care centers with dedicated neurocritical care units for management. SDH commonly occur over the convexity of the brain, often secondary to trauma. While many prognostic factors, treatment strategies, and outcomes for convexity SDH have been reported, little is known about outcomes of tentorial and falcine SDH. This study describes features and outcomes of isolated tentorial and falcine SDH. 

Of 210 patients with SDH, mean age was 69.5 years (SD 16.2); 117 (56%) were male; 30 (14%) required intubation, 98 (47%) underwent surgical SDH evacuation. Twenty-seven patients had isolated falcine or tentorial SDH, with known traumatic etiology in 23, and 3 in the setting of coagulopathy. None of the falcine/tentorial SDH patients required surgery or intubation. Compared with convexity SDH, patients with falcine/tentorial SDH were younger (59.7 vs. 70.9 yrs, p = 0.01), had higher admission GCS scores at the referring hospital (p = 0.01) and RUMC (p = 0.004), and shorter median ICU-LOS (1 vs. 3, p < 0.0001). All patients (100%) with falcine/tentorial SDH had favorable outcome versus 68% with convexity SDH (p = 0.0005).

Isolated tentorial or falcine SDH represent a benign entity among patients with acute SDH, with no need for surgical intervention, short LOS, and favorable outcome. Our data indicate that for patients with isolated falcine/tentorial SDH, in the absence of other factors requiring higher level of care, transfer to a neurocritical care center may not be indicated.

The presence of coagulopathy is common after severe trauma and has been associated with increased mortality. The aim of this study was to identify whether isolated severe traumatic brain injury (TBI) is an independent risk factor for coagulopathy.

Adult patients admitted to a Level I Trauma Center within 6 hours of injury underwent comprehensive coagulation assessment by means of classic tests, thromboelastography (TEG) and advanced laboratorial analysis, including the measurement of coagulation factors (CF) and biomarkers of all phases of the hemostatic cascade. Patients were categorized according to the Abbreviated Injury Scale (AIS): Group 1 -isolated severe TBI (AIS head > 3 + AIS non-head < 3); Group 2 -severe multisystem trauma associated with severe TBI (AIS head > 3 + AIS non-head > 3); Group 3 -severe multisystem trauma without TBI (AIS head < 3 + AIS non-head > 3). Primary outcome was the development of coagulopathy and in-hospital mortality.

345 patients were included, 48 patients in Group 1, 137 in Group 2, and 160 in Group 3. Group 1 had lower rates of coagulopathy (12.5% vs. 30.5 vs. 22.5, p < 0.05) and disseminated intravascular coagulopathy (6.25% vs. 13.9 vs. 11.2, p < 0.05) when compared to Group 2 or 3. TEG parameters and CF levels did not differ statistically among the three groups. Isolated severe TBI was not an independent risk factor for coagulopathy (OR 1.06; 0.35-3.22 CI, p= 0.92). However, severe TBI patients (Group 1 and 2) who developed coagulopathy had higher mortality rates than coagulopathic Group 3 patients (50% vs. 19%, p < 0.05). The presence of coagulopathy (OR 5.61; 2.65 -11.86 CI, p < 0.0001) and isolated severe TBI (OR 11.51; 3.9 -34.2 CI, p < 0.0001) were independent risk factors for in-hospital mortality.

Isolated severe traumatic brain injury is not an independent risk factor for the development of coagulopathy. However, severe TBI patients who develop coagulopathy have extremely high mortality rates.

Incidence of vasospasm following traumatic brain injury (TBI) is one-third as compared to aneurysmal subarachnoid hemorrhage (aSAH). Since pathophysiology and clinical course are different for cerebral vasospasm (CVsm) in TBI patients, there are less established clinical guidelines to treat this condition. Cerebral angioplasty and milrinone based hyperdynamic therapy is gaining acceptance in management of clinical CVsm after aSAH. But similar protocol to treat CVsm after TBI is absent.

Retrospective chart review of a patient with severe TBI who developed clinical vasospasm and treated with cerebral angioplasty and milrinone infusion.

A 28-year-old African man was admitted with GCS of 7 after fall from golf cart, sustaining skull base fracture, traumatic subarachnoid hemorrhage and bifrontal and left temporal contusions. Cerebral angiogram performed at admission ruled out aneurysm. Neurological deterioration on post-bleed day (PBD) 2 correlated with increased cerebral edema in association with evolving cerebral contusions and treated with hyperosmolar therapy using mannitol. His clinical improvement documented as spontaneous eye opening and acknowledging examiner's presence led to extubation on PBD 3. On PBD 8 and 9, patient developed new onset progressive right-sided face and arm weaknesses that led to clinical suspicion of CVsm. Severe CVsm was observed in left anterior and middle cerebral arteries on cerebral angiography that was treated with angioplasty in addition to intra-arterial milrinone therapy. This was followed by intravenous infusion of milrinone with maintenance of mean arterial pressure at 80-95 mm Hg and hypertonic hyperosmolar therapy to maintain serum sodium at 145-150 meq/L. Patient subsequently regained right upper extremity strength and resolution of facial weakness. He had minimal expressive aphasia at discharge.

CVsm should be considered in patients with severe TBI who have late neurological deterioration. Cerebral angioplasty and milrinone infusion with maintenance of normotension to borderline hypertension appears safe in patients with cerebral contusions.

Non-neurological complications involving a single or multiple organ systems during intensive medical care in critically ill patients of traumatic brain and spine injuries is significant as a cause of poor prognosis but often neglected. The aim of this study was to assess the frequency of such complications in neuro ICU and analyze their impact on morbidity and mortality.

A prospective observational study on 200 patients of varied demographic profile admitted in neuro ICU over a period of 6 months for conservative /operative management, with traumatic brain and spinal cord injury and associated multisystem involvement was conducted. Significant predefined parameters addressing the nonneurological complications occurring during their ICU stay were recorded including respiratory, cardiovascular, Infection, acute kidney injury (AKI), gastrointestinal complications, electrolyte disturbances and bleeding complications. The study period was from admission to the ICU till the discharge from the ICU or demise.

63% of patients developed respiratory complications in the form of chest infiltrate (50%) and atelectasis (10.31%). 35.5% of patients suffered from cardiovascular compications. 37% of patients had dyselectrolytemia, commonest being hypernatremia due to hypovolemia (70%). Sepsis was observed in 23.5%. Bleeding diathesis and acute renal injury were observed in 22% & 3.5% of patients respectively. 17% of the patients succumbed to injury out of which 64.7% was due to non -neurological cause. Further results will be dealt in detail with inferences at the meeting.

Intensivists in neuro ICU must consistently assess the non-neurological complications in traumatic brain and spine injured patients and deliver appropriate care to bring down the mortality and morbidity.

Financial Support: None

The use of anticoagulant or antiplatelet medications has become increasingly common and is a well-established risk factor for worsening of hemorrhage in trauma patients. Moreover, traumatic intracranial hemorrhage may also present with concomitant dysfunction of coagulation. To date, the use of point-of-care (POC) tests to assess patient coagulation status has not been extensively investigated in mild traumatic brain injury (TBI).

A retrospective review of 190 mild TBI patients who underwent both conventional and POC testing as part of their admission coagulopathy workup was conducted. Coagulation deficiency was defined as an INR > 1.4, a reaction time (r-value) on rapid thromboelastography (r-TEG) > 50s, or a therapeutic Verify Now Aspirin (VN-ASA) level of < 550 ARU. 

The coagulopathy POC panel consisting of r-TEG and VN-ASA successfully identified patients with self-reported anticoagulant or antiplatelet usage. In addition, POC testing also distinguished a subset of mild TBI patients with an occult coagulopathy that would have otherwise been missed. Standardization of these POC assays on admission in TBI may help guide patient resuscitation in the acute setting.

The vast majority of the 1.7 million traumatic brain injuries (TBI) in the U.S. annually are considered mild. While mortality or need for neurosurgical intervention is rare in the mild TBI population, a small number of patients may progress with potentially devastating clinical consequences. Here, we propose to clarify which patient or injuryspecific factors are most predictive of disease progression

Retrospective review of 625 adult patients who presented following a reported trauma with a GCS 13-15 and an abnormal non-contrast head CT. Additionally, all patients underwent a follow up head CT to assess interval progression. Medical history, with particular emphasis on the mechanism of injury, use of anticoagulant or antiplatelet medications, as well as type and location of hemorrhages, was recorded.

Of the 625 patients included for analysis, 142 (22.7%) demonstrated radiographic findings consistent with progression of their intracranial hemorrhage. In these patients, the types of intracranial hemorrhages with the highest likelihood of progression were intraparenchymal contusions (incidence of 53% vs 19% in patients with stable follow up CT) and intraventricular hemorrhages (19% vs 6.6%). Interestingly, patients with concomitant skull fracture were almost twice as likely to have progression of their intracranial hemorrhage regardless of the underlying hemorrhagic subtype (39% vs 22%). Finally, almost half the patients demonstrating progression presented with a GCS 13-14, while more that 75% of patients with stable repeat head CT presented with GCS 15.

A significant minority of mid TBI patients will have progression of their intracranial injury on interval imaging. In our cohort, the patient's presenting GCS and subtype of hemorrhage appear to most closely correlate with a higher risk of progression. Improved characterization of the factors that underlie this phenomenon will help establish guidelines for the disposition and acute management of high risk patients.

The ability to predict outcomes in the acute period after moderate or severe traumatic brain injury (TBI) is limited. The amount of tissue below certain apparent diffusion coefficient (ADC) thresholds on diffusion weighted magnetic resonance imaging (DWI MRI) has been shown to correlate with patient prognosis in other neurological diseases, but data in TBI patients is lacking.

This retrospective observational study investigated patients with moderate or severe TBI. The MRIs obtained postinjury days 1-13 were analyzed. The brain was automatically outlined using a brain extraction tool implemented in MRIcron software, and the ADC value of each voxel within the brain was determined. The percentage of voxels below different ADC thresholds within brain tissue was calculated. The timing of MRI after injury and the correlation with outcome were analyzed. A good outcome was defined as discharge to home or a rehabilitation facility.

Seventy-six patients were analyzed. Thirty-five patients (46%) had a good outcome. The timing of MRI scans did not differ between groups, but the mean age did (43±18 yrs vs. 55±20 yrs, p< 0.01, good vs. poor outcome). Patients with poor outcome had significantly higher percentage of brain volume with ADC < 400x10 -6 mm 2 /sec (0.88±0.7% vs. 0.62±0.28%, first MRI for each patient with poor vs good outcome, p< 0.05). Using a ROC curve analysis and Youden's index, an ADC < 400x10 -6 mm 2 /sec in 0.5% of brain was 80% sensitive and 43% specific for poor outcome (p< 0.05). Quantitative DWI MRI was better able to differentiate outcome groups when performed on post-injury day 1-4.

Quantitative MRI offers additional prognostic information in acute TBI. A whole brain tissue ADC threshold of < 400x10 -6 mm 2 /sec in 0.5% of brain may be a novel prognostic biomarker. The optimal timing of MRI after injury to use this quantitative technique appears to be at post-injury day 1-4.

Studies examining outcome in acute brain injury of vascular origin (i.e., ICH, ischemic stroke) as well as investigations on treatment performance in acute coronary patients identified significant racial disparities across various medical specialties and care settings. We were interested in ethnicity-related differences in adult brain trauma patients with respect to variance in admission demographics and treatment course during the acute hospitalization phase.

A total 3,125 TBI patients from the prospective New York State TBI-Trac® database (20 Level I and 2 Level II trauma centers in New York State; June 2000 to December 2009) were studied. Of those, 632 patients were excluded because of missing data. 2,370 patients were analyzed to identify race/ethnicity differences using two week mortality and by generating 3 independent outcome models: A dichotomized outcome dead versus alive; B stratified outcome by outcomes scenarios: death, GCS 3-5, GCS 6-8 or GCS >9; and C in-hospital course as either worsening, anticipated, or improved. For all binary variables chi-square analysis was employed (mean ± SD) and associations were evaluated using multivariate logistic regression analysis (OR; 95% CI) (SAS 9).

Whites accounted for 64% (n=1597), Blacks 14% (n=351), Hispanics 16% (n=396) and others 2% (n=26). Prognosticator frequencies were areflexic pupils (30%), abnormal admission CT (84%), male gender (77%), age >60 years (17%), and hypotension on admission (19%). At 14 days 23% (n=638) had died. Analysis of Blacks (15%) versus non-Blacks (85%), Whites (74%) versus non-Whites (26%), and Hispanics (16%) versus non-Hispanics (84%) did not show a statically significant difference along racial and ethnic subgroups after adjustment for all admission prognosticators.

While several studies demonstrated race/ethnicity difference in TBI long-term outcome, mostly due to socioeconomic challenges, low education, uninsured status, non-English speaking, and lack of community integration, we identified no outcome discrimination during the acute phase of TBI treatment.

Spinal cord injury initiates a cascade of local and systemic persistent inflammatory processes that lead to secondary injury and impair functional recovery. Tumor necrosis alpha (TNFa) is an important mediator of secondary injury. Inhibition of TNFa with a sequestering agent, soluble TNF-receptor 1 (sTNFR1), results in a dose-dependent improvement in behavioral outcome in a rodent model of cervical spinal cord injury as well a reduction in peri-lesional microglial activation (Huie et al., in preparation) . The present study investigated the effects of delayed intrathecal administration of sTNFR1 on peripheral inflammatory profiles.

Long-Evans female rats (n=52) received intrathecal delivery of 350 ng sTNFR1 90 minutes following unilateral C5 contusion injury (75 kdyne) or C5 laminectomy without injury. Animals were sacrificed at 3h, 24h or 7d after injury.

In two groups, spinal cord, serum and spleen samples were harvested and analyzed for inflammatory markers by Luminex multiplex assay or quantitative PCR. In other groups, animals were used for spinal cord histological assessment and flow cytometric analysis of peripheral leukocytes.

Intrathecal sTNFR1 was found to reduce levels of key pro-inflammatory cytokines in serum as well as expression of pro-inflammatory genes and downstream mediators in spleen. Reduction in peripheral inflammation was correlated with decreased spinal cord TNFa levels and reduced infiltration of activated macrophages at the injury site on histology. Further, by flow cytometry, we find decreased CD11b high monocytes in peripheral blood following sTNFR1 treatment.

Our data demonstrate both local and systemic inflammatory responses are activated following SCI and improved functional outcome with TNFa inhibition is associated with modulation of the local inflammatory responses in the spinal cord. Intrathecal TNFa inhibition also results in reduced expression of peripheral inflammatory markers and mediates a reduction in the circulating pool of inflammatory monocytes.

Traumatic brain injury (TBI) affects ~1.7 million Americans and costs ~$60 billion in the United States annually. Contusion expansion is a common cause of secondary brain injury in TBI and is associated with increased mortality. The mechanism of contusion expansion is poorly understood. The purpose of this study was to identify risk factors that predict contusion expansion.

We undertook a retrospective observational study of all patients with acute TBI and cerebral contusion who underwent serial CT imaging and intracranial pressure monitoring at San Francisco General Hospital from 2004-2010. Contusion expansion was defined as any increase in size based on radiology reports or visual review by an investigator. Demographics, imaging, coagulation parameters, and status on the Glasgow Outcome Scale (GOS) at hospital discharge were also assessed.

241 patients with traumatic cerebral contusions were identified. The median age was 45 years, 73% were male, and median Glasgow Coma Scale (GCS) was 9. Contusion expansion occurred in 74.7% of patients and was associated with a poor discharge GOS 1 or 2 (46% vs. 23% without contusion expansion; p=0.002). In univariate analysis, contusion expansion was significantly associated with age (p< 0.01), platelet count (p=0.02), presence of a subdural hematoma (p< 0.01) or traumatic subarachnoid hemorrhage (tSAH)(p < 0.01), and interval hemicraniectomy or craniotomy (p=0.054); but not with sex, emergency department GCS, initial PTT, initial INR, or time between CT scans. In multivariable analysis, contusion expansion was independently associated with age (p < 0.01), tSAH (p< 0.01) and interval hemicraniectomy (p=0.036) but not with sex, time between CT scans, GCS, subdural hematoma, or coagulation parameters.

Contusion expansion is a common form of secondary brain injury and is associated with poor outcome. Identifying predictors of contusion expansion may lead to modifiable targets for intervention.

Head-to-head studies comparing the effectiveness of mannitol (MAN) and 23.4% hypertonic saline (HTS) in reducing elevated intracranial pressure (ICP) are lacking. We sought to develop a drug-response curve (DRC) for HTS and compare it to that of MAN.

Retrospective review of 88 patients admitted to the neuro-ICU of three academic medical centers between 4/2011 and 3/2013, who experienced elevated ICP and received 23.4% HTS. Mannitol data from 172 patients were abstracted from a meta-analysis published by Sorani et al. in 2008. Regression analysis was performed for MAN and HTS to construct DRC, and the slope of the respective lines compared. Student's t and Wilcoxon rank sum tests were used according to the normality of the data.

The mean age of the HTS group was 42.8 +/-15 years and 64% were males. Traumatic brain injury, subarachnoid hemorrhage and intracerebral hemorrhage were the most common diagnoses (89%). The median drug dose was 2.94 (IQR: 1) Vs. 3.1 (IQR: 1.9) mOsm/Kg (p= 0.9), while absolute ICP reduction was 14 (IQR: 11) Vs. 11 (IQR: 12.5) mmHg (p= 0.3) in the HTS and MAN groups, respectively. Regression analysis showed a significant relationship between HTS dose and ICP reduction (p= 0.01), but not with MAN (p= 0.5). Doses of HTS of >3 mOsm/Kg showed a linear association with ICP reduction (p= 0.01), whereas doses of 3 mOsm/Kg or less did not (p= 0.056).

There appears to be a linear relationship between HTS dose and ICP reduction. Furthermore, at doses >3 mOsm/Kg equiosmolar amounts of HTS seem to be superior to MAN at reducing ICP. We hypothesize that HTS follows linear kinetics at doses >3 mOsm/Kg, but non-linear below that threshold.

Guidelines for brain death determination (BDD), developed at an institutional level, lead to variability of practice between trauma centers.

Policies for BDD were requested from all Ohio Trauma Centers (OTC). Guidelines were divided into four categories: guideline performance, preclinical, clinical and confirmatory testing. Policies were compared with AAN guidelines (AANG) for discrepancies and for differences between Levels I, II and III OTC.

Response rate was 66% out of 44 OTC (64% Level I, 69% Level II and 59% Level III). Criteria most consistent with AANG (over 80%) were: absence hypothermia (93%); coma (89%), pupillary reflex (93%), corneal reflex (93%), gag reflex (93%), ocular movements (93%), response to cranial pain (86%); apnea testing (100%), EEG (96%) cerebral angiography (82%) and neuromuscular blocking (93%). Criteria 60-80% compliant: sedatives absence (68%), endocrine disorder (68%), acid-base disorder (68%) electrolyte disorder (68%); normal blood pressure (68%); presence of cough reflex (79%); and radionuclide scintigraphy (79%). Criteria 40-60% compliant: multiple exams (57%) waiting period between exams (43%); absence hypotension (43%) and hypoxemia (43%); response to pain (57%); and TCD performance (46%). Criteria < 40% compliant: absence of shock (36%), alcohol (32%) and hypovolemia (36%); presence of jaw jerk reflex (21%) and facial movements (32%); perform CT angiography (39%), SSEP (29%), MRI/MRA (21%), and atropine challenge (7%). A trend towards significant differences between the Level I, II and III OTC were: absence of hypothermia (89% vs 100% vs 60%, p=0.06), presence of cough reflex (100% vs 78% vs 60%, p=0.10) and radionuclide scintigraphy (100% vs78% vs 60%, p=0.10).

Wide variation exists in brain death policy in different OTC. Highest variability was confirmatory testing between the OTC. Highest variability from AANG was in clinical examinations. We recommend that the American College Surgeons Committee on Trauma develop uniform guidelines for BDD for verified trauma centers.

Traumatic brain injury (TBI) is a major public health problem that impacts young adults. Since severe TBI patients lack decision-making capacity, the providers and patient surrogates are often faced with the challenging task of deciding whether to continue with aggressive life-prolonging care or to transition to comfort-focused care with an expected outcome of natural death. The assumption is often made that aggressive care is appropriate for young patients who suffer severe TBI despite the high likelihood of a poor outcome. However, the young community's attitude towards goals of care after severe TBI has not been studied.

A questionnaire-based survey study on young adults was conducted to assess their attitude towards aggressive care after a hypothetical case of severe TBI. To simulate a realistic clinical decision-making dilemma, the respondent's willingness to receive aggressive care despite a high likelihood of moderately severe-to-severe longterm neurological disability after the treatment was specifically assessed. The highest degree of neurological disability they would be "willing to live with" was based upon the descriptions from the modified Rankin Scale. Logistic regression was performed to determine the factors associated with the decision to favor aggressive care.

Among a total of 120 community-dwelling young adults (mean age: 19±1 years) who were surveyed, 79 (66%) were willing to live with severe motor disability, 78 (65%) were willing to live with expressive aphasia, and 53 (44%) were willing to live with receptive aphasia. Despite being presented with a high likelihood of long-term moderately severe-to-severe disability, 65 of the 115 respondents (57%) favored aggressive care. A willingness to live with receptive aphasia was the only independent factor that predicted aggressive care (OR 2.50, 95% CI: 1.15 to 5.46).

Even among the young adults, preference of care was divided between aggressive and conservative approaches when presented with a hypothetical case of severe TBI.

Studies suggest that sleep characteristics detected by electroencephalography (EEG) may be predictive of neurological recovery after traumatic brain injury (TBI). We sought to determine whether sleep features were associated with functional outcome after severe TBI.

Medical records of patients admitted with severe TBI from 2009-2013 who underwent 24 hours of continuous EEG (cEEG) monitoring within 14 days from injury were reviewed retrospectively. EEG reports were reviewed for sleep elements (vertex waves, sleep spindles, and K complexes) and epileptiform activity. Patient outcomes included discharge disposition and modified Rankin Scale (mRS). Logistic regression analysis and Fisher's exact tests were used to determine differences in outcome between patients with and without sleep characteristic

Mean patient age was 50.2 (range 15-97) years. 83% were men. 64 patients underwent cEEG monitoring (range 24-168 (mean 50.6) hours). Sleep features could be determined for 58 patients (90%). 9 (14%) displayed status epilepticus, 5 (8%) electrographic seizures and 12 (19%) epileptiform discharges. Status epilepticus or electrographic seizures were universally associated with a poor outcome (mRS 4). Sleep characteristics, including vertex waves, sleep spindles, and K complexes, were present in 17 patients (30%) and were associated with better outcome (88% discharged to home or acute rehabilitation-OR 13.0; 95%CI 2.6-64.8); 41% had an mRS< 4; p = 0.01). Lack of sleep elements on cEEG correlated with a poor outcome at hospital discharge (mRS 4: OR 3.93, p=0.049; 95%CI 1.01-15.4). Similarly, 63% of patients without sleep characteristics died or required transfer to a skilled care facility (p < 0.001).

These data suggest that the presence of sleep features on EEG in the acute period following severe TBI predict better recovery, while the absence of normal sleep characteristics portend a poor prognosis for hospital discharge. Whether sleep elements detected by EEG may predict longer-term prognosis remains to be determined.

Introduction ATP-binding cassette (ABC) transporters function to selectively regulate the brain milieu through active efflux of substrates. Little is known about how traumatic brain injury (TBI) shifts the levels of these transporters and alters microenvironments. Similarly, changes in the expression of ABC transporters after TBI could influence therapeutic drug penetration and outcomes. We hypothesize that quantifiable changes occur in ABC transporter expression after TBI.

Adult male Sprague-Dawley rats (n=3/group) underwent moderate TBI midline fluid percussion injury (FPI) then were killed at eight time points post-injury. Tissue from parietal cortex, hippocampus, and thalamus was analyzed via Western blot and compared to sham injured animals (n=4) using student t-test.

Bcrp decreased (P< 0.05) compared to sham at days 5, 7, 14, and 56 post-injury in parietal cortex. Bcrp hippocampal and thalamic expression decreased (P< 0.05) at all points except day 3 post-injury. Mrp1 increased (P< 0.05) compared to sham at days 1, 2, 7, and 14 post-injury in parietal cortex and thalamus. Mrp1 hippocampal expression increased (P< 0.05) at days 7 and 14 post-injury. P-gp increased (P< 0.05) compared to sham at days 1, 2, 3, and 5 post-injury in parietal cortex but increased (P< 0.05) on days 1 and 2 post-injury in hippocampus. Pgp in thalamic tissue increased (P< 0.05) on day 1 post-injury.

We found Bcrp decreased significantly at both early and late time point's post-TBI. This could cause decreased efflux of substrates like glutathione and estradiol. We found an increase in Mrp1 and P-gp expression acutely. Increased ABC transporters could cause elevated efflux of substrates like opioids, anti-seizure medication, and prostaglandins. These data could influence clinical care because TBI therapeutic drugs may not reach therapeutic brain levels if administered during a period of overexpression. ABC transporter expression may serve as a biomarker for personalized medicine in tailoring therapeutic delivery to individual patients.

The CLEAR-ER trial demonstrated safety of the combination of eptifibatide plus intravenous (IV) rt-PA in acute ischemic stroke (AIS). We compared outcomes for patients with severe strokes in the combination therapy arm of CLEAR-ER to IV rt-PA control patients from the contemporaneously enrolling IMS III trial.

CLEAR-ER was a phase II safety trial that randomized AIS patients (5:1) to 0.6mg/kg rt-PA plus eptifibatide versus standard rt-PA (0.9mg/kg). IMS III was a phase III efficacy trial comparing IV rt-PA plus endovascular therapy versus standard rt-PA. For this analysis, we compared the severe cohort (NIH stroke scale 10) of CLEAR-ER combination therapy patients to the standard rt-PA arm of the IMS III trial patients with NIH stroke scale 10. All patients had baseline modified Rankin score (mRS) of zero or one. Four approaches to outcomes were evaluated: mRS dichotomization as "excellent" (mRS 0-1); mRS dichotomization as "good" (mRS 0-2); severity-adjusted mRS dichotomization based on baseline NIHSS; and, a shift analysis.

Fifty-three combination arm CLEAR-ER patients and 209 IV rt-PA arm IMS III patients had baseline NIH stroke scale 10. Combination arm patients showed a trend toward improved outcomes over rt-PA patients at 90 days: 39.6% vs 27.3% for dichotomized excellent outcomes (P=0.08); 47.2% vs 39.2% for dichotomized good outcomes (P=0.29); 43.4% vs 32.5% for severity-adjusted dichotomized good outcomes (P=0.14); and, a favorable shift (Cochran-Mantel-Haenszel P=0.09).

In patients with severe AIS, IV rt-PA plus eptifibatide may improve outcomes over IV rt-PA alone. This trend was consistent across multiple approaches that have been proposed for outcome evaluation in acute stroke trials. A phase III trial to establish the efficacy of eptifibatide plus rt-PA for improving AIS outcomes, including those with severe strokes at baseline, is warranted.

Financial Support: Dr. Adeoye -research support from Genentech Dr. Khatri -PI of the PRISMS and THERAPY trials research support from Genentech and Penumbra

Cerebral venous thrombosis (CVT) is an uncommon type of stroke in many countries (1-2%). This is not the case in many arid hot-climate countries such as Saudi Arabia. CVT has extremely varied clinical presentations, and the mode of onset is also highly variable, with anything from sudden to progressive over weeks, so that CVT can mimic a host of conditions, such as ischemic or hemorrhagic stroke. However, it is unclear whether thrombolytic therapy is associated with adverse outcomes in this population. We report the clinical characteristics and outcomes of patients treated with intravenous tissue plasminogen activator (IV-tPA) with the confirmed diagnosis of CVT. Treatment with IV-tPA may lead to potentially serious complications, the most devastating being intracranial hemorrhage.

We identified CVT patients who received IV-tPA with initial diagnosis of acute ischemic stroke. Clinical and radiological findings were collected, including early neurological worsening and hemorrhagic transformation on unenhanced computed tomography at 24 hours. Clinical outcome was divided into three categories: complete recovery, partial recovery, and major disability or death.

Two patients presenting with acute stroke-like symptoms within the window for IV-tPA were identified. Both received IV-tPAwhich was followed 24 hours later by intravenous heparin infusion with significant clinical improvement. Minor cerebellar hemorrhagic infarction was seen in the follow-up computed tomography scan (located within the area of subacute infarction). There was no early neurological deterioration, and complete recovery was observed in both of the patients.

In our study, we identified two patients who receivedIV-tPA with final diagnosis of CVT. IV-tPA therapy was complicated in one patient by a minor cerebellar hemorrhage, without obvious neurological worsening. More studies are needed to explore the safety of tissue-type plasminogen activator in the context of CVT.

The purpose of this survey is to describe the current variations in practice patterns among stroke physicians regarding the use of CT scans 24-hours post-tPA.

A Survey Monkey survey was distributed to the stroke experts within strokeNET, a new NIH stroke network with over 200 hospitals.

59 responses have been received to date. Neurologists, vascular neurologists, neurointensivists and emergency physicians responded. 36% of the responders treat more than 50 strokes per year. When asked their practice in obtaining a 24-hour post-tPA brain imaging as a "safety scan" as part of routine practice without clinical change, 50% always obtain a scan, 16% most of the time, 12% often do, while 21% rarely or never do. However, 59% of those who routinely obtain the scan felt it didn't change their management more than 90% of the time, and no expert felt it changed their management more than 40% of the time. Holding antithrombotic therapy, the most commonly cited potential change in management based on the CT, was most likely in those with large infarct size and/or hemorrhagic transformation (HT). If a safety scan showed HT, 49% of experts would delay transfer of the patient out of the ICU, even without clinical change. When given specific patient scenarios without clinical change, however, 85% would get a 24-hour scan in patients with atrial fibrillation and a plan to start warfarin, and 52% would scan for high grade carotid disease with planned early endarterectomy.

This survey demonstrates a wide variation in practice patterns among stroke experts regarding the utility of routine safety scans 24 hours post-tPA. Assuming there is a potential risk of harm with radiation, in addition to the cost of such scans; further evaluation and study of the utility, cost effectiveness and the safety of such scans is recommended.

Literature review shows that very limited data is available on factors predicting mortality after onset of Acute Ischemic Stroke (AIS). Presently, there is little known about the influence of pre-stroke medications on subsequent AIS in-patient hospital mortality. Lipid lowering agents (LLA), antiplatelet and antihypertensive are known to reduce stroke recurrence and may improve outcome amongst AIS survivors. Yet, LLA influence on AIS hospital mortality is not clearly studied. Using a multicenter prospectively collected database we analyzed the possible predictors that might impact AIS hospital mortality.

Pooled data was collected using the University health consortium database from 1999 to 2004. Patients were dichotomized to 2 groups: Death during initial hospitalization post stroke and discharged from hospital (home, rehab, long term care). Using Chi square and T-tests, univariate analysis was performed on the following: demographics, stroke types and severity, cardiovascular, pulmonary and neurological co-morbidities, pre-stroke medications including: LLA, antihypertensives, anticoagulants and antiplatelet agents, as well as post stroke complications. Multivariate stepwise logistic regression analysis was used to determine which univariate predictor variables independently predict mortality during initial hospitalization after AIS.

Of the 3522 patients, 201 died after AIS. Cohort mean age was 67 years. Univariate predictors of mortality were stroke severity and post stroke complications. ASA, other antiplatelet agents were associated with reduced mortality. LLA demonstrated a trend (p=0.08). In the final multivariate analysis, stroke severity and post stroke complications were associated with increased mortality while ASA and other antiplatelet drugs were negative predictors of mortality. LLA, antihypertensives and anticoagulants were not predictive of mortality.

After AIS, unlike previous reports from smaller studies, LLA were not predictive of AIS in patient hospital mortality. Yet, severity of stroke and post stroke complications were most predictive of inpatient hospital mortality.

Thrombelastography (TEG) provides a global, dynamic measure of coagulation. We examined the effect of antiplatelet (AP) medications on coagulability in acute stroke patients as measured by TEG.

We prospectively enrolled patients presenting with acute ischemic stroke (AIS) and spontaneous intracerebral hemorrhage (ICH) to a single academic medical center between 2009 and 2014. Venous blood was collected from patients upon arrival to the emergency department and analyzed with TEG. Patient demographics and baseline TEG values were compared among 4 different drug use groups: aspirin only, clopidogrel only, both aspirin and clopidogrel, and no AP. Multivariable regression models were conducted to compare the differences of TEG components after adjusting for potential confounding and interactive effects.

202 patients were included, 139 with AIS and 63 with ICH. 48 patients (24%) were taking aspirin alone, 12 (6%) were taking clopidogrel, 16 (8%) were on dual AP therapy, and 126 (62%) were not on AP medications. Dual antiplatelet use was associated with prolonged mean R time (time to initiate clotting) of 5.5 min as compared to no antiplatelet use (4.6 min, p=0.04). Additionally, mean MA (final clot strength) and angle (rate of clot formation) were decreased in the dual AP group (MA=59.3 mm, angle=57.8 degrees) as compared to the no antiplatelet use group (MA=64.5 mm, angle=64.5 degrees; p=0.04 and p=0.01 respectively). Patients on single antiplatelet therapy (either aspirin or clopidogrel) did not differ from the no AP therapy group in any TEG parameters measured.

Dual antiplatelet therapy with aspirin and clopidogrel is associated with a detectable coagulopathy which may have implications in the management of acute ischemic and hemorrhagic stroke patients. The effects of single antiplatelet therapy may not be demonstrated by TEG, and alternative tests such as platelet mapping or platelet function assays should be considered in these patients.

Financial Support: J Grotta: Supported by Tissue and Data Cores of National Institutes of Health 5P50NS044227-08. Haemonetics Corporation loaned a TEG coagulation analyzer Model 5000 and provided supplies.

Basilar artery occlusion (BAO) is a rare and often disabling if not fatal cause of stroke. Endovascular recanalization has the potential to improve outcomes in patients with BAO but intervention must be done before extensive infarction occurs. Early recognition and timely diagnosis are critical.

We describe 5 cases of delayed BAO diagnosis presenting to a tertiary care center between 2010 and 2013 and share lessons learned from these cases.

The 5 patients with delayed BAO diagnosis ranged in age from 37-57 years; 3 were female and 2 were male. Time from symptom onset to presentation at the tertiary facility ranged from 1 hour to 2 weeks. Three patients were transferred from other hospitals; one presented to our ED for a second opinion; and one patient presented initially to our ED. Presenting symptoms varied widely, and consisted of: (1) neck pain with headache, hemiparesis, dysarthria;

(2) subacute vertigo with acute headache; (3) nausea/vomiting with headache; (4) syncope with hemifacial numbness; (5) unresponsiveness. Four patients initially had transient symptoms ultimately attributed to BAO. All patients had negative acute head CTs. All patients decompensated requiring Neurointensive Care. Prior to BAO diagnoses, patients were treated for presumed seizures, complicated migraine, meningitis, encephalitis and CNS Lupus. The time of ED presentation to imaging demonstrating BAO ranged from 8-43 hours. Ultimately one patient died and the other 4 required tracheostomy/PEG and were discharged to long term acute care facilities.

Delay in BAO diagnosis can have devastating consequences. Young age, initially mild deficits and prolonged symptom duration (up to 2 weeks) contributed to the delay in diagnosis in these cases. BAO should be considered in all patients presenting with symptoms potentially referable to posterior circulation regardless of patient age and symptom duration. In these patients imaging that includes cerebral vasculature should be performed expeditiously.

Tracheostomy is one of the most commonly performed procedures for critically ill patients; however, variations in practice are inconsistent amongst clinicians and across institutions. The primary objective of our study is to survey the levels of care received by ischemic stroke patients admitted to the neurosurgical intensive care unit (NSICU), and ascertain the frequency and clinical parameters associated with tracheostomy placement.

A retrospective database was generated using ICD-9 billing codes to identify patients with cerebral infarction who were admitted to the NSICU over a two-year period (2012-2013). We evaluated each patient's medical record for placement of tracheostomy, age, gender, size and location of stroke, vessel involvement, NIHSS, length of ICU stay, PEG placement, comorbidities, and treatment intervention. Any tracheostomies placed at outside institutions or prior to NSICU admission were excluded. Statistical analysis was performed to assess the variables that contributed to placement of a tracheostomy.

We identified 72 patients (36 male, 36 female) admitted to the NSICU with a diagnosis of ischemic stroke. From this population, we found 8 that received a tracheostomy during their NSICU stay, correlating to 11% of such patients. Using statistical analysis, we identified significance with increased ICU length of stay for tracheostomy vs non-tracheostomy (17.8 vs 7.0 days) and PEG placement, and positive trends with high admission NIHSS score (20 vs 14), and infarct territory greater than 50%, as conditions that were favorable for inpatient tracheostomy. The average day of tracheostomy was 11.9 ±3.6 days.

Further studies will need to be performed to accurately assess the variables contributing to early tracheostomy. Increasing the study population may improve our ability to determine the clinical parameters that portend a greater need for its placement, and lead to the formation of early NSICU tracheostomy guidelines.

Cocaine use is a known risk factor for stroke and has been associated with worse outcomes. Cocaine may cause a procoagulable state by a number of different proposed mechanisms, including platelet activation, endothelial injury, and tissue factor expression. This study analyzes the effect of cocaine use on thrombelastography (TEG) in acute stroke patients.

Patients presenting with acute ischemic stroke (AIS) and spontaneous intracerebral hemorrhage (ICH) to a single academic center between 2009 and 2014 were prospectively enrolled. Blood was collected for TEG analysis at the time of presentation. Patient demographics and baseline TEG values were compared between two groups: cocaine and non-cocaine users. Multivariable Quantile regression models were used to compare the median TEG components between groups after controlling for the effect of confounders.

91 patients were included, 53 with AIS and 38 with ICH. 8 (8.7%) patients were positive for cocaine, 4 (50%) with AIS, and 4 (50%) with ICH. There were no significant differences in age, blood pressure, platelet count, or PT/PTT between the two groups. Following multivariable analysis, cocaine use was associated with shortened median R time (time to initiate clotting) of 3.8 minutes compared to 4.8 minutes in non-cocaine users (p=0.04). Delta (thrombin burst) was also earlier among cocaine users (0.4 minutes) compared with non-cocaine users (0.5 min, p=0.04). The median MA and G (measurements of final clot strength) were reduced in cocaine users (MA=62.5 mm, G=7.8 dynes/cm 2 ) compared to non-cocaine users (MA=66.5 mm, G=10.1 dynes/cm 2 ; p=0.047, p=0.04, respectively).

Cocaine users demonstrate more rapid clot formation but reduced overall clot strength based on admission TEG values. These findings suggest cocaine may induce thrombin generation through tissue factor release or other mechanism, resulting in a relatively weaker thrombin-rich clot. Further studies are needed to examine the impact on bleeding risk in acute stroke.

Financial Support: James C Grotta: Supported by Tissue and Data Cores of National Institutes of Health 5P50NS044227-08. Haemonetics Corporation loaned a TEG coagulation analyzer Model 5000 and provided supplies.

Rapid control of blood pressure (BP) is an important treatment goal in patients with (AIS), as severe hypertension has been linked to adverse outcomes. However, "overshoot" (hypotension due to long-acting IV antihypertensives) is a significant risk, and a recent study linked excessive BP reduction to adverse outcomes in neurological injuries. 1 We tested Clevidipine, a new IV calcium channel antagonist with extremely rapid onset (90 seconds) and offset (5-10 minutes), in neuro-ICU patients with AIS.

Patients with systolic blood pressure >180 mmHg received IV clevidipine with BP targets (highest acceptable pressure = cap, lowest acceptable pressure = floor) set by the treatment team. Pressure was measured continuously using an arterial line. Initial dose was 4-8 mg/hr, increased in a stepwise fashion every 90 seconds until target was achieved. Primary outcome measures were median time to BP within target and % of patients achieving BP within target range. Secondary parameters included time within range during administration of the drug. Safety parameters included percentage of patients with "overshoot" below the set blood pressure floor, and time to recovery above the set floor. Biochemical parameters including triglycerides were monitored in all patients.

The study is ongoing; 18 patients have been enrolled. BP targets were achieved in all patients. Median time to target was 4 minutes (average 3.2±4.2). Average dose required to achieve target was 13.0 mg/hr. Time within BP target range until discontinuation was 99%. No patient (0%) had overshoot below the set floor.

Clevidipine is an ultra-rapid and effective method to control BP in patients with AIS, without the drawbacks of alternatives like nitroprusside (ICP increase, cerebral/coronary steal), nicardipine, hydralazine and labetolol (high infusion volume required, longer onset/offset times). Clevidipine should be considered in the treatment of hypertension in patients with acute neurological injuries. Reference. Financial Support: None

The purpose of this review was to evaluate the likelihood of a positive stroke outcome from intravenous (IV) recombinant tissue plasminogen activator (r-tPA) in patients >100 kg when compared with patients 100kg.

This was a retrospective chart review of patients receiving IV r-tPA at an academic medical center from January 1, 2011 to January 1, 2014. Data evaluated included dosing characteristics of r-tPA and effects on patient outcomes including hospital length of stay (LOS), baseline National Institute of Health stroke scale score, discharge disposition, incidence of hemorrhagic conversion, and death/hospice.

A total of 110 patients (28 patients >100kg and 82 patients 100kg) with diagnosis of ischemic stroke and >18 years were included. Hospital LOS (patients >100kg mean: 7.6 days and patients 100kg mean: 6.88 days) and baseline NIHSS (patients >100kg mean: 11.9 and patients 100kg mean: 11.76) was comparable between both groups. In the group with patients >100kg, 64.3% were discharged home compared to patients 100kg, 56.1% were discharged home. Patients >100kg had total r-tPA dose average of 87.1mg (0.73mg/kg total r-tPA dose average, 0.08 mg/kg loading dose, 0.65mg/kg continuous infusion average); patients 100kg total r-tPA dose average was 68.42mg (0.0898 mg/kg total r-tPA dose average, 0.089 mg/kg loading dose average, 0.808 mg/kg continuous infusion average). Zero patients in >100kg group had hemorrhagic conversion versus 7 (8.54%) patients in 100kg group had hemorrhagic conversion. Two patients in >100kg group died versus 7 patients had an outcome of death or hospice in 100kg group.

There is not an increase in unfavorable outcome from stroke in patients with >100kg even though these patients received total r-tPA dose that is less than 0.9mg/kg due to maximum allowable dose limit of 90mg.

Time is brain. A process to improve door to needle times for CVA patients who are eligible for thrombolytic therapies and interventional radiology treatments is vital for improving a CVA patient's quality of life. In order to increase these times, processes need to be in place to streamline care efficiently. We created the neurocritical care RN (NCRN) role to aid in this process.

In order to aid the ER in providing efficient care to CVA patients, the NCRN role was created. The NCRN is a neurocritical care trained RN who responds to stroke alerts in the ER and throughout the hospital. The NCRN coordinates with the on-call neurologist, interventional neuroradiologist, neurointensivist, and imaging services to facilitate efficient care and correct hospital unit placement of CVA patients. Other duties of the NCRN are to coordinate transfers of neurocritically ill patients from outside facilities to the Neurovascular ICU, as well as help aid RNs around the facility in caring for neurological critical care patients.

Since the creation of the NCRN role door to needle times have decreased while our neurocritical care patient population has increased. The patients have been appropriately allocated to the Neurovascular ICU to receive the care, rather than being placed in any open ICU bed.

The NCRN Role is a vital component in the care of our neurocritical care patients. It has shown to improve door to needle times, transfers into the neurovascular ICU, and overall outcome of our neurocritical care population. It facilitates transition from the ER to the Neurovascular ICU and provides the family and patient with care continuity.

With NCRN presence starting in the ER to the ICU it has also improved patient hand-off between caregivers and dual neurological assessments to provide the highest level of patient safety.

Multiple factors determine outcome and infarct volume in acute stroke. While CT angiography (CTA) and CT perfusion (CTP) are routinely used for diagnosis, treatment planning, and prognosis, the processing and interpretation of CTP requires valuable additional time potentially delaying earliest possible reperfusion. The presence of collateral blood flow (CF) to the ischemic region is crucial for neuronal survival in acute large vessel occlusion. While prior studies have shown that better CF results in smaller core infarct size at presentation, we undertook this study to systematically investigate correlation between CF and cerebral blood volume (CBV) and cerebral blood flow (CBF) abnormalities on CT perfusion in addition to the relationship between CF, final infarct size, and patient outcome.

Retrospective chart review of patients presenting with acute stroke due to middle cerebral artery and/or internal carotid artery terminus embolus was performed by two trained neuroradiologists blinded to outcome using a prospective database from 2012-2014. Fifty patients met inclusion criteria; unenhanced CT (UCT), CTA, and CTP of these patients were reviewed. Using CTA, collateral blood flow on affected side was graded relative to the contralateral unaffected hemisphere using a scale of 0-3 with score of 0 = no collaterals, 1 = < 50%, 2 = > 50% but < 100%, and 3 = greater than or equal to 100%. The CBV and CBF were measured in the vessel territory and compared with the CF score.

We found a strong inverse correlation between CF score, core infarct volume, and both the extent and degree of CBV and CBF reduction on CTP. Our findings suggest that CF score combined with absence or presence of early ischemic changes on UCT is sufficiently predictive of perfusion abnormalities and core infarct volume.

Collateral blood flow scoring is a predictor of core infarct volume, final infarct size and clinical outcome.

To determine the impact of acute myocardial infarction (AMI) and administration of rt-PA on survival of patients with acute cerebral ischemia( ACI) in United States during 2002-2001.

Data from Nationwide Inpatient Sample (NIS) was queried from 2002 -2011 for inpatient admissions with a primary diagnosis of ACI using International Classification of Diseases, 9 th Revision, Clinical Modification (CM) coding (ICD-9). A multivariate stepwise regression analysis was used to assess the significance of variables affecting overall survival.

During a decade the NIS recorded 886,094 ACI admissions with 26693 rTPA administration (3.015 %) and 17,526 diagnoses of AMI (1.98%). The overall cumulative mortality of cohort was 5.65%. The shortest median time to death was in patients with AMI and no rTPA (31 days, 95%CI: 29-34), followed by patients with AMI and rTPA (61 days, 95%CI: 44-NA), and patients who didn't develop AMI and had no rTPA (101 days 95%CI: 90-114). The longest median time to death was in the group that didn't have AMI but received rt-PA (166 days, 95% CI: 92-NA). On Kaplan-Meier analysis, the survival fractions for the AMI and non-AMI groups diverged significantly over time in ACI patients (log-rank p< 0.0001).

Our study demonstrates strong associations between rTPA administration and AMI and decreasing median time to death of ACI patients. AMI has a more significant association than rTPA with decreasing survival in these patients. These observations may be related to increased cardiovascular disease burden in a subset of patients. Considering the high clinical burden of AMI on mortality of ACI patients, prompt diagnosis and treatment of associated cardiovascular diseases may improve outcome and warrant further study.

Mechanical ventilation (MV) and tracheostomy are frequently performed in ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH). Little is known about the incidence, associated conditions, and outcome of these patients at a population level.

The incidence of MV and tracheostomy for stroke (IS/ICH/SAH) were examined using California statewide administrative claims data (1/1/2005 to 12/31/2011). The ICD-9-CM codes for tracheostomy (31.1-31.2) were validated by blinded retrospective chart review of 50 patient encounters (sensitivity: 100%, specificity: 96%). Previously validated ICD-9-CM codes were used to identify patients admitted with IS (433.x1, 434.x1, and 436), ICH (431), and SAH (430), and whether they underwent MV (96.70-96.72) and tracheostomy. Descriptive statistics (95% confidence intervals) were used to report incidence and mortality rates. We examined associations with previously reported risk factors for MV using multiple logistic regression with backward stepwise elimination of variables not associated with MV (p< 0.20).

There were 387,591 hospital admissions with either IS, ICH, or SAH. 38,867 or 10.0% (9.9-10.1%) underwent MV (IS = 6.3% [6. 

Ten percent of stroke patients receive MV. Over half of these patients die, despite the fact that younger patients are more likely to receive MV. Further studies are needed to better understand optimal management for this common, yet poorly studied intervention in stroke.

The exposure to neurocritical care among neurology residents is highly variable. In spite of proven success of Simulation based learning (SBL) in teaching critical care, emergency medicine, and anesthesiology, studies evaluating SBL in neurocritical care are still lacking.

Eligible PGY-2 neurology residents (N=10) from Columbia university and Weill-Cornell were randomized into SBL and traditional didactic teaching groups. High-fidelity Sim-Man 3G was used to simulate realistic scenarios of acute ischemic stroke, intracranial pressure (ICP) crisis, and status epilepticus. Learning objectives were assessed using crisis resource management (CRM) assessment tools including identification of key actions (0=no, 1=with prompt, 2=never), Ottawa CRM checklist, and knowledge based pre-and post-intervention tests. Mean±SD, median, and Wilcoxon rank-sum tests were calculated.

Acute stroke case: mean key action scores (maximum score 28) were 17. There were no statistically significant differences found between groups for either of the pre-specified outcomes.

Simulation based learning offers promise as a tool for objectively assessing some of the ACGME competencies that are more difficult to evaluate via traditional means. Studies with larger N and longer follow-up are needed to assess the efficacy, learner-retention and satisfaction rates among groups.

Introduction RN burnout is a problem within the nursing community and leads to decrease in staff morale and quality of patient care. Research shows that implementing shared governance in the hospital setting, at a hospital wide or unit wide level improves patient care and staff morale.

We implemented a Unit Based Practice Council (UBPC) in our Neurovascular ICU.

The Neurovascular ICU UBPC is made up of bedside RNs who identify problems in practice and work with physicians and nursing management to find a solution and implement it. The UBPC coordinates educational opportunities for the staff and identifies areas of education that staff needs. Since implementation of the UBPC, RN staff morale has increased. The UBPC has also implemented process improvements to improve patient care outcomes. In the beginnings of the UBPC the staff was asked to take the "AACN Healthy Work Environment Survey", follow-up surveys will be available to staff annually to track progress.

Implementation of a UBPC improves RN staff morale and patient outcomes in the Neurovascular ICU. It allows bedside RNs to be in control of their practice and keep up-to-date in evidence based guidelines. The RNs can improve processes associated in caring for neurocritical care patients in collaboration with MDs and nursing management. Having this control over their practice increases morale and improves patient outcomes.

The Neurosciences Critical Care Unit (NCCU) is a developing unit which remains in the process of onboarding RN staff. A 2013 survey identified inconsistencies in how neurological specific assessments and interventions were communicated in RN handoff. It was concluded that the use of a standardized template would be helpful in the exchange of communication between RNs. A template creates repetition that allows for a large amount of complex information to be conveyed in a concise manner. Additionally, a standardized format allows for pattern recognition and shifts the focus from a task oriented report to one of intention. Therefore, a neuroscience specific handoff template was created.

The 12 point questionnaire was repeated seven months after the initiation of a handoff template. Comprehensiveness in report remained the focus in order to deliver a thorough exchange of information subsequently providing an arena for safe and optimal patient care. We queried 46 RNs over a 4 week period of time. Of those, 29 were NCCU RNs and 17 Surgical Intensive Care Unit RNs who floated into NCCU.

Using the handoff template improved information provided in RN report in the key areas previously identified: knowledge of 1) primary diagnosis, 2) information to assume responsibility for patient care, and 3) the plan of care. The response of "always" increased by 9%, 30%, and 30% respectively with a resultant decrease in "usually".

We are moving towards a focus of intention demonstrated by the significant increase in percentages in key areas. With consistent use of the template, we can anticipate continued improvement in all areas of handoff.

High-quality healthcare for patients and their families includes effective and comprehensive palliative care. The integration of critical care and palliative care is increasingly recognized as a necessary component of healthcare services for the critically ill. The outcomes of palliative care delivery by neurocritical care teams have not been extensively discussed. Following the implementation of a palliative care bundle, we will be evaluating data from patients, families, and providers in a neuroscience intensive care unit (NICU) to determine satisfaction with palliative care delivery and staff adherence to the intervention.

Patients with an admitting diagnosis of subarachnoid hemorrhage (SAH), intracranial hemorrhage (ICH), and subdural hemorrhage (SDH), are greater than nineteen years of age, and are hospitalized more than seventy-two hours are included to receive the palliative care bundle. The bundle requires documentation of the patient's ability to make independent decisions, presence of a legal surrogate decision-maker (SDM), possession of an advanced directive (AD), and completion of a structured family meeting between hospital days three and five. Patients and their families are voluntarily interviewed using a modified version of the Veteran's Affairs Post Bereavement Survey to determine satisfaction. Medical and nursing staff bundle adherence is analyzed on a monthly basis.

This project will be completed in summer 2014. It is anticipated that there will be high overall patient and family satisfaction scores, an increase in the percentage of adherence rates from initial bundle implementation to project end, and qualitative data from patients, families, and providers supporting the use of a primary palliative care bundle in the NICU.

Provision of palliative care is an essential and meaningful service that defines patient and family centered care in the NICU. Implementation of a standardized palliative care bundle should promote delivery of high quality services to patients and their families.

The well rounded neurocritical care nurse practitioner (NP) should possess the skill set to safely place a central venous catheter in any of the three standard locations: subclavian, internal jugular (IJ), and femoral sites. To improve ease of internal jugular and femoral placement and to minimize complications, ultrasound guidance is considered the standard of care. To support our neurocritical care unit's (NCCU) NP's comfort with ultrasound guided central access placement techniques, didactic and simulated training tools were created to enhance NP learning.

Before and after measurements were obtained utilizing an evaluation tool. The evaluation tool incorporated a series of questions surrounding comfort with: performing ultrasound techniques; identifying anatomic and ultrasound anatomy; determining NP comfort and competence with ultrasound and central catheter equipment; identifying the suitability of an insonated vein for cannulation; and determining the ability of the NP to plan a safe needle course. A thirty minute didactic overview of ultrasound principles, anatomic structures, and equipment utilization was followed by 60 minutes of simulation training and practice.

Four NCCU NPs participated in ultrasound guided IJ and femoral central line training. The mean score on the competency section rose from 71% to 84% on preliminary data (n=2). An increase in the mean cumulative scores of the self-reported comfort level of these items was noted (20 to 35.5 out of 50 possible points). Each of the NPs felt comfortable progressing to proctored placement on live patients at the end of the educational activities.

Structured learning utilizing ultrasound guided simulation training for central line placement is feasible and may lead to improved competency and comfort of neurocritical care NPs. Future research needs to occur with larger groups of practitioners Financial Support: None

Nurses, who comprise over 55% of the health care workforce, play a critical role in health care, as a review of the literature demonstrates that optimal nursing staff ratios correlate with decreased mortality, lower rates of adverse events, and shorter lengths of stay. To our knowledge, few studies have evaluated nursing staff ratios within the neurosurgical intensive care unit (NSICU), which utilizes more invasive hemodynamic monitoring than general ICUs. The aim of this study is to analyze nursing ratios within the NSICU, pre and post acquisition of a portable CT scanner, to evaluate how well optimal rates are maintained.

We surveyed the patient and nursing populations in our 16-bed NSICU over a 4 week period before and after implementation of a portable CT scanner, by recording the respective censuses at 30 minute intervals for each of the day and night shifts. From this, patient-to-nurse ratios were extrapolated and plotted in Excel. Staffing levels, CT scan volume, and average patient volume were analyzed to account for sample size differences. Statistical analysis was used to assess the significance of the results.

We found that there was a statistically significant decrease in patient-to-nurse ratios (2.14 2.00) after acquisition of the portable CT scanner (p=0.0003, Mann-Whitney test). 137 in-radiology CT scans were performed prior to portable CT, and 96 in-radiology and 17 portable afterwards, corresponding to an average of about 4 scans per day, respectively. There were no statistical difference between day and night shifts, CT scan volume, average patient volume, and overall staffing levels for both timeframes.

Technologies, such as portable CT, demonstrate utility in improving optimal patient-to-nurse ratios in the NSICU. This, in effect, will allow for reduced nursing burden and greater availability for patient care. Further studies will need to be performed to analyze associations between staffing levels and patient outcomes.

There is no nationally recognized tool currently available to monitor key outcome and process measures in an intensive care setting, a place where 59% of all in-house mortality occur in or include a stay. Additionally, patient care services rendered in these units account for 20% of overall hospital costs. The Neurocritical Care Service (NCC) at University of California San Diego Health System developed a dashboard to monitor, track and report key outcome and process measures relevant to our NCC ICU utilizing the University HealthSystem Consortium Clinical Database (UHC CDB).

We identified metrics important to the NCC aimed at improving quality of care, including mortality, ventilator associated pneumonia, ventricular catheter meningitis, length of stay, as well as MRI and CT utilization and hospital direct cost. We then extracted this data from the UHC CDB and developed an NCC specific dashboard that is updated on a quarterly basis.

At UCSD Health System we found that during the life of the dashboard, we experienced an increase in NCC cases per year (+125, +50), a decrease in mean ICU length of stay (LOS) (-2 days, -33%, p=0.001), decreased O/E inhospital LOS (-0.19, -14%, p=0.002), decreased O/E in-hospital mortality (-0.21, -21%, p=0.960) and decreased O/E direct cost (-0.04, -3%, p=0.828).

The NCC ICU dashboard at UCSD has been a powerful tool allowing us to routinely monitor and track compliance with key neurocritical care outcomes that have then driven operational efficiencies and improved patient care. Our dashboard can serve as a demonstration for how other healthcare organizations can leverage UHC CDB to develop similar tools to improve health care delivery and patient outcomes in the intensive care setting.

The University of California San Diego Health System initiated a Neurocritical Care (NCC) service, under the direction of an NCC fellowship-trained/board-certified neurointensivist in January 2012. The NCC service consists of an NCC team (three NCC-trained attendings with continuous resident coverage) that admits and provides primary management for all ICU-level neurosurgical/neurological patients. The majority of NCC patients are housed in one ICU with nurses NCC-educated by the NCC director.

We analyzed the University HealthSystem Consortium (UHC) data for all NCC patients with a primary diagnosis of hemorrhagic stroke (both intracranial hemorrhage (ICH) and subarachoid hemorrhage) from 2013, compared with neurosurgical/neurological ICU patients from 2011, prior to NCC establishment. We also evaluated hemorrhagic patients from all academic hospitals in California with established NCC units over the same time period as a control group.

At UCSD Health System, we found that observed in-hospital hemorrhagic mortality decreased from 24.7% in 2011 to 21.9% in 2013(-2.8, -11%), with risk-adjusted in-hospital mortality index (observed/expected mortality) decreasing from 1.22 to 0.92 (-0.3, -25%). In addition, ICU length of stay (LOS) for these patients decreased from 8.4 to 6.2 days (-2.2 days, -26%). During this same time, other academic California hospitals with NCC units observed an increase in observed mortality from 17.8% to 19.5% and a decrease in in-hospital mortality index from 1.07 to 0.99 (-0.1, -7.5%). There was also a decrease in ICU LOS from 8.9 to 7.9 days (-1 day, -11%).

Implementation of a primary NCC service at UCSD has been followed by decreased risk-adjusted in-hospital mortality index and ICU length of stay in hemorrhagic stroke patients over baseline and to a level at or better than other academic California hospitals with established NCC units. With increasing focus on outcomes-based reimbursement, our experience provides an example of infrastructural methods that improve outcomes.

Few studies have examined the effect of an intensivist in a Neurocritical Care (NCC) unit. The purpose of this study was to identify both patient and economic benefits of a new requirement for a mandatory intensivist consultation on admittance into the NCC unit. In November 2010, our hospital changed the NCC unit to a partially closed unit, which required patients to have a mandatory intensivist consultation upon admittance. Previously, the intensivist consultation was optional. The objective of this study was to compare patient length of stay (LOS), complications and outcomes before and after implementation of mandatory intensivist consults.

A retrospective review comparing 1,551 patients admitted to the NCC unit from November 2009-October 2010 (prior to the new requirement) with 1,702 patients admitted from January-December 2011 (after the new requirement) was performed. This included examining patient LOS, Acute Physiology and Chronic Health Evaluation (APACHE) scores, service line closure rates for the unit, ICU readmission rates, and mortality. The number of consults during each of the two time periods was also analyzed.

The analysis revealed that despite comparable APACHE scores, implementation of mandatory intensivist consults reduced overall NCC length of stay, 4.6 days vs. 3.7 days, (p< 0.001) and increased number of patients admitted to the unit per month, 129 patients vs. 142 patients, (p=0.017) based on APACHE monthly counts. In addition, the percentage of patients declined for transfer due to a closed service line decreased, 12.36% to 5.66%, (p=0.020). Mortality rates remained below national predicted values and infection rates remained unchanged.

Implementation of mandatory intensivist consults in the NCC decreased LOS and allowed an increased number of NCC unit admissions while maintaining overall quality of care.

Studies have shown that 85% to 99% of medical device alarm signals are false and/or clinically insignificant resulting in desensitization and alarm fatigue. The Joint Commission now requires hospitals to have a plan regarding alarm management. We sought to determine the frequency and duration of alarms in our neurological intensive care unit (NICU).

Device alarms generated by 604 patient admissions between February, 2009 and January, 2013 were collected using the Bedmaster EX data acquisition system (Excel Medical, Jupiter, FL). Data collected include the alarm acuity levels 1 (lowest) to 7 (highest), alarm duration, and details of the alarm trigger. Analyses were conducted using general linear models.

In total 1,147,617 device alarms were recorded over 5,624 patient days (20, 427) . Response time varied significantly with the type of alarm (P < 0.001) and level of acuity (P< 0.001). Low acuity device warning alarms (e.g., RR leads failure) took the longest to respond to (mean: 256 seconds, SD: 3581 seconds). Clinical alarms regarding cardiac functioning (e.g., asystole) were responded to most quickly (mean: 16.5 seconds, SD: 144 seconds) whereas intracranial pressure alarms took approximately 1 minute to respond to (mean: 67 seconds, SD: 287 seconds).

Alarms are frequent in the neurological intensive care unit and device alarms may alert continuously for over an hour adding to noise levels. Strategies to analyze alarms in real time should be devised to reduce the overall frequency of alerts clinicians receive.

Intracranial pressure (ICP) monitoring is recommended in most comatose patients with acute brain injury. We aimed to evaluate a new brain tissue probe for combined ICP, brain temperature (Temp), cerebral blood volume (CBV), and cerebral blood flow (CBF) monitoring.

The NeMo Probe® (NeMoDevices AG, Switzerland) is a conventional ICP probe supplied with a temperature sensor and optical fibers for near infrared spectroscopy (NIRS). After central venous injection of indocyanine green (ICG), the mean transit time of ICG (mttICG), CBV, and CBF are calculated. Combined NIRS-ICG measurements were performed in 13 patients with subarachnoid hemorrhage (n=12) and traumatic brain injury (n=1). The useracceptance was compared with conventional brain tissue probes using a 3-graded questionnaire (better, equal, worse). At least 2 repetitive NIRS-ICG measurements were performed daily to calculate the coefficients of variation.

The monitoring duration was on average 148 ± 61 hours. The user-friendliness of the NeMo Probe® was estimated to be better or equal to conventional brain tissue probes in all cases. No serious adverse device-related events occurred. There was a good correlation between ICPNeMo and ICPControl (r=0.758, p=0.01) as well as between TempNeMo and TempControl (r=0.848, p=0.01). Mean values for mttICG was 6.8 ± 0.2 seconds, CBV 3.3 ± 0.3 ml/100g, and CBF 30.9 ± 2.6 ml/100g/min. The coefficients of variation for repetitive mttICG, CBV, and CBF measurements were 3.7%, 9.7%, and 9.1%, respectively.

The results demonstrate a high acceptance rate concerning the user-friendliness of the NeMo Probe®. As a first step, the accuracy of the measurement values was investigated by repeated measurements. The reproducibility of the results was satisfactory for decision making in the clinical environment. Future studies are needed to validate the measurement values with a standard method for CBF-monitoring as well as to estimate the sensitivity and specificity to detect secondary ischemia after acute brain injury. 

Phenylephrine is an alpha-adrenergic receptor agonist that is used commonly in the neurocritical care unit (NCCU) to treat hypotension and induce therapeutic hypertension with the goal of optimizing cerebral and spinal perfusion pressures.

After appropriate approval from the institutional IRB and Pharmacy and Therapeutics Committee, the authors implemented the use of peripheral phenylephrine in a concentration of 40 mcg/mL at a rate not to exceed 2 mcg/kg/min for a maximum of 12 hours. The clinical indications for peripheral phenylephrine use was restricted to select brain injured patients: 1. Augmentation of cerebral and spinal perfusion pressures 2. Emergent management of hypotension in patients without central venous access to avoid drop in cerebral/spinal perfusion pressures. A medication use evaluation and retrospective chart review was conducted to assess the practice of peripheral phenylephrine administration. Objectives of the review were to evaluate for major and minor complications of peripheral phenylephrine use. Minor adverse events were defined as erythema, swelling, and pain at the site of the peripheral IV, and major adverse events as IV infiltration, thrombophlebitis and skin necrosis.

20 patients were identified as having received peripheral phenylephrine during their admission to the NCCU from August 16 th , 2013 to February 16 th , 2014. The average duration of infusion was 14.3 hours. One of the 20 patients experienced a minor adverse event. This IV was removed and the patient proceeded to receive peripheral phenylephrine for an additional 13 hours without further complication. There were no major adverse events.

After analysis of the data, use of peripheral phenylephrine infusion at this concentration, appears to be safe and without major adverse events when used for an average of 14.3 hours in carefully selected patients, and with ICU monitoring.

After cardiac arrest (CA), the American Heart Association recommends weaning inspired oxygen (FiO2) "to achieve an arterial oxygen saturation [SaO2] 94%...to avoid potential oxygen toxicity." This risks inadequate cerebral oxygen delivery. We hypothesized that brain tissue hypoxia (BTH) would occur commonly in severely brain injured post-CA patients and be more frequent when SaO2 was < 98%. We further hypothesized that arterial oxygen tension (PaO2) and mean arterial pressure (MAP) would be determinants of brain tissue oxygen (PbtO2).

We monitor intracranial pressure (ICP), temperature, PbtO2 and jugular venous oxygen saturation in patients with severe neurological injury (extensor posturing or worse) after CA. We collected data hourly and defined BTH as PbtO2< 20mmHg. We calculated median frequency and duration of BTH events, and compared the frequency with SaO2 >98% vs 94-98%. We used generalized estimating equations to test the correlation of ICP, temperature, time from arrest, PaO2, MAP, arterial oxygen content and PaCO2 with PbtO2, then constructed an adjusted model using predictors with an unadjusted P< 0.1. Finally, we calculated arterial-brain oxygen (a-B) gradient and repeated correlation test procedures.

Seven patients were monitored for 750 hours. All patients experienced BTH (median 6.5 episodes/patient (range 1-10), median duration 1.8 hours/episode (range 0.5-48)). BTH was present in 31% of hours overall (range 2.5-77%), 61% of hours when SaO2 was 94-98% and 29% when SaO2 was >98% (P< 0.001). Predictors of PbtO2 that persisted after adjustment (P < 0.01) were time, PaO2 and MAP. The median a-B gradient was 119mmHg (IQR 83-162mmHg) but fell rapidly over the first 24h.

In severely injured post-CA patients, BTH occurs frequently, appears to be delivery responsive, and occurs more commonly when SaO2 is 94-98%. The risk-benefit ratio between limiting BTH vs. limiting hyperoxia must be carefully considered in light of existing guidelines in these severely injured patients.

Critical care units are responsible for an enormous number of cost saving, metric driven initiatives and at the same time that they are expected to provide optimal patient care. Busy units are often under staffed and the physicians have to ration their time to each patient based on need. When there are conflicting needs it may be a difficult choice as to which patient gets that necessary level of attention. This conundrum is most evident with the organ donor population. When a physician has a "crashing" patient that is likely to survive and one that is not, resources are typically shunted to the survivable patient. Neurocritical care physicians and engineers at the University of Wisconsin developed the Digital Intern to tackle this problem head-on. The software was embeded into the electronic medical reocrd (EMR) to directly communicate orders to allied health professionals.

The number of organs recovered and the cost to recover them from the standpoint of critical care time billed were compared between the control year and the treatment year when the Digital Intern was operational.

The organs recovered per donor (excluding research) were 2.83 in the control year and 3.54 in the treatment year. The results were statistically significant (p< 0.0359). In the control year the critical care hours billed averaged 5.9 per donor and 2.3 in the treatment year. These results were statistically significant (p< 0.001). Cost savings averaged $2685 per donor.

The Digital Intern is designed to manage complex patients where simple PRN orders wouldn't be effective and detailed PRN orders might be too confusing to follow. It is fast, effective, and efficient. Future iterations may extend care to other patient populations where defined metrics can be used to optimize medical management. In the meantime, the neurocritical care physician has no worry of being sidelined.

External ventricular drains (EVDs) are both a therapeutic and diagnostic tool used every day by neurosurgeons.

Hemorrhage is a common complication of EVD placement and has recently been recognized to occur more frequently than originally believed. Risk of hemorrhage with removal of an EVD has not been well described, and no universal recommendations exist regarding timing of anticoagulation and/or antiplatelet agents before removal of an EVD. We investigated the affect of anticoagulation and antiplatelet agents on hemorrhage caused by removal of an EVD.

After obtaining IRB approval, a database was created to all who required EVD placement from January 2012 to December 2013 at our institution. A retrospective chart review was completed and all imaging was reviewed for evidence of hemorrhage on placement and removal of the EVD.

179 EVDs were placed in 134 patients during the designated time period. Hemorrhage occurred in 46 patients (26%) on placement with an average volume of 0.82cm 3 ± 2.44cm 3 , while 17 patients (9.5%) had hemorrhage on EVD removal, with an average volume of 7.34cm 3 ± 19.86cm 3 . Anticoagulation or antiplatelet agents were started in 60 "high risk" patients (45%) prior to EVD removal. Imaging was performed on 91 patients after removal, with hemorrhage in 6 (14.40cm 3 ± 33.18cm 3 ) of the high risk group and 11(3.49cm 3 ± 5.87cm 3 ) in the normal group, OR 0.8 (CI 0.27-2.40, P = 0.98).

Multiple studies have investigated hemorrhage related to EVD placement with rates varying from 0-42%, while very few studies have described hemorrhage secondary to EVD removal. The risk factors associated with EVD removal have not been investigated. We found no correlation between the use of anticoagulation and antiplatelet agents and an increased risk of hemorrhage on EVD removal.

Neurocritical care beds are a valuable, but scarce resource. The purpose of this study was to quantify discharge delays from the neuroscience intensive care unit (NICU) at a tertiary-care teaching hospital and examine the impact on overall hospital length of stay (LOS). Secondary goals were to evaluate the effect of NICU delays on patient physical/occupational therapy services and accuracy of initial clinician estimates of NICU and hospital LOS.

We conducted a prospective cohort study of consecutive patients discharged from NICU at Massachusetts General Hospital from March 6th, 2013 through April 14th, 2013. Patients admitted for primary neurosurgical interventions were excluded from the study. Patients were defined to have experienced a discharge delay when deemed ready for transfer/discharge from the NICU but not physically transferred/discharged from the unit within 8 hours of time first ready.

65 patients were transferred from the NICU with an average transfer delay of 25 hrs 51 min (median = 13 hrs 3 min) of which 42% of patients were delayed at least 8 hours, while 23% were delayed at least 48 hours. The primary reason for delay was identified as lack of bed availability. Transfer delay had no effect on hospital LOS. Clinician estimates regarding date of transfer were inaccurate (within 24 hours in only 16% of patients) and underestimated NICU LOS in ~95% of patients. Prediction of NICU LOS was most accurate in patients with diagnoses of brain tumor compared to other common diagnoses (seizure, ischemic stroke, or intracerebral hemorrhage).

Discharge delays from the NICU were a common problem, but did not affect overall hospital LOS. Delays had a negative effect on total physical therapy time patients received. Clinician estimates of NICU LOS must be improved for discharge planning and resource allocation such as physical therapy.

Clinical outcomes assessment requires trained staff. We tested the hypothesis that patient-reported outcomes on the web would be correlated with a validated interview.

We assessed patients with intracerebral and subarachnoid hemorrhage at one, three and 12 months follow-up with a validated interview for the modified Rankin Scale (mRS, a validated ordinal scale from 0, no symptoms to 5, severe disability). Health-related quality of life (HRQoL) was assessed on the web with NIH Patient Reported Outcomes Measurement Information System (PROMIS) and Neuro-QOL using computer adaptive testing by the patient, proxy reporting by a caregiver, or proxy entry by study staff.

A coincident mRS and HRQoL assessment were available for 149 (71%) of 209 patients at one, three or 12 months. There were 89 assessments with proxy entry by study staff, 89 by the patient on the web, and 58 with proxy report by a caregiver on the web. PROMIS physical function assessments were completed in median of 4 questions, and T Scores were associated with the mRS (P< 0.001), regardless of respondent. Mean T scores in every category of the mRS were different from every other category (P 0.003 for all). Results were similar for Neuro-QOL mobility.

Web-based HRQoL assessment with NIH PROMIS and Neuro-QOL is feasible and correlated with a validated interview for the mRS. T scores distinguished between individual categories of the mRS, detecting modest differences in physical function and mobility HRQoL. PROMIS and Neuro-QOL provide powerful and sensitive outcomes for potentially large cohorts.

We prospectively studied the consent patterns of a prospective, randomized, placebo-controlled trial in terms of best-practice and failed-consent elements, and simulated them to enhance future recruitment among the clinical trial.

CLEAR-III trial is a prospective, randomized, placebo-controlled trial studying the effect of recombinant intraventricular tissue plasminogen activator (rtPA) versus saline (placebo) injections in terms of intraventricular hemorrhage (IVH) reduction and safety. Data was collected on "best" and "failed" consent practices during the clinical trial. These best and failed consent practices were then simulated into a Simulation Center video presentation as an education intervention to educate all study sites to improve consent conversion. Pre -and postpresentation screen failures and refusal of consent were analyzed by Fisher's exact test for significance.

The overall conversion rate rose from 4.5% to 5.8% after the presentation. The year prior to the presentation the study had 100 randomizations out of 2225 screen failures, compared to 116 randomizations out of 2007 screen failures after presentation (P=0.08). While this trend did not reach statistical significance, anecdotal reports from site managers suggest the presentation was useful and helped 'salvage' some consents. The number of 'refused consent over 'other failures' to enroll in the study pre intervention (n=33/2192) compared post-intervention (n=25/1982) was not significant (P=0.59). In the subset of sites that participated in the live webinar presentation, the incidence of consent refusal out of total screen failures dropped from 2.5% (23/923) at baseline to 1.8% (15/834) after the presentation (p=0.33).

Randomized, placebo-controlled trial consent process may be improved by identification of best-practice and failed consent elements, followed by simulated video portrayals of these elements to provide quality improvement to study sites, principal investigators and coordinators. However this intervention did not change the rate of refused consent in the trial which requires further study and likely due to multiple confounding factors.

The current guidelines recommend all intracerebral hemorrhage (ICH) patients be managed in a facility with capacity to perform neurosurgical and neuro-interventional procedures. However, many transferred ICH patients do not receive these interventions. Therefore, we sought to assess the annual excess cost of inter-island transfer (IT) of ICH patients who were transferred to a tertiary center with such capacity.

Consecutive patients with ICH between June 2011 and January 2014 were enrolled into a prospective cohort study. Patients were considered to have received subspecialized tertiary care (STC) if any neurosurgical procedure (craniotomy, craniectomy, and/or ventriculostomy) or cerebral angiogram (diagnostic and/or therapeutic) were performed. Minimum cost of IT for ICH patients was estimated based on the informal survey of a local company that provides IT. Total excess cost was estimated as excess cost per IT multiplied by the portion of IT patients not receiving any STC. Univariate and multivariable analyses were performed to identify factors significantly related to the likelihood of receiving STC.

Among a total of 200 ICH patients enrolled in the cohort study, 38 patients (19%) were admitted from the neighbor islands through IT. Among them, only 13 patients (34%) received STC. Since the remaining 25 IT patients did not receive any STC, this translates to approximately $250,000 of total excess cost over 2.5 year period (approximately $100,000/year) that could have been avoided if these patients had not been transferred. None of the clinical factors in our model were significantly associated with the likelihood of receiving STC.

Approximately two-thirds of ICH patients with IT did not receive any STC and could have potentially received similar care at their initial hospital. The estimated excess cost of IT was $100,000 per year. Further study is needed to better assess factors that could identify patients most likely to benefit from IT.

Financial Support: Dr. Nakagawa was supported in part by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number P20MD000173.

In patients with intracerebral hemorrhage (ICH), packed-RBC transfusion may be detrimental whereas platelettransfusion's effects are controversial. Prior studies suggest different transfusion thresholds in patients with coronary artery disease (CAD). This study examines the association between transfusion and outcomes in ICH patients with and without CAD.

ICH patients admitted to the Tulane Stroke Center from 07/08-01/14 were included. Patients with age< 18 years, in-hospital strokes and outside hospital transfers were excluded. Demographic and clinical data were analyzed in patients with and without CAD using Chi-square and Wilcoxon Rank-Sum tests. Primary outcome measure was discharge modified-Rankin score of 5-6 (dmRS=5-6). The association between transfusion and outcomes was assessed with logistic regression.

Out of 214 ICH patients identified, 25 (11.7%) had CAD on admission. CAD patients were younger than non-CAD patients (60 vs. 67; p=0.007) and had a higher frequency of antiplatelet use (AP-use) (68% vs. 24%; p< 0.001). There was no difference in pRBC-transfusion between patients with CAD compared to those without (8% vs. 13%; p=0.500). CAD patients had a higher odds of receiving a platelet-transfusion (OR=3.69, 95%-CI=1.47-9.25, p=0.005); however, this association was no longer statistically significant after accounting for age and AP-use (OR=2.55, 95%-CI=0.66-9.89, p=0.170). ICH Patients who received pRBC-transfusion had greater odds of dmRS=5-6 (OR=6.11, 95%-CI=2.38-15.80, p< 0.001) than those without transfusion. After adjusting for age, admission hematocrit, admission ICH score, CAD, and intubation, this association was no longer statistically significant (OR=4.11, 95%-CI=0.80-21.00, p=0.090). After accounting for the same covariates including CAD, ICH patients who received a platelet-transfusion had a higher odds of dmRS=5-6 (OR=2.17, 95%-CI=0. 66-7.16, p=0.20) , however this association was statistically insignificant.

Transfusion is not a significant independent predictor of poor outcomes (dmRS=5-6) in ICH patients regardless of CAD history. It may serve as a marker of the severity of overall medical illness in ICH patients.

Low serum albumin has been correlated with poor outcomes in various diseases. Albumin is a chief component of plasma protein and is required to maintain normal permeability, prevent platelet aggregation besides having other important properties. Hypoalbuminemia, is a frequent finding in acute ischemic stroke and is associated with more severe stroke and poor clinical outcome. There is limited data on its impact on outcome in patients with intracerebral hemorrhage.

We reviewed our prospective database of patients admitted to our tertiary care medical center with intracerebral hemorrhage between January 2009-June 2012. All consecutive patients with intracerebral hemorrhage who had serum albumin levels upon admission were included. We analyzed the demographics, risk factors, etiology, location, volume of intracerebral hemorrhage, clinical and laboratory parameters, complications, mortality and outcome at discharge. Patients were divided into two groups based on the serum albumin levels. A cut of level of 3.4 g/dl and lower was considered as hypoalbuminemia. Both groups were compared using the Fisher's exact test.

Poor outcome was defined as in-hospital death, hospice and discharge to nursing home.

During this study period 90 patients met our inclusion criteria (42 patients had normal levels and 48 had hypoalbuminemia). The baseline characteristics, risk factors, hematoma, etiology, location, volume, laboratory parameters, length of hospital stay, length of intensive care unit stay, complication were similar between both groups. Although hypoalbuminemia, did not impact mortality, there was a significant impact on poor outcome (57% vs 31%, p=0.019) (O.R 3.0; 95% CI: 1.2-7.2).

Serum albumin is a readily available test that may be helpful in correlating outcomes in patients with intracerebral hemorrhage. Larger prospective studies are required to confirm these results.

Placement of intraventricular catheter (IVC) after intraventricular hemorrhage (IVH) is often life-saving, but carries the risks of hemorrhage and misplacement. If an IVC stops draining cerebrospinal fluid (CSF) due to clotting, it must be replaced, increasing the complication risk. We report intra-IVC instillation of rt-pA to lyse obstructing thrombi and avoid removal and replacement of the catheter.

We reviewed all patients with IVC placement admitted to a tertiary center Neuro-ICU over 6 years, who received rt-pA due to intra-catheter thrombosis. Intraventricular catheter position was confirmed by head CT before rt-pA was administered. The protocol mandated instillation of 1-2 mg rt-pA (volume 1-2 ml) into the IVC under sterile conditions, without additional flush in order to avoid extra-IVC leakage of the drug. IVC was then clamped for 1 hour and subsequently opened to drain. If no clinical improvement was noted after IVC patency was established with CSF drainage, emergent head CT was obtained to exclude hemorrhagic complication.

Nine patients (mean age 55, 33% female) were included. IVH resulted from subarachnoid (67%) and intracerebral hemorrhage (33%). No reliable ICP waveform was present before the instillation of the drug. Two patients received rt-pA on 2 separate occasions. The mean instilled dose was 1.46mg (range 1-2mg). No IVC was unclamped early on. Gradual return of ICP waveform during the clamping period was noted and all IVCs drained bloody CSF after reopening. The post-unclamping initial mean ICP was 14.6mm Hg and the first-hour mean CSF drainage was 14.7ml. No patient developed hemorrhagic complications and no IVC was changed after this procedure. One patient developed CSF infection one month later, which was deemed unrelated to rt-pA administration.

In this small case series, intracatheter rt-pA instillation was an efficient and safe way to lyse intra-catheter thrombi, reinstitute reliable ICP measurements and CSF drainage and avoid IVC replacement.

Systolic blood pressure guided management of spontaneous intra-cerebral hemorrhage (sICH) has been demonstrated to be safe and clinically feasible. Secondary injury caused by the hematoma such as perilesional ischemia impairs cerebral auto-regulation. We hypothesize that the first 24 hours Systolic, Diastolic, Mean arterial pressure and heart rate variability have effect on these processes and can influence outcome of patients.

Retrospective review of patients with sICH admitted from June 2010 to 2011 at the Neuro-critical care unit of the University Hospital. Demographics, ICH score, Blood pressure and heart rate recordings in the first 24 hours from onset, and clinical outcomes using 30 day mortality, length of ICU stay, and ability to transfer from bed to chair after ICU discharge were studied. Variability was measured using variance P (VARP) and Interquartile range (IQR)

In 80 

Controlling variability of other hemodynamic parameters such as MAP and HR, other than systolic blood pressure may reduce secondary injury from sICH in the acute phase hence improving functional outcome.

Intracerebral hemorrhage (ICH) is defined as intra-parenchymal bleeding with or without intra-ventricular extension. CT angiography (CTA) is widely used as a screening tool to identify a source. CTA can have adverse effects such as contrast-induced nephropathy, allergic reactions and radiation exposure. The utility of CTA in altering management of patients with spontaneous ICH may be restricted to a small subset.

A retrospective review was done of 944 patients admitted to Temple University Hospital with a diagnosis code of ICH. Patients who had antecedent history of trauma, subarachnoid hemorrhage, hemorrhagic conversion of an infarct, or hemorrhage within a brain tumor were excluded.

From the cohort of 940 patients with ICH, 207 (22%) underwent a CTA during hospitalization. Of these, 202 (97.5%) were negative. In this group, the mean age was 62 and 73.2% had hypertension; 52% of the ICH involved the basal ganglia and 30% involved the thalamus. Five of 209 (2.4%) had a positive CTA demonstrating an underlying vascular abnormality that caused the ICH; Two had aneurysms, one a venous angioma, one an AVM and one a pseudo-aneurysm. In this group, the mean age was 58, and 60% had hypertension. Two were frontoparietal, one temporo-parietal, one periventricular and one cerebellar in location. CTA changed management in three of these five patients: two had aneurysm coiling or embolization and one underwent a surgical treatment of AVM. Patients with a positive CTA tended to be younger and have cortical involvement, whereas those with a negative CTA were older, with hemorrhage affecting deeper brain structures.

CTA in older hypertensive patients with hemorrhages in deeper brain structures is a low yield procedure and does not change treatment or confidence in diagnosis. The similarity in prevalence of hypertension in the two groups could be reflective of the inner city population.

Timing and mode of renal replacement therapy (RRT) among patients with renal failure (RF) and spontaneous intracerebral hemorrhage (sICH) varies due to concern for rapid osmolar shifts. We aim to describe clinical characteristics, timing and complications in patients with RF and sICH undergoing continuous RRT (CRRT) versus intermittent hemodialysis (IHD) in an academic Neurocritical Care Unit (NCCU).

Retrospective study of 112 patients admitted to an NCCU from 2000 to 2013, with sICH and RF (ICD 584.4-9, 585.1-9). Thirty-seven patients underwent RRT during NCCU admission and were included for analysis and grouped by initial RRT mode (CRRT vs. IHD). We analyzed timing and factors associated with mode of RRT selected and neurologic/non-neurologic complications associated with each mode.

Mean(±SEM) age in all 112 patients was 59±15 years. 75 patients who did not undergo RRT had peak creatinine of 2.66±1.59. CRRT was the initial mode in 62% of those who underwent RRT. The most common reason for RRT initiation was acute RF(44%) in the CRRT group while it was "chronic RF on IHD" in the IHD group 

sICH patients initiated on CRRT in the NCCU have lower GCS, higher EVD usage, but better renal function compared to patients started on IHD. Better understanding of compartmental shifts, change in edema volume and intracranial pressure during RRT may guide decision making regarding RRT among sICH patients.

Studies show that racial/ethnic minorities are less likely to terminate life-sustaining treatment after an acute medical condition compared to non-Hispanic whites. However, the end-of-life decision-making process among Native Hawaiians and other Pacific Islanders (NHOPI) has not been described. Therefore, we sought to assess the racial differences in the prevalence and rate of withdrawal of life support (WOLS) after acute intracerebral hemorrhage (ICH), a hemorrhagic stroke with high rate of mortality and morbidity.

A retrospective study was conducted on patients admitted to a primary stroke center in Honolulu with diagnosis of spontaneous ICH. Medical records were reviewed for occurrence of withdrawal of life support (WOLS) and time-to-WOLS. Unadjusted and multivariable logistic regression models, accounting for age, sex, treating providers, risk factors and ICH severity, were performed to determine associations between race and WOLS after ICH. Kaplan Meier analysis and Cox Regression were performed to estimate and compare differences in time-to-WOLS.

A total of 396 ICH patients (non-Hispanic whites 15%, NHOPI 18%, Asians 63%, others 4%) were studied. Overall, NHOPI were significantly younger compared to non-Hispanic whites (55±16 vs. 68±16 years, respectively, p < .001) although ICH severity and presentation were similar. In the univariate analysis, NHOPI had lower prevalence of WOLS compared to non-Hispanic whites (OR 0.35, 95% CI: 0.15, 0.80). Kaplan Meier analysis showed a significantly longer time-to-WOLS among NHOPI compared to non-Hispanic whites (p = < .01). However, in multivariate analysis, NHOPI race was no longer a significant predictor of WOLS when adjusted for age (OR 0.59, 95% CI 0.25, 1.43) and in the fully adjusted model (OR 0.68, 95% CI 0.20, 2.39).

Native Hawaiians and other Pacific Islanders were less likely than non-Hispanic whites to withdraw life support after ICH. However, this difference was mainly driven by the young age of NHOPI and not from an independent racial/cultural factor.

Troponin elevation in ischemic stroke and subarachnoid hemorrhage is well studied and is an independent prognostic factor for mortality. However, the significance of troponin elevation in spontaneous intracranial hemorrhage (sICH) is not well studied. This study describes troponin elevation in patients with sICH and explores underlying associations.

This is a retrospective analysis of 208 patients from July 2012 to October 2013 who presented to our hospital with sICH. Of these, 145 patients with sICH (without AVM, Aneurysm, hemorrhagic conversion of ischemic infarct, trauma) were included in the study. Bleeds were categorized by their sidedness (right/left) and location (lobar, deep, or posterior fossa). ICH volume was measured by ABC/2 method after testing for inter-rater reliability.

Categorical and continuous variables were tested using appropriate statistical methods.

The mean age of patients was 64.0 ± 15.3 years. Troponin was measured in 133 patients and it was elevated in 49% of the patients (range 0.033-3.36 ng/ml). EKG changes reflecting possible ischemia was present in 28% (40/145) patients, although ST-T changes associated with troponin elevation was noted in 5% (8/145) patients only.

Troponin elevation did not have any significant association with side of the bleed, location, and initial hematoma volume or hematoma expansion. Troponin elevation was however significantly associated with mortality status of the patient at the time of discharge (p= 0.004, OR= 3.69, 95% CI 1.5, 9.0)

Troponin elevation in sICH does not appear to be associated with hematoma characteristics. However, it is significantly associated with mortality status of the patients at discharge. Whether troponin elevation independently contributes to mortality in sICH requires further investigation.

Prognostic significance of peri-hematomal edema (PHE) after intracerebral hemorrhage (ICH) is unclear. We investigated whether PHE expansion rate from baseline to 24 hours predicts mortality after ICH.

ICH, PHE and intraventricular hemorrhage (IVH) volumes were measured for 110 subjects who presented with primary supratentorial ICH and received head computed tomography (CT) scans at baseline and 24-hours post-ICH. Logistic regression was performed to evaluate the relationship between PHE expansion rate and 90-day mortality.

Patients who died had an average expansion rate of 0.74 mL/h compared to 0.17 mL/h in survivors. There was a strong association between PHE expansion rate and 90-day mortality (OR 2.99, 95% CI 1.48-6.03, p = 0.002). In a multivariable model accounting for presence of significant hematoma expansion, defined as more than 12.5 mL growth, PHE expansion rate was a significant predictor of 90-day mortality (OR 2.79, 95% CI 1.38-5.64, p = 0.004). This association remained in a multivariable model accounting for hematoma expansion, baseline ICH volume, and baseline Glasgow Coma Scale score (OR 2.19, CI 1.08-4.45, p = 0.03).

PHE expansion rate predicts mortality in ICH and may represent a novel therapeutic target. 

Statins may be a promising therapy after SAH and act through several mechanisms, including upregulation of eNOS promoting vasodilation and increasing CBF. We sought to determine if the initiation of statin therapy after acute SAH increases CBF and the response to induced hypertension during the peak period of risk for delayed cerebral ischemia (DCI).

Statin naïve patients admitted < 3 days of aneurysmal SAH with WFNS 2 were eligible. They were randomly assigned to receive 80 mg simvastatin/day or placebo for 21 days. On post SAH day 7-9 CBF, metabolism (CMRO2) and oxygen extraction (OEF) were measured with PET before and after raising MAP by 25±5%. Angiography was performed ±24 hours of PET. Cerebrovascular resistance (CVR) (MAP/CBF) and autoregulatory index (AI) (% MAP/% CVR) were calculated; AI 2 was considered normal. Clinical DCI, hospital disposition and 90 day modified Rankin Scale score were recorded. Results are presented as simvastatin vs. placebo, CBF and CMRO2 in ml/100g/min and MAP in mmHg

We studied 13 patients in the simvastatin and 12 in the placebo groups 8.6±1.3 and 8.0±1.8 days after SAH. Age was similar (59±12 vs. 60±10 years); there were fewer poor grade (WFNS 3-5) patients in the statin group (13%; 42%; p=0.28). Baseline MAP was 110±10; 110 ± 12. Global CBF, OEF and CVR did not differ (40 ± 12; 43±13); (0.35±0.08; 0.37±0.11); (3.00±1.0; 2.81±1.0). At MAP of 135±7;137± 5 mmHg, global CBF, OEF and CMRO2 did not change in either group. AI did not differ; 1.39±0.90; 1.32±0.80. Two patients in each group had AI slightly above the upper limit of normal (2.2-3.6). Moderate or worse angiographic vasospasm was present in 42% vs.45%; DCI developed in 14%; 55% (p=0.074). Good outcome (mRS 0-2) occurred in 75% vs. 80%.

We conclude that statins may reduce DCI after SAH but do not act via a cerebrovascular hemodynamic mechanism.

Financial Support: NIH P50 NS055977

The modified Rankin scale (mRS) is the most common measure of functional outcomes in stroke-related conditions. This resource intensive assessment requires multiple one-on-one encounters with trained personnel to follow long-term functional outcomes. We hypothesized that a simple, rapid, on-line survey completed by a patient or surrogate could generate an accurate mRS score compared to trained personnel in patients discharged after subarachnoid hemorrhage (SAH).

Methods 51 SAH patients were consented and included in the study. The survey (ranging from 2-14 questions) had an adaptive hierarchical design to minimize the number of responses required to generate the mRS score. Patient/surrogate self-reported mRS scores were compared to the mRS scores obtained by trained personnel via telephonic structured interview. Assessments occurred at 14, 90, or 365 days. A weighted kappa (kw) was calculated.

The kw between patient/surrogate and trained personnel scores was 0.85 (p< 0.001). Patients responded directly to the survey 53% of time; surrogates responded 47% of the time. 41% had a survey mRS of 0, 27% had a 1, 14% had a 3, 12% had a 4, 4% had a 5. 59% were Hunt Hess (HH) 1-2, 20% HH 3, and 21% HH 4-5. Age range was 19 to 83. Exact agreement occurred in 71% of cases. 53% of disagreements occurred with surrogate entries. 80% of surveys were completed in less than 5 minutes.

In this sample of SAH patients, there was very good inter-rater reliability between the patient/surrogate group and trained personnel group. The percent of exact agreements (71%) is similar to previously published studies of interobserver reliability using similar interview methodology. The results of our study suggest that patient/surrogate survey responses can reliably and efficiently generate mRS scores compared to trained personnel after SAH and other forms of stroke.

Owing to the recent advance of emergency medical system, moribund subarachnoid hemorrhage (SAH) patients have a chance to be rescued when they arrive immediately after onset. According to the World Federation of Neurological Surgeons (WFNS) committee, Glasgow Coma Scale (GCS) of 3 to 6 are classified into Grade V, however, little is known whether patients with lower GCS score fare worse or not in Grade V category.

A consecutive series of 190 WFNS V SAH patients since 2002 were retrospectively reviewed to analyze their Glasgow Outcome Scale (GOS) at 6 months in relation to their admission GCS score and other clinical parameters. All of these patients were sedated and intubated immediately after arrival.

The patients distribution in accordance with the GCS scores in descending order from 6 to 3 was: 50, 22, 27, and 91, respectively, and aneurysm obliteration was completed in 45, 21, 17, and 61, respectively, with 139 of them by clipping. The median time form onset to arrival was 38 minutes in 140 patients in whom onset time was identified. Rate (%) of good recovery (GR)/moderate disability (MD) was 9.9/13.2, 0/18.5, 4.6/27.3, 14.0/16.0, respectively. There was no difference in favorable outcome (GR + MD) by the GCS score, but GR ratio was higher in GCS 3 and 6 subgroup compared with GCS 4 and 5 subgroup (p=0.037, Fisher's exact test). Parameters associated with favorable outcome were younger age (p=0.0005), presence of light reaction (p=0.033), absence of cerebral/intraventricular hematoma (p=0.018), low serum d-dimer level (p=0.0032), and shorter time from onset to arrival (p=0.036) (Student's t-test). No patients arrived after 100 minutes or later after SAH onset had favorable outcome.

GR ratio was higher in GCS 3 and 6 subgroup than that of GCS 4 and 5 subgroup for those arrived very early after onset.

Our aim was to evaluate patients with SSAH with admittance in a neurocritical intensive and intermediate care unit and trying to understand which factors at admission have an impact in the outcome and time of stay in unit and also to document if our population of patients corresponds to what has already been published.

In this work we've characterized our population of SSAH in the years of 2012 and 2013. To complete this task we made a retrospective study and analyzed the data using SPSS (Statistical program for social sciences version 20) using the appropriate statistical test depending on the variables used.

We've found that our sample was composed of 90 cases mainly of women (62,2%), aneurism was the etiology in 74,4% of cases and we had only one case of arterial-venous malformation. The most frequent complications were hydrocephalus 37,7% and vasospasm 29,9%, an intra ventricular hemorrhagic component existed in 52,3% of all cases, 30% were submitted to endovascular treatment and 30% were submitted to aneurism clipping, 40% had a Glasgow coma scale (GCS) at admittance of 15. Ten patients passed away and these were older, had a higher probability of death according SAPSII score, lower GCS and less time spent in unit (p< 0,05), we verified that there was no difference between the alive and dead groups concerning the time between the onset of symptoms and the first medical observation and the time from the first medical observation until hospital admittance.

In sum our study shows similar results to those found on literature concerning gender, age and etiology. Scores used namely Hunt & Hess, Fischer, GCS and SAPS II and III were able to predict higher risk of mortality. Timing of medical observation and admittance may have less importance in the outcome than would be expected.

Continuous electroencephalogram (cEEG) can be helpful to detect for vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage (SAH). We describe a patient with vasospasm detected very early using real-time cEEG in aneurysmal SAH and treated by successful chemical angioplasty.

A 50-year-old woman without any past medical history presented with a severe bifrontal headache, which was found to be due to SAH with ruptured aneurysm on anterior communicating artery (Fisher grade 3). cEEG and daily transcranial doppler (TCD) for detecting vasospasm were carried out from post-bleed day (the first day of SAH is day 0) 5 to 9 according to predetermined cEEG protocol. Our cEEG protocol for vasospasm is as follows; 1) cEEG monitoring was performed using a 21 electrode longitudinal bipolar montage according to the international 10-20 system. 2) Check the real-time quantitative cEEG (ADR, alpha power, delta power, amplitude EEG and density spectral array) at least every 2 hours during the working time, 3) Send captured quantitative cEEG monitor screen without any kind of patient's information to neurointensivist every 2 hours during the non-working time, 4) Be focused on F3-C3/F4-C4 and C3-P3/C4-P4 in AcoA aneurysm, C3-P3/C4-P4 in MCA bifurcation and C3-P3/C4-P4 and P3-O1/P4-O2 in posterior communicating artery.

On bleed day 6, progressive decrement of ADR on the left side (especially more decrease in C3-P3 than F3-C3) compared to the right was detected using the regular checking-up of the real-time quantitative cEEG. After then, neurointensivist checked immediately her neurologic status. She developed global aphasia and left hemiparesis because of vasospasm. Stat chemical angioplasty was performed and she recovered without any significant neurologic deficit and discharged at home.

Real-time and protocol based cEEG can reduce the detection time of vasospasm in aneurysmal SAH and also improved clinical outcome.

Cerebral vasospasm (VSP) is a frequent complication after traumatic brain injury (TBI) and carries significant morbidity and mortality. TBI is associated with the severest casualties from Operation Iraqi Freedom and Operation Enduring Freedom. The purpose of this study was to evaluate the transcranial Doppler (TCD) determined incidence of posttraumatic cerebral vasospasm (VSP) and intracranial hypertension (ICH) after wartime TBI patients admitted to WRNMMC.

Patients were identified using a computerized registry and a prospective TCD database. TCD recordings of mean Cerebral Blood Flow Velocities and Pulsatility Indices of the anterior and posterior circulation vessels were recorded using a 2-MHz transducer (Doppler Box, DWL/Compumedics, Germany). 122 patients were investigated with daily TCD studies and comprehensive TCD protocol and published diagnostic criteria for VSP and ICH were applied.

TCD signs of mild, moderate and severe VSP involving anterior circulation vessels were observed in 71%, 42% and 16% of patients, respectively. TCD signs of mild, moderate and severe VSP involving posterior circulation vessels were observed in 57%, 32% and 14% of patients, respectively. TCD signs of ICH were recorded in 43%, eight patients (7%) underwent transluminal angioplasty for post-traumatic symptomatic VSP treatment.

These findings demonstrate that VSP and ICH are frequent complications of combat TBI, therefore daily TCD monitoring is recommended for their recognition and subsequent management. Acknowledgements: The opinions and views expressed herein belong solely to those of the authors. They are not nor should they be implied as being endorsed by the Uniformed Services University of the Health Sciences, Department of the Army, Department of the Navy, Department of Defense or any other branch of the Federal government of the United States. This paper supported in part, by the US Army Medical Research and Material Command's Telemedicine and Advanced Technology Research Center (Fort Detrick, MD, USA).

Financial Support: I am full-time employee for private practice

Depressive symptoms may contribute to quality of life after subarachnoid hemorrhage (SAH). The joint commission has emphasized the importance of screening for depression in the acute setting after SAH. The prevalence and risk factors for depressive symptoms acutely after SAH have not been well described. In this study, we assessed the feasibility of routine depression screening in SAH patients.

This is a retrospective study of patients admitted with SAH between February 2013 and December 2013 at a tertiary academic institution. Eligible patients were screened by social workers for depression using the modified Patient Health Questionnaire-9 (PHQ-9) 24-48 hours before discharge. We defined a score of >4 as having significant depressive symptoms. In patients who had depressive symptoms, patient education about depression was performed.

Out of the 134 patients admitted during the time period, 113(84%) were eligible to be screened. 21 patients were not screened because of death, comfort care measures only or intubated on discharge. Out of those eligible, 75 patients (66%) were screened for depression. Of patients those who were screened, 32 (46.67%) were positive for depressive symptoms. The median (IQR) on the mPHQ-9 was 4 (2-8, range 0-20). Age, Hunt-Hess, sex, ethnicity, fisher scale were not significantly associated with depressive symptoms. Screening positive for depression trended towards an association with ICU length of stay more than 8 days (OR 2.375, P= 0.09). mPHQ-9 scores correlated with hospital length of stay (r= 0.250, p = 0.03). Screening positive for depression was not significantly associated with functional status at discharge.

It is feasible to perform routine depression screening in patients with SAH in the acute setting. Depressive symptoms are common and may be associated with length of stay in the hospital. Further studies examining the impact of early depressive symptoms on long term clinical outcomes after SAH should be performed.

A variety of cEEG features have demonstrated retrospective accuracy for detecting post-SAH delayed ischemic neurologic decline (DIND) or delayed cerebral infarction (DCI). We evaluated the performance of a clinical neurophysiologist reporting cEEG prospectively as part of a SAH clinical practice guideline at our institution.

Nontraumatic Hunt-Hess Grade 4-5 or Fisher Group 3 SAH patients met inclusion criteria for the clinical cEEG ischemia monitoring guideline. cEEG was scored in the clinical neurophysiology report for the prospective determination of the following features prior to DIND/DCI: 1) new percent alpha variability decline, 2) new alphadelta ratio decrement or asymmetry, 3) new focal slowing, 4) new epileptiform discharges, or 5) a new subjective impression of focal electrographic worsening. DIND and DCI events were prospectively recorded by a research coordinator interviewing the neurocritical care team with subsequent adjudication and secondary review of the electronic medical record for DIND/DCI events occurring after the first day of cEEG monitoring and before cEEG discontinuation. The maximal peak systolic velocity (PSV) measured during daily clinical transcranial Doppler ultrasonography (TCD) was also recorded.

52 patients underwent cEEG ischemia monitoring over 12 months; 25% (13) developed DCI/DIND. Worsening in any cEEG feature was 76% sensitive for predicting DCI/DIND; upon logistic regression, no single feature contributed to the majority of detections. PSV>200 cm/s, criteria for sonographic vasospasm within our vascular laboratory, provided similarly high sensitivity (69%); however, cEEG or TCD alone provided a low positive predictive value for DCI/DIND (PPV, respectively 34% and 26%). A combined criteria maintained sensitivity (69%) for DIND/DCI while improving PPV (71%).

Prospective clinical cEEG ischemia monitoring and reporting affords sensitive detection of DCI and DIND. Concordant findings of cEEG worsening during sonographic vasospasm increase the confidence that DCI or DIND will ensue. These electrophysiologic criteria for SAH ischemia detection may provide useful selection criteria for clinical trials of early interventions.

Financial Support: Dr. Rosenthal's research was supported by the Andrew David Heitman Foundation for Neuroendovascular Research. Dr. Westover was supported by a grant from the American Brain Foundation.

Hypertonic saline (HTS) is widely used to treat elevated intracranial pressure (ICP) but duration and extent of the intervention are poorly understood.

We studied 23 consecutive subarachnoid hemorrhage (SAH) patients that underwent multimodality monitoring and had ICP data available while receiving HTS. We compared the effect of 23.4% or 14.6% HTS on ICP in those with global cerebral edema (GCE) and midline shift. Patients were treated with 23.4% vs 14.6% based on pharmacy availability and not due to medical reasons. We used generalised estimating equations to assess relationships among variables over time.

We identified 81 episodes of ICP crisis leading to administration of HTS (49 with 23.4% and 32 with 14.6%). Mean age was 47+12 years, median admission Glasgow Coma Scale score was 5 [3-14] and median recorded time was 465 [147-1310] hours. Following HTS administration, mean ICP reduced from 26 mmHg at treatment to 13 mmHg and 8 mmHg within 30 and 60 minutes, respectively. When GCE was present (72 events [89%]), ICP reduced significantly less (P=0.001) in the 90 minutes following HTS administration. Within 15 minutes of treatment mean ICP in GCE patients decreased to 19 mmHg compared to 13 mmHg and 9 mmHg compared to 6 mmHg after an hour respectively. In contrast patients with midline shift (50%: 3 mm, 25%-75%: 0.1-10.2mm) did not significantly affect the effectiveness of HTS administration to lower ICP. No differences in ICP reduction were observed between 23.4% and 14.6% sodium chloride administration.

Hypertonic saline effectively reduced ICP within 60 minutes. SAH patients without GCE tended to respond better to HTS therapy than those with GCE.

Spontaneous hyperventilation (SH) can occur in acute brain injury, but the incidence of SH following subarachnoid hemorrhage (SAH) is unknown. Hyperventilation decreases cerebral blood flow and therefore may worsen delayed cerebral ischemia (DCI). This study was conducted to determine the incidence of SH in SAH and its association with DCI and functional outcome.

Consecutive subjects (1/2010-3/2014) were identified from a prospective registry of spontaneous SAH patients and assessed for the presence of SH. SH was defined as pCO2< 35mmHg and pH>7.45 in the presence of normal pO2 (>70mmHg) while breathing spontaneously or overbreathing the ventilator. Bivariate logistic regression was conducted to determine clinical characteristics that are significantly associated with SH. Multivariable logistic regression analyses were performed to determine the association of SH with DCI and poor functional outcome, which was defined as discharge modified Rankin scale (mRS)>3.

Of 317 subjects, 207 with arterial blood gas analyses obtained while breathing spontaneously or overbreathing the ventilator were included in the study. Of these, 113 (55%) had SH, 66 (32%) experienced DCI and 112 (54%) had poor discharge outcome. The following characteristics were significantly associated with SH in bivariate analysis (odds ratio, [95% confidence interval]): pneumonia 3.5 (1.8-7.0); neurogenic myocardial injury 2.2 (1.2-4.1); perimesencephalic SAH etiology 0.2 (0.1-0.7); WFNS 1.4 (1.1-1.7); Hunt-Hess 1.6 (1.2-2.1); DCI 3.5 (1.8-6.6); poor discharge mRS 3.0 (1.7-5.4). In a multivariable logistic regression analysis adjusting for age, gender, WFNS, Hjidra, and SAH etiology, SH was significantly associated with DCI (3.4, 1.7-6.8). SH was additionally associated with poor discharge outcome, after adjusting for age, gender, pneumonia, neurogenic myocardial injury, WFNS, Hjidra and DCI (2.5, 1.1-5.8).

Spontaneous hyperventilation is common following SAH and is associated with DCI and poor discharge outcome. Further study is needed to determine the pathophysiology underlying this association Financial Support: None

Angiographic evidence of severe cerebral vasospasm along with focal neurological deficits in nonaneurysmal subarachnoid hemorrhage patients is a rare occurrence. Despite trauma being the most common cause of subarachnoid hemorrhage, there is minimal information available on vasospasm in this particular population. This case presents a unique clinical situation where a patient suffered from unrelenting vasospasm ultimately resulting in a right frontal infarct.

A 52-year-old female underwent an elective surgery for removal of nasal polyps at an outside facility. While in recovery, the patient complained of severe headache that was accompanied by nausea and vomiting. The patient was discharged home the same day, and over the course of the next week continued to have severe persistent headaches. Four days after surgery she presented to a local ED where her head CT revealed bilateral subarachnoid hemorrhage. She was then transferred to the neuro intensive care unit at our tertiary care center. Upon arrival the patient was noted to have left sided weakness and facial droop. She was taken emergently for an angiogram where severe bilateral ACA spasm and right MCA emboli were noted, so intra-arterial tPa, abciximab and verapamil were subsequently administered. Her post-operative course was complicated by right frontal ischemic stroke, continued bilateral ACA and MCA vasospasm requiring a second angiogram with intra-arterial verapamil, placement of a central line, and induced hypertension requiring a norepinephrine infusion.

After a prolonged hospital course, the patient was discharged with minimal functional deficits.

Critical care providers must remember vasospasm in this patient population is characterized by a different onset and duration, and possible pathogenesis when compared to aneurysmal subarachnoid hemorrhage patients.

Small clinical trials have demonstrated benefit with both simvastatin and pravastatin for the prevention of vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). Simvastatin was the agent of choice at our institution, but concerns related to high dose simvastatin use caused a shift in practice to pravastatin in 2011. No clinical trials to date have compared the efficacy of these agents for vasospasm prevention. Our aim was to evaluate the comparative efficacy of simvastatin and pravastatin for vasospasm prevention.

Retrospective cohort study of patients admitted with Fisher grade 3 aSAH from August 2010 to August 2012. Daily transcranial doppler (TCD) velocities were obtained in all patients. TCD vasospasm was defined using previously published velocity cutoff values and Linegrad ratios. Radiographic vasospasm was defined as vasospasm on CT or cerebral angiogram. Angiographic vasospasm was defined as vasospasm on cerebral angiogram only.

Fifty-eight (60.4%) of 69 patients included experienced TCD vasospasm in any cerebral artery. Thirty-one (54.5%) patients were in the pravastatin cohort vs 27 (61.4%) in the simvastatin cohort (P = 0.86). No difference in the incidence of middle cerebral artery (MCA) vasospasm among the pravastatin and simvastatin cohorts was found (46.2% vs 43.2%; P = 0.77), although the median left MCA velocity was statistically higher in the simvastatin cohort (102 vs 87; P = 0.001). No statistically significant differences were found between the two groups as it relates to radiographic vasospasm, angiographic vasospasm, time to any vasospasm, hospital length of stay, ICU length of stay, or in-hospital mortality.

No clinically significant differences were observed between simvastatin and pravastatin. There was a statistically higher median left MCA velocity in the simvastatin cohort, but it did not correlate with a higher incidence of MCA vasospasm. Further randomized, controlled clinical trials are needed to establish the comparative efficacy of available agents.

Early brain injury (EBI) after subarachnoid hemorrhage (SAH) is the most important determinant of clinical outcome. Global cerebral edema (GCE) is a manifestation of EBI after SAH and is an independent risk factor for poor outcome. The inability to quantify GCE has limited further investigations into pathomechanisms of GCE after SAH.

Patients with SAH were enrolled into a prospective observational database. Initial CT scans were graded for the presence or absence of GCE in a qualitative manner using established criteria. Volumetric analysis of sulcal space and cisternal blood volume was performed using MIPAV (Medical Image Processing, Analysis and Visualization Ver 7.0.1). Selective sulcal volume (SSV) was defined as total mL of sulcal volumes on axial CT slices from above the most cranial section of the lateral ventricles to the last visible section. Automated contour selection tool in MIPAV was used to measure areas of sulci and cisternal blood. Venous blood was collected within 48 hours of admission. Cytokines levels were measured by a multiplexed bead array assay.

A total of 97 patients with volumetric and cytokine analysis were included in this study. Mean age was 51(±14 years), 69/97(68%) were female. 83% were Fisher 3 with a median HH score of 3. 23/97(24%) had GCE. Mean sulcal volumes differed between patients with GCE and without GCE (5.5ml v 24ml; p< 0.01). SSV correlated negatively with serum IL-6 (r=-0.41;p=0.01). Volume of total intracranial blood (r= 0.45; p< 0.01) and cisternal blood (r=0.27, p=0.03) significantly correlated with serum IL-6. Lower SSV was an independent predictor of poor mRS outcome at discharge (p=0.02) while controlling for age, gender, initial Hunt-Hess Grade and aneurysm size.

GCE can be objectively quantified using volumetric analysis of selective sulcal volume measurements. SSV was negatively associated with serum IL-6 levels. Lower SSV was associated with worse outcomes after SAH.

Cognitive and behavioral problems continue to be important contributors to morbidity after SAH and ICH even in patients with good neurological outcomes. Accumulating evidence demonstrates that early physical and cognitive rehabilitation improve functional outcomes in stroke. Based upon their physiological stability patients may or may not be able to participate in physical or occupational rehabilitation. We hypothesize that patients might be able to participate in cognitive rehabilitation even in a bed-bound state while they are in the ICU.

After obtaining IRB approval, we started enrollment in April, 2014. Demographic, clinical, radiological, outcomes data which are already being collected as part of two large prospective databases at our center; Subarachnoid Hemorrhage Outcomes Project (SHOP) and Intracerebral hemorrhage Outcomes Project (ICHOP) will be utilized for data collection. Only English speaking patients >=18 are currently eligible for enrollment. For online cognitive training modules we are collaborating with Lumos labs. No patient information will be shared with Lumos labs. Patients are screened every day for their ability to participate in a 20 minute training session till the time of their discharge and are provided with login information at the time of discharge. Patients will be contacted via telephone at 1, 3, 12 months post discharge to follow-up regarding their compliance

We have enrolled 8 patients so far; five patients with SAH and three with primary ICH. 5/8 patients have been successfully able to `participate in one or more sessions of ultra-early online cognitive training. 2/8 patients were not able to participate due to seizures and sedation. One patient with SAH was not able to participate due to refractory headaches

This is an on-going pilot study. Although there are some anticipated clinical challenges in implementing an ultraearly cognitive rehabilitation program in the ICU settings, our enrollment thus far suggests feasibility.

Poor-grade subarachnoid hemorrhage (SAH) is associated with high rates of disability and mortality. This study addressed the value of the motor component of Glasgow Coma Scale (mGCS) to predict long-term functional outcomes.

A consecutive cohort of poor-grade SAH patients (WFNS 4 and 5), admitted to a high-volume SAH center between January 2009 and June 2013, were retrospectively assessed. Only patients who survived the first 24 hours after admission were included. GCS was recorded at admission, after external ventricular drain (EVD) insertion and hourly while the patient was in the intensive care unit. Functional outcome by the modified Rankin score (mRS) was assessed at least 3 months after the hemorrhage.

130 poor-grade SAH patients survived 24h, 50 had poor (mRS 3-6) and 80 had favorable outcome (mRS 0-2). The poor outcome group had lower mean GCS (5 ±2.3 vs. 8 ±2.2, p< 0.01) and mean mGCS (2 ±1.5 vs. 4 ±1.3, p< 0.01) on admission. The mean mGCS after EVD insertion was lower in the poor outcome group (5 ±1.3 vs. 6 ±0.3, p< 0.01). 98% of favorable outcome group achieved mGCS 5 within 72 hours. No patients with mGCS 3 at 24, 48 or 72h recovered to achieve a favorable outcome, therefore motor GCS < 4 yielded 100% specificity and 100% positive predictive values for poor functional outcome. In the regression model, mGCS 4 at 72h was independent associated with poor functional outcome (OR 25.2; 2.5-626.0 CI, p< 0.05).

Motor GCS < 4 after 24h of hemorrhage is highly specific for poor long-term outcome after SAH. Poor-grade SAH patients who did not achieve a mGCS of 4 or greater after 24h of hemorrhage went on to have a poor outcome despite aggressive treatment. This information could prove useful in prognosticating outcomes for individual patients.

Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high rates of morbidity and mortality. Most morbidity is attributed to cerebral ischemia occurring in up to 30% of patients mostly between days 4 and 10.

Multiple therapies have attempted to prevent or reverse ishcemia after aSAH. 3-hydroxyl-3-methylglutaryl coenzyme a reductase inhibitors (statins) have had mixed results preventing cerebral ischemia. This study compares patients exposed and not exposed to statins during hospital admission and effect on outcomes.

This was an IRB approved single center retrospective cohort study of aSAH patients greater than 18 years old that received statins during admission (statin group) compared to those that did not (no statin group). The primary outcome was incidence of new infarct on CT scan. Secondary outcomes included incidence of vasospasm by TCD or angiography and Glasgow Outcome Score at follow up.

33 patients were in the statin group and 83 were in the no statin group. The admission median GCS and median WFNS scores were similar between groups (14 vs 14 p=0.53; 2 vs 2 p=0.47). There was a trend toward the statin group spending more days in the hospital (14.4 vs 12.9 p=0.29). Rates of infarct on CT scan were similar between groups (45% vs 35% p=0.4). Evidence of narrowing by TCD was similar between groups (58% vs 46% p=0.38). Angiographic vasospasm was not different between groups (24% vs 22% p=0.96) Glasgow Outcome Score (n=96) was also not different between groups.

This small retrospective study was unable to detect differences in outcomes between aSAH patients who did or did not receive statins during hospital admission. The results of large randomized clinical trials are needed to determine effects of statin therapy on outcomes in this patient population.

The state of both CBF and O2 reduction that results from a reduction of cerebral perfusion is associated with a severe compromise of vascular reserve. It has been reported that there is a significant correlation between CBF and tissue oxygenation, despite the fact that many variables can alter tissue oxygen. This study will examine the premise that tissue oxygen values or changes can provide an insight into CBF values or changes.

In 68 patients post SAH, CBF (Hemedex) and tissue oxygen (Licox) were monitored concurrently. Both probes were inserted in a fixed relationship and distance into the white matter via a duo Hummingbird bolt (Innerspace). All data were collected and stored through a CNS monitor (Moberg Research). Analysis included a comparison of paired values obtained simultaneously for every 2 seconds over a monitoring period that ranged from 3-8 days. A second analysis examined the changes of CBF that correlated with changes of tissue oxygen.

An examination of heat maps of all paired datasets for each patient revealed that while in a few patients a relationship is evident, in the vast majority there was no relationship. When examining the variance of CBF for each PbO2 value, the sigma of the relationship was much larger than the change of tissue O2.

Utilizing the absolute value of tissue oxygen or the changes of tissue oxygen, one can make no predictably useful conclusion about CBF.

Financial Support: Yes, presenting author has minor stock position in Innerspace

Herpes Simplex Virus Encephalitis (HSVE) imposes a significant disease burden across the United States. Here we describe hospitalization trends in adults with HSVE diagnosis, examining demographic and hospitalization characteristics, with particular emphasis on how these have changed over time.

Data from hospital discharges from 2001-2010 in the Nationwide Inpatient Sample were analyzed retrospectively. Patients aged 18 years and older with a principal diagnosis of HSVE (ICD-9-CM code 054.3) were included.

On , representing a 157% increase, while the consumer price index for hospital inpatient service rose 40% across the period. Older patients were more likely to be hospitalized and to accrue higher charges (p< 0.05). However, overall hospitalization incidence, length of stay, and mortality did not vary across time.

Charges for inpatient care in HSVE have more than doubled in the past decade despite relatively constant rates of hospitalization and mortality. Further research is warranted to better understand these trends.

Theories regarding the pathophysiology of propofol infusion syndrome (PRIS) implicate mitochondrial toxicity and changes in fatty acid metabolism as potential mechanisms for syndrome development. Valproic acid (VPA) has also demonstrated an effect on mitochondrial electron transport and -oxidation, and may contribute to the development of PRIS when administered concomitantly. This study was designed to describe the development of symptoms of PRIS in patients treated with propofol and VPA.

Patients received propofol for > 24 hours, and at least 1 dose of VPA within 96 hours prior to, or within the first 72 hours of the infusion. Data were collected from the time propofol was initiated to 24 hours following its discontinuation, or for a maximum of 96 hours, whichever was shorter. For each 24 hour period, patients were evaluated for symptoms of PRIS, including rhabdomyolysis, hypotension, hepatic transaminitis, metabolic acidosis, hypoxia, hyperthermia, hypertriglyceridemia, cardiac dysfunction, and renal failure. Additional data were collected regarding propofol and VPA exposure.

Of 25 included patients, 24 (96%) developed at least one symptom of PRIS. The most commonly observed symptoms were hypotension, renal failure, hyperthermia, and hypoxia. One patient (4%) developed the constellation of symptoms satisfying the definition for PRIS. The degree of propofol or valproic acid exposure did not strongly predict symptom development. Eight patients (32%) expired during the evaluated hospital admission, including the patient with PRIS. The incidence of PRIS and mortality in this study were greater than previously reported in a large study of patients exposed to propofol alone.

Development of individual symptoms of PRIS was common in this small cohort of patients. One patient developed PRIS with lower propofol exposure than previously identified in the literature as a risk factor, suggesting valproic acid may act as a triggering factor for PRIS and warrants continued evaluation.

Sympathetically-mediated immunosuppression after stroke and TBI may be beneficial in preventing autoimmune responses against brain tissue, but also contributes to infections such as pneumonia. We hypothesized that, due to their physical relationship with sympathetic and parasympathetic nerves, pulmonary glial cells (PGCs) mediate this immunosuppression locally in lung tissue. We characterized these understudied cells and tested whether cellspecific inhibition of the immune regulator TGFbeta would affect pulmonary immune responses.

Immunohistochemisty was used to characterize PGCs. 

PGCs express the glial markers GFAP and S100beta and closely associate with autonomic nerves. After LPS, Tbr2 fl/fl mice exhibited twice as much neutrophil MPO at 5 and 24 hour timepoints. Lung IL-6 levels were also 30% higher than in WT 5 hours after LPS (p=0.0073). A multiplex Luminex assay demonstrated significant elevations in five other chemokines and cytokines that stimulate neutrophil responses, at 5 and 24 hours after LPS. Mortality was 80% in Tbr2 fl/fl mice vs. 33% in WT (p=0.0012). In DN mice exposed to E.coli, mortality was higher at 24 hours (p=0.0084) and neutrophil infiltration around the airways was significantly increased at 5 hours (p=0.0055).

TGFbeta signaling in PGCs is critical for limiting the pulmonary immune response. This is the first evidence that PGCs play a key role in pulmonary inflammation and thus may provide a target to locally modify sympatheticallymediated immunosuppression at infection sites.

Financial Support: R01 NS067132 from NIH/NINDS.

The systemic-inflammatory-response-syndrome (SIRS) presents as a cluster of clinical findings including tachycardia, tachypnea, leukocytosis/leucopenia and hyper-/hypothermia seen in patients with infectious or noninfectious causes. We propose a brain-induced-response-syndrome that is different from SIRS and results from an immediate sympathetic excess that leads to systemic derangement fulfilling SIRS criteria and multiorgan dysfunction (MOD).

Case report from a tertiary referral center.

A 66-year-old man with suprasella arachnoid cyst underwent transsphenoidal cyst fenestration and emerged normally. Seven hours post-surgery he deteriorated to stupor with mydriasis and bilateral flexion posturing followed by hypertension, tachycardia, tachypnea, desaturation, and hyperthermia. CT showed extensive tension pneumocephalus and central downward herniation. Findings/CXR identified ARDS; TTE delineated new hypokinesia; decreased urine output; labs remarkable for brisk leukocytosis, hyperglycemia, hypoalbuminemia, and elevated creatinine and troponin. Negative blood/CSF cultures. After stabilization and skull defect closure, full recovery and resolution of imaging/laboratory abnormalities occurred within 40 hours.

The patient's sudden deterioration fulfilled all criteria for SIRS and subsequent MOD, syndromes known to be initiated by systemic hyperinflammation caused by inflammatory cytokines (InflCy). However, InflCy production follows a predictable time pattern with first systemic release 6-24 hours after the inciting event. In contrast, our patient developed progressive, systemic deterioration minutes after brain injury onset due to excess sympathetic drive. Extracerebral organ dysfunction, commonly neurogenic pulmonary edema (NPE) and myocardial stunning, are known to occur after brain injury; however, this patient illustrates that a) systemic multiorgan dysfunction can occur immediately after severe brain injury, b) involves organs/systems beyond NPE and cardiac stunning, c) is initiated by sympathetic excess and not InflCy release, and d) differs from classic SIRS. Differentiating a braininduced-response-syndrome (BIRS) from SIRS shifts focus to immediate CNS stabilization as the primary treatment and to different treatment options such central/peripheral sympatholytics to protect systemic organs from excessive sympathetic discharge.

Inhaled pulmonary vasodilators are commonly used as rescue agents in critically ill patients with refractory hypoxia. We sought to describe the effect of inhaled epoprostanol and nitric oxide on cerebral hemodynamics in patients with severe brain injury and fulminant respiratory failure.

We reviewed data for all patients in our intensive care unit who received inhaled nitric oxide or epoprostenol with concurrent intracranial pressure monitoring from January 2012 to March 2014. All intracranial pressure measurements were obtained from external ventricular drains except for one patient with a fiberoptic intraparenchymal device. All patients suffered from severe traumatic brain injury.

Inhaled pulmonary vasodilators were initiated 8 times in 4 patients during the study period. Mean intracranial pressure decreased from 21 mmHg to 18 mmHg after initiation of an inhaled vasodilator (p=0.18, 95% CI=-6.17 to 1.42). Mean cerebral perfusion pressure increased from 64 mmHg to 67 mmHg (p= 0.19, 95% CI=-1.90 to 8.15). Mean PaO2 increased from 60 mmHg to 82 mmHg (p=0.01 CI=6.7 to 38.8) and median PaCO2 decreased from 46 mmHg to 42 mmHg (p= 0.08). Median PaO2 to FiO2 ratio increased from 60 to 93 (p= 0.017).

Our preliminary data show that inhaled pulmonary vasodilators have no effect on intracranial hemodynamics despite a significant increase in arterial oxygenation.

We report a challenging case of dural venous sinus thrombosis with a complex etiology and heparin resistance secondary to Anti thrombin III deficiency (AT).

A 20-year-old previously healthy and currently 8-weeks pregnant female presented with worsening headaches, nausea, decreasing GCS and acute respiratory failure. Imaging showed extensive clots in multiple dural venous sinuses including the superior sagittal sinus, transverse, sigmoid, jugular veins, and straight sinus. She was started on systemic anticoagulation and had an endovascular thrombolysis with mechanical clot removal with limited success. A comprehensive hypercoagulable workup was intiated. Complicating the ICU care was the development of ARDS and heparin resistance with an inability to reach the target PTT of 60-80s. At her peak heparin dose she was receiving > 35000u/24hrs and her PTT was < 50s. AT III deficiency was suspected as a possible etiology of her heparin resistance. Fresh frozen plasma was administered for AT repletion. The first therapeutic PTT was achieved after almost 36 hours after starting the heparin infusion. Given her high thrombogenic risk and challenges with conventional anticoagulation regimens, we transitioned to Argatroban for systemic anticoagulation. She currently meets anticoagulation goals.

Discussion: Heparin produces its major anticoagulant effect by inactivating thrombin and inctivated factor X through an antithrombin (AT)-dependent mechanism. For inhibition of thrombin, heparin must bind to both the coagulation enzyme and AT. A deficiency of antithrombin leads to a hypercoagulable state and decreased efficacy of heparin that places patients at high risk for thromboembolism

Heparin resistance, especially in the setting of critical illness should raise the index of suspicion for AT deficiency. Argatroban is an alternate agent for systemic anticoagulation in the setting of heparin resistance.

Rapid BP control is a key initial goal in hemorrhagic stroke. In ICH this decreases hematoma expansion risk; in SAH, re-bleed risk before securing the aneurysm. However, excessive BP reduction was linked to adverse outcome in a national registry of neurocritical patients. 1 Moreover, hypertension can become a goal in SAH if vasospasms occur. Clevidipine is a new IV calcium channel antagonist with rapid onset (90 seconds) and offset (5-10 minutes), making BP control titrateable. This prospective intervention study used clevidipine to manage BP in hemorrhagic stroke.

The study is ongoing, with 34 ICH and 24 SAH patients enrolled so far. BP was measured continuously via arterial line. Patients received clevidipine (starting dose 4-8 mg, increased every 90 seconds as needed until target was achieved), with BP targets set by the treatment team. Outcomes included median time to target, % patients achieving target, and time within target range as % of total time on clevidipine. Safety parameters included "overshoot" and time to recovery above the BP floor. When targets were modified (e.g. after coiling/clipping a ruptured aneurysm) the new targets were used from the time first achieved.

Target BP was achieved in 58/58 patients (100%). Median time to target was 6 (average 4.9±6.8) minutes. Average dose required to achieve target was 19.6 mg/hr. Time within target range until discontinuation was 98%. 3 patients (5%) had an overshoot (mean 9, range 5-14 mmHg; average duration 4.3 minutes).

Clevidipine was highly effective in controlling BP in hemorrhagic stroke, with excellent safety profile. Additional advantages included low infusion volumes (often a problem with nicardipine). Doses to achieve BP targets were higher than previously reported in cardiothoracic surgery patients, possibly reflecting the hyperadrenergic state associated with acute brain injury. Reference. 1. Mayer SA et al. Crit Care Med 2011; 39:2330-36 Financial Support: None

Hyponatremia occurs frequently in patients with acute brain injury and may contribute to adverse outcome. In addition, it can aggravate neurologic dysfunction, complicate neurological assessments, and contribute to symptoms such as gait dysfunction that can impair efforts at mobilization and rehabilitation. Various studies have shown that SIADH is the most frequent cause of hyponatremia in patients with acute neurological injuries. However, standard therapies for SIADH such as fluid restriction are often impractical, counterindicated or impossible in neurocritical patients (e.g. patients with SAH). Thus many patients are treated with hypertonic saline, which is usually effective but at the price of inducing hypervolemia with possible (worsening of) cardiac dysfunction, and will often require central venous access and ICU monitoring. We tested tolvaptan (Samsca R ), a novel oral ADH antagonist that promotes aquaresis, as an agent to treat neurologically and hemodynamically stable patients with acute neurological injuries and suspected SIADH.

So far 37 patients with acute neurological injury (29 SAH, 4 ICH, 2 AIS, 2 post-brain tumor surgery) who had no counterindications (e.g. liver dysfunction) were treated with tolvaptan according to a predefined protocol. Most (n=31) had previously received hypertonic saline and had experienced recurrence of hyponatremia when this was discontinued. All underwent extensive workup for causes of hyponatremia before treatment was initiated. Of note, liberal fluid intake was ordered in all patients.

Average sodium levels were 129.4 meq before treatment. 34 patients responded to the initial dose (15 mg) of tolvaptan, 3 required a dose of 30 mg. Sodium levels increased to 135.8 meq within 48 hours. Median treatment duration was 5 days (average 4.3 days). No significant side effects were noted.

Tolvaptan may be useful in selected patients with acute neurological injuries who develop SIADH, in the more stable phases of their injury. It should not be used in severe symptomatic hyponatremia.

Intracranial pressure (ICP) monitoring is an important tool for the neurointensivist when faced with potential brain herniation in the setting of a poor neurological exam. However, patients at risk of bleeding may not be suitable candidates for invasive ICP monitoring. Here we report the case of an 18-year-old female with diffuse intracranial venous thromboses, known to already be on full dose anticoagulation, in which EEG monitoring was utilized to assess response to hyperosmolar therapies for elevated ICP.

We present the case of an 18-year-old female with superior sagittal, bilateral transverse and straight sinus thromboses with a clinical exam indicative of increased intracranial pressure. Invasive ICP monitoring could not be utilized because she was on full-dose anticoagulation. EEG was performed to help evaluate response to hyperosmolar therapy. Her initial clinical presentation was concerning for poor GCS < 8 with flexor posturing, and lumbar puncture prior to anticoagulation revealed opening pressure of 55 cm H2O. Initial EEG showed diffuse background slowing and disorganization with intermittent bursts of monomorphic 2 Hz delta activity suggestive of FIRDA. After initiation of hyperosmolar therapy with mannitol and 23.4% hypertonic saline, the patient's neurological exam improved significantly. Continued EEG during this phase showed improvement in background organization and complexity, as well as improvement in the admixture of frequencies with greater differentiation and reactivity.

EEG is a helpful bedside tool with potential as a non-invasive adjunctive monitor for elevated intracranial pressure in selected patients in which invasive ICP monitoring cannot be obtained.

Animal studies suggest that pentobarbital may impair pulmonary vascular autoregulation that would lead to excessive hypoxia. However, the effect of pentobarbital-associated hypoxia has not been adequately studied in neurocritical care patients. Therefore, we sought to assess the prevalence of pentobarbital-associated hypoxia in the neuroscience intensive care unit and determine the associated clinical factors.

A retrospective review of all patients requiring pentobarbital intravenous continuous infusion who were admitted to the neuroscience intensive care unit (NSICU) from 1/1/2006 to 12/31/2013 was conducted. Inclusion criteria were 1) age 18 years, 2) administration of pentobarbital intravenous continuous infusion, 3) pentobarbital infusion for a minimum of two days within five days of admission, and 4) mechanical ventilation. Exclusion criteria were 1) pentobarbital infusion < 2 days and/or > 5 days after date of admission, or 2) development of new hypoxia prior to pentobarbital administration. The prevalence of acute hypoxia, defined by PaO2/FiO2 (P:F) ratio < 300 mmHg within 48 hours of pentobarbital infusion was assessed. Multivariable analysis using logistic regression was used to determine the predictors of acute hypoxia after pentobarbital infusion.

Among the 160 screened patients who received pentobarbital, 50 patients (41 TBI, 5 status epilepticus, 4 others) met the inclusion and exclusion criteria. Overall, 28 patients (56%, 95% CI 15-41%) developed acute hypoxia within 48 hours of pentobarbital infusion. Among those who developed hypoxia, 7 (25%) patients had a mildly abnormal chest X-ray (CXR) and 4 (14%) had a normal CXR on the day hypoxia developed. In the logistic regression model, none of the factors independently predicted pentobarbital-associated hypoxia.

A considerable number of patients developed new hypoxia after pentobarbital infusion, despite normal or mildly abnormal chest X-ray findings. A large prospective study is needed to further characterize the clinical factors that may increase the risk of its incidence.

Symptomatic third ventricular colloid cysts (CC) may present with headaches, obstructive hydrocephalus, and rarely sudden death. Sudden death has traditionally been attributed to herniation and brainstem compression. We present a case of CC complicated by severe neurogenic stunned myocardium (NSM), offering an alternative mechanism for sudden death.

Case report from an urban tertiary referral center.

A previously healthy 30-year-old woman presented to the emergency department with progressive headache and mild confusion. Non-contrast brain computed tomography showed hydrocephalus in bilateral lateral ventricles. Magnetic resonance imaging (MRI) revealed a 1x0.9cm CC in the anterior third ventricle. Upon returning from MRI, she developed supraventricular tachycardia (SVT) and then became hypotensive and cyanotic. Her mental status deteriorated necessitating intubation. After resuscitation, bedside transthoracic echocardiogram showed ejection fraction 10% with apical sparing. Milrinone and vasopressin were started resulting in improved hemodynamic and echocardiographic parameters. An external ventricular drain (EVD) was placed. Follow up cerebral imaging showed acute infarctions in bilateral posterior cerebral artery territories. Over the next 7 days, her cardiac function improved (EF 40%) and vasopressors were discontinued. She underwent uneventful endoscopic fenestration of the colloid cyst on day 10.

NSM has rarely been reported in association with CC. Prior reports have been confounded by generalized seizurelike activity or preceding cardiac arrest, which may independently cause NSM and/or cardiomyopathy. In our case, a significant increase in intracranial pressure may have occurred while the patient was supine in MRI leading to a sympathetic surge and subsequent myocardial stunning. Alternatively, there could have been direct stimulation of the nearby hypothalamus by the third ventricular CC, resulting in SVT. This case suggests that sudden death associated with CC may be due to acute cardiac failure from NSM rather than brain herniation as previously thought.

NeuroCritical Care Units (NCCU) possess a high incidence of catheter associated urinary tract infections (CAUTIs) among all ICUs. Our NCCU exceeded benchmarks for 10 of 11 quarters from 2011-2014. We sought to identify major sources of CAUTI to improve prevention measures.

Retrospective cohort study of patients with CAUTI meeting Centers for Disease Control (CDC) criteria identified by an infection preventionist over a 16 month period (2013) (2014) . The highest prevalence diagnostic groups [intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH)], representing 54% of CAUTI cases were compared to patients with ICH/SAH without CAUTI during the same time period. Risk factors were identified through multivariate logistic regression.

Of 37 

CAUTI in ICH and SAH occurs predominantly in patients with lower GCS and in those with severe diarrhea despite use of FMS, but is independently associated only with increased foley days. Targeting CAUTI prevention to vulnerable patients should include novel strategies for mitigating contamination of the genitourinary tract and alternatives for urinary output measurement in long-term management of ICH/SAH patients.

Children with functionally univentricular congenital heart disease commonly undergo the Fontan procedure to increase systemic oxygenation and reduce ventricular overload. Multistaged Fontan repair may involve takedown of the subclavian arteries. The systemic complications of Fontan physiology include protein losing enteropathy, hepatic fibrosis, pleural effusions, and thromboembolism. Adult survivors with Fontan physiology may develop heart failure or arrhythmias, requiring further surgical revisions. The potential acute post-operative neurologic complications following revision have not been reported.

We performed a retrospective chart review of the post-operative course of adults with repaired single ventricle congenital heart disease who underwent Fontan revision and were evaluated by the neurocritical care service at our institution.

Three patients were identified, ages 34 (male), 35 (female) and 42 (female), seen in the Cardiac ICU or in neurocritical care clinic. All patients had the Fontan procedure in childhood, and subsequently underwent either Fontan conversion or heart transplantation. Patient 1experienced an episode of relative hypotension and decreased cerebral perfusion three days after Fontan conversion, and suffered an ischemic brainstem stroke resulting in transient locked-in syndrome. Patients 2 and 3 were evaluated by the neurocritical care service preoperatively, had higher target blood pressures peri-operatively and suffered no neurologic injury. Patients 1 and 2 underwent neuroimaging. Both of these studies were abnormal, one with atrophic vertebral arteries with nonvisualized proximal vessels; the other patient had an occluded left vertebral artery.

Adults with complex congenital heart disease have well-recognized systemic pulmonary, kidney and hepatic complications of their cardiac disease. However, the potential for post-operative neurologic complications is high due to the high central venous pressures associated with hepatic fibrosis, and the aberrant posterior circulation due to loss of a vertebral artery. These patients need careful management of fluids and blood pressure to optimize cerebral perfusion and reduce the risk for vertebrobasilar ischemia.

Guidelines recommend cerebral perfusion pressure (CPP) of 50-70mmHg and intracranial pressure lower than 20mmHg for the management of traumatic brain injury (TBI). However, adequate individual targets persist controversial, since patients have different perfusion. Bedside assessment of cerebral autoregulation (CAR) may help to customize CPP-guided treatment. The main objective was to assess staff compliance and outcome impact to a new method of CAR-guided treatment based on continuous evaluation of cerebrovascular pressure reactivity (PRx).

Prospective study of severe TBI adult patients managed with multimodal brain monitoring in a Neurocritical Care Unit. CPPopt was automatically defined as CPP with the most negative PRx using recent published method. Patients were managed using CPPopt targets whenever possible and otherwise CPP was managed following guidelines. In addition, other CPPopt estimates were calculated using cerebral oximetry (cox-CPPopt), brain tissue oxygenation (orxs-CPPopt) and cerebral blood flow (cbf-CPPopt).

Eighteen patients with a total multimodal brain monitoring time of 5520h were enrolled. For the all-time period of monitoring 61% of patients had a U-shaped curve for CPPopt, 28% had either ascending or descending curves and 11% had no fitted curve. CPP correlated with CPPopt (r=0.83, p< 0.0001) with a bias of -2.2±4.2mmHg. Comparison between other estimates of optimal CPP and CPPopt revealed similar limits of precision but the lowest bias (-0.1mmHg) was obtained with cox-CPPopt. Patients with overall CAR (PRx< 0.25) spent less time with impaired autoregulation compared to patients without autoregulation (p=0.007). Preserved CAR was associated to higher Glasgow coma score on admission (p=0.01) and better Glasgow outcome score (GOS) (p=0.01). Patients with GOS< 3 had a nearly significant higher fraction of time with impaired autoregulation (p=0.055). CPP was significantly lower than CPPopt on patients with GOS< 3 (p=0.04).

CAR evaluation with CPPopt management at bedside is feasible and seems to be associated to better outcome. The cox-CPPopt methodology using noninvasive cerebral oximetry warrants further evaluation.

The practice of simultaneous tracheostomy and percutaneous endoscopic gastrostomy (PEG) placement has not been well studied in patients in the neurocritical care unit (NCCU). Our study compared patient characteristics and outcomes associated with simultaneous (STPEG) and non-simultaneous (NSTPEG) tracheostomy and PEG placement in the neurocritically-ill.

We performed a retrospective cohort study on 398 patients admitted in our NCCU from April 2008 to July 2013 who underwent tracheostomy placement. Of the 120 charts reviewed 91 were included for analysis. Primary outcome include NCCU and hospital length of stay (LOS). Secondary outcomes include pre-discharge prealbumin, time-towean from the ventilator (hours) and PEG-related complications. Descriptive analyses were performed using ttests, Fisher-exact tests and Wilcoxon rank-sum tests as applicable.

Of the 91 patients included in the study (mean age 55±18, 54% females), 76 (84%) patients underwent STPEG. The most common etiologies for admission were ICH, SAH and TBI in STPEG and ICH, elective postoperative and ischemic strokes in NSTPEG. 

Our data to date demonstrated that although STPEG method is safe and well tolerated in neurocritically ill patients, they get weaned from the ventilator post-tracheostomy longer. This knowledge may play a role in the neurointensivist's decision making of tracheostomy and PEG placement in the NCCU.

Urinary tract infection is the most common nosocomial infection accounting for greater than 30 percent of nationally reported infections. Specifically 80% of these infections are associated with an indwelling catheter.

Complications related to CAUTIs have been correlated with increased mortality, hospital cost, length of stay, and decreased patient satisfaction. Reducing catheter associated urinary tract infections is a national patient safety priority.

This was a quality improvement initiative conducted at a tertiary academic neurocritical care unit from March 2013-March 2014. Multidisciplinary quality rounds (MQR) in the afternoon were started in March 2013 to assess Foley care. MQR focused on necessity of Foley, orders for discontinuation, and active detection of UTI's on presentation. MQR was rolled out in 2 phases. Phase 1: MQR team consisted of the nurse manager, infection preventionist, and dedicated quality nurse. Phase 2 was the addition of an attending physician. CAUTIs were defined using National Health Safety Network definition with third party validation by a hospital epidemiologist. Rates of CAUTI during period of intervention were compared to standard of care treatment in the preceding two years Feb 2011-Feb 2013.

There was no difference between number of patients before and after intervention (243+/-29 vs 250 +/-15 p=0.15), Foley days (544+/-94 v 557 +/-88 p=0.68) and Utilization ratio (.68 v 0.65 p=0.4). There was an increase in patient days (800+/-73 v 852 +/-64 p=0.04). Standardized infection ratio (SIR) decreased from a quarterly average of 1.47+/-0.3 SD to 0.88+/-0.3 SD (p=0.03). Average monthly rate of 6.8 CAUTI's a month decreased by 38% to 4.2 (p=0.02).

The implementation of multidisciplinary quality rounds in the NSICU significantly decreased the rates of CAUTIs by 38% and decreased SIR to under 1. The addition of a physician enhances the effectiveness of multidisciplinary quality rounds.

Warfarin anticoagulation is known to worsen outcomes following ICH, partly due to an increased risk of hematoma expansion. The use of a 4-factor PCC (4fPCCC) for reversal of warfarin in ICH has not been well described. We report our single-center experience. 

Thirteen patients (ICH 84%, SAH 8%, SDH 8%) were included. Mean age was 77.1 ± 9.7 years and 70% were females. GCS on admission was 13 (11.5-15 ul (129.5-269.5, p=0 .1). One NSTEMI (7.7% patients) was observed within 24 hours of 4fPCC administration. Survival at discharge was 77%.

In this small cohort of patients, preliminary results demonstrated no instances of hematoma expansion with 4fPCC treatment, as compared to historical rates of 54% in similar patients. In addition, a drop in platelet count was observed in the majority of subjects. Documented rate of adverse effects was similar to that previously reported in other patient populations.

Financial Support: Primary author previously served on advisory board for CSL Behring. No active affiliations with the company.

Secondary ischemic lesions detected by DWI recently described in patients with intracerebral hemorrhage (ICH) raise a concern regarding the safety of aggressive blood pressure (BP) lowering in such patients. Our aim was to evaluate the prevalence of acute brain infarcts in patients with spontaneous ICH and to examine associations of DWI lesions and clinical and treatment features, specifically the use of sodium nitroprusside, one of the most frequently used drugs for BP lowering in ICH in Brazil.

We evaluated consecutive patients admitted with spontaneous ICH from January/2009 to January/2014 to a tertiary hospital in whom DWI was performed within 15 days of admission. We compared patients with and without DWI abnormalities. Univariable analyses were conducted using chi-square, Mann-Whitney and Student-t tests as appropriate. Multivariable logistic regression was not performed due to insufficient number of outcomes.

Among 41 

Acute brain infarction was common after spontaneous ICH. Patients with atrial fribrillation, those with more MAP lowering and those treated with sodium nitroprussiate had a trend towards a higher frequency of ischemic lesions.

External ventricular catheter (EVD) placement is the standard intervention in patients with intraventricular hemorrhage (IVH) to divert cerebrospinal fluid and reduce intracranial pressure. We hypothesized that a semiquantitative method of EVD tract hemorrhage (EVD-TH) would correlate with a computerized quantitative measurement of EVD-TH to gauge intracranial hemorrhage (ICH) severity, and that ICH severity would correlate with EVD placement accuracy.

CLEAR-III is a multicenter trial of subjects with symptomatic IVH who are randomized to either tissue plasminogen activator (TPA) or saline (placebo) injections via EVD. All CT scans were analyzed for quantitative EVD -TH volumetrics at Johns Hopkins neuroimaging laboratory. A semi-quantitative (Jackson) method was utilized which graded bleeding at superficial (< 2cm calvarium), middle, and deep EVD tract locations using a categorical scale (0-3, with 0 = no TH, 1=trace, 2=TH, and 3 = TH with mass effect). EVD placement accuracy was graded via modified Karkala scale. ICH without adjacent EVD were not analyzed.

We reviewed 173 noncontrast head CTs (NCHCT) of the first 100 patients enrolled in the trial. There was no significant association between EVD placement accuracy and the EVD-TH semiquantitative method (p =0.44) which suggests that initial placement may not be factor on worsening EVD-TH. A significant relationship between semi quantitative and quantitative data (p

The data demonstrate a positive correlation between semi-quantitative and the quantitative EVD-TH methods. However, EVD placement accuracy did not correlate with worsening ICH volume, but exposure to TPA-treated patients cannot be analyzed until trial completion. The data suggest relative safety of standard EVD placement by neurosurgeons in the trial and data safety monitoring within the trial before injections occur into the EVD.

Financial Support: Dr Hanley is principal investigator of the CLEAR III trial and receives funding from the NIH/NINDS and Genentech supporting the trial.

CNS hemorrhage is the one of leading causes of death in adults treated with ECMO for refractory hypoxic ARDS but incidence and effect on outcome is unknown. We present a review of intracranial imaging findings from our center.

All ECMO patients underwent CT head just after cannulation per center protocol. Patients received heparin 100 units/kg bolus and were maintained on heparin or bivalirudin infusion with monitoring of factor Xa activity and ACT and PTT respectively. Cerebral monitoring was done with serial exams, serial pupillometry and continuous cerebral oximetry. Repeat scans were performed on as-needed basis. 2014 (36 veno-venous, 7 veno-arterial) . One patient had pre-existing traumatic SAH before cannulation. Initial scan revealed intracranial hemorrhage in 4 (9%) patients -all intraparenchymal and subarachnoid hemorrhages. No extra-axial bleed was identified. Serial CT scans were performed until stability, anticoagulation was held for 48-72 hours and aminocaproic acid infusion was used for 72 hours. No patient developed massive ICH. One patient had concomitant hypoxic ischemic injury due to recent cardiac arrest. Pupillary change led to emergent neuroimaging in 2 additional patients. Intra-parenchymal, subarachnoid and intra-ventricular bleeds and hydrocephalus was identified. One patient received a ventriculostomy. Both patients had support withdrawn. Survival to discharge was 33 (76%) with one still on ECMO.

In our series, two-thirds of patients with intracranial hemorrhage did not progress to massive bleed or need withdrawal of ECMO. Intracranial hemorrhage at initiation of ECMO appears to be tolerated in setting of prudent anticoagulation regimen and use of antifibrinolytics. Clinically detectable ICH on ECMO was catastrophic. Early detection of CNS bleeding with routine imaging and aggressive monitoring may provide an opportunity to reduce mortality.

Joint Commission patient safety measures have placed increased focus on infectious outcomes in ICU patients. We hypothesized infectious complications were related to increased mechanical ventilation (MV) days and tracheostomy rates in patients with intracerebral hemorrhage (ICH).

A prospective, observational study was conducted of ICH patients who underwent MV between 7/2008-10/2011. Patients who underwent withdrawal of life-sustaining treatment were excluded. Admission demographics, clinical status, past medical history, radiographic features, and medical complications were compared between patients with and without prolonged MV days and patients with and without tracheostomy using chi-squared and Mann-Whitney U tests. Multivariable logistic regression models were constructed to identify factors associated with prolonged MV days and tracheostomy.

Of 126 ICH patients, 70 (56%) received MV and 17 underwent withdrawal, leaving 53 patients for analysis. The median MV days was 10 (range 1-69) and 25/53 (47.2%) underwent tracheostomy. Both prolonged MV days and tracheostomy were associated with tracheobronchitis, fever, meningitis/ventriculitis, sepsis, use of a cooling device, IV sedation, hydrocephalus and ICH evacuation (all P< 0.05). MV days were also significantly longer in tracheostomy patients (21 vs 4; P< 0.0001). In multivariable logistic regression analysis, after adjusting for admission GCS, independent factors associated with tracheostomy included: fever (aOR 67.7, 95% CI 4.4-1037, P=0.002), sepsis (aOR 13.6, 95% CI 1.2-152, P=0.034) and ICH evacuation (aOR 70.8 (95% CI 2.8-596, P=0.007). Fever, sepsis and ICH evacuation also predicted prolonged MV days in multivariable analysis (all P< 0.05). Admission GCS, NIHSS, ICH volume, ICH score, past medical history and mechanism of ICH were not associated with tracheostomy or prolonged MV days.

Infectious complications, particularly fever and sepsis are associated with tracheostomy and prolonged MV days in intubated patients with ICH, irrespective of admission clinical status or size of ICH. Aggressive infection and fever control may be critical to improving ventilator liberation rates.

Intraventricular thrombolysis (IVT) may improve outcomes after intraventricular hemorrhage by facilitating ventricular clot resolution. We examined in-hospital outcomes and resource utilization after thrombolysis in patients with intracerebral hemorrhage requiring ventriculostomy in a 'real-world' setting.

Retrospective cohort. We identified adults with primary diagnosis of non-traumatic intracerebral hemorrhage (ICD-9 code 431) requiring ventriculostomy from the Nationwide Inpatient Sample (NIS) from 2002-2011. NIS is a 20% stratified random sample of all admissions to non-federal hospitals in the United States. The primary outcome was inpatient mortality and the secondary outcomes were favorable discharge (composite of discharge to home or rehabilitation), and unfavorable discharge (skilled nursing facility, hospice or death). Safety outcomes studied were bacterial meningitis and permanent ventricular shunting. Population estimates were extrapolated using standard NIS weighting algorithms. (58,770 [33,379-88,434] vs 42,052 [21,757-71,481 ] USD, P< 0.001), but cost of care per day LOS was similar in both groups (P=0.285).

IVT for intracerebral hemorrhage requiring ventriculostomy resulted in lower inpatient mortality and a trend toward favorable discharge outcome with similar rates of inpatient complications compared to the non-IVT group.

Palliative care utilization following intracerebral hemorrhage (ICH) has been studied in small populations, with poor generalizability. We aimed to explore the utilization of palliative care in ICH at a population level using a large national database.

Intracerebral hemorrhage patients with and without palliative care were identified from the 2002-2011 Nationwide Inpatient Sample by using ICD-9 codes. Demographics, comorbidities and surgical procedures were compared between palliative and non-palliative patients. The primary outcome was in-hospital mortality, while the resource utilization measures were discharge total hospital charges and length of stay.

Of the 

Palliative care utilization has been on the uptrend over the last decade. Gender and racial differences, and hospital characteristics appear to influence palliative care use in the United States. While resource utilization measures are lower in these patients, there is an inherent bias of self-fulfilling prophecy of poor outcome. 

The Haptoglobin (Hp) phenotype has been shown to be a predictor of clinical outcomes in cerebrovascular disorders. We sought to determine if the Hp phenotype was predictive of functional outcomes after spontaneous intracerebral hemorrhage (ICH).

Patients admitted with a diagnosis of ICH were divided into three groups based on their genetically determined Hp phenotype: 1-1, 2-1, and 2-2. Outcome measures included in-hospital mortality and modified Rankin score (mRS) at 30 days. Pearson's Chi Square and Wilcoxon-Mann-Whitney tests were used for categorical and continuous variables respectively. Logistic regression was used to assess association between Hp genotype and ICH outcomes.

A total of 94 patients were included in the study. The distribution of Hp phenotype in the 94 ICH patients was-Hp 1-1: 12 (13%), Hp 2-1: 46 (49%), Hp 2-2: 36 (38%). The three Hp subgroups did not differ in terms of demographic variables, comorbidities or ICH characteristics. Favorable functional outcomes were noted among 4 patients (33.4%) in Hp 1-1, 2 (4.3%) in Hp 2-1 and 4 (11.1%) in Hp 2-2. In the univariate analysis, Hp 2-1/2-2 phenotypes were less likely to have mRS 0-2 at 30 days (OR: 0.16, CI: 0.04-0.68, p=0.013). There was a non-significant trend towards increased mortality in Hp 2-1/2-2 compared to Hp 1-1, with mortality being 8% in Hp 1-1, 17% in Hp 2-1 and 25% in Hp 2-2, p=0.328). In the regression model adjusted for confounders, Hp 2-1/2-2 phenotypes had significantly lower odds of having favorable outcome (mRS 0-2) compared to Hp 1-1 (p=0.018). Hp 2-1 (OR: 0.05, 95% CI: 0.01-0.47, p< 0.001) and 2-2 (OR: 0.14, 95% CI: 0.02-0.86, p=0.045) each had poor functional outcomes.

Following ICH, individuals with Hp allele 2 (2-1,2-2) had worse functional outcomes than individuals with the Hp 1-1. There was no association between Hp phenotype and mortality.

Delirium symptoms following acute brain injury include altered consciousness and disorganized thinking. They are associated with later worse functional outcomes in patients with acute ischemic stroke and intracerebral hemorrhage, and worse health-related quality of life in patients with intracerebral hemorrhage. There is no known neurologic basis for delirium symptoms in patients with intracerebral hemorrhage. We tested the hypothesis that hematoma location is predictive of delirium symptoms.

We prospectively identified 90 patients with intracerebral hemorrhage who underwent routine twice-daily screening for delirium symptoms with a validated examination. Voxel-based lesion-symptom mapping with acute computed tomography was used to identify hematoma locations associated with delirium symptoms.

Acute delirium symptoms were predicted by hematoma of right-hemisphere subcortical white matter (superior longitudinal fasciculus) and parahippocampal gyrus using a whole-brain-corrected P< 0.05 threshold. Hematoma including these locations increased relative risk for delirium by 6.8 (95% CI 2.7-17.0; Z=4.1, P< 0.0001). Disruption of long-range cortical networks that normally support attention and conscious awareness was thus associated with delirium symptoms acutely. Furthermore, we found that acute delirium symptoms were associated with poorer health-related quality of life measured up to 1-year follow-up, specifically in the domain of reported executive cognitive function.

Hematoma location predicts subsequent symptoms of delirium, which is in turn predictive of later worse healthrelated quality of life. Future research might determine which cognitive impairments underlie reduced health-related quality of life, subtype delirium by its attributes, and determine whether focal injury is associated with delirium symptoms in other populations.

Clinical practice guidelines assist in evidence-based care and improve outcomes. Variability in practice patterns affects adherence with guidelines. This study describes adherence to the American Stroke Association's (ASA) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (sICH) at a primary stroke centercertified academic medical center and determines association between guideline adherence and outcomes in patients with sICH.

Patients admitted with a diagnosis of sICH were identified using electronic health records and data related to demographics and care received were retrospectively collected. A non-adherence score (NAS) was created using the clinical parameters relating to 18 selected guideline recommendations from ASA. Co-primary endpoints included rate of full adherence and percentage of overall adherence to the sICH guidelines. The effects of guideline adherence on in-hospital mortality, length of stay (LOS), discharge location, and mRS were investigated. Data were analyzed using descriptive statistics and multivariate logistic regression.

Of 202 patients, 131 were included in the analysis. Full guideline adherence was observed in 10 patients (7.6%), with a mean adherence rate of 88% overall. Guideline adherence was not achieved in 58% of patients for blood pressure control during first 24 hours and improved only marginally at the time of discharge (48%). Guideline adherence was lacking in other areas: blood glucose control (21%), no prophylactic antiepileptic drug use (19%), and pharmacologic venous thromboembolism prophylaxis (22%). Total adherence was higher for class I recommendations (94.2%) than with class II recommendations (75.8%). NAS did not predict in-hospital mortality, LOS, discharge location, or mRS.

There was disparity between the rate of complete and overall guideline adherence, probably affected by the adherence rates stratified by recommendation class. Adherence may be improved by targeting a few key recommendations. However, recommendations themselves need to be more robust to further study if guideline adherence affects patient outcomes.

Warfarin remains the most commonly used oral anticoagulant. For the treatment of warfarin reversal in addition to intravenous vitamin K, our institution switched to recently FDA-approved 4-factor prothrombin complex (PCC-4), replacing previously used 3-factor prothrombin complex concentrate (PCC-3) with fresh frozen plasma. Our objective was to retrospectively compare PCC-3 to PCC-4 in reversing warfarin in patients who were actively bleeding.

Management of patients with symptomatic subdural hematoma includes conservative treatment and surgical evacuation. However, it is unclear whether surgical evacuation results in better functional outcome in elderly patients. Therefore, we sought to determine if patients over age 80 fare better following craniotomy for subdural hematoma evacuation than conservative treatment.

We performed a retrospective study of patients aged 80 years or above who were treated for symptomatic subdural hematoma at our institution from November 2012 to April 2014. Baseline demographics, antiplatelet or anticoagulant use, and coagulopathy reversal data were collected. Primary outcome was estimated Modified Rankin Score (mRS) at hospital discharge. Secondary outcomes included ICU and hospital length of stay. A good outcome was defined as mRS 3, whereas a poor outcome was defined as 4. Independent samples t-test was used to look for differences.

71 patients met inclusion criteria. Their mean age was 87.04 years old. 26 (36.6%) patients underwent craniotomy and 45 (63.4%) were managed conservatively. Craniotomy patients had poorer outcomes (88% with mRS 4) compared to conservative management (64% with mRS 4) (p = < 0.001), and longer ICU (p = 0.002) and hospital length of stays (p = 0.011).

In elderly patients with subdural hematoma, craniotomy may lead to worse functional outcome compared to conservative management. Further investigations, including randomized controlled trials, are warranted.

Tumor related intracerebral hemorrhage (ICH) represents 0.8-4.4% of all spontaneous ICH. Causes of tumor related ICH include intratumoral bleeding, cerebral metastases, coagulation disorders and complication of chemoradiotherapy. Specific guidelines for critical care management of metastatic ICH are lacking and studies on outcomes have been sparse. We describe seven patients with metastatic ICH and followed their clinical course.

We reviewed clinical records of 7 patients with discharge diagnoses of metastatic ICH with known primary malignancy by tissue biopsy admitted to the neuro-critical care unit between 2010-2014.

Out of 7 patients, five were males. Mean age was 64 years. Acute to subacute motor symptoms were seen in five (71%) patients. Melanoma and Small Cell Lung Cancer were the common primary malignancies. On presentation, mean systolic blood pressure was 145 mm Hg and mean platelet count was 197,000/uL. Supratentorial hematoma was seen in 5 patients (71 %). Mass effect was seen in all cases. Midline shift seen in 3 cases (43 %). Five patients (71.4 %) received corticosteroid therapy. Four patients (57%) received prophylactic anti-epileptic medication. Two patients (28%) received continuous hypertonic saline as osmotherapy. Four patients (57%) received radiotherapy. Time of initiation of radiotherapy was variable ranging from 1-20 days from presentation. Emergent radiotherapy was performed in 1 patient with infratentorial ICH. Recurrence of hematoma was seen in three patients (43%). Out of these three patients, two patients never recieved radiotherapy and one patient had recurrence prior to initiation of radiotherapy. Delayed initiation of radiotherapy results commonly to increased recurrence of metastatic ICH.

Early recognition of metastatic disease as the etiology of ICH is important, particularly when it is the presenting manifestation. Despite the overall poor prognosis of metastatic cancer, early radiotherapy may increase survival and offer quality of life in selected group of patients. A larger case series is needed Financial Support: None

Delayed intracerebral hemorrhage (ICH) due to radionecrosis is a rare complication after radiotherapy of brain for arteriovenous malformation (AVM). The risk can be theoretically higher in patients on chronic anticoagulation for other systemic disease. There are no current case reports of such delayed complication in patients who are being treated with novel oral anticoagulants like Rivaroxaban for atrial fibrillation.

Case report with review of literature

We report a case of a 64-year-old right handed Caucasian man with past medical history of hypertension, congestive heart failure, rheumatoid arthritis, pulmonary fibrosis and ruptured left parietal AVM treated with gamma knife radiosurgery in 2009. A follow up MRI brain in 2011 showed changes in left parietal lobe consistent with radiation necrosis. Catheter cerebral angiography in 2012 showed complete obliteration of the AVM. He developed non-valvular atrial fibrillation in 2013, and treatment was initiated with Rivaroxaban. He was admitted in 2014 with new onset confusion and altered sensorium. CT head showed a 50 cc left pariet-o-occipital hematoma with surrounding edema, and transfalcine herniation. Oral anticoagulation was discontinued, despite a CHADS2 score of 4 (8.5% risk of ischemic events). There was no comparative data for future risk ICH if chronic anticoagulation is resumed, particulalry in context of radiation necrosis. He was discharged from the hospital two weeks later and was referred to cardiology for a left atrial appendicular occlusion procedure.

This case presents a unique dilemma of whether to continue oral anticoagulants to prevent further cardioembolic strokes in a patient with spontaneous ICH after radiation necrosis. As in our patient we opted for surgical treatment for atrial fibrillation, as the risk of restarting anticoagulation was theoratically higher.

The ABC/2 formula overestimates intracerebral hemorrhage (ICH) volume with increasing error for larger hematomas. We previously showed that using a denominator of 2.4 is a simple, objective way to improve rapid ICH assessment for both large and small hematomas. Our objective was to validate the ABC/2.4 method based on analysis of hematoma shape and location.

Two independent readers assessed diagnostic computed tomography (CT) scans of 364 patients enrolled in the MISTIE II(N=100) and CLEAR III(N=264) clinical trials. Location was divided into deep and lobar hemorrhages. ICH shape was designated as: (I)round to ellipsoid, (II)irregular with frayed margins, and (III)multinodular to separated. We compared averaged ABC/2, 2.4, and 3 with planimetry volumetric calculations using median percentage deviation with regard to hematoma site and shape. 

ABC/2 consistently over-estimates ICH volumes. Median difference between planimetry and ABC/2 increases with greater departures from elliptical lesions suggesting that ABC/2 is a biased estimate of ICH volume. Using a denominator of 2.4 is a simple, objective way to improve rapid ICH assessment with the existing measurement paradigm, which is consistent in both non-elliptical shaped lesions, and for deep and lobar ICH.

Pompe's Disease is glycogen storage disease that manifests as vasculopathy, progressive neuropathy and myopathy. There are a few reports of vasculopathy in this disease, thought to be from small and medium vessel arteriopathy. We present a case of late-onset Pompe's disease with microhemorrhages and review of the pertinent literature.

We describe a case of microhemorrhages in a patient with known late onset Pompe disease.

Our patient was noted to have numerous microhemorrhages concentrated in posterior circulation distribution in what can best be described as central microhemorrhages, distinct from amyloid angiopathy pattern. Previous autopsy studies have found vacuoles in the vessel wall resulting in small aneurysms as a part of the Pompe syndrome.

There is an accumulating body of evidence that suggests cerebral vasculopathy as one of the primary manifestations of adult onset Pompe's disease. This is manifested as dolichoectasia of basilar artery, aneurysms and microhemorrhages that are central in distribution. The primary pathology is thought to be glycogen deposition in small and medium size intracranial vessels. Controlling blood pressure aggressively and screening intracranial vascular imaging is recommended. Further definition of the syndrome is continuing from phenotypic and genotypic dimensions.

Intracerebral Hemorrhage (ICH) remains a devastating type of stroke. Besides blood pressure control, treatment options including surgery, remain limited. Decompressive hemicraniectomy (DCH) in patients with spontaneous ICH may be considered a salvage therapy. The purpose of this study was to compare the outcome of patients with primary ICH who had DCH performed versus expected outcome based on the ICH score.

A retrospective chart review was conducted between 2011-2014 at our institution of patients with ICH and DCH. Charts were reviewed for demographics, previous medical history, and serial neurological exams. Glasgow coma scale (GCS) and computed tomography scans were then reviewed at the time of admission, allowing calculation of ICH scores. Functional outcome was assessed over the phone using the Simplified Modified Rankin Scale Questionnaire (smRSq).

We identified 16 patients in this cohort with a mean age of 53± 15 years and 50% male. The overall mortality in our patient population was 31%. The median ICH score for our cohort was 2 (IQR 0.75-3.25). The average time to DCH was 65.1±104 hours and 25% had clot evacuation with their DCH. Preoperative GCS and discharge GCS were 6 and 12, respectively. The average length of follow-up was 582 days. The median mRS on discharge was 5 (IQR 4.75-5.25), while on follow-up the median mRS was 4 (IQR 2-6). Overall, 64% of the patients had an mRS 4 at last follow-up compared to 55% as predicted based on the ICH score. 50% of patients improved by 1 or more mRS points during followup.

This case-series suggests that patients with ICH associated with significant cerebral edema may potentially benefit from DCH. Further research in a larger patient population conducted prospectively is warranted to assess the potential benefit of DCH in ICH.

Acute inflammatory polyradiculoneuropathy, known as Guillain-Barré syndrome (GBS), can cause severe neurologic morbidity. Treatment typically involves a course of intravenous immunoglobulin (IVIG) or plasmapheresis (PLEX). A second course of treatment is sometimes recommended, but no evidence-based guidelines exist to inform this decision. There may be clinical or laboratory features of GBS that predict retreatment.

We performed a retrospective chart review of patients diagnosed with GBS admitted to the Mayo Clinic Hospital in Rochester, MN between 01/01/1996 and 11/01/2012. The inclusion criteria were the diagnosis and treatment of idiopathic acute inflammatory polyradiculoneuropathy. Descriptive statistics and univariate analysis of clinical parameters were performed. Severity was graded by the GBS Disability Score (GBSDS).

135 patients were included. The mean age was 54 and the cohort was 41% female. At admission, 49% of the cohort was bedridden or ventilator dependent (poor GBSDS >3). Mean time from symptom onset to first treatment was 9.7 days. Retreatment was performed in 29% of the cohort at a mean time of 21.4 days from symptom onset. There was a significant association between time to first treatment and retreatment (p = 0.045), although time to poor GBSDS and retreatment were not significantly associated (p = 0.388). Retreatment was also associated with poor GBSDS at 7 days (p = 0.002) and 14 days (p < 0.0001) from hospital admission. No other clinical variable was associated with retreatment, including age, GBSDS at admission, Miller-Fisher variant phenotype, method of treatment (IVIG or PLEX), cerebrospinal fluid protein at admission, or serum sodium at admission.

In a large retrospective referral center cohort, only shorter time from symptom onset to first treatment and duration of poor GBSDS were associated with retreatment. Further research is needed to establish guidelines for GBS retreatment.

Guillain-Barré syndrome (GBS) has been rarely reported with recent Epstein-Barr virus (EBV) infection, particularly in younger patients after initial infection or immune compromised patients. The reactivation of EBV as a cause of GBS after non myeloablative stem cell transplantation has also been reported. There are no case reports in literature describing an older immune competent patient with high viral load of EBV, with initial presenting symptoms of GBS.

Case report with review of literature

We present an extremely unusual case of a 53-year-old Caucasian woman with past medical history of recurrent sinusitis and asthma. She presented with two weeks history of painful cervical lymphadenopathy without any associated night sweats, or weight loss, followed by painful paresthesias in the feet and gait disturbance. Over the next several days of hospitalization, she developed ascending flaccid quadriparesis with generalized areflexia and respiratory failure. The diagnosis of GBS was confirmed with clinical examination, cerebrospinal fluid analysis and electromyography/nerve conduction velocity (EMG/NCV) testing. Initial ancillary data also showed leukocytosis (17K) with marked eosinophilia (26%). Peripheral smear showed absolute eosinophilia. CT of chest and abdomen showed diffuse lymphadenopathy. An excisional cervical lymph node biopsy showed follicular and paracortical hyperplasia with increased EBV positive lymphocytes, consistent with EBV related lymphadenitis. Serologies for EBV showed >390,000 copies of EBV DNA per milliliter, positive EBV nuclear antigen, positive IgG EBV and negative IgM EBV. CSF analysis for EBV was negative. Patient was treated with plasmapheresis and required ventilator support due to poor respiratory effort. In addition, she was treated with intravenous ganciclovir. She had a protracted recovery and was dicharged to a long term acute care facility.

This is an extremely unusual case of an adult patient, otherwise immune competent, with high viral loads of EBV (with positive EBV IgG and EBV nuclear antigen but negative EBV IgM) in the setting of diffuse painful lymphadenopathy and eosinophilia presenting with GBS.

The apnea test is mandatory to confirm brain death unless a medical contraindication exists; however, it is considered difficult for the patients receiving extracorporeal membrane oxygenation (ECMO). We report a case series of 4 pediatric patients who underwent apnea testing on Venous Arterial (VA)-ECMO after development of clinical signs of brain death. To date, this is the largest case series to describe apnea testing in pediatric patients with hypoxic-ischemic brain injury supported on VA-ECMO.

Patients who underwent brain death examination while supported with VA-ECMO between 2005 and 2014 were identified from a prospective ECMO database. Details of the brain death examination and clinical course were obtained from a retrospective chart review.

A total of 5 patients were identified in which brain death examination was done while they were supported on VA-ECMO. The apnea test was not performed on one patient where a nuclear scan was done. In 4 patients, apnea testing was performed after identifying loss of all brain stem reflexes. One patient was on therapeutic hypothermia which was discontinued and the neurological evaluation was done after rewarming

Apnea testing is an essential component of the brain death examination, and is not described in patients on VA-ECMO by current guidelines on the determination of death by neurologic criteria. We have shown it can be performed in a modified way by decreasing the sweep gas flow through the ECMO membrane to allow for appropriate rise in arterial carbon dioxide levels.

Financial Support: None

The microglial response plays an important role in injury and recovery after hypoxia-ischemia (HI) in the developing brain, but age-dependent differences in microglial responses are poorly understood. The aim of the current study was to assess for differences in the effect of microglial suppression after HI in infant and juvenile mice. We hypothesized that administration of minocycline after HI would result in suppression of microglial activation in both age groups, and would improve brain injury after HI in younger mice.

HI was induced in P9 and P30 mice using the Vannucci method of carotid artery ligation and subsequent exposure to 10% O2 for 50 minutes. Mice were administered minocycline (45mg/kg ip, 2h and 24h post-HI) or vehicle and sacrificed for flow cytometry (microglia quantification) and immunostaining (MAP2, neurological injury score) at 2 days and 9 days post-HI.

HI induced a significant increase in activated microglia in ipsilateral vehicle treated hippocampus on day 2 post-HI and a delayed increase in the cortex and striatum at post-HI day 9. Minocycline treatment resulted in a significant decrease in microglia activation in the hippocampus at post-HI day 2 in P9 and P30 mice. Interestingly, microglia responses remained suppressed in P9 mice, while P30 mice demonstrated a rebound increase in microglia activation. Additionally, minocycline treatment resulted in significant improvement in injury scores in P9 mice but not P30 mice at day 2 and day 9 post-HI.

Minocycline treatment resulted in a sustained suppression of microglial activation and proliferation in P9 but not P30 mice. Minocycline treatment decreased neurological injury at day 2 and day 9 post-HI only in P9 mice. Ongoing experiments will assess for age-dependent differences in baseline expression of microglial genes associated with M1 phenotype and M2 phenotype, and the effect of minocycline treatment on M1 and M2 microglial responses after HI.

CBF is an important variable in Neurocritical care but a non-invasive monitor of CBF has not been available. A recently developed approach is based on an opto-acoustic adaptation of near infrared spectroscopy. Our objective was to determine whether the acousto-optic CBF monitor would detect changes in CBF which are known to occur with propofol(decrease) and subsequent endotracheal intubation (increase)(1).

Methods 57 patients scheduled for elective non-intracranial surgery were enrolled of which 42 were analyzed. Patients with intracranial disease were excluded. A Cerox3215F (Ornim, Israel) acousto-optic CBF monitor was used. On arrival in the operating room, the acousto-optic transducers were applied bifrontally. Baseline values were obtained. Subsequently changes in CBF from baseline were determined at three points: two minute baseline, the lowest value over three minutes after propofol injection and the highest value over five minutes after laryngoscopy. SaO2 and mean arterial pressure were determined at the same time points. Data were evaluated by repeated measures ANOVA.

CBF decreased to 83+14% of baseline after propofol (P< 0.001) and increased to 146+34% of baseline after endotracheal intubation (P< 0.001). Concurrently SaO2 remained >95% across all measurement times. At each measurement time MAP was 105 + 15 mmHg (baseline), 84+ 18(propofol) (P< 0.001), and 96 + 22mmHg(laryngoscopy) (P=0.11)

Our data are congruent with TCD observations (1) 

Antiplatelet regimen in stent-assisted treatment of intracranial aneurysm is not universal and varies from center to center. Objectives: To determine the safety, feasibility and clinical outcome of patients who underwent Enterprise stent-assisted repair of intracranial aneurysm using acute loading doses of aspirin and clopidogrel.

Consecutive patients underwent enterprise stent-assisted repair of aneurysm using loading doses of aspirin 324 mg and clopidogrel 300 mg were enrolled.The outcome was measured using national institute of health stroke scale (NIHSS) and modified Rankin Scale (mRS)

47 patients with mean age of 53 ± 13 underwent 56 stent-assisted procedures to treat 53 (2 ruptured cases) aneurysms. Stent deployed in (98%) but one who underwent aneurysm coiling. There was no intra-operative hemorrhagic event. Small left subtrachnoid hemorrhage was observed in one with right middle cerebral artery aneurysm (MCA). Intra-operative asymptomatic MCA branch occlusion developed in one and MCA was recanalized using inreaarterial eptifibatide. Coil fractured developed in one, which was corrected by placement of stents without clinical consequences. Post-operative thromboembolic events was observed in 2 cases (4%); first event developed day 2 with NIHSS 6 in a 42 years old woman with a giant right ICA giant aneurysm and who recovered completely (NIHSS 0, mRS 0) in 90days. The second event was visual distortion developed on day 2 in a 66 years old woman with basilar artery aneurysm. Her symptoms resolved completely. Immediate complete and near complete obliteration of aneurysm was observed in 66% and subtotal in 34%. There was no mortality or permanent disability in our series. 90 days mRS 0 and 1 was observed in 96% and mRS 2 in 4%.

Using loading doses of aspirin and clopidogrel in Enterprise stent-assisted repair of intracranial aneurysm is not only safe and feasible but associated with good clinical outcome. Further studies are required.

Epidural anesthesia (EA) is a common procedure utilized in women undergoing cesarean section (CS). However, inadvertent puncture of the thecal sac may lead to injection of anesthetic directly into the subarachnoid space, often without clinical consequence. We present a case where epidural anesthesia was complicated by transient onset of coma, apnea, loss of all brainstem reflexes minutes after delivery.

Case report from a tertiary referral center.

We describe a 23-year-old healthy woman who was 39 weeks pregnant and underwent emergent CS utilizing EA with lidocaine/epinephrine 1:200,000 and morphine dosed to surgical level. Minutes after delivery she vomited twice, and rapidly became unresponsive to sternal rub, prompting stroke code activation and intubation. Neurological examination revealed a comatose patient with flaccid tetraplegia and loss of all brainstem reflexes with 8mm fixed pupils bilaterally. Emergent head CT identified subarachnoid air in the basilar and suprasellar cisterns; CTA of head/neck were unremarkable; MRI showed normal DWI. Within 60 minutes she gradually regained brainstem reflexes, was arousable and following commands; she was then extubated and had a normal examination except for mild paraparesis secondary to epidural anesthesia.

Serious anesthesia-related EA complications such as high neuraxial block, respiratory arrest, and unrecognized spinal catheter placement are known (SCORE project). However, deep coma after EA is extremely rare and thought to be due to rostral migration and accumulation of subarachnoid air directly compressing the brainstem. However, this case report demonstrates that intoxication of brainstem structures by anesthetic may be causative as 1) both progression (within minutes) and resolution (within 2 hours) of coma followed the pharmacokinetics of injected drugs, 2) while the volume and location of identifiable subarachnoid air (initial CT during coma and MRI after improvement) remained unchanged; and 3) the clinical symptomatology resembled progressive loss of caudocranial function typical for intoxications.

Mortality of craniotomies is included as a quality of health care. There are many factors that can affect the mortality of craniotomies, but the impact of teaching institutions on outcome is missing in medical literature. The study seeks to assess the impact of teaching institutions on the mortality of craniotomy patients.

Data was acquired from the national information on measures of health care quality based on the NIS, using the Agency for Healthcare Research and Quality (AHRQ) Quality Indicators. Mortality of craniotomies across the United States was compared between teaching and non-teaching institutions between 2000-2011.

During 12 years of study, craniotomy mortality as an inpatient quality indicator was significantly higher in males and elderly (P-Value < 0.0000). The mortality of craniotomies decreased significantly from 97.9 per 1000 in 2000 to 35.7 in 2011 (P-Value < 0.0000). The mean and median cohort mortality was 71.124 and 73.126 respectively. When considering the impact of teaching institutions on mortality, it was significantly higher only in 2004 (P-value < 0.0000). The effect of teaching institutions was significantly protective of craniotomy patients in 2000, 2002, 2006, 2008, 2009, 2010 , and 2011 (P-value < 0.0000) and was neutral in other years.

Craniotomy mortality has been significantly decreasing from 2000 to 2011. The effect of teaching institutions on mortality has been variable but, most of the time, protective. Teaching hospitals are often level I trauma centers with a more complicated patient population, which affects mortality. On the contrary, these hospitals may go to extra measures to be more thorough in patient care for the sake of education. Furthermore, there may be more concern with hygiene and infection control practices. Having more healthcare providers with different levels of experience, including students, residents, and attending physicians, brings more people involved in patient care to prevent errors.

The prognostic significance of reactive and continuous background on EEG during and after therapeutic hypothermia (TH) is unclear.

This is a retrospective analysis of consecutive cardiac arrest patients who underwent both TH (goal 33 C), and continuous EEG monitoring for 72 hours at Columbia University Medical Center from 2008 to 2013. The EEG reactivity was categorized into (present or absent), and continuity into continuous (< 10%) and discontinuous (>10% period of suppression). Different groups (Group 1: absent/absent; Group2: present/absent; Group 3: present/present; Group 4: absent/present) were created based on their pattern on the day of event and postrewarming phase. Rates of poor (CPC>3) outcome was compared in different groups.

A total of 130 patients with mean age (63±17 years), CPC>3 (76%), change of reactivity in group 1, 2, 3, 4 (59%, 7%, 24%, 10%), and continuity (35%, 18%, 42%, 5%) respectively. Group 1 had 100% poor outcome compared to 28% in group 3. Group 2 patients who later lost their reactivity had poor outcome in 87.5%. Group 4 had no difference in outcomes. For background continuity, group 1 had the lowest incidence of poor outcome (63%) compared to group 2: (77%), with highest incidence in patients with discontinuous background during and after TH (group 3: 92%). change of background from discontinuous to continuous after TH mantained higher rates of poor outcome (group 4: 86%). The group with discontinuous background compared to continuous background on both days had 6.5-fold higher risk of poor outcome (p=0.002).

There was a higher incidence of patients whose reactivity and continuity whether present or absent did not change due to TH and these groups have the highest rates of good and poor outcomes respectively, after cardiac Arrest. Future studies should evaluate the prognostic value of these patterns by prolonged EEG monitoring beyond 72 hours.

Japan Resuscitation Council (JRC) released JRC guidelines 2010, in which a concept of neuro-resuscitation (NR) was proposed ahead of the world. Based on NR, JSEM (Japanese Society for Emergency Medicine) developed a training system named ACEC (Advanced Coma Evaluation and Care) for learning initial managements of acute impaired consciousness caused by various pathologies. In this paper, we introduce a simulation training according to ACEC system and report its effect for medical education.

ACEC algorithm consists of three steps: (1) primary survey for resuscitation including the assessment and treatment of Airway, Breathing, Circulation, Disability of the central nervous system, Epilepsy, Fever and Freeze (abnormal temperature), abnormal level of blood Glucose, Hydrogen (acidosis), and Ions (abnormal levels of blood electrolytes), (2) secondary survey for emergencies and (3) tertiary survey for connecting specialists of each field. Thirty-eight fifth-year medical students in our university joined in this training. We used 3G human simulator made by Laerdal Medical and employed five training scenarios of emergency treatments for patients with acute impaired consciousness caused by (1) hemorrhagic stroke, (2) status epilepticus, (3) heat stroke, (4) bacterial infection and (5) diabetic ketoacidosis selected from 21 ACEC scenarios, which were designed on a clinical map possessing a two-dimensional fashion with a treatment of ACEC algorithm. All the students took a same examination consisting of 10 multiple choice questions (MCQ) before and after their training. We compared scores of the MCQ between before and after.

Average scores of the MCQ before and after the training were 4.13 (95%CI: 1.32 6.95) and 7.42 (95%CI: 4.98 9.86). A significant difference was observed in these two averages (p < 0.05).

The system and the materials of ACEC can be effective for medical students to learn neurological emergencies.

HaNDL is described as a self-limited benign entity and was first described in 1981. Although not entirely understood, the pathogenesis of HaNDL is thought to involve a post-infectious or inflammatory mechanism in which auto-antibodies are directed against neuronal or vascular antigens. An aseptic leptomeningeal vasculitic process results into headache and neurological deficits and secondary injury in the setting of elevated in ICP may also occur.

This is a case report with review of previously described cases (Pubmed search). A previously healthy 31-year-old woman developed rapidly declining mental status and respiratory failure following a course of 10 days of daily persistent headache. There were no other antecedent triggers identified. The patient's rapidly progressed to coma (Glascow Coma Scale of 5T) following admission and was emergently resuscitated in an ICU setting.

Extensive imaging and serological diagnostic work-up failed to yield a specific etiology. An emergent lumbar puncture revealed a lymphocytic pleocytosis with elevated protein and intracranial pressure (ICP) over 55cmH2O. EEG monitoring did not reveal any features suggestive of seizures. MRI brain with gadolinium revealed subtle but diffuse leptomeningeal enhancement without any focal lesion. Patient's poor neurological examination was thought to be secondary to elevation in ICP; in the setting of impaired autoregulation, and cerebral hyperemia (vasogenic edema) secondary to inflammatory cascade. The patient was aggressively treated with pulmonary support, hyperosmolar therapy, acetazolamide, and CSF shunting via lumbar drain. The patient made a complete recovery within 3 weeks with eventual normalization of CSF profile. She had no neurological sequaelae.

HaNDL has previously been characterized as a self-limited headache syndrome with a benign course. This case illustrates an atypical presentation of a rare syndrome culminating in uncontrolled elevated ICP. Additionally, we highlight the need for a high index of suspicion when patient present with unusual pattern of headaches accompanied by non-focal exam suggesting elevated ICP.

Patients with posterior reversible encephalopathy syndrome (PRES) present with acute onset of headache, decreased level of consciousness and often, seizures. The differential diagnosis is extensive and includes inflammatory and infectious processes. Spinal fluid analysis is sometimes indicated to differentiate among these possibilities, but can also create diagnostic confusion because expected CSF findings in PRES are not known. The purpose of this study was to describe CSF patterns in patients with PRES.

The pathophysiology of non-obstructive hydrocephalus involves alteration in cerebrospinal fluid (CSF) pathways.

The exact mechanism has yet to be elucidated. As arachnoid CSF egress is a major route of CSF removal, damage or alteration to the growth of arachnoid cells may influence the rate of CSF absorption. We investigated the effect of soluble factors secreted by fibroblasts and the presence of bilirubin on arachnoid cell growth.

Methods 4 x 10 6 arachnoid cells from an immortalized rat cell line were plated in the basal compartment of transwells in triplicate, while fibroblasts were plated in each apical chamber. Cell counts at day 3, 5, and 7, and growth rates were obtained using a hemocytometer and compared to controls. Similar experiments were conducted with bilirubin (1mg/mL concentration), which was added to fibroblasts in the apical chamber. DNA content in the cell cultures was determined using the DNeasy Blood and Tissue Kit.

The control cell counts for days 3, 5, and 7 were 1.43 x 10 5 , 1.95 x 10 5 , and 2.30 x 10 5 , respectively. Arachnoid cells in the presence of fibroblasts had cell counts of 9.57 x 10 4 , 1.50 x 10 5 , and 2.14 x 10 5 on days 3, 5, and 7 respectively, and when exposed to both fibroblasts and bilirubin, the cell counts were 9.65 x 10 4 , 1.35 x 10 5 , and 1.92 x 10 5 on days 3, 5, and 7. DNA content was reduced at all time points.

Arachnoid cells are closely related to CSF as they form the barrier of the subarachnoid space and arachnoid granulations. Fibroblasts and bilirubin are encountered in inflammation and/or hemorrhage, and we show that arachnoid growth decreases in the presence of both fibroblasts and bilirubin. Given its intimate relationship with CSF, it is possible that this decreased growth may affect absorption and thus the development of hydrocephalus.

Background Non-herpetic acute limbic encephalitis (NHALE) is a poorly described entity currently with no known cause. It was first identified in 1994 in the Kyushu district of Japan and only recently has it been described in more detail. It is characterized by a clinical presentation similar to HSV encephalitis with MRI imaging findings often showing bilateral hippocampal and amygdala hyperintensities. Detailed work-up however including HSV PCR, ELISA, and post-mortem analysis in select cases have been negative for herpes simplex encephalitis. Its clinic course is notable for altered behavior, fever, and prolonged seizures with cognitive deficits being a common sequelae. It generally carries a favorable prognosis, however, and is therefore important to recognize. A correlation has been found between NHALE and autoantibodies against glutamate receptor epsilon2 and delta2. (GluR-epsilon2 and GluR-delta2). Here we present a consolidated case series of 24 patients gathered from previously listed case reports in Japan including 4 patients of our own as well as review the implications of this important entity.

Following an extensive literature review, we gathered 24 cases of non herpetic acute limbic encephalitis predominantly from Japan including 4 of our own and present our findings.

Among the patients we listed there is a common presentation of altered behavior, fever, and prolonged seizures. Workup is notably negative for HSV encephalitis and inpatient stay is often prolonged to weeks or months. There is also a correlation with autoantibodies against glutamate receptor which may aid in diagnosis and prognosis is generally favorable.

NHALE is a known entity with a similar presentation to HSV limbic encephalitis. Given the generally favorable prognosis and known correlation with glutamate receptor antibodies, it is an important entity to consider in the critical care setting.

Neurological prognosis in comatose patients is assessed via the clinical exam and clinician's judgment, and is often subjective. Neurophysiological tests, namely, event related potentials (ERPs), are inexpensive, readily available and noninvasive tests. ERPs can be used to demonstrate higher level cortical processing in comatose patients and contribute to the prediction of neurological recovery.

17 comatose patients, defined by Glasgow Coma Scale (GCS) < 9, underwent electroencephalogram (EEG) recordings while hearing a series of randomly computer-generated tones (1000Hz standard and 1200Hz deviant), presented randomly with 90% and 10% probabilities respectively. The EEG was processed offline producing the ERPs by averaging neuro-electrical signals to the standard and deviant tones. Mismatch negativity (MMN) and the N100 waveforms were extrapolated and analyzed from this recording. Outcome was assessed at 6 months with the Glasgow Outcome Scale Extended. Patients were grouped by outcome, awake vs. non-awake, according to question 1 of the Glasgow Outcome Coma Scale Extended. This was defined as being able to obey simple commands or speak.

Of the 11 follow-ups conducted, 4 patients awoke from coma (36.3%). Of these patients, 2/4 had both the N100 wave form present and a positive MMN. The 2/4 remaining patients who awoke had neither the N100 nor MMN present. Of the 7 patients who did not awake (63.6%), the N100 waveform was present in 1 only (sensitivity 85.7%, specificity 50%). Absence of MMN was 71.4% sensitive and 50% specific in predicting non-awakening.

The absence of the N100 waveform is highly sensitive but nonspecific in predicting non-awakening from coma. MMN is less sensitive than the N100 wave form and nonspecific. Limitations include small sample size, mixed etiology of coma, and the impact of both aphasia and withdrawal of care on outcome assessment. Further data in a larger and more homogeneous sample need to be collected for conclusive results.

Financial Support: None

The electroencephalogram (EEG) has been useful as a predictor of outcome during resuscitation after experimental cardiac arrest (CA). Previously our group has used different EEG entropy and spectral measures as a means to forecast outcome after CA. Additionally, we have shown that EEG bursting and burst counts may be a powerful tool to show that EEG shows a robust recovery. Now we show that EEG gamma band activity from 30-50 Hz often synonymous with bursting is an effective tool for discerning recovery status.

We subjected rats (N=9) to nine minutes of asphysxic cardiac arrest after gas washout. Rats were then resuscitated. Animals were subjected to a behavioral neuro-deficit score or NDS assessment testing at 72 hr postreturn of spontaneous circulation (ROSC). An NDS of 60 or greater served as the delineator of favorable outcome. Two channels of EEG were recorded continuously for entire experiment. EEG was filtered and the filter output was subjected to an instantaneous, point-by-point energy operator. Data points were averaged in one minute intervals and then the gamma energy fraction or relative gamma was formed.

Eight 10-minute energy estimates calculated from 90 to 170 minutes post-ROSC were subjected to repeatedmeasures ANOVA statistical testing. Gamma fraction could distinguish the groups with a p-value of less than 0.02. Individual epoch t-tests showed differences at p< 0.03. Gamma activity in the EEG post-cardiac arrest may provide critical outcome information.

This buttresses earlier work that suggests that EEG entropy and high frequency activity are candidate markers for recovery of arousal and cognition. In the awake, aroused state, generalized desynchronization of EEG is accompanied by dynamic, bi-directional, coherent oscillations between reciprocal thalamocortical and corticothalamic projections. These oscillations occur in the high frequency range, clustering around 40Hz, the so called gamma rhythms which are prominent in the reawakening animal.

Impaired consciousness of varying duration frequently follows hemorrhagic stroke. Structural injury may explain the inability to regain consciousness but prolonged impairment of consciousness without structural injury is poorly understood.

In this prospective observational study of 130 comatose aneurysmal subarachnoid hemorrhage (SAH,N=94) and intracerebral hemorrhage patients (ICH,N=36), we explored the ability and timing of recovery to follow simple commands while in the hospital. Based on daily interruption of sedation (except in status epilepticus [N=4] or refractory intracranial pressure (ICP) crisis [N=10]) we determined the first time that patients were able to follow simple commands. We compared those with to those without diffuse bi-hemispheric, diencephalic, tegmental and thalamic structural injury (Plum&Posner,ISBN #978-0-19-532131-9) based on serial CT(N=130) and MRIs(N=66).

Overall, 48% (N=62) of comatose patients (48%[N=45] of SAH and 47%[N=17] of ICH patients) started following simple commands while in the hospital (median post bleed day 18 [IQR 12, 21] ). Amongst those with bilateral, extensive structural injury 93%(13/14) had prolonged impairment of command following (compared to those without P=0.001;OR 0.1;95%-CI 0.1-0.6). 57%(17/30) and 44%(38/86) of those with partial or no structural injury had prolonged impairment of consciousness. None of those with diffuse bi-hemispheric (N=9), tegmental (N=3), or thalamic (N=2) and only one patient with diencephalic injury (N=6) started following commands. Frontal lobe injury if absent or unilateral was not but if bilateral was associated with failure to recover command following if extensive and bilateral (14%[3/21] vs 51%[59/109]).

We confirm that structural injury of the brainstem, diencephalon, thalamus, and cortex is associated with prolonged impairment of consciousness but almost half of those without structural injury have prolonged impairment of consciousness and only a small fraction of these are medication induced. Structural injury below the resolution of standard imaging likely accounts for some of this variability but non-structural causes may play a role in some patients.

Brain injury can have lasting neurologic sequelae. Many patients suffer from disorders of attention and arousal following brain injury. Most of the therapies offered to these patients are largely supportive. Our goal was to create a clinical practice survey to evaluate which specific medications are currently being used by neurointensivists in the management of attention and arousal disorders following brain injury.

We organized an 8 question unvalidated survey. Our sampling population was primarily made up of neurointensivists, medical intensivists, neurosurgeons and anesthesiologists. The survey was conducted through email and was available for participation: November 15, 2013 through November 29, 2013. The survey was sent to 1366 Neurocritical Care Society (NCS) members. We utilized descriptive statistical analysis when reviewing our percentage data.

We received 122 completed on-line responses. More than half of our respondents were neurointensivists (54.9%). 59.8% of the respondents selected amantadine as their medication of choice to address attention and arousal issues. 69.4% of the respondents initiated therapy more than a week out from injury. 34.4% of the respondents treat their patients for more than 2 weeks. 55.7% of respondents reported trying another agent, if the initial selection did not improve wakefulness. 76.2% selected traumatic brain injury (TBI) as the primary diagnosis of patients receiving pharmacologic treatment. Overall, 50.4% of the respondents felt that medications were effective only a quarter of the time. Interestingly, 99.1% of the respondents reported their institution does not follow a clinical practice guide line when using pharmacologic agents to treat disorders of attention and arousal.

In the survey, amantadine, a dopaminergic agent, is used most frequently. However, there are a variety of medications and time schedules that are utilized. Our results show that nearly all respondents do not have an institutional policy directing medication therapy for disorders of attention and arousal following brain injury.

Sonographic evaluation of optic nerve sheath diameter (ONSD) is increasingly used as a non-invasive technique for detecting raised intracranial pressure. This study aims to find out the normal ONSD in healthy Nepalese adults.

In a prospective observational study, ONSD was measured 3 mm behind the globe using 6 to 13 MHz linear probe. Subjects were examined in supine position with their eyes closed and in neutral position. Tranducer was placed horizontally and in each eye, an average of three readings were documented.

One hundred healthy subjects above 18 years of age were enrolled in the study. The ONSD ranged from 2.5 -4.9 mm with a mean of 3.9 mm and standard deviation of 0.5 mm. There was no significant difference in ONSD measurement between males and females (p=0.064) and between right and left eye (p=0.695). There was no relationship between ONSD and age (R 2 =0.014, p=0.243).

The range for normal ONSD in healthy Nepalese subjects is 2.5 -4.9 mm with no significant relationship with gender, age and side of the body.

Patients with sickle cell anemia (SSC) are at increased risk for stroke. Periodic blood transfusions decrease velocities < 200cm/s -1 in middle cerebral (MCAs) monitored by Transcranial Doppler (TCD) and prevent strokes. Sanguinate (PEGylated carboxyhemoglobin bovine) is an intravenously administered product that combines the beneficial functions of a carbon monoxide releasing molecule in dilating vessels with an oxygen transfer agent.

A 23-year-old Jehovah witness woman with sickle cell/ °-thalassemia trait was admitted with encephalopathy and respiratory distress. She had been recently discharged from another hospital after multi-organ failure, including myocardial infarction secondary to severe anemia, cerebral infarction, and acute kidney injury requiring hemodialysis. Despite lowest hemoglobin (Hg) 3.1 g/dL she strictly refused transfusion. Patient was managed with intubation and mechanical ventilation due to hypoxia (PaO2 54.3, sPaO2 88.4%, pH 7.48 and PaCO2 38.2) and anemia (Hg 4.6 g/dL), antibiotics for pneumonia and hemodialysis for oliguric acute tubular necrosis. She remained delirious despite these measures. 500ml infusion of 40 mg/mL SANGUINATE was given IV and repeated in 24 hours. After initial extubation failure, two more units of anguinate were provided.TCD was performed serially.

Initial TCD revealed hyperemia with high blood flow velocities. After Sanguinate was administered a gradual velocity reduction was observed in both MCAs (for example, right MCA baseline 151 ± 3.2 vs 48 hours post last transfusion 120 ± 3.2 cm/s -1 , p < 0.001, ANOVA). A similar trend was noted in the posterior circulation. The encephalopathy resolved, she improved hemodynamically, was successfully extubated after a second attempt and, despite Hb of 3.1 g/dL upon extubation, she had resolved dyspnea and left the hospital.

Sanguinate is a promising alternative to human blood transfusion in treating symptomatic SCD patients. It improved respiratory failure, encephalopathy and cerebral hemodynamics and facilitated extubation in the setting of severe anemia.

Financial Support: Dr Abe Abuchowski is the CEO/CSO of Prolong Pharmaceuticals, which provided the drug free for compassionate use in this patient

Paroxysmal sympathetic hyperactivity (PSH) is a recently recognized syndrome characterized by episodic fever, tachycardia, hypertension, tachypnea, diaphoresis, muscle rigidity, and pupillary dilatation. Traumatic brain injury is the most common etiology leading to PSH followed by hypoxia and subarachnoid hemorrhage. There are few reports of imaging features of PSH to identify the causative location.

Case report.

A previously healthy 23-year-old man was found unresponsive with vomit at home. His Glasgow Coma Scale was 11 (E4, V2, M5) on arrival. Initial brain CT scan revealed acute ischemic lesion in the left occipital lobe. CT angiography showed near occlusion of the distal basilar artery (BA). Emergent DSA demonstrated faint filling of the distal BA and the right posterior cerebral artery. Perforators around the basilar bifurcation were seen. Despite antiplatelet treatment, he further deteriorated. MRI taken next day revealed progress of ischemic lesions involving bilateral thalami, bilateral occipital lobes, right cerebellar hemisphere, and vermis. A crescendo-shaped thrombus was seen in the distal BA lumen. Based on these radiological findings, the lesion was diagnosed as BA dissection. Repeated DSA demonstrated tapering occlusion of the BA. He remained stuporous while the 8th day after admission he presented episodic fever, tachycardia, tachypnea, hypertension, diaphoresis, pupillary dilatation, and muscular stiffness, which occurred 4 to 5 times a day with duration around 30 minutes. Diagnosis of PSH was made. His PSH episodes gradually decreased after administration of clonidine, bromocriptine, amantadine, and gabapentin. He could obey verbal commands when he discharged to rehabilitation hospital 2 months later.

A case of PSH due to BA dissection was presented. BA dissection has not been reported as a cause of PSH. The present case is noteworthy in localizing the possible responsible lesion of PSH.

Seizures and status epilepticus (SE) in comatose patients after cardiac arrest are believed to be associated with mortality. However, in the comatose population with severe brain injury, the EEG diagnosis of seizures and SE continue to vary widely among practitioners and institutions.

We conducted a retrospective study of 36 comatose survivors of cardiac arrest admitted to Johns Hopkins Bayview Medical Center who were referred for consultation regarding SE. EEGs were reviewed independently of clinical course and outcome. EEG and clinical characteristics were compared between survivors and non-survivors, and between those who did and did not regain consciousness during admission.

The mean patient age was 58.2 years, 56% were male, and overall survival was 28% (10/36). Except for a longer ICU stay in survivors, (43 versus 15 days, p=0.03), no difference was noted between survivors and non-survivors by SOFA Score; location of arrest; initial cardiac rhythm; and therapeutic hypothermia. 24/36 EEGs exhibited seizures/epileptiform activity, however, this did not correlate with mortality; 6/24 with seizures on EEG survived and 3/24 regained consciousness by discharge. Specific EEG parameters (e.g. GPED, PLEDS, reactivity) correlated poorly with outcome, except for generalized versus frontal seizures, which correlated with mortality (p=0.034). Using a dichotomized (favorable versus unfavorable) composite EEG score comprising reactivity, background activity, seizure localization, and the absence of GPEDs, significant difference was seen between those who did and did not regain consciousness (p=0.01).

The clinical or EEG diagnosis of epileptiform activity, seizures or SE did not predict death and should not be used routinely to guide decisions regarding withdrawal of life sustaining treatment. Preliminarily, we found a simple dichotomized composite scoring of EEG that predicted the recovery of consciousness in this population. A larger, prospective study is needed to validate our findings.

Following hypoxic ischemic brain injury (HIBI), suppression-burst (S-B) EEG pattern, status myoclonus (MS), and elevated neuron specific enolase are poor prognostic indicators. Eye-opening (EO) is a myoclonus variant seen after HIBI that can be misinterpreted as volitional movement, potentially becoming a source of confusion and creating false hope for families which can hinder medical decision-making. Correlation of EO with EEG is helpful in determining an accurate diagnosis and prognosis, as well as educating families and caregivers.

Retrospective chart review of in-hospital cardiac arrests (CA) who developed EO myoclonus was conducted from a prospective Mayo Clinic Florida CA database from 2007 to 2013. Clinical, radiographic, and laboratory data were reviewed; EEG and video were reviewed from segments of continuous video EEG to correlate with EO.

314 CA occurred during the study period; 79 underwent therapeutic hypothermia; 11 developed EO myoclonus (10 CA and 1 non-cardiac cause). All patients were evaluated with EEG within 24 hours of initial injury. Seven (64%) exhibited S-B pattern on EEG, 1 (9%) had generalized periodic discharges (GPDs), 1 (9%) had suspected GPDs versus MS, 1 (9%) had intermittent epileptic myoclonus without S-B pattern, 1 (9%) had bitemporal slowing with mild non-specific encephalopathic changes without true S-B pattern. The latter patient suffered HIBI from noncardiac cause with good outcome and near complete recovery except for mild residual action myoclonus. All patients (10/11 or 91%) with EEG showing S-B, GPDs, epileptic myoclonus and SM died.

EEG helps define severe patterns such as S-B, GPDs, and MS that predict patient outcome. EO myoclonus associated with these patterns on EEG appears to portend a poor prognosis after CA. EO myoclonus associated with non-cardiac etiology may carry a more favorable prognosis than seen post CA. Family education of such patients is important to understand such eye opening is not volitional.

Status epilepticus and other malignant EEG patterns (MEP) are prevalent and strongly associated with mortality and poor outcome in cardiac arrest (CA). Since the advent of induced hypothermia (IH), cases of favorable outcome despite development of MEP have been reported. We herein describe a case series of patients who survived despite the development of MEP.

Review of medical records and cEEG from patients undergoing IH after CA between April/2010 and June/2013. MEP were defined as myoclonic status epilepticus (MSE), status epilepticus (SE), convulsive seizures, and generalized periodic discharges (GPD). Only subjects who developed MEP and survived to hospital stay were included. A Cerebral Performance Category score (CPC) of 1-2 at hospital discharge was considered good outcome.

Four hundred subjects were screened. One-hundred and nineteen subjects (29.8%) survived to hospital discharge, and twenty survivors (5%) experienced MEP. Median cEEG duration was five days (IQR 3-7), and ten subjects (50%) developed MEP within the first 24h of EEG monitoring. Generalized periodic discharges were the most common MEP (10 cases), followed by SE (5), MSE (4), and convulsive seizure (1). Malignant EEG patterns started during hypothermia in eight (40%) subjects, and nine (45%) required three or more anti-seizure drugs. Eight (40%) subjects were discharged home or to an acute rehabilitation facility, and two (10%) had a CPC score of 1-2 at hospital discharge. Two subjects with MSE were discharged to an acute rehabilitation facility with CPC scores of 3. The two subjects with good outcome developed EEG background reactivity in the first 24 hours of recording and did not have signs of anoxic injury on brain MRI.

Post-anoxic malignant EEG patterns are prevalent and associated with poor outcome. Presence of EEG background reactivity and lack of structural damage on brain MRI may identify patients more likely to survive with good outcome.

Refractory Status epilepticus (RSE) carries a dismal prognosis, with mortality rates of 39%, and poorer functional outcomes than non-refractory SE. Rapid anesthetic coma induction with continuous intravenous (cIV) infusion of midazolam, propofol or pentobarbital (i.e. refractory therapy) is the recommended approach to this clinical entity, but course can be prolonged and results variable. The recognition of increasing mortality and morbidity with increasing duration of RSE and the detrimental effects of prolonged anesthetic coma and mechanical ventilation points to the necessity of improving the efficiency of therapy for this clinical entity. Purpose: To determine whether the combination of cIV insulin infusion with the standard therapy for RSE is feasible, acceptably safe, and effective in achieving rapid resolution of electrographic seizure or EEG-burst suppression, as well as reducing the rate of breakthrough seizures during the tapering phase of the refractory therapy, compared with standard RSE treatment alone.

Prospective, single center, randomized, controlled pilot study in adult patients with non-anoxic RSE. Subjects will be randomized to standard therapy for RSE plus cIV insulin infusion (with or without concomitant dextrose infusion), or standard RSE therapy alone.

The primary outcomes will be feasibility and safety of adjuvant cIV insulin infusion. Safety outcome measures will be mortality, hypoglycemia (BG < 70) and severe hypoglycemia (BG 40). The secondary outcome will be effectiveness of adjuvant cIV insulin as measured by time to resolution of RSE and rate of breakthrough seizures.

The refractoriness of SE is, in part, underlain by internalization of GABAA receptors with ensuing loss of GABAmediated inhibition in neuronal networks. Insulin has been shown to increase surface membrane expression of GABAA receptors in central nervous system neurons. This trial expects to determine whether adjuvant cIV insulin infusion has a role for the treatment of RSE.

Seizures are commonly seen in patients with hepatic dysfunction. It is unclear if seizures in patients with hepatic dysfunction are associated with worse outcome, and what clinical features identify patients at increased risk of developing seizures in this population. The objectives of this study are to evaluate if seizures or epileptiform discharges (SED) found on electroencephalography (EEG) in patients with hepatic dysfunction are associated with higher in-hospital mortality, and to identify clinical features associated with finding SED on EEG.

Patients undergoing EEG were enrolled into a prospective registry between January 2007 and November 2013. EEGs were performed at the discretion of the primary team and were interpreted by board-certified epileptologists.

Electronic medical records were reviewed for clinical variables and to identify patients with hepatic dysfunction. Binary logistic regression models with backward conditional variable selection were developed to test whether the occurrence of seizures was independently associated with in-hospital mortality, and to identify clinical markers associated with SED.

82 patients were studied. Of these patients, 28 (34%) had SED on EEG. SED were associated with in-hospital mortality (odds ratio 4.83, [95% CI 1.25-18.87], p=.023). Other associated variables identified on regression modeling were the use of immunosuppression medication and encephalopathy grade. Independent predictors of SED found on multivariate analysis were encephalopathy grade, alkaline phosphatase level and aspartate aminotransferase levels.

SED are associated with in-hospital mortality in patients with hepatic dysfunction. Predictors of SED include encephalopathy grade, alkaline phosphatase and aspartate aminotransferase levels.

Super-refractory status epilepticus (SRSE) is defined as refractory status epilepticus that persist for 24 hours or more despite appropriate anesthetic therapy. The ketogenic diet (KD) is an established antiepileptic treatment in some children with epilepsy. However, there is limited evidence for its use in adults with SRSE.

We present a case of Creutzfeldt-Jakob disease (CJD) presenting as SRSE in a 44-year-old woman with a history of depression who was involved in a minor motor vehicle collision due to witnessed seizures. Initial EEG revealed complex partial status epilepticus. Diagnostic studies were unremarkable including five contrast-enhanced brain MRIs, four lumbar punctures, paraneoplastic, autoimmune and infectious studies. Intractable clinical and subclinical seizures continued as captured on continuous video EEG despite treatment with lorazepam, levetiracetam, lacosamide, valproic acid, fosphenytoin, clobazam, midazolam and propofol. Burst suppression was achieved with pentobarbital, however seizures returned upon weaning. Further treatment included therapeutic hypothermia for a total of 120 hours, intravenous steroids, intravenous immune globulin and later on plasmapheresis for possible autoimmune encephalitis with mild improvement in seizure frequency. Once SRSE persisted enteral KD was started on day 27.

Marked clinical improvement and resolution of SRSE was noted five days after KD initiation. Results later returned supporting the diagnosis of CJD with positive CSF 14-3-3, Tau protein and real-time quaking-induced conversion. Family declined biopsy given patient had considerable clinical improvement. She was discharged to inpatient rehabilitation on a modified Atkins diet (MAD). At three-month follow-up, she remained on MAD and seizure burden was reduced to once daily on clobazam, valproic acid, lacosamide, phenobarbital, levetiracetam and clonazepam with tapering plans.

This case suggests the potential value of KD in patients with SRSE. Future studies evaluating the role of KD earlier in the treatment of SRSE in the adult population should be pursued.

Cardiac arrest is the most common cause of death in the Unites States with over 350,000 deaths per year. Seizures in these patients are associated with poor outcomes. We investigate the association of cardiovascular, neurological and metabolic factors with status epilepticus in hospitalized patients with cardiac arrest from a large nationwide registry.

All hospitalized patients included in the nationwide inpatient sample (NIS) 2011 database with a confirmed discharge diagnosis of Cardiac arrest, as per the ICD-9-CM code 427.5 were identified. NIS is the largest all-payer inpatient database in the United States. Multivariable logistic models were used to determine the associations of African American race, anoxic brain damage, hypothermia, acid-base disturbances, hyposmolarity, hypocalcemiamagnesemia and hypoglycemia with status epilepticus amongst these patients.

From the 8,023,590 admissions in the NIS 2011 database, 34,739 patients with cardiac arrest were identified. Patients had a mean age of 65.69(+18.05) years, 45.3 % (15731) were women. We used weighted analysis to estimate the national values. 164,109 cardiac arrest patients were thus analyzed with status epilepticus identified in 2350 (1.41%) patients. The model was adjusted for Age, sex, race, income, residence, anoxic brain damage, brain trauma, hypothermia, myoclonus, stroke, sepsis, cardiac shock, metabolic encephalopathy, acute renal failure, anuria-oliguria, hypoxemia, hypocalcemia-magnesemia, hypoglycemia, acid-base disorders, osmolality and phosphate disorders. African American race (OR 1.18), anoxic brain damage (OR 10.81), hypothermia (OR 1.62) and the metabolic disturbances such as hyposmolarity (OR 1.34), hypocalemia-magnesemia (OR 1.91), acidosis (OR 1.31), alkalosis (OR 1.41) and hypoglycemia (OR 1.62) were independently associated with risk of status epilepticus (P< 0.005).

In this large national database African American race, anoxic brain damage, hypothermia and specific metabolic disturbances were associated with an increased risk of status epilepticus. Further studies are needed to understand if correcting these factors can improve outcomes.

Limited evidence from retrospective studies suggests that cEEG impacts patient outcomes. This study aimed to prospectively investigate disposition (home, inpatient rehabilitation [IR], nursing home [NH], death) and discharge GCS (GCSD) as outcome measures in ICU patients who did (cEEG-group) or did not receive (non-cEEG-group) cEEG monitoring.

Data were prospectively collected from 222 patients, divided equally into cEEG-group and non-cEEG-group. Two sub-cohorts were created based on admission diagnosis. (A) TBI or stroke with hemorrhage (25.8%)/TBI or Stroke without hemorrhage (14.5%)/other (59.7%) regardless of hemorrhage; (B) TBI (19%)/Stroke (21.3%)/other (59.7%) . Patients admitted due to seizures only were excluded. Primary outcomes were disposition and GCSD. Explanatory variables included: demographics, comorbidities, admission GCS (GCSA), and duration of ICU stay.

Ordinal logistic regression and general linear modeling were used to identify factors associated with disposition and GCSD, respectively.

After controlling for GCSA, there were no significant differences in both outcomes between cEEG-group and non-cEEG-group for 1) any diagnosis or 2) diagnosis listed within the sub-cohorts A and B. Differences in disposition within sub-cohorts A and B were significant (p< 0.0001) regardless of cEEG monitoring. Most common disposition was IR for TBI-patients (54.76%), NH for stroke-patients (40.43%), and home for patients with other diagnosis (40.43%). Disposition in cEEG-group was home (13.1%), IR (12.7%), NH (14.5%) and death (10.4%); and in non-cEEG-group was home (16.7%), IR (11.3%), NH (12.7%), and death (8.6%). Disposition was significantly impacted by age (p=0.0016; OR=0.975, 95% CI=0.960-0.990), duration of ICU stay (p=0.0007; OR=0.969, 95% CI=0.951-0.987;) and GCSA (p=0.0104; OR=1.088, 95% CI=1.020-1.160). There was no significant difference in either GCSA between cEEG-group and non-cEEG-group [9.9(4.1) vs 10.9(3.8)] or GCSD [11.5(4.5) vs 11.9 (4.5)], respectively.

There were no differences in disposition and GCSD of ICU patients who did or did not receive cEEG monitoring. Other outcome measures (e.g. modified-Rankin scores) need to be investigated.

Refractory status epilepticus (RSE) is a life-threatening condition characterized by failure to respond to antiepileptic drugs (AEDs). Here, we present a case of prolonged RSE (> 100 days), which resolved with plasma exchange (PLEX) followed by rituximab.

A 23-year-old woman presented with a 4-day history of URI symptoms with fevers and new-onset seizures. Upon admission, her seizures increased in frequency and duration. She was transferred to the ICU for continuous EEG monitoring and induction of a barbiturate coma. CSF revealed 18 WBC (91% segs) with normal protein and glucose. EEG showed both generalized tonic clonic and subclinical seizures. MRI showed restricted diffusion in the splenium. An extensive work-up revealed only elevated mycoplasma and Coxsackie B antibodies.

She was treated with multiple AEDs, as well as trials of pentobarbital, midazolam, ketamine, magnesium, ketogenic diet and hypothermia, in various combinations. Methylprednisolone and IVIG were ineffective. PLEX notably decreased her seizure activity and drip requirements. However, this effect lasted only 2-3 weeks before seizure activity increased again. Thus, she underwent another course of PLEX followed by rituximab. After a 4-week rituximab course, her drips were weaned. The patient woke up and began following commands.

Febrile Illness-Related Epilepsy Syndrome (FIRES) and New Onset Refractory Status Epilepticus (NORSE) describe a severe epileptic encephalopathy in previously healthy individuals. In this case, we exhausted most treatment options reported in the literature. We suspected a post-infectious autoimmune mechanism given our patient's preceding febrile illness, and felt this hypothesis was confirmed by the initial response to PLEX. Treatment with rituximab expanded the gains made with PLEX allowing our patient to begin her recovery. There are several reports in the literature of rituximab treatment for FIRES, with limited success. Yet, for cases of prolonged RSE, a course of PLEX followed by rituximab should be considered, as there are few alternatives.

Financial Support: Dr. Berkeley is on the Speaker's Bureau for UCB, makers of lacosamide. This drug is not specifically discussed in this abstract, but is one of the many AEDs the patient described was given.

Myoclonus and generalized periodic discharges (GPDs) are independently associated with poor outcome in coma patients post cardiac arrest (Bouwes et al 2012 , Foreman et al 2012 . Determining if myoclonus and other myogenic artifacts are of cortical origin on cEEG can be difficult secondary to the muscle artifact obscuring the underlying EEG background. The use of a short-acting neuromuscular blocker in these patients can be useful for identifying the background cerebral activity.

Retrospective review of cEEGs in patients who had post-anoxic myoclonus and received cisatracurium while being monitored.

Nine patients (mean age 60.3 years, range 34-74 years; 6:9 M:F) met inclusion criteria of clinical post-anoxic myoclonus. The initial cEEG patterns immediately prior to neuromuscular blockade showed myoclonic artifact with continuous slowing (5/9; 55.6%), burst suppression with myoclonic artifact (3/9; 33.3%), and continuous myogenic artifact obscuring cEEG (1/9; 22.2%). After intravenous administration of cisatracurium (range 10-100mg), the cEEG tracings improved in 7/9 (77.8%) revealing previously unrecognized patterns: continuous EEG seizures in 3/7 (42.8%), lateralizing slowing (1/7; 14.3%), burst suppression (1/7, 14.3%), GPDs (1/7, 14.3%), and in the patient who had an initially uninterpretable cEEG from myogenic artifact, continuous slowing (1/7, 14.3%).

Short-acting neuromuscular blockade is useful in determining background cerebral activity on cEEGs otherwise partially or completely obscured by muscle artifact in patients with post-anoxic myoclonus. Fully understanding background cerebral activity is important in prognostication and treatment, particularly when there are underlying EEG seizures.

Financial Support: None

Seizures are common after traumatic brain injury (TBI). Phenytoin has traditionally been used for seizure prophylaxis or treatment in TBI patients, but the adverse-effect profile and need for frequent monitoring lead to search for safe alternatives. Because of its safety profile and ease of use, Levetiracetam is frequently used for seizure prophylaxis in TBI patients. Evidence suggests that Levetiracetam systemic clearance may be faster in neurocritical care patients.

Six TBI patients received intravenous Levetiracetam at recommended dose (500 mg or 1000 mg every 12 hrs) for seizure prophylaxis for 7 days post-TBI. After a minimum of 3 doses, blood samples were collected 30 minutes before the next dose (trough level). Samples were sent to Mayo clinic lab for determination of serum Levetiracetam concentrations.

Patients' characteristics were as follows: age (31 ± 8 years), BMI (26 ± 6), GCS (7 ± 3), APACHE II score (16 ± 5), serum creatinine (0.6 ± 0.1 mg/dl), and creatinine clearance (193 ± 64 ml/min). Four patients received Levetiracetam at a dose of 500 mg every 12 hours and 2 patients received it at a dose of 1000 mg every 12 hours. All trough levels were significantly subtherapeutic, ranging from < 2.0 to 4.4 mcg/ml (reference range for trough concentration: 12.0-46.0 mcg/mL). None of the patients developed clinical seizures.

When given at recommended doses, Levetiracetam therapeutic concentrations were not achieved in TBI patients, suggesting high systemic clearance rate in this patient population. Higher doses or more frequent doses may be needed to achieve target trough concentrations. When appropriate Levetiracetam dosing is identified in future studies, then it can be appropriately studied and compared to other anti-epileptic drugs in the management of seizures in TBI patients.

Rhythmic and periodic EEG patterns have been increasingly recognized in critically ill patients. Although criteria have been proposed to distinguish whether these patterns represent ictal or interictal phenomena, their significance, and whether they represent nonconvulsive status epilepticus (SE) in comatose individuals without additional overt signs of seizures, remains unclear. Prior research has been confounded by multiple variables, including non-uniform patient pathology. In this study, we focused on patients with the same underlying potential seizure etiology (cardiac arrest, CA) to determine whether survival differed between those with unequivocal electrographic SE and continuous equivocal EEG patterns.

This was a retrospective study of CA patients diagnosed with presumed SE who underwent EEG at a university hospital (1/1/2005-10/31/2012). Status epilepticus was classified as unequivocal (clear electrographic seizures) or equivocal (rhythmic/periodic EEG pattern). Baseline data included age, gender, CA rhythm and duration, hypothermia and medical co-morbidities. Outcome was survival. Continuous and categorical data was assessed using 2-tailed t-testing and Pearson's Chi2, respectively. Logistic regression analysis adjusted for covariates. Significance was set at p< 0.05.

The cohort consisted of 45 subjects, mean age=60 years (range: 25-92), 18(40%) male. Eleven (24.4%) subjects survived. The majority of subjects with available cardiac rhythm data exhibited asystole (N=38/43,88%). Mean CA duration=20 minutes (range:5-80), and 14/45(31%) subjects underwent hypothermia. There was no significant difference in baseline features. EEG was unequivocally consistent with SE in 29(64.4%) subjects, of whom 2 were in nonconvulsive SE. Sixteen (35.6%) demonstrated equivocal EEG patterns. In 10/16(62.5%) subjects, equivocal EEG patterns were clinically correlated to seizure-like activity, while clinical correlate was absent in 6/16(37.5%). After adjusting for demographic, medical and CA characteristics, survival did not differ between subjects with equivocal versus unequivocal SE.

In cardiac arrest patients, comatose individuals with continuous equivocal EEG patterns demonstrated equally poor survival compared to those with unequivocal convulsive and nonconvulsive electrographic status epilepticus.

Nonconvulsive seizures (NCSz) are frequent following acute brain injury and have been implicated as a cause of secondary brain injury but mechanisms that cause NCSz are controversial. Pro-inflammatory states are common after many brain injuries and inflammatory mediated changes in blood-brain-barrier permeability have experimentally been linked to seizures.

In this prospective observational study of aneurysmal subarachnoid hemorrhage (SAH) patients we explored the link between the inflammatory response following SAH and in-hospital NCSz studying clinical (systemic inflammatory response syndrome, SIRS) and laboratory markers of inflammation (tumor necrosis factor receptor 1,TNF-R1; high sensitivity C-reactive protein,hsCRP). Logistic regression, cox proportional hazards regression, and mediation analyses were performed to investigate temporal and causal relationships.

Among 479 SAH patients, 53(11%) had in-hospital NCSz. Patients with in-hospital NCSz had a more pronounced SIRS response (OR1.9 per point increase in SIRS; 95%-CI1.3-2.9), inflammatory surges were more likely immediately preceding NCSz onset, and the negative impact of SIRS on functional outcome at 3 months was mediated in part through in-hospital NCSz. In a subset with inflammatory serum biomarkers we confirmed these findings linking higher serum TNF-R1 and hsCRP to in-hospital NCSz (OR1.2 per 20 point hsCRP increase [95%-CI1.1-1.4]; OR2.5 per 100 point TNF-R1 increase [95%-CI2.1-2.9]). The association of inflammatory biomarkers with poor outcome was mediated in part through NCSz.

In-hospital NCSz were independently associated with a pro-inflammatory state following SAH reflected in clinical symptoms and serum biomarkers of inflammation. Our findings suggest that inflammation following SAH is associated with poor outcome and this effect is at least in part mediated through in-hospital NCSz.

Myoclonic status epilepticus (MSE) is still considered predictive of a fatal outcome in cardiac arrest survivors. However, some patients have had favorable outcomes with MSE. The aim of this study was to identify determinants of outcome in patients with MSE.

We retrospectively identified and performed a subgroup analysis of twenty-three patients with myoclonus, that are part of a cohort of 101 patients treated for anoxic encephalopathy after cardiac arrest in our institution between May 2011 and May 2014. Myoclonus was defined as any clinical description consistent with jerking movement of the face, arms and legs. MSE was defined by the presence of a time-locked EEG correlate to the myoclonus. The onset of myoclonus was defined as either before therapeutic hypothermia (TH), during TH, during rewarming, or after rewarming (in days). Electrographic patterns of burst suppression and nonconvulsive status epilepticus electrographic markers were also noted. Outcome was assessed according to the Glasgow-Pittsburgh Cerebral Performance Categories (CPC), dichotomized as good (CPC1-3) or poor (CPC4-5).

Of the twenty-three patient with myoclonus, only three had a good outcome. Two of them developed myoclonus before hypothermia that recurred after rewarming. Neither patient presented with a malignant EEG pattern (suppression-burst, GPDs on a suppressed background or suppression) at any point. They did not receive anticonvulsants. Both made a good recovery (CPC 2 and 3). One patient developed MSE two days after rewarming. Myoclonic movements were associated with GPDs, but the underlying EEG background was continuous and variable. The patient was treated with lorazepam, phenytoin, valproate, levetiracetam, midazolam and ketamine. She made a good recovery (CPC = 3).

Early myoclonus before TH, and MSE after rewarming are not always associated with a poor outcome. EEG findings may have a higher prognostic significance than myoclonus. In particular, malignant patterns may invariably be associated with poor outcome.

Financial Support: None

Median CSF protein was significantly higher in patients with vasogenic edema involving the thalamus (96 vs 53 mg/dL, IQR 76-134, p 0.0007) compared to those without involvement of thalamus. Median WBC count was 1 cells/uL (IQR 1-2) and with lymphocytic predominance (48%)

Conclusions Albuminocytologic dissociation can also be seen in patients with PRES. Knowledge of this finding is important to avoid unnecessary tests to evaluate elevated CSF protein. The presence of CSF pleocytosis should prompt

Under identical conditions, two assessors simultaneously evaluated the left (OS) and right (OD) pupils of consented patients. An interim analysis of the first 200 samples (final N = 1,183) was performed, evaluating only between-assessor observational data. Results Currently, 210 paired observational assessments of OS and OD pupils have been completed. There was composite agreement in all three parameters (size, shape, reactivity) for 75 (35.7%) OS and 71 (33.8%) OD. Both assessors scored the pupil size identically in 92 (43.8%) OS and 88 (41.9%) OD assessments; pupil shape was scored identically in 201 (95.7%) OS and 200 (95.2%) OD assessments; pupil reactivity was scored identically by both assessors in 165 (78.6%) OS and 152 (72.4%) OD assessments. Complete non-reactivity (fixed pupil) was scored identically by both assessors in 19/31 (61.3%) OS and in 4/10 (40%) OD assessments. assessing pupillary findings. Furthermore

We conducted a single-center, retrospective cohort analysis of adult patients on warfarin who received PCC-3 or PCC-4 for INR reversal. We evaluated PCC-3 between August 2012 and January 2013 and PCC-4 between August 2013 and January 2014. We excluded patients not actively bleeding. The main outcome was the percentage of patients who achieved warfarin reversal defined as INR < or = 1.3 at first INR check post factor administration. We recorded baseline demographics including PCC dose, location of bleed, pre-and post-treatment INR and time to INR reversal.

We included 35 patients in the PCC-3 group and 18 patients in the PCC-4 group. Intracranial hemorrhage was the most common site of bleeding [26 (70%) in PCC-3 vs. 12 (66%) in . Patients in the PCC-3 arm received a mean dose of 26 units/Kg compared to 28 units/Kg in the PCC-4 arm. The mean pre-treatment INR was 2.3 in the PCC-3 group compared to 2.9 in the PCC-4 group (p=0.03) with post-treatment INR recorded as 1.4 vs 1.2, respectively (p< 0.01). Warfarin reversal was achieved in 15 (43%) patients who received PCC-3 and 15 (83%) patients who received PCC-4 (p< 0.01). Faster time to INR reversal was noted in the PCC-4 group vs PCC-3 (220 vs 300 minutes, p=0.48).